ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0035166;post-embryonic hemopoiesis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;35.890675140735624;8.67846133901236;0.0012012285974498564;0.7669372290569613;[KLF4]
GO:0015793;glycerol transport;7.0;1.0;0.8509193652572005;9.628524252492122;38.31975435487899;7.9853141584524145;0.0012825276927178712;0.7592887026755414;[AQP9, AQP1]
GO:1902311;regulation of copper ion transmembrane transport;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;56.266460488832536;9.777073627680469;0.0018831877960343868;0.875;[SLC31A2]
GO:1901224;positive regulation of NIK/NF-kappaB signaling;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;238.82315740091596;5.572381008289503;0.007993196151321231;0.6599718239061428;[TNF, HAVCR2, IL18, ACTN4, GREM1, IL23A, IL1B, CHI3L1, TLR7, TLR6, TLR4, TLR2, NOD2, CCL19, CD14, TNFSF14, TNFRSF10B, EIF2AK2, NLRP12, CD27, IL18R1]
GO:1901223;negative regulation of NIK/NF-kappaB signaling;8.0;1.0;0.875;9.628524252492122;239.1998693179246;6.686031174322154;0.008005804360164796;0.7169239451870815;[NLRC3, NLRP12, NLRP3]
GO:0060369;positive regulation of Fc receptor mediated stimulatory signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.577230958104572;294.1477435792768;8.390779266560578;0.009844860261815976;0.7800242071602487;[LYN]
GO:0002244;hematopoietic progenitor cell differentiation;4.0;0.811012628672052;0.655506314336026;8.935377071932177;21.066225782797595;5.395046993006588;7.050676185779127E-4;0.5259029541176994;[TOP2A, SPI1, TNFRSF13B, SOX4, PDGFRA, ESCO2, KIT, HOXB4, HOXB3, RBM47, PLD4, GATA3, JAM3, TGFB1, ACE, INHBA, PTPRC, BCL2, PTPN6]
GO:0005986;sucrose biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;323.9113917813964;9.083926447120524;0.010841022781596602;0.8154717862087246;[FBP1]
GO:0002479;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;6.0;1.0;0.8231203125901445;9.628524252492122;33.24930607151726;6.518977089658987;0.0011128243517809471;0.6565011041187423;[CHUK, ITGB5, TAP1, CD36, FCGR1A, FCGR1B]
GO:0030947;regulation of vascular endothelial growth factor receptor signaling pathway;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;67.94038154209638;6.409777797693995;0.002273903427840277;0.6509166472493662;[ITGB3, MYOF, HHEX, HGS, IL1B, NEDD4, EMILIN1]
GO:2001204;regulation of osteoclast development;9.0;0.8933024483968273;0.8428918493787028;9.510741216835738;200.3946012839482;7.292166977892469;0.006707026961541477;0.769162383550154;[TYROBP, TNFSF11, LILRB1, LTF, FBN1]
GO:2001205;negative regulation of osteoclast development;10.0;1.0;0.9152410118609203;9.628524252492122;1250.359070569308;8.16763571524637;0.041848392841848644;0.8329342821725234;[LILRB1, LTF, FBN1]
GO:0071499;cellular response to laminar fluid shear stress;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;52.23891675539742;7.8311634786251565;0.0017483895318303475;0.6907270763441554;[KLF4]
GO:0071258;cellular response to gravity;5.0;1.0;0.7902410118609202;9.628524252492122;37.20981579086828;9.777073627680469;0.0012453790478602876;0.7902410118609202;[PTAFR]
GO:2000110;negative regulation of macrophage apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;256.26138950429646;7.9853141584524145;0.008576838086431384;0.8046099625986299;[GHSR, CCL5, IRF7, NOD2, CCR5]
GO:2000117;negative regulation of cysteine-type endopeptidase activity;11.0;0.8259837884571596;0.845420846558242;9.538912093802434;565.4444864912041;5.076593261888053;0.018924918095861203;0.6920461678283469;[TNFAIP8, AQP1, LAMP3, RPS6KA1, AKT1, PLAUR, SERPINB9, TNFRSF1B, MMP9, PAX2, POR, SFRP2, BIRC5, NAIP, LTF, BIRC3, LEF1, IFI6, NLRC4, PTGS2, CST7, THBS1, CST3, SFN, SNCA, TNFSF14, TNFRSF10C, TNFRSF10B, DHCR24, KLF4, FABP1, VIL1, CD27]
GO:0036006;cellular response to macrophage colony-stimulating factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;8.16763571524637;0.0027327542132076126;0.7408135829017477;[CSF1R]
GO:2001202;negative regulation of transforming growth factor-beta secretion;10.0;1.0;0.9152410118609203;9.628524252492122;670.9356820924863;9.083926447120524;0.02245561347672384;0.8797934328124444;[FN1, LILRB1]
GO:0048008;platelet-derived growth factor receptor signaling pathway;8.0;0.7763722522362496;0.7631861261181248;9.186691500213083;31.002284443533863;6.280566066213989;0.0010376185600805164;0.6961884407023742;[PDGFRB, NRP1, PDGFRA, PDGFA, PDGFRL, NR4A3, PDGFD, PDGFC]
GO:0006612;protein targeting to membrane;10.0;0.811012628672052;0.8207473261969463;9.414950152194063;149.73401455281405;4.753193106834193;0.0050114627152184205;0.6583195283905053;[NCF1]
GO:0048011;neurotrophin TRK receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;58.19790639729547;6.781341354126479;0.0019478315524021762;0.7217981122146513;[SORT1]
GO:0048010;vascular endothelial growth factor receptor signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.186691500213083;31.002284443533863;5.572381008289503;0.0010376185600805164;0.6599718239061428;[CYFIP1, NRP1, NRP2, NCF1, NCF2, ITGB3, NCF4, CYBB, VAV1, SH2D2A, NCKAP1L, FYN, MAPK14, SULF1, PTK2]
GO:0097411;hypoxia-inducible factor-1alpha signaling pathway;5.0;1.0;0.7902410118609202;9.628524252492122;23.17027026302992;8.390779266560578;7.75488093814194E-4;0.7193458537639684;[CYBB]
GO:0048015;phosphatidylinositol-mediated signaling;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;26.42836680105094;5.649939242635378;8.845336528452411E-4;0.6398575208746181;[CSF1R, PTAFR, PIK3CD, GATA3, AKT1, KCNH1, PDGFRB, PDGFRA, EDN1, GSN, GAB2]
GO:0006606;protein import into nucleus;9.0;0.8933024483968273;0.8428918493787028;9.551563211355994;277.5355368998559;5.288437257948329;0.009288864654271135;0.6666915524892495;[NUP107, CSE1L, NUP62, NUP133, SYK, TSC2, MMP12, NUP54, NUP85, NUP88, RANBP2, RANBP1, NUP155, RANBP6, PML, NUP35, RAN]
GO:0048255;mRNA stabilization;10.0;0.8933024483968273;0.861892236059334;9.577230958104572;1968.7172834448895;6.088194173566533;0.06589119574637584;0.7265915450270957;[RBM38, SLC11A1, AXIN2, MAPK14, E2F1, MYD88]
GO:0048013;ephrin receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;5.395046993006588;0.0010376185600805164;0.6509029541176994;[EPHB2, EPHB1, AP2M1, MMP2, MMP9, EPHA3, EPHA2, SDC2, PAK1, FYN, LYN, PTK2]
GO:2000363;positive regulation of prostaglandin-E synthase activity;6.0;1.0;0.8231203125901445;9.628524252492122;43.017486512842105;8.67846133901236;0.001439756560360439;0.7669372290569613;[ITGAM, ITGB2, NOD2]
GO:2000121;regulation of removal of superoxide radicals;7.0;0.8259837884571596;0.7639112594857803;9.4949928598676;93.21217700056023;7.474488534686424;0.003119727678695759;0.7331650565203278;[GCH1, CD36, TNF]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[CD86, CSF3, CD80, PIK3CD, TNF, FGF5, TNFSF11, CCR7, PDGFRB, PDGFRA, IGFBP5, GAB1, IL18, F3, VAV1, EREG, BTC, LCK, KIT, CHI3L1, ADAM8, HBEGF, ENG, PDGFA, GATA3, THBS1, CD19, FYN, CCL19, ICOS, TGFB1, CCL21, TRAT1, EGF, PTK2, KITLG, LIN28A, CD28, NOX4, TEK, HPSE]
GO:0051898;negative regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.79440420981607;6.063501560976162;0.00799223380789131;0.6850877518099798;[TSC2, KLF4, SIRT1, PKHD1, BANK1, AKT1, EPHA2]
GO:1903422;negative regulation of synaptic vesicle recycling;7.0;0.8933024483968273;0.7975705894556142;9.533214072687796;60.463658338724606;8.67846133901236;0.0020236642308374482;0.7947362817240173;[CYFIP1]
GO:1904998;negative regulation of leukocyte adhesion to arterial endothelial cell;9.0;1.0;0.896240625180289;9.628524252492122;105.70174406809066;9.777073627680469;0.0035377422485653965;0.896240625180289;[KLF4]
GO:0002220;innate immune response activating cell surface receptor signaling pathway;10.0;0.8653626801206646;0.8479223519212526;9.523163736834295;627.0113613116039;5.572381008289503;0.020985505989509944;0.7002128357670632;[FCN1, CLEC10A, ICAM2, ICAM3, LILRA2, PAK1, KLRK1, MUC13, FFAR2, FYN, MUC15, PRKACB, LYN, FCER1G, CHUK, SYK, CARD9, PRKCD, NFKB1, MUC3B, CLEC4A, CLEC4D, CLEC4E, CARD11]
GO:0002221;pattern recognition receptor signaling pathway;10.0;0.6467165523344657;0.7385992880281531;8.89455507741192;408.2729656680319;5.049685808968129;0.01366452873909497;0.6734821789659555;[FCN1, ITGAM, ITGB2, TNFAIP3, CTSS, IFIH1, FFAR2, CD36, HAVCR2, CHUK, DDX58, PRKCE, CD180, IRAK3, TLR1, BTK, IRF7, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, S100A9, S100A8, TLR2, COLEC12, UNC93B1, LY96, NOD2, HSPD1, CLEC7A, S100A14, CD14, MAP2K6, NR1H4, NFKBIA, MARCO, MYD88]
GO:0002223;stimulatory C-type lectin receptor signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;628.1099736002739;5.618190544320798;0.02102227555412486;0.7197434780388068;[CLEC10A, ICAM2, ICAM3, PAK1, KLRK1, MUC13, FYN, MUC15, PRKACB, LYN, FCER1G, CHUK, SYK, CARD9, PRKCD, NFKB1, MUC3B, CLEC4A, CLEC4D, CLEC4E, CARD11]
GO:0042953;lipoprotein transport;8.0;1.0;0.875;9.628524252492122;68.44752614357394;7.138016298065211;0.0022908771012512216;0.7400384854347593;[MSR1, CUBN, LRP1, CD36, LRP2, ZDHHC17]
GO:0071276;cellular response to cadmium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;6.139487467954083;0.0026274528238337297;0.6370939872166814;[JUN, GSN, CHUK, NCF1, CYBB, FOS, MMP9, AKT1, HMOX1]
GO:0006816;calcium ion transport;8.0;0.6696747006330769;0.7098373503165385;8.690254613899192;35.67391733828006;4.3132418226548594;0.001193973908871026;0.5955793873968269;[DENND5B, PHB2, SLC8A1, CTGF, PRKCE, F2R, CACNA2D3, CALCRL, CUL5, PSEN2, ITPR3, CACNA1F, CORO1A, CCR1, VDR, CAV1, BSPRY, PTPRC, ATP2A3, FASLG, JPH2, CCR7, CCR5, TRPC7, TRPC3, TRPC1, TMEM37, LCK, XCL1, SLC24A2, SLC24A1, SLC24A4, ATP2C2, CCL8, PLN, CCL5, NPY, FYN, CCL19, CCL21, FKBP1B, RAMP1]
GO:2000377;regulation of reactive oxygen species metabolic process;5.0;0.660418147677249;0.6204500856995447;8.475844742553736;26.78229071161683;4.7018998124466425;8.963791676210415E-4;0.5306963869301438;[PID1, HP, TNF, CLU, AKT1, CYP1B1, CD177, PDGFRB, PRKCD, AGTR1, FPR2, SLC30A10, FOXO1, KLRK1, TGFB1, AGXT2, CAV1, BST1, BCL2, NOX4, CDKN1A, ITGAM, ITGB2, BRCA1, RAC2, CD36, CD34, IL10, EDN1, SYK, PAX2, DNM2, IFNG, IL1B, TLR6, TLR4, PTGS2, THBS1, AIF1, GNAI2, SNCA, GCH1, MAPK14, KLF4, PTX3]
GO:2000134;negative regulation of G1/S transition of mitotic cell cycle;9.0;0.7980440201809971;0.7952626352707877;9.394909401310617;355.88113835876356;5.244474134527214;0.011911021428637128;0.6644432763129993;[CDKN1A, BTG2, SOX4, TFDP1, PCNA, CCNB1, GPNMB, NACC2, E2F1, CCL2, SFN, E2F7, PLK2, KLF4, PML, CNOT3, CDK1, BCL2, EZH2]
GO:2001222;regulation of neuron migration;7.0;0.7866048967936545;0.7442218136540277;9.510741216835738;102.29339340919134;6.221725566191056;0.0034236678193284823;0.6690987000520388;[SEMA6A, COL3A1, FLRT2, FLNA, PLXNB2]
GO:1900163;positive regulation of phospholipid scramblase activity;9.0;1.0;0.896240625180289;9.628524252492122;406.95467434623936;9.777073627680469;0.013620406714939737;0.896240625180289;[PRKCD]
GO:1903672;positive regulation of sprouting angiogenesis;8.0;0.8653626801206646;0.8076813400603323;9.446202695698167;183.7504864323888;6.139487467954083;0.00614996341619065;0.6889736746265369;[IL10, PPP1R16B, GHSR, NRP1, ANXA1, PLK2, PTGS2, KLF4, DLL1, AGTR1, HMOX1]
GO:0005980;glycogen catabolic process;8.0;0.9326813400603323;0.8413406700301662;9.593432932680852;697.8253482490202;7.292166977892469;0.023355586403854624;0.747921758369865;[PYGL]
GO:0002230;positive regulation of defense response to virus by host;8.0;1.0;0.875;9.628524252492122;73.08237040089334;6.599019797332524;0.0024460011674546805;0.712474179321389;[DDX58, LILRB1, PARP9, IL23A, IL12RB1]
GO:0002224;toll-like receptor signaling pathway;11.0;0.6763753087927167;0.7706166067260205;9.040737587590003;409.6592600291497;5.311165509025885;0.01371092676377766;0.7040422034557006;[ITGAM, ITGB2, CTSS, CD36, HAVCR2, CHUK, PRKCE, CD180, IRAK3, TLR1, BTK, IRF7, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, S100A9, S100A8, TLR2, COLEC12, UNC93B1, LY96, HSPD1, S100A14, CD14, NR1H4, NFKBIA, MYD88]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[CD40, AQP1, CHEK1, AKT1, IL1B, TLR8, TLR7, TLR5, TLR4, ENG, PTGS2, CASP8AP2, TGFB1, TNFSF14, TNFRSF10B, NFKB1, COL1A1, LTBR, MYD88]
GO:0030913;paranodal junction assembly;6.0;1.0;0.8231203125901445;9.628524252492122;88.99224575364705;7.8311634786251565;0.00297849037755313;0.7236063770733796;[EPB41L3, CD9]
GO:0000050;urea cycle;6.0;1.0;0.8231203125901445;9.628524252492122;229.46365912673008;7.292166977892469;0.007679942167085809;0.6960420709600095;[CEBPA, ARG1, CAD]
GO:2000145;regulation of cell motility;5.0;0.46812423412493653;0.5243031289233886;6.883086519318291;34.54403569627484;3.0677692874221707;0.001156157787140571;0.44712687588555144;[SERPINE1, SPINT2, ADARB1, MYLK, C3AR1, AKT1, CYP1B1, HOXA7, MEF2C, PRKCE, CLDN7, PADI2, PDGFA, FPR2, GATA3, THY1, PLA2G7, EPB41L5, KLRK1, FLRT2, PDGFD, PDGFC, HMOX1, NCKAP1L, S100A14, PLCG1, ELANE, LYN, JUN, JAG1, ACE, HACE1, JUP, PLK2, FN1, NR2F2, COL1A1, NOX4, SNAI2, GPR18, ARHGAP4, MMP28, TIMP1, ANXA1, ANXA3, TACR3, SIRT1, F3, TMEFF2, PLCB1, HBEGF, ENG, PTAFR, PTGS2, GPNMB, NTF3, FLNA, CCL19, JAM3, CCL21, CCL20, SULF1, COL3A1, PKN1, PF4, SEMA5B, PLXND1, ATP8A1, ITGA2B, CXCL13, TNF, SLC8A1, CXCL16, PYCARD, DACH1, PHLDA2, SEMA6A, IGFBP5, IGFBP3, F2R, TPM1, ADAM9, ADAM8, CD274, CSF1R, CD151, TACSTD2, CORO1A, CXCL10, CXCL11, DAB2, CXCL12, PTPRC, BCL2, PLXNB2, ITGB3, PIK3CD, CYR61, DUSP10, EMILIN1, ITGA4, XCL2, XCL1, CX3CR1, LRP1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, SEMA4B, TIE1, KLF4, IL1RN, SPARC, LGALS3, IL1R1, ACTN4, MIF, EREG, BTC, SFRP2, IL23A, PFN1, TRIB1, EPHA2, TWIST1, CCR1, TNFSF14, PPBP, PTK2, BST1, NRP1, PTPRR, NRP2, ECM1, CD40, PTPRK, EPB41L4B, RAC2, CTSH, CCR7, CCR6, CCR2, EDN1, GAB1, IL1A, CEACAM1, CEACAM6, IL1B, KIT, SGK1, SP100, AIF1, GNAI2, PAK1, CXCR3, CXCR2, PDPN, CTNNA1, MPP1, CD74, IL33, PODN, DLC1, ETS1, PLAU, ARHGDIB, IL6R, PDGFRB, PDGFRA, POSTN, VCL, C5AR1, FBLN1, STAP1, TGFB2, TGFB1, SELP, VIL1, IL6, BMP2, NR4A3, FES, DOCK5, CXCL6, CXCL9, DOCK4, MCTP1, TNFAIP6, LAMC2, CXCL1, CXCL3, CXCL2, CXCL5, MYOCD, DDX58, ARAP3, MMP9, DCN, FGR, GREM1, IFNG, LAMA4, LAMA3, LEF1, THBS1, SPOCK3, EGF, LAMB1, MAPK14, SOD2, TEK]
GO:2001235;positive regulation of apoptotic signaling pathway;8.0;0.6997970393407541;0.724898519670377;9.176539128749065;291.4603159253591;4.6590798152637145;0.009754914476767216;0.6132655584219551;[PYCARD, PPP2R1A, PRKCD, MAL, S100A9, ATF3, S100A8, NACC2, TP53BP2, SFN, TNFSF12, CAV1, INHBA, BCL2, NOX1, ITM2C, BCL2L1, PLEKHF1, CTSH, TIMP3, YWHAH, PLAUR, MMP9, SIRT1, TFDP1, LCK, THBS1, E2F1, CTNNA1, GSN, BIK, G0S2, GZMB, PML, PPP1CA, LTBR]
GO:0002281;macrophage activation involved in immune response;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;81.79914540449643;7.379178354882098;0.0027377437822370863;0.7004918368257019;[CX3CR1, IL33, SUCNR1, TYROBP, SYK, PRKCE, HAVCR2]
GO:0002283;neutrophil activation involved in immune response;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;82.20461051260416;3.594988720963838;0.002751314334510546;0.5347672556313635;[CDA, CYFIP1, ABCA13, PSMD3, C3AR1, PRSS3, PRKCD, RNASE3, RNASE2, BIN2, PADI2, CFD, FPR1, FPR2, CFP, GNS, C3, S100A12, NCKAP1L, ELANE, S100A11, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, GRN, PTAFR, ALOX5, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, RAB31, ADAM8, SLC27A2, S100A9, S100A8, BRI3, HVCN1, GPR84, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, HPSE, ITGAM, ITGB2, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, FGL2, TTR, CPPED1, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, CD14, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CCT2, FCER1G, MME, SYK, RHOG, CEACAM1, CEACAM6, CEACAM8, TLR2, LILRA2, LILRA3, CST3, CXCR1, CXCR2, CD58, CCT8, GCA, LILRB2, LILRB3, QPCT, CD68, FCN1, MPO, PLAU, SIRPA, CD97, CHRNB4, CD93, CYBB, OSCAR, DOK3, TYROBP, PRTN3, VCL, PSMD14, C5AR1, MGAM, HSPA6, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, PLAUR, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0048679;regulation of axon regeneration;10.0;0.6799073451904818;0.7551946844561612;9.136047767394327;147.26161645906015;6.686031174322154;0.004928713776034301;0.7571649570480019;[FKBP1B, SPP1, TNR, KLF4, RGMA]
GO:0006886;intracellular protein transport;8.0;0.5537205960740763;0.6518602980370382;8.117066748418225;90.55259897265384;3.0436717358431102;0.0030307139955665606;0.5306535141162272;[, NUP107, PHB2, AKT1, HOMER3, WLS, NUP85, NUP88, MMP12, SNX17, NCF1, CSE1L, TNF, CLU, LAMP2, AP2M1, RAB32, RAB31, SLC27A2, EVI5, BCL6, BCL3, ARL4C, NLGN1, UNC93B1, RAB21, PML, VPS41, IFIT1, ARFIP1, EGR2, POLA2, CD24, AKAP12, XPO1, TMED6, SYK, STRADB, RAB33B, NAPA, HSD17B4, STX11, RANBP2, RANBP1, CD74, RANBP6, NEDD4, NUPL2, RAMP1, SCARB2, TSC2, ATP1B1, HGS, COPB2, TGFB1, NUP155, NFKBIA, TBCK, NUP62, YWHAH, NUP133, TBC1D9, IFNG, EHHADH, NUP54, HSPD1, NUP35, RAN]
GO:0006887;exocytosis;6.0;0.6696747006330769;0.657957662906683;8.375761283996754;37.082880499217325;3.1596706497059923;0.0012411306378830758;0.4847060165558207;[, CDA, CYFIP1, SERPINE1, ABCA13, PSMD3, C3AR1, PRSS3, PRKCD, RNASE3, RNASE2, BIN2, PADI2, SERPING1, CFD, FPR1, PDGFA, FPR2, CFP, GNS, C3, S100A12, NCKAP1L, ELANE, S100A11, LYN, JUP, FUCA1, FN1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, TIMP3, TIMP1, ANXA3, ARG1, NFAM1, ANXA5, F5, PSMA5, PSMA2, SERPINB10, GRN, PTAFR, ALOX5, FLNA, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, PF4, ATP8A1, PROS1, ITGA2B, HP, F13A1, APEH, CLU, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, RAB31, ADAM8, SLC27A2, S100A9, S100A8, BRI3, HVCN1, LIN7A, GPR84, CORO1A, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, COPS5, PTPRC, LCN2, HPSE, LAT, ITGAM, ITGB3, ITGB2, PIK3CD, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, VWF, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, FGL2, CCL8, TTR, CCL5, PCDH7, CPPED1, FCGR2A, P2RX1, IMPDH2, VPS41, PTPN6, MNDA, FOLR3, SPARC, LGALS3, ANPEP, ACTN1, SLC11A1, ACTN4, MIF, CHIT1, SLPI, CRISPLD2, TLN1, LLGL2, STXBP2, MGST1, CD14, A2M, CCR1, PRG2, NBEAL2, PPBP, BST1, TF, VNN1, ORM1, ECM1, CTSZ, CTSW, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CCT2, FCER1G, MME, RHOG, LAT2, HCK, CEACAM1, CEACAM6, KIT, CEACAM8, TLR2, LILRA3, STX11, CST3, PAK1, CXCR1, CXCR2, CD58, CCT8, GCA, LHFPL2, LILRB2, LILRB3, QPCT, CD68, FCN1, MPO, PLAU, SIRPA, CD97, CHRNB4, CD93, APLP2, CYBB, OSCAR, DOK3, TYROBP, PRTN3, VCL, PSMD14, C5AR1, RASGRP1, MYH10, MGAM, TGFB2, TGFB1, SYT2, HSPA6, SELP, NR4A3, SELL, MS4A3, TNFAIP6, CRISP3, TNFAIP2, CXCL1, SIRPB1, HK3, PLAUR, MMP8, SYNGR3, MMP9, FGR, MMRN1, CHI3L1, LTF, CLEC12A, RETN, THBS1, EGF, MAPK14, CD9, S100P, PTX3]
GO:0060326;cell chemotaxis;5.0;0.6393367784920305;0.6099094011069355;8.152617732682543;30.286927728949156;4.458953633836253;0.0010136762146226118;0.5182721080578558;[IL1RN, CSF3R, CXCL13, CXCL16, LGALS3, EDNRB, CCRL2, C3AR1, TNFSF11, IL6R, EPHB1, PDGFRB, PDGFRA, CXADR, PRKCD, CH25H, HOXB9, BIN2, AGTR1, PRKCQ, ADAM8, S100A9, S100A8, EPHA2, CALCA, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, CORO1A, NUP85, S100A12, NCKAP1L, CCR10, CCR1, TGFB2, EGR3, VCAM1, AZU1, DEFA1, PPBP, NR4A1, CXCL10, CXCL11, IL6, CXCL12, NRP1, CXCL6, CXCL9, DOCK4, ITGB2, HMGB2, PIK3CD, CXCL1, CXCL3, CXCL2, CXCL5, CCR9, PDE4B, FFAR2, CCR7, CCR6, CCR5, CCR2, IL10, ANXA1, FCER1G, SYK, RHOG, GAB1, VAV1, IL1B, KIT, XCL2, XCL1, HBEGF, CX3CR1, CCL13, LEF1, CXCR5, CXCR4, CXCR6, CCL8, CXCR1, CCL7, CCL5, CXCR3, CXCR2, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, PF4]
GO:0006401;RNA catabolic process;7.0;0.5945822691631375;0.6482104998387692;8.775746926340293;532.6118641417924;4.304802954008995;0.01782603977326812;0.5710671885190304;[PPP2R1A, MAGOH, RNASE6, RNASE3, RNASE2, GSPT1, UPF3B, LSM5, LSM3, LIN28A, CNOT3, FEN1, MLH1, EIF3E]
GO:0006879;cellular iron ion homeostasis;10.0;0.8436909121759173;0.837086467948879;9.474373572664863;186.73793370626092;5.69953618377475;0.006249950587919157;0.706715557354699;[ALAS2, TFRC, ABCB6, SLC40A1, HEPH, HMOX1, SLC11A1, CYBRD1, TF, LCN2, LTF, ABCG2]
GO:0030502;negative regulation of bone mineralization;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;172.15796001199809;6.943860283624253;0.005761971989496609;0.7060287030842711;[CCR1, GREM1, ECM1, GATA1]
GO:0006878;cellular copper ion homeostasis;10.0;0.8653626801206646;0.8479223519212526;9.523163736834295;186.04478652569694;7.138016298065211;0.006226751575577643;0.7802794972956796;[SLC31A2, ATP7B, CCDC22]
GO:0032928;regulation of superoxide anion generation;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;29.554879433861746;6.781341354126479;9.891752169867288E-4;0.6977174774718518;[TGFB1, ITGAM, SYK, PRKCD, ITGB2, FPR2, GNAI2, CD177]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[PRF1, ADARB1, IFIT1, IFIT3, IFIT2, PYCARD, HERC5, DHX58, TRIM25, IFNA14, RSAD2, IFNA16, RNASE6, RNASE2, IL23A, IFNA10, DDX60, NLRP3, IFNA21, EIF2AK2, ISG15, AZU1, DEFA1, CXCL10, IL6, PTPRC, BCL2, SERINC5, APOBEC3A, IFNA5, IFNA4, IFNA7, CXCL9, CD40, IFNA2, IFNA8, OASL, IFIH1, DDX58, PARP9, PLSCR1, IFNG, OAS1, OAS3, IRF7, TLR8, TLR7, ZMYND11, UNC93B1, SAMHD1, IL33, MX2, CARD9, LILRB1, PML]
GO:0019722;calcium-mediated signaling;7.0;0.7192862368539868;0.710562483684194;8.712233520617966;27.814661162170232;4.835431205071165;9.309316775279788E-4;0.598203541955087;[MCTP1, LRRK2, CETN3, CALML4, SLC8A1, GRM5, EDNRB, CCRL2, CCR9, TNFSF11, CCR7, CCR6, CCR5, CCR2, EDN1, AVPR1A, ATP1B1, LAT2, BTK, AGTR1, CX3CR1, CAMK2D, CXCR5, CXCR4, FPR2, CXCR6, PLN, CXCR1, CXCR3, CXCR2, DMD, PLCG1, CCR10, CCR1, VCAM1, CCL20, AZU1, SELE, SELP, FKBP1B, CALM3, LAT]
GO:2001243;negative regulation of intrinsic apoptotic signaling pathway;9.0;0.7436939687323844;0.7680876095464813;9.413412872875176;597.3701724921605;5.233778845410465;0.0199934420750612;0.663896318730187;[LRRK2, CLU, AKT1, PLAUR, MIF, MMP9, SIRT1, SFRP2, NDUFS3, BCL2A1, TAF9, PTGS2, FIGNL1, CD74, WFS1, SOD2, VNN1, CXCL12, BCL2, SNAI2, GRINA, BCL2L1]
GO:2001244;positive regulation of intrinsic apoptotic signaling pathway;9.0;0.7671156992804218;0.7797984748205;9.413412872875176;596.4251749563025;5.75172193694532;0.019961813857978603;0.6903839525180965;[PLEKHF1, NACC2, CAV1, SIRT1, LCK, BCL2, S100A9, ATF3, S100A8, NOX1, BCL2L1]
GO:0051603;proteolysis involved in cellular protein catabolic process;6.0;0.6519675769143192;0.6491041010473041;8.270400768338927;49.64990487012002;3.4509241545253704;0.001661737633989536;0.49960073433695684;[, PSMD3, ADAMTS12, HACE1, PLK1, TGFB1I1, SIRT1, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, USP1, USP9Y, PSMC6, PSMC2, RNF43, CUL5, WFS1, CDK1, SCPEP1, DTL, HM13, RNF24, GZMA, PML, CDC20, TRIM25, SKP2, CDC34, CTSZ, CTSW, CTSS, CTSH, CTSB, RNF144B, RANBP2, RANBP1, FAP, NEDD4, MAD2L1, BUB1B, PSMD14, CCNB1, UBE2C, ISG15, TNFAIP3, AURKB, TBX21, CPVL]
GO:0051601;exocyst localization;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;40.77205030767364;7.57984905034425;0.001364603831334836;0.710754145523778;[, TNFAIP2]
GO:2001022;positive regulation of response to DNA damage stimulus;7.0;0.7043150770688792;0.7030769037916401;8.890925309361343;86.91339641844894;5.382624473008031;0.0029089131611469855;0.6261870311244675;[BLM, PCNA, FMR1, BRCA1, NACC2, PRKCD, H2AFX, PARP9, SIRT1]
GO:0060311;negative regulation of elastin catabolic process;8.0;1.0;0.875;9.628524252492122;870.446617572591;9.777073627680469;0.029133064939058265;0.875;[CST3]
GO:0002292;T cell differentiation involved in immune response;7.0;0.7586651285174919;0.7302519295159464;9.260799472366804;150.83672260445746;6.686031174322154;0.00504836936133411;0.692843310444282;[EOMES, FCER1G, LEF1, RORA, GATA3, CLEC4D, BCL3, CLEC4E, IL18R1]
GO:1902523;positive regulation of protein K63-linked ubiquitination;12.0;0.9326813400603323;0.9144609826203107;9.593432932680852;695.4271152056829;8.67846133901236;0.02327531970216374;0.8919372290569614;[PTPN22, NOD2]
GO:0006897;endocytosis;5.0;0.6324783794010864;0.6064802015614634;8.088079211544972;26.35802846831835;3.582668236575797;8.821794921490709E-4;0.47345883209051776;[SPARC, TFRC, CLEC10A, ICAM3, KIAA1109, DPYSL2, CUBN, SLC11A1, HSPG2, RIN2, CFI, FPR2, CD14, IGHA1, ELANE, SLAMF1, MSR1, MARCO, DENND1B, ACHE, ADM, ASGR1, ASGR2, STAB1, CD36, ANXA1, FCER1G, SYK, ANXA3, NME1, CEACAM1, RARA, RHOU, CD302, CD5L, TMPRSS2, IGKC, CXCR1, CXCR2, SORT1, LILRB1, SNX17, NEDD4, SIGLEC1, RAMP1, SCARB2, NCF2, NCF4, HP, LY75, CXCL16, LOXL2, PYCARD, AP2M1, CD93, TSC2, RAB31, PRTN3, CALCRL, PLD4, ADRB2, CORO1A, IGLV1-44, CD163, SYT2, CAV2, CAV1, LRP1B, MARCH3, DAB2, IGKV3-20, LRP12, BCL2L1, LRRK2, ITGB3, ITGB2, ITGAL, GHR, ITGA4, DNM2, PECAM1, COLEC12, NLGN1, LRP1, CEBPE, LRP2, DLL1, FCGR1A, FCGR1B, ATP9A, SNCA, NLGN4Y, CD6, CD5, CD9, FCGR2B]
GO:0006898;receptor-mediated endocytosis;6.0;0.6799073451904818;0.6630739851853854;8.48339194818912;28.437470009997963;4.178651668682095;9.517765291732001E-4;0.536816753253722;[SCARB2, SPARC, TFRC, HP, CXCL16, LOXL2, AP2M1, CUBN, HSPG2, RAB31, CALCRL, CFI, FPR2, ADRB2, IGLV1-44, CD14, IGHA1, MSR1, CD163, CAV2, CAV1, LRP1B, MARCO, DAB2, IGKV3-20, LRP12, ACHE, ITGB2, ADM, ASGR1, ASGR2, STAB1, CD36, FCER1G, SYK, ITGA4, DNM2, CEACAM1, COLEC12, LRP1, CD5L, TMPRSS2, LRP2, DLL1, IGKC, CXCR1, CXCR2, FCGR1A, FCGR1B, SNCA, LILRB1, CD6, SNX17, CD5, NEDD4, CD9, FCGR2B, RAMP1]
GO:0060313;negative regulation of blood vessel remodeling;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;101.63443030228625;8.67846133901236;0.0034016129171686622;0.7669372290569613;[CST3]
GO:0006895;Golgi to endosome transport;7.0;1.0;0.8509193652572005;9.628524252492122;52.5351401021073;6.8867018697843045;0.0017583038606610233;0.7031056191423581;[SORT1, KIF16B]
GO:0048208;COPII vesicle coating;6.0;1.0;0.8231203125901445;9.628524252492122;62.43707956725794;5.6339389012889365;0.0020897128633926582;0.6112402100070131;[NAPA, SERPINA1, CTSZ, TGFA, F5]
GO:0006888;ER to Golgi vesicle-mediated transport;6.0;1.0;0.8231203125901445;9.628524252492122;49.13394272044514;4.493869898942481;0.001644468845175705;0.5529370282083849;[, PROS1, NRBP1, COPB2, TGFA, SPTA1, SERPINA1, CTSZ, SPTAN1, TMED6, F5, RAB33B, NAPA, GOPC]
GO:0009913;epidermal cell differentiation;5.0;0.7436939687323844;0.6620879962271125;8.712233520617966;24.20171999872632;5.277263957350204;8.100097882234571E-4;0.560120536057681;[YAP1, CSTA, DSP, MED1, ST14, JAG1, ANXA1, KLF4, USH2A, EREG, FA2H, ADAM9, EPHA2]
GO:0072531;pyrimidine-containing compound transmembrane transport;5.0;0.7866048967936545;0.6835434602577475;9.176539128749065;43.69743852505243;7.474488534686424;0.0014625139422920369;0.6724867031240476;[AQP9, SLC28A1, SLC19A2]
GO:0071447;cellular response to hydroperoxide;5.0;0.8653626801206646;0.7229223519212526;9.485423408851448;143.11325921270426;7.697632086000634;0.004789871992277907;0.6838982747154925;[DAPK1, PRKCD, MGST1, CD36, AIF1]
GO:0071205;protein localization to juxtaparanode region of axon;5.0;0.9326813400603323;0.7565816818910864;9.510741216835738;40.92839637806193;8.16763571524637;0.0013698365936084043;0.7079342821725234;[EPB41L3]
GO:0050766;positive regulation of phagocytosis;8.0;0.7671156992804218;0.7585578496402109;9.34084218004034;175.32691305650852;5.825829909099042;0.005868033996023792;0.6729332124801218;[SIRPG, TNF, SIRPB1, C2, PYCARD, C3, STAP1, CCL2, SIRPA, NCKAP1L, CD36, FCER1G, SLC11A1, AZU1, DNM2, IL1B, PTX3, FCGR2B]
GO:0050764;regulation of phagocytosis;7.0;0.6873818243518346;0.6946102774331178;9.05316010758856;47.10255867462412;5.4730085344763;0.0015764802492890249;0.6308092762312435;[SIRPG, TNF, SIRPB1, PYCARD, SIRPA, CD36, FCER1G, SYK, SLC11A1, DNM2, FGR, HCK, IL1B, PRTN3, TLR2, C2, C3, STAP1, CCL2, NCKAP1L, CSK, TGFB1, AZU1, PTX3, FCGR2B]
GO:0071449;cellular response to lipid hydroperoxide;6.0;1.0;0.8231203125901445;9.628524252492122;183.55905670791182;9.777073627680469;0.006143556435587972;0.8231203125901445;[MGST1]
GO:0050765;negative regulation of phagocytosis;8.0;0.8436909121759173;0.7968454560879586;9.503361109538115;175.4194889364855;7.069023426578259;0.005871132427413739;0.7365101867784198;[TGFB1, PRTN3, CSK, FCGR2B, TLR2]
GO:0014003;oligodendrocyte development;5.0;1.0;0.7902410118609202;9.628524252492122;34.09911675737102;6.558197802812269;0.001141266750656509;0.6256275524841266;[LYN, EIF2B3, TGFB1, GSN, CD9, WASF3]
GO:0019934;cGMP-mediated signaling;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;28.507808342730176;7.069023426578259;9.541306898693577E-4;0.7365101867784198;[EDNRB, PRKAR1B, PRKAR2B, CD36]
GO:0060100;positive regulation of phagocytosis, engulfment;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;308.80984280932773;7.57984905034425;0.010335587528013168;0.7838744581139225;[STAP1, NCKAP1L, CD36]
GO:0014002;astrocyte development;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;34.09911675737102;6.832634648514029;0.001141266750656509;0.639662265535933;[PLP1, TSPAN2, DLL1, S100A9, S100A8]
GO:0060585;positive regulation of prostaglandin-endoperoxide synthase activity;6.0;1.0;0.8231203125901445;9.628524252492122;94.41559583685607;8.67846133901236;0.003160005024139943;0.7669372290569613;[EDN1, NOD2]
GO:0060586;multicellular organismal iron ion homeostasis;10.0;1.0;0.9152410118609203;9.628524252492122;58.33118610341119;7.57984905034425;0.0019522923042219213;0.8028748447945538;[SLC11A1, SLC40A1, RHAG]
GO:0090197;positive regulation of chemokine secretion;10.0;0.8933024483968273;0.861892236059334;9.567899630675686;759.1048076819071;7.292166977892469;0.025406554763140368;0.7881627702307852;[PYCARD, CSF1R, IL33, POSTN]
GO:1901687;glutathione derivative biosynthetic process;5.0;0.9326813400603323;0.7565816818910864;9.55953138100517;153.56954054457893;6.686031174322154;0.005139834318413505;0.6321649570480018;[MGST1]
GO:0002265;astrocyte activation involved in immune response;5.0;1.0;0.7902410118609202;9.628524252492122;30.94542743681365;8.67846133901236;0.0010357156072335748;0.7340579283277371;[LRP1]
GO:0071230;cellular response to amino acid stimulus;6.0;0.7140352122741334;0.6801379187272112;8.962045319014338;283.89643900763554;5.6339389012889365;0.009501758323378283;0.6112402100070131;[CEBPB, ABCB4, TNF, SESN3, PDGFD, PDGFC, FYN, PDGFRA, MMP2, CYBB, COL1A1, COL3A1, COL1A2, COL4A1, COL5A2, COL6A1, RRAGD, BCL2L1]
GO:0050772;positive regulation of axonogenesis;10.0;0.7436939687323844;0.7870879962271125;9.36383169826504;884.0118179988558;5.395046993006588;0.02958707998943757;0.6911439659786198;[ROBO2, CYFIP1, NRP1, PLXND1, PAK1, ARHGDIA, FN1, CXCL12, MAP1B, PLXNB2]
GO:0050777;negative regulation of immune response;5.0;0.5193749703860713;0.549928497053956;7.293149336675085;78.83017544275083;4.909539177224887;0.0026383750295169523;0.5413150737011212;[IFNA2, TNFAIP3, TNF, LGALS3, DUSP10, DHX58, CTLA4, IL13RA2, JAK3, CCR2, HAVCR2, IL10, CD96, CR1, ANXA1, ARG1, SERPINB9, IRAK3, MMP12, ADCYAP1, CEACAM1, XCL1, SERPING1, CLEC12B, NLRC3, HLX, INPP5D, TBX21, HMOX1, A2M, LYN, IL33, TGFB2, TGFB1, NR1H2, LILRB1, COL3A1, PTPRC, BCL6, PTPN6, FCGR2B, IL7R]
GO:0050776;regulation of immune response;4.0;0.37937792944451876;0.4396889647222594;5.635843344046521;22.446924158408432;2.846578861728843;7.512783506617425E-4;0.39557417536826767;[, CYFIP1, TFRC, CLEC10A, SLA2, MYB, TRBC1, C3AR1, UBASH3A, PRKACB, MED1, MEF2C, CXADR, PRKCH, PRKCE, PRKCD, SERPING1, PRKCQ, CFB, CFD, CFH, HHLA2, CFI, FPR1, FPR3, FPR2, GATA3, THY1, CFP, PRKCZ, C2, C3, KLRK1, C7, HMOX1, NCKAP1L, S100A14, PLCG1, IGHA1, HLA-DQA2, HLA-DQA1, ELANE, LYN, JUN, HLA-DRB4, FZD5, KIR2DS1, KIR2DS2, COL1A1, COL1A2, HLA-DRB1, DENND1B, ITK, SIGLEC9, IFIH1, CTLA4, JAK3, HLA-DPA1, HAVCR2, ANXA1, ARG1, IFNGR1, FCRL3, NFAM1, IFNGR2, PAWR, SERPINB9, PAX5, FOS, SIRT1, MMP12, FCER2, PLSCR1, RARA, TLR10, HLA-DQB1, PTAFR, UNG, HLA-DMB, CCL19, IL12RB1, NR1H2, CARD9, NR1H4, KIR3DL1, COL3A1, HLA-DPB1, PKN1, CLC, SIGLEC7, LGR4, PROS1, CXCL13, TNF, CLU, PYCARD, IGHG1, FCGRT, GRAP2, IL13RA2, CD177, LAG3, CD180, MSH6, CLEC4A, ADCYAP1, CLEC4D, MSH2, ADAM8, CLEC4E, S100A9, S100A8, BLK, CD274, LY96, CLEC7A, IGLV1-44, MAP2K6, EIF2B3, BMX, NFKB1, PTPRC, BCL6, BCL2, HLA-DRA, LAT, MYD88, ITGAM, ITGB2, PIK3CD, TREM2, PTPN22, ITGAL, TREM1, TNFSF13B, FCGR3A, DUSP10, ITGB7, CR2, CR1, CHUK, ITGA4, PVRIG, LCK, XCL1, LCP2, BIRC3, C1S, UNC93B1, C1R, NLRC3, NLRC4, NOD2, CCL5, FYN, CSK, FCGR1A, FCGR1B, FCGR2A, PTPN6, MNDA, CD247, FCGR2B, CLEC2D, ICAM2, ICAM3, LGALS3, DHX58, ICOSLG, RSAD2, SLC11A1, MIF, EREG, IL23A, BTK, TXK, STXBP2, CD1E, CD1D, CD1C, CD1B, CD1A, CD79B, CD79A, CD19, INPP5D, SLAMF7, CD14, A2M, PAG1, SH2D1A, TNFSF13, PILRA, PTK2, MARCO, CD28, CD24, CD200, IGHM, ECM1, CD40, IFNA2, CD3G, CD3E, CD3D, CTSS, RAC2, FCER1A, CTSH, MUC13, CD38, FFAR2, CTSG, CCR7, MUC15, CD36, CD34, CD33, CCR2, IL10, FCER1G, SYK, IL18, GAB2, PARP9, LIME1, VAV1, LAT2, TLR1, NCR1, HCK, CEACAM1, IL1B, KIT, IGHD, TLR8, TLR7, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA1, LILRA2, PAK1, IGKC, NPDC1, CD74, IL33, LILRB1, LILRB2, MLH1, CD40LG, C1QC, CD86, FCN1, CD80, TRAC, IL18RAP, IL6R, CD96, THEMIS, MUC3B, OSCAR, TYROBP, CD8B, CD8A, KLRF1, CD300C, CARD11, KLRB1, C5AR1, KIR2DL1, KIR2DL2, CACNA1F, DDX60, KIR2DL3, RASGRP1, KIR2DL4, STAP1, NLRP3, KLRC1, BTNL8, TGFB2, TGFB1, VCAM1, CAV1, CRTAM, NFKBIA, IL6, NR4A3, SELL, FES, KLRD1, IL7R, IGKV3-20, HMGB2, TNFAIP3, PDE4B, DDX58, MMP2, IRAK3, FGR, ZAP70, IFNG, LTA, IRF7, LTF, COLEC12, CLEC12B, SAMHD1, HSPD1, CNR1, HLX, TBX21, TRAT1, MAPK14, CD4]
GO:2001268;negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway;13.0;1.0;0.9625549647676366;9.628524252492122;1177.790893893302;8.16763571524637;0.039419601275621635;0.8802482350792397;[PLAUR, MMP9]
GO:0060333;interferon-gamma-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.514393750639154;0.00101047745553359;0.6329257181104212;[CIITA, IFI30, OASL, TRIM25, HLA-DPA1, IFNGR1, IFNGR2, PRKCD, HCK, IFNG, OAS1, OAS3, IRF7, HLA-DQB1, CAMK2D, SP100, PTAFR, NCAM1, FCGR1A, FCGR1B, HLA-DQA2, HLA-DQA1, HLA-DRB4, VCAM1, PML, HLA-DPB1, HLA-DRA, HLA-DRB1]
GO:2001044;regulation of integrin-mediated signaling pathway;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;41.8512380110395;7.212124270218933;0.0014007232725606145;0.6919486831672181;[BST1, CTNNA1, FLNA, TIMP1, CD177]
GO:0048469;cell maturation;3.0;0.6954798709641801;0.5458602480722345;8.242229891372231;25.22197897315013;4.886724499458715;8.441569379239579E-4;0.4480276307483924;[CDKN1A, IHH, BRCA2, ROPN1L, FBXO5, HOXA5, RUNX2, EREG, BTK, FAM20C, CFTR, CEBPA, EPB42, GATA3, CCNB1, CCL19, FZD5, CCL21, NR4A2, FEV, GNAQ, SLC26A8, PLP1, SLC26A3]
GO:0060334;regulation of interferon-gamma-mediated signaling pathway;8.0;0.8933024483968273;0.8216512241984136;9.510741216835738;117.87544056254812;6.558197802812269;0.003945184914619341;0.7103865406232063;[MED1, ARG1, IFNGR1, NR1H2, IFNGR2, TXK, PARP9, IFNG]
GO:0006876;cellular cadmium ion homeostasis;10.0;1.0;0.9152410118609203;9.628524252492122;329.3407122754199;9.777073627680469;0.011022737252460356;0.9152410118609203;[SLC11A1]
GO:1901216;positive regulation of neuron death;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;58.38287487682085;5.370354380416217;0.001954022280951067;0.5977604853516485;[ITGAM, CTSZ, ITGB2, FASLG, CLU, MYB, FOS, KMO, CDC34, IL1B, TLR6, TLR4, TP53BP2, FYN, SNCA, EGR1, JUN, TGFB2, EIF2S1, FCGR2B, UBE2M]
GO:0006631;fatty acid metabolic process;7.0;0.5408746917014966;0.6213567111079488;7.849668188099975;91.0232021896581;4.037280715501235;0.0030464646617242943;0.5573860888006872;[, SCARB2, ACSM5, CYP1B1, ACSL1, ACSL5, MIF, POR, SLC27A3, SLC27A2, MGST1, ACAT1, C3, PRKAR2B, CYP4F2, CYP4F3, CYP4F12, FA2H, TBXAS1, TECR, ACSM2A, ETFA, BRCA1, GHR, ACADM, HIBCH, EDN1, ELOVL4, CYP4A11, ELOVL6, ELOVL7, NDUFS6, EHHADH, ACSBG1, HSD17B4, AOAH, PTGS2, CYP3A4, PTGS1, ALOX5, SNCA, CD74, PNPLA8, MAPK14, SCD, NDUFAB1, PLP1]
GO:0070371;ERK1 and ERK2 cascade;10.0;1.0;0.9152410118609203;9.628524252492122;233.3964595037646;6.481236761676141;0.007811569456414605;0.7466917612613706;[MED1, MAP2K2, EGF, IQGAP3, TNFSF11, CTSH]
GO:0070372;regulation of ERK1 and ERK2 cascade;10.0;0.8653626801206646;0.8479223519212526;9.541512875502493;158.98679164778278;4.069963362931594;0.0053211448376282704;0.623379127513894;[PHB2, TNF, CTGF, PYCARD, TNFSF11, EPHB2, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, ATF3, EPHA3, EPHA2, CSF1R, C5AR1, PDGFA, FBLN1, FPR2, TNFRSF11A, SLC30A10, PRKCZ, RASGRP1, PKHD1, PDGFD, PDGFC, SLAMF1, LYN, CCR1, JUN, TGFB1, LIF, FN1, MARCO, BMP2, NOX4, NRP1, PTPRR, TREM2, PTPN22, CYR61, DUSP10, TIMP3, CCR7, EMILIN1, CD36, HAVCR2, SYK, DUSP1, DUSP6, CEACAM1, IL1B, KIT, XCL2, CHI3L1, XCL1, TLR4, CCL13, NOD2, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CSK, CCL19, CCL18, CD74, CCL23, CCL21, CCL20, TIE1, KLF4, CD4, NLRP12, PTPN6, TEK]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CD86, CXCL6, CXCL9, CD40, IL1RN, CSF3, CD80, SERPINE1, HMGB2, TNFAIP3, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, PYCARD, EDNRB, PDE4B, CTSG, CD36, CCR5, HAVCR2, IL10, GHSR, MEF2C, ARG1, CD180, PDCD1LG2, TNFRSF1B, IL1B, RARA, ADAM9, TLR4, CX3CR1, CD274, CEBPB, CEBPE, KLRK1, STAP1, NLRP3, CCL2, CD14, ABCA1, CCL20, NR1H2, DEFA4, NR1H4, LILRB1, DEFA1, LILRB2, PPBP, MAPK14, NFKB1, CXCL10, CXCL11, IL6, PF4]
GO:0071223;cellular response to lipoteichoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;155.87545856417063;7.474488534686424;0.005217011319337755;0.7053660038532718;[CCL20, TREM2, CD36, CD14, MAPK14, TLR2]
GO:0070373;negative regulation of ERK1 and ERK2 cascade;11.0;1.0;0.9324289523296623;9.628524252492122;1180.902522994834;5.6339389012889365;0.039523744701365535;0.7205488497465309;[PTPRR, FBLN1, DUSP10, TIMP3, CSK, EMILIN1, EPHB2, LYN, DUSP1, LIF, KLF4, DUSP6, NLRP12, TLR4, ATF3]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PHB2, TNF, CTGF, PYCARD, TNFSF11, EPHB2, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, EPHA3, EPHA2, CSF1R, C5AR1, PDGFA, FPR2, TNFRSF11A, SLC30A10, PRKCZ, RASGRP1, PDGFD, PDGFC, SLAMF1, CCR1, JUN, TGFB1, MARCO, BMP2, NOX4, NRP1, TREM2, PTPN22, CCR7, CD36, HAVCR2, IL1B, KIT, XCL2, CHI3L1, XCL1, CCL13, NOD2, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CD74, CCL23, CCL21, CCL20, TIE1, CD4, TEK]
GO:0071226;cellular response to molecule of fungal origin;5.0;1.0;0.7902410118609202;9.628524252492122;58.24779613319063;9.083926447120524;0.00194950131696474;0.7547934328124444;[SYK, BTK]
GO:0071224;cellular response to peptidoglycan;6.0;1.0;0.8231203125901445;9.628524252492122;318.29655603595194;8.16763571524637;0.010653099282220678;0.7408135829017477;[NLRP3, TREM2, NOD2]
GO:0071225;cellular response to muramyl dipeptide;7.0;1.0;0.8509193652572005;9.628524252492122;334.57737126116905;8.16763571524637;0.011198003516026267;0.7686126355688037;[PTPN22, NOD2]
GO:0014005;microglia development;5.0;1.0;0.7902410118609202;9.628524252492122;67.63861772680754;8.67846133901236;0.0022638036645123614;0.7340579283277371;[TSPAN2, TLR2]
GO:0042536;negative regulation of tumor necrosis factor biosynthetic process;8.0;1.0;0.875;9.628524252492122;858.4851481575464;7.9853141584524145;0.0287327253223603;0.7833693374183408;[IL10, GHSR, BCL3, LILRB1]
GO:0045806;negative regulation of endocytosis;7.0;0.7192862368539868;0.710562483684194;9.057979394024509;124.57926064357885;5.8650506222523235;0.004169555739685066;0.6508583268319309;[MCTP1, LGALS3, CSK, TGFB1, NR1H2, CAV1, LILRB1, PRTN3, FCGR2B, EPHA3, TLR2]
GO:0014068;positive regulation of phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;5.602686357784832;0.007979625599047746;0.6615216408886768;[CSF3, NCF1, PDGFA, CCL5, PDGFD, PDGFC, FYN, PDGFRB, PDGFRA, TGFB2, F2R, IL18, SIRT1, PTK2, DCN, FGR, SELP, GH1, NEDD4, KIT, CD28, PTPN6, TEK]
GO:0014067;negative regulation of phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;238.79440420981607;7.292166977892469;0.00799223380789131;0.747921758369865;[TSC2, TWIST1, NLRC3, KLF4]
GO:0045807;positive regulation of endocytosis;7.0;0.6873818243518346;0.6946102774331178;8.89763674394933;124.48668476360231;4.886724499458715;0.0041664573082951335;0.6008266834154484;[LRRK2, FMR1, SIRPG, SERPINE1, TNF, CLU, SIRPB1, PYCARD, SIRPA, CD36, FCER1G, SYK, SLC11A1, ACTN4, DNM2, GREM1, SFRP4, IL1B, NLGN1, CD151, LRP1, DLL1, C2, RAB21, C3, NTF3, STAP1, CCL2, NCKAP1L, CCL19, CD14, SNCA, CCL21, EGF, AZU1, SELE, TF, DAB2, PTX3, FCGR2B]
GO:0014063;negative regulation of serotonin secretion;8.0;1.0;0.875;9.628524252492122;272.1012405442988;8.390779266560578;0.009106983645799836;0.8041048419030481;[LILRB1]
GO:0051490;negative regulation of filopodium assembly;9.0;1.0;0.896240625180289;9.628524252492122;173.84791521056468;8.67846133901236;0.005818533269131697;0.8400575416471059;[PRKCD]
GO:0042531;positive regulation of tyrosine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;1230.2749798860389;5.618190544320798;0.04117619640118775;0.7197434780388068;[CSF1R, CD40, IFNA2, GHR, CCL5, FYN, IL6R, LYN, LIF, IL18, OSM, PARP9, GH1, IL6, IFNG, IL23A, KIT]
GO:0008625;extrinsic apoptotic signaling pathway via death domain receptors;7.0;0.9326813400603323;0.8172600352873667;9.523163736834295;52.44533375847466;6.311337724880743;0.0017552981231601008;0.6736814700148209;[FASLG, TNF, CASP8AP2, SORT1, DAPK1, TNFRSF10B, BCL2]
GO:0042535;positive regulation of tumor necrosis factor biosynthetic process;8.0;1.0;0.875;9.628524252492122;857.3444905607055;7.379178354882098;0.028694548539119222;0.7523715242355574;[TLR1, CYBB, AZU1, TLR4, THBS1, CCR2]
GO:0097484;dendrite extension;5.0;1.0;0.7902410118609202;9.628524252492122;51.99108915072818;7.474488534686424;0.0017400949649324319;0.6724867031240476;[CYFIP1]
GO:0031638;zymogen activation;7.0;0.8259837884571596;0.7639112594857803;9.387362195675234;102.5832240862455;6.113511981550823;0.00343336819125881;0.663564652301091;[C1R, F11, CD5L, DHCR24, ASPH, PLAU, PERP, CTSH, PRSS3]
GO:0032727;positive regulation of interferon-alpha production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;84.40547105694755;6.7325511899570465;0.0028249751562838235;0.6952223462072524;[CHUK, DDX58, HSPD1, MMP12, IFIH1, IRF7, TLR8, TLR7, TLR4]
GO:0051005;negative regulation of lipoprotein lipase activity;7.0;1.0;0.8509193652572005;9.628524252492122;65.18845533903233;8.16763571524637;0.0021817989343965133;0.7686126355688037;[SORT1]
GO:0030307;positive regulation of cell growth;6.0;0.6954798709641801;0.6708602480722345;8.712233520617966;80.64681300048527;4.733648510761223;0.0026991762537066665;0.5651993175676412;[CYFIP1, NRP1, CPNE5, CXCL16, RPS6KA1, AKT1, CD38, EDN1, AVPR1A, SFRP2, MAP1B, S100A9, S100A8, HBEGF, TAF9, LEF1, PAK1, SFN, TGFB2, SYT2, FN1, CXCL12, BCL2]
GO:0030308;negative regulation of cell growth;6.0;0.6913464685778243;0.6687935468790567;8.673012807464685;80.89021177018715;4.623782033182691;0.0027073225914839173;0.5595807407949613;[CDA, NRP1, SEMA5B, CDKN1A, ARHGAP4, TCHP, PPP2R1A, HNF4A, TNR, SEMA6A, DCC, SIRT1, GREM1, PSRC1, SFRP2, NDUFS3, FBP1, PAK1, FRZB, SPP1, TGFB2, TGFB1, CDKN2C, SEMA4B, INHBA, PML, BCL6, BCL2, SIPA1]
GO:0010933;positive regulation of macrophage tolerance induction;7.0;1.0;0.8509193652572005;9.628524252492122;164.43476621900118;9.777073627680469;0.005503483643668157;0.8509193652572005;[IRAK3]
GO:0010936;negative regulation of macrophage cytokine production;8.0;1.0;0.875;9.628524252492122;311.05347994333346;8.16763571524637;0.010410680043746014;0.7926932703116032;[TGFB2, TGFB1, IRAK3]
GO:0032728;positive regulation of interferon-beta production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;84.40547105694755;6.343086423195323;0.0028249751562838235;0.6753050999230941;[HMGB2, IFIH1, DDX58, IRF7, TLR8, TLR7, TLR4, TLR2]
GO:0032729;positive regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;5.6339389012889365;0.002183412136085803;0.6112402100070131;[PTPN22, CD3E, TNF, PYCARD, PDE4B, IL6R, CCR2, HLA-DPA1, HAVCR2, SLC11A1, IL18, IL23A, IL1B, LTA, TLR8, TLR7, TLR4, TXK, RASGRP1, HSPD1, KLRK1, CD14, IL12RB1, IL12RB2, FZD5, CD2, BCL3, HLA-DPB1, IL18R1, CD244]
GO:0032722;positive regulation of chemokine production;6.0;0.7140352122741334;0.6801379187272112;8.734706376470026;66.68357405504983;5.8067817141283475;0.002231839212302133;0.6200793994936333;[CSF1R, TWIST1, TNF, PYCARD, HMOX1, FFAR2, IL6R, HAVCR2, EGR1, CD74, IL33, POSTN, EIF2AK2, AZU1, MIF, ADCYAP1, IL1A, IL6, IL1B, TLR7, TLR4, TLR2]
GO:0032720;negative regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.92712208559752;5.926926025970411;0.002875903446815721;0.6540226378555745;[ORM1, TNFAIP3, TWIST1, PTPN22, NLRC3, GPNMB, CD34, HAVCR2, SLAMF1, IL10, GHSR, NR1H4, LILRB1, IRAK3, BCL3, RARA, BPI, TLR4, GPR18]
GO:0051248;negative regulation of protein metabolic process;6.0;0.4463712279514003;0.5463059265658446;6.752138736570697;129.5306506172274;2.7979283526116596;0.004335274306141412;0.46620649865967934;[PID1, SPI1, SERPINE1, SPINT2, ADARB1, AKT1, DAPK1, PRKCE, PRKCD, SPINT1, PRKAR1B, SERPING1, ATF3, THY1, PRKCZ, C3, FLRT2, PRKAR2B, SFN, NCKAP1L, ELANE, LYN, JUN, PLK1, EIF2AK2, NR2F2, PKIG, CDKN1A, BTG2, SERPINA1, LRRC4, TIMP2, TIMP3, TIMP1, JAK3, DUSP2, SERPINB2, DUSP1, BGN, SERPINB9, PAX5, SIRT1, DUSP6, PAX2, RARA, GAS1, HBEGF, ENG, SERPINB10, LRRC19, FAM129A, PTGS2, NTF3, FLNA, DMD, CDKN2C, NR1H2, FABP1, PKN1, FMR1, PROS1, TNF, CLU, PYCARD, LAMP3, MEN1, PPP1R16B, LAG3, IGFBP5, CISH, IGFBP3, FOXO1, SOCS2, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, PTPRC, CNOT3, BCL3, LRRK2, ITGB3, PTPN22, ALAD, HHEX, DUSP10, EMILIN1, CR1, TNFRSF1B, BIRC5, BIRC3, PPP1R15A, CEBPA, NLRC4, FYN, CSK, KLF4, PML, EIF3E, PTPN6, AQP1, EDNRB, PPP2R1A, RPS6KA1, FBXO5, EPHB2, SOX4, IL1R2, PAQR3, MIF, POR, SFRP2, SLPI, TRIB1, NAIP, TWIST1, INPP5D, A2M, TNFSF14, LIF, CD27, CALM3, ITM2A, ITM2C, PTPRR, ECM1, CTSZ, BRCA1, IL10, EDN1, GP1BA, CEACAM1, BANK1, IL1B, TLR4, CSTA, IFI6, CST7, GNAI2, CST3, PURA, TM4SF20, LILRB1, LILRB2, PODN, NLRP12, FKBP1B, MAD2L1, GHSR, APLP2, TSC2, FBLN1, CCNB1, TGFB1, CAV1, CRIM1, ISG15, INHBA, EIF2S1, VIL1, IL6, LIN28A, GNAQ, TNFAIP8, TNFAIP3, LRRTM4, NUP62, MYOCD, PLAUR, IRAK3, MMP9, DCN, GREM1, COL6A3, ZMYND11, LTF, TAF9, LEF1, THBS1, SPOCK3, SNCA, PTX3]
GO:0042789;mRNA transcription by RNA polymerase II;11.0;1.0;0.9324289523296623;9.628524252492122;1288.3918881325048;6.832634648514029;0.043121317018375266;0.781850206004675;[MED1, C5AR1, LMO2, FLNA]
GO:0045814;negative regulation of gene expression, epigenetic;7.0;0.7671156992804218;0.7344772148974115;9.081980546124052;80.1036275103501;5.2552850506314295;0.0026809963241870454;0.6196748871422394;[CREBZF, SPI1, SUV39H1, BMI1, H2AFX, SIRT1, EZH2]
GO:0042307;positive regulation of protein import into nucleus;9.0;0.9326813400603323;0.8625812952104552;9.592156608321247;778.7460608588023;6.063501560976162;0.02606392983099081;0.706328376990269;[LRRK2, PTGS2, CDH1, ECT2, MED1, TGFB1, JUP, PRKCD, MAPK14, IFNG, CDK1]
GO:0042308;negative regulation of protein import into nucleus;9.0;0.9326813400603323;0.8625812952104552;9.592156608321247;779.1118030345037;7.138016298065211;0.026076170892464952;0.7612791106150483;[MDFIC, CD36, PKIG]
GO:0006691;leukotriene metabolic process;7.0;0.7586651285174919;0.7302519295159464;9.193206181234276;59.92630818990423;6.343086423195323;0.002005679604940167;0.6753050999230941;[SYK, CYP4F2, CYP4F3, CYP4A11, CYP4F12, ALOX5, TLR2]
GO:0002092;positive regulation of receptor internalization;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;393.55365953464764;6.599019797332524;0.013171886809326083;0.7337148045016781;[GREM1, SFRP4, SYK, EGF, FMR1, NTF3, SELE]
GO:0000902;cell morphogenesis;4.0;0.6260725219892441;0.563036260994622;7.923776160253697;43.26261951924051;4.420487353008457;0.0014479609414792109;0.47606392880653703;[CYFIP1, COL12A1, LST1, IHH, SPINT2, ANTXR1, CLU, CDH5, C1GALT1C1, CDH3, POF1B, CDH1, MED1, MEF2C, ACTN1, COL23A1, CLDN3, ADAM8, EPHA2, SLC1A3, EPB41L5, NCKAP1L, ECT2, ST14, TGFB2, BCL11B, VDR, FN1, BCL6, ID1, NOX4, IL7R, NRP1, COL14A1, ITGB3, LAMC1, ITGB7, ITGA4, STRADB, GP1BA, GREM1, PALLD, COL6A2, CDH11, COL6A1, COL6A3, CDH17, YAP1, LEF1, PDPN, SLITRK6, FLNA, LAMB1, MAPK14, GRHL2, TEK]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[CDA, KCNG2, PRF1, TCL1A, TNFSF11, MIF, OLFM4, CLDN3, KCTD12, KCTD15, BLM, MGST1, ITPR3, ACAT1, CD79B, CD79A, NACC2, HMOX1, ECT2, VASP, CAV1, EHD3, DPYS, CD3G, CD3E, CD3D, ALAD, EMILIN1, TK1, FCER1G, KCND2, VWF, ARG1, NUP54, ACPP, FBP1, COLEC12, NLGN1, HM13, KCNA5, NLRC4, SAMHD1, PLN, RXRA, GCH1, SOD2, MARCKS, RAD51, P2RX1, IMPDH2, GOPC, CD247, RBMX]
GO:0008631;intrinsic apoptotic signaling pathway in response to oxidative stress;7.0;0.8653626801206646;0.7836007053175329;9.523163736834295;52.930841574252625;6.943860283624253;0.001771547632825523;0.7060287030842711;[PRKCD, PML, MELK, BCL2, CYP1B1]
GO:0009725;response to hormone;4.0;0.5257808277979137;0.5128904138989568;7.033269545535256;21.85620986101781;3.280298637494607;7.315076747364311E-4;0.41775462487096104;[CYFIP1, IL1RN, PID1, SPARC, AQP1, EDNRB, AKT1, PRKACB, JUNB, PTGDR, MED1, MEF2C, PRKCE, PRKCD, EREG, SFRP4, CLDN4, POR, ADCY9, PRKAR1B, SIK1, ABCB4, SLC30A10, GATA1, PRKAR2B, LYN, EGR1, EGR2, JUN, CDC6, NR2F2, COL1A1, SDC1, EZH2, ROBO2, CDKN1A, GABRB1, BTG2, ADM, BRCA2, CTSS, TIMP2, CTSH, TIMP3, CD38, CCR7, TIMP1, CTSB, IL10, EDN1, ANXA1, DUSP1, ANXA3, ARG1, TACR3, AVPR1A, FOS, SIRT1, NME1, CEACAM1, IL1B, KIT, RARA, MMP19, ACSBG1, ENG, TLR2, YAP1, PCNA, PTGER2, PTAFR, PTGS2, AIF1, GNAI1, CST3, PAK1, SPP1, CCL19, CCL21, SORT1, SORBS1, POU4F1, FOSB, RAMP1, TNC, IHH, TNF, ETS1, CTGF, SESN3, RUVBL2, MEN1, PDGFRB, GHSR, LHCGR, POSTN, IGFBP5, LMO2, CYBB, ADCYAP1, RAB31, LOX, ADAM9, FECH, FOXO1, ACAT1, SOCS2, IGFBP7, CYC1, GAS2L1, EIF2B3, TGFB2, TGFB1, CAV1, DHCR24, INHBA, NFKB1, NR4A2, NR4A1, GH1, IL6, KIF18A, CXCL12, NR4A3, NASP, BCL2, ALPL, FBN1, HMGB2, FHL2, GHR, ALAD, HHEX, CA2, UQCRFS1, GLP2R, CAD, TGFBR3, CCNA2, RETN, THBS1, P2RY6, PLN, RBBP8, FYN, CSK, TSHR, CD4, TEK]
GO:0032715;negative regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.96654663153603;6.166155715036245;0.002174371849661483;0.6384578026126634;[ORM1, TNFAIP3, PTPN22, NLRC3, TNF, INPP5D, NCKAP1L, CSK, HAVCR2, SLAMF1, IL10, GHSR, NR1H4, IRAK3, NLRP12, BANK1, BPI, TLR4]
GO:0006206;pyrimidine nucleobase metabolic process;7.0;0.7307253602413294;0.7162820453778652;9.242861771680136;227.00687585227206;6.8867018697843045;0.007597715841851099;0.7031056191423581;[CDA, ALDH6A1, RRM1, DPYS, DPYD, CAD, TYMP]
GO:0032956;regulation of actin cytoskeleton organization;7.0;0.559792591703537;0.630815661108969;7.718981747607684;34.11626247365944;3.9689311377000256;0.0011418406023505395;0.553890688213353;[CYFIP1, CSF3, CELSR1, F11R, CTGF, PYCARD, EPS8, ARHGDIA, STMN1, ARHGDIB, ARFIP1, PDGFRB, TMOD1, PDGFRA, MEF2C, PRKCE, TPM1, PRKCD, PFN1, EPHA3, CSF1R, TACSTD2, PDGFA, CORO1A, SPTA1, STAP1, NCKAP1L, VASP, TGFB1, VIL1, BST1, CXCL12, FES, JMY, ID1, NOX4, NRP1, LMOD1, ARHGEF10L, ARHGAP6, CCR7, SPTAN1, EDN1, RHOG, RHOH, ARAP1, CIT, HCK, TMEFF2, RHOU, SHANK3, LRP1, SYNPO2, CAPG, PAK1, NTF3, EPS8L1, FLNA, EPS8L3, JAM3, GSN, CCL21, DLC1, TEK]
GO:0032959;inositol trisphosphate biosynthetic process;8.0;1.0;0.875;9.628524252492122;361.00324016623335;9.083926447120524;0.012082453566540795;0.839552420951524;[PTAFR]
GO:0010942;positive regulation of cell death;5.0;0.5391707831400974;0.559826403430969;7.325939159498076;41.77857356132841;3.304727333179569;0.0013982912588225433;0.45924492136526085;[MYB, AKT1, CYP1B1, HOXA5, MEF2C, DAPK1, PRKCD, ATF3, HMOX1, SFN, PLCG1, BARD1, LYN, JUN, NOX4, NOX1, CDKN1A, ADM, CTLA4, TIMP3, ANXA1, DUSP1, PAWR, FOS, SIRT1, F3, DUSP6, AES, PTGS2, FGD3, FGD4, FRZB, CASP8AP2, GSN, BIK, G0S2, POU4F1, HP, TNF, CLU, CTGF, PYCARD, IGFBP3, F2R, MELK, MAL, ADAM8, S100A9, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, BCL2, BCL2L1, ITGAM, PLEKHF1, LRRK2, ITGB2, PIK3CD, FASLG, CYR61, ITGA4, TFDP1, LCK, LRP1, NLRC4, CCL5, E2F1, CCL2, FYN, GZMA, GZMB, PML, P2RX1, MNDA, FCGR2B, IFIT2, PPP2R1A, SOX7, SOX4, TIAM2, SFRP4, SFRP2, CDC34, IFI27, SIK1, INPP5D, TP53BP2, EGR1, TNFSF12, ITM2C, TOP2A, CD40, CTSZ, CTSH, CD36, IL10, VAV1, IL1B, TLR6, TLR4, CXCR2, CTNNA1, SORT1, LILRB1, PPP1CA, NLRP12, CD40LG, FAP, DLC1, PDGFRB, KMO, NLRP3, ECT2, TGFB2, TGFB1, VDR, CAV1, INHBA, EIF2S1, IL6, BMP2, NR4A3, JMY, UBE2M, TNFAIP8, YWHAH, ARHGEF12, PLAUR, AXIN2, MMP9, DNM2, IFNG, LTA, CAMK2D, BCL2A1, THBS1, HSPD1, CNR1, SNCA, HSPE1, SOD2, LTBR]
GO:0048096;chromatin-mediated maintenance of transcription;11.0;1.0;0.9324289523296623;9.628524252492122;1311.6223032101445;7.57984905034425;0.043898818105007634;0.8200627852632958;[CHEK1, PADI2]
GO:0031623;receptor internalization;7.0;0.7248374789738407;0.7133381047441208;9.201080237665183;64.84818556283533;5.682729065458369;0.0021704104112101165;0.6415343939386686;[ACHE, CALCRL, LRP1, TFRC, ITGB2, ADM, CXCR1, CXCR2, CD36, AP2M1, SNCA, FCER1G, SYK, CAV1, LILRB1, DNM2, CEACAM1, RAB31, NEDD4, CD9, RAMP1]
GO:0051259;protein complex oligomerization;5.0;0.7763722522362496;0.6784271379790451;9.089527751759436;40.42272244673708;3.6012063575747084;0.0013529121422039536;0.47440687246051283;[CDA, PRF1, IKZF1, TCL1A, TNFSF11, MCCC2, MIF, CLDN3, KCTD12, KCTD15, MGST1, PRKCZ, ACMSD, CD79B, CD79A, HMOX1, VASP, JUP, COL1A1, EHD3, COL1A2, ACHE, DPYS, CD3G, CD3E, CD3D, TK1, FCER1G, KCND2, ARG1, KCNA5, RXRA, CTNNA1, CD74, GCH1, GOPC, KCNG2, CHRNB4, OLFM4, BLM, ITPR3, RASGRP1, ACAT1, NACC2, NLRP3, ECT2, CAV2, CAV1, TNFAIP3, ALAD, NUP62, EMILIN1, ADSL, VWF, COL6A2, COL6A1, NUP54, ACPP, FBP1, BIRC3, COLEC12, NLGN1, CAMK2D, HM13, NLRC4, NOD2, SAMHD1, PLN, CCL5, RRM1, SOD2, MARCKS, RAD51, P2RX1, IMPDH2, TEK, CD247, RBMX]
GO:0051017;actin filament bundle assembly;6.0;0.7866048967936545;0.7164227609869718;9.143016436710422;39.792633402144126;5.734022359845919;0.001331823628924752;0.6163584827319739;[ITGB5, AIF1, EPS8, PLS1, ACTN1, PAWR, ACTN4, SORBS1, MARCKS, ZYX, LCP1]
GO:0043406;positive regulation of MAP kinase activity;12.0;0.7043150770688792;0.8002778511245842;9.369013057007038;2605.6877929993507;4.201124524534153;0.08721002546492271;0.6629660161470909;[, IL1RN, TNF, PROK2, TNFSF11, PDGFRB, MAP2K2, F2R, MIF, ADAM9, ADAM8, C5AR1, FPR1, TGFA, PDGFA, TNFRSF11A, IQGAP3, RASGRP1, PDGFD, PDGFC, S100A12, ELANE, DRD4, MAP2K6, TGFB1, FZD5, FZD8, EIF2AK2, GH1, BMP2, CDK1, NOX4, CSPG4, CD24, EZH2, CD40, LRRK2, GHR, MAP4K1, EDN1, SYK, DUSP6, MDFIC, IL1B, KIT, PDE5A, TLR6, TLR4, CXCR4, NOD2, THBS1, PAK1, NTF3, CSK, CCL19, CD74, EGF, MAPK14, CD40LG, PKN1]
GO:0043407;negative regulation of MAP kinase activity;12.0;0.811012628672052;0.8536266269261705;9.539970855150678;2610.1786565788484;5.4730085344763;0.08736033062741366;0.7280102235641875;[PTPN22, DUSP10, PPP2R1A, NUP62, DUSP2, DUSP1, PAQR3, PRKCD, IRAK3, DUSP6, SFRP2, IL1B, LYN, CAV1, PTPN6]
GO:0002062;chondrocyte differentiation;4.0;0.8933024483968273;0.6966512241984136;9.446202695698167;21.066225782797595;6.039404009397101;7.050676185779127E-4;0.5588554019015759;[MEF2C, TGFB1, IHH, AXIN2, MAPK14, RUNX2, BMP2, TGFBI]
GO:0045820;negative regulation of glycolytic process;12.0;0.8933024483968273;0.8947715367885583;9.593432932680852;4965.344842205602;7.292166977892469;0.1661856233483844;0.8210420709600095;[FBP1, CBFA2T3]
GO:0002063;chondrocyte development;4.0;0.8933024483968273;0.6966512241984136;9.474373572664863;32.15320660831846;6.943860283624253;0.001076138889173156;0.6051093378270707;[SFRP2, COL11A1, SULF1, RUNX2, SULF2]
GO:0022900;electron transport chain;4.0;0.7140352122741334;0.6070176061370667;8.475844742553736;29.758801740447502;4.623782033182691;9.96000313069993E-4;0.48646042820481683;[DMGDH, NCF1, NCF2, COX6A1, LOXL2, CYBB, COX6B1, POR, COX7A2L, UQCRC1, NDUFB10, UQCRB, UQCRH, CYC1, UQCRQ, P4HA2, NOX4, COX7B, ETFA, COX7C, ALDH2, UQCRFS1, COX8A, GPX2, NDUFC2, NDUFS8, NDUFS7, ASPH, NDUFS6, NDUFS4, NDUFS3, NDUFB7, NDUFB6, NDUFB4, NDUFB3, NDUFB2, NDUFB1, UQCR10, COX5B, COX5A, SNCA, NDUFA8, NDUFA7, NDUFA6, NDUFA4, NDUFA3, NDUFA2, COX6C, NDUFAB1]
GO:0045824;negative regulation of innate immune response;7.0;0.6240278086381567;0.6629332695762788;8.460919092337061;174.18841360624353;5.970411137910149;0.005829929444006407;0.6562464685024372;[CLEC12B, TNFAIP3, NLRC3, DUSP10, DHX58, A2M, HAVCR2, CD96, CR1, ARG1, NR1H2, LILRB1, SERPINB9, IRAK3, MMP12, CEACAM1, SERPING1]
GO:0043401;steroid hormone mediated signaling pathway;6.0;0.7508913569872202;0.6985659910837546;8.801845679307654;25.735219620490994;4.909539177224887;8.613346405038622E-4;0.5741943744303455;[TGFB1I1, FHL2, HNF4G, RORA, BRCA1, NR3C2, HNF4A, YWHAH, MED1, CCNE1, RARA, PADI2, YAP1, NR1I2, LEF1, RXRA, VDR, NR1H2, NR1H4, DEFA1, NR2F2, NR4A2, NR4A1, NR4A3, NEDD4, RAN]
GO:0006417;regulation of translation;7.0;0.5221699919663294;0.6120043612403652;8.01908634005802;212.8215771898108;3.9901762463137618;0.007122946661558481;0.554977164055858;[CYFIP1, MAGOH, RPS6KA1, AKT1, SOX4, DAPK1, UPF3B, EIF2AK2, CD28, BTG2, BANK1, RARA, PTAFR, FAM129A, PURA, RXRA, PPP1CA, FMR1, TNF, IGFBP5, S100A9, EIF2S1, IL6, LIN28A, CNOT3, BCL3, GRM5, PPP1R15A, THBS1, CCL5, EIF4H, EIF3K, EIF3H, EIF3E, EIF3D]
GO:0032707;negative regulation of interleukin-23 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.96654663153603;9.083926447120524;0.002174371849661483;0.7876727335416686;[TLR4]
GO:0032700;negative regulation of interleukin-17 production;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;65.25422870398782;7.292166977892469;0.002184000309729388;0.6960420709600095;[TGFB1, IFNG, NCKAP1L, TLR4]
GO:0030520;intracellular estrogen receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;54.01143535742291;6.7325511899570465;0.0018077141342769656;0.719302980950052;[DEFA1, PADI2]
GO:0043410;positive regulation of MAPK cascade;10.0;0.6634067003016617;0.7469443620117512;9.174268980214526;1017.2390743488962;3.4929394666096676;0.03404607636272706;0.5938700986216354;[, IL1RN, PHB2, PROK2, TNFSF11, EPHB2, EPHB1, PRKCE, MIF, EPHA3, EPHA2, FPR1, TGFA, PDGFA, FPR2, SLC30A10, IQGAP3, PRKCZ, PDGFD, PDGFC, S100A12, ELANE, SLAMF1, CCR1, JUN, FZD5, LIF, FZD8, EIF2AK2, MARCO, NOX4, CD27, CD24, NOX1, EZH2, NRP1, CD40, TIMP2, CCR7, CD36, HAVCR2, MAP4K1, EDN1, GPR37, SYK, FCRL3, DUSP6, MDFIC, BANK1, IL1B, KIT, TLR6, PLCB1, TLR4, CCL13, CXCR4, GNAI2, PAK1, GPNMB, NTF3, CCL19, CCL18, CD74, CCL23, CCL21, CCL20, CARD9, OSM, CD40LG, PKN1, NCF1, TNF, CTGF, PYCARD, PDGFRB, PDGFRA, MAP2K2, IGFBP3, F2R, ADCYAP1, ADAM9, ADAM8, CSF1R, C5AR1, TNFRSF11A, ADRB2, RASGRP1, PSAP, DRD4, MAP2K6, TGFB2, TGFB1, CAV2, GH1, IL6, BMP2, CDK1, CSPG4, LRRK2, TREM2, PTPN22, GHR, XCL2, CHI3L1, XCL1, PDE5A, NOD2, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CSK, EGF, TIE1, MAPK14, CD4, LTBR, TEK, FCGR2B]
GO:0051279;regulation of release of sequestered calcium ion into cytosol;9.0;0.7369933605727446;0.7647373054666613;9.242861771680136;148.50473241193134;5.486614186532078;0.004970319748245178;0.676826329833192;[CXCL9, CAMK2D, THY1, CORO1A, SLC8A1, JPH2, PLN, CD19, DMD, PLCG1, SNCA, LYN, TGFB1, TRPC1, PRKCE, F2R, CXCL10, CXCL11, FKBP1B, XCL1, PTPN6, CALM3, F2RL3]
GO:0019730;antimicrobial humoral response;5.0;0.8259837884571596;0.7032329060895001;9.292052015870908;43.185159168215264;5.132682728539097;0.0014453684132401858;0.5527266452925662;[IGHM, CXCL6, CCL13, CXCL9, HIST1H2BK, CXCL1, CXCL13, CXCL3, CXCL2, CLU, CXCL5, GNLY, S100A12, CTSG, IGHA1, PRSS3, ELANE, CAMP, DEFA4, SLC11A1, RNASE6, RNASE3, AZU1, DEFA1, PPBP, LYZ, CXCL10, CXCL11, SLPI, BCL3, LCN2, PRTN3, BPI, S100A9, IGKV3-20, S100A8, LTF, PF4]
GO:0032930;positive regulation of superoxide anion generation;8.0;1.0;0.875;9.628524252492122;144.57516735605006;7.004484905440688;0.00483880074220378;0.7332096838060964;[TGFB1, ITGAM, PRKCD, ITGB2, FPR2, GNAI2, CD177]
GO:0019319;hexose biosynthetic process;6.0;0.7508913569872202;0.6985659910837546;9.148951172230236;135.7739215098454;5.8650506222523235;0.004544230964338322;0.6230592741648748;[CHST15, BPGM, FBP1, ATF3]
GO:0021879;forebrain neuron differentiation;6.0;0.7980440201809971;0.722142322680643;9.0094850440859;26.729186262933762;7.069023426578259;8.946018095145202E-4;0.6846304993685643;[CSF1R, BCL11B, LEF1, INHBA, SHANK3]
GO:0006002;fructose 6-phosphate metabolic process;5.0;0.8653626801206646;0.7229223519212526;9.34084218004034;72.82688802824934;7.57984905034425;0.0024374504023614934;0.6778748447945537;[FBP1]
GO:0006000;fructose metabolic process;6.0;0.7980440201809971;0.722142322680643;9.0689084645567;34.676020684410545;7.069023426578259;0.0011605752059146955;0.6846304993685643;[PFKFB4, ALDH1A1, FBP1]
GO:0042730;fibrinolysis;9.0;1.0;0.896240625180289;9.628524252492122;252.8988266382142;6.7325511899570465;0.008464296133413719;0.740543606130341;[SERPINB2, PLAU, PROS1, SERPINE1, PLAUR, SERPING1, GP1BA]
GO:0009756;carbohydrate mediated signaling;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;23.17027026302992;8.390779266560578;7.75488093814194E-4;0.7193458537639684;[COLEC12, CLEC7A]
GO:0032526;response to retinoic acid;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;43.78950961223322;5.123113277522946;0.0014655954787213788;0.5522372631225753;[YAP1, TNC, PHB2, AQP1, RXRA, MYB, CTSH, HOXA2, CD38, IGFBP7, LYN, ABCA1, PDGFRB, DUSP1, TIE1, KLF4, PAX2, COL1A1, RARA, EPHA3]
GO:0010977;negative regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;494.1264199049594;4.793467005972133;0.016537966589312465;0.6413787507847162;[NRP1, SEMA5B, LRRK2, CTSZ, ARHGAP4, LGALS1, ARHGDIA, TNR, CD38, EPHB2, YWHAH, SEMA6A, DCC, PAQR3, RGMA, NLGN1, LRP1, THY1, SPP1, LINGO1, PLK2, SEMA4B, PTK2, ID1, PMP22, ITM2C]
GO:0033619;membrane protein proteolysis;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;49.64990487012002;6.166155715036245;0.001661737633989536;0.6384578026126634;[HM13, PSEN2, CTSH, TGFB1, NFKB1, ADAM9, PRTN3, PRKCQ, RBMX]
GO:0010976;positive regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;493.1928131726474;4.231896183200907;0.016506719612173492;0.6126599927924817;[SCARB2, CYFIP1, CPNE5, PLXND1, FMR1, ARHGDIA, ADCYAP1, MAP1B, S100A9, EPHA3, LYN, FZD1, SYT2, FN1, CXCL12, FES, PLXNB2, EZH2, ROBO2, NRP1, NME1, SHANK3, NLGN1, RAB21, PAK1, CNR1, FYN, FKBP1B, CAMK1]
GO:0032760;positive regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.9095484537234;5.587418885654044;0.002875315273172136;0.6366602269110988;[ORM1, LRRK2, CLU, PYCARD, IFIH1, CD36, CCR2, HAVCR2, FCER1G, DDX58, CYBB, MIF, TLR1, IL23A, TLR4, TLR2, PTAFR, LY96, TWIST1, NOD2, THBS1, RASGRP1, CCL19, CD14, FZD5, CARD9, AZU1, CD2, PF4]
GO:0032765;positive regulation of mast cell cytokine production;9.0;1.0;0.896240625180289;9.628524252492122;311.82526325162985;8.67846133901236;0.010436510936514811;0.8400575416471059;[FCER1G, NR4A3]
GO:0060397;JAK-STAT cascade involved in growth hormone signaling pathway;8.0;1.0;0.875;9.628524252492122;26.42836680105094;7.212124270218933;8.845336528452411E-4;0.7438283705770736;[LYN, GHR, GH1, PRL, JAK3]
GO:0042747;circadian sleep/wake cycle, REM sleep;5.0;1.0;0.7902410118609202;9.628524252492122;21.52050227545479;8.67846133901236;7.202718439648486E-4;0.7340579283277371;[CST3]
GO:1905875;negative regulation of postsynaptic density organization;8.0;1.0;0.875;9.628524252492122;179.1445802505115;9.777073627680469;0.005995807881329661;0.875;[LILRB2]
GO:1904300;positive regulation of transcytosis;7.0;1.0;0.8509193652572005;9.628524252492122;59.34352194186286;9.777073627680469;0.001986174273691794;0.8509193652572005;[PTAFR]
GO:1904306;positive regulation of gastro-intestinal system smooth muscle contraction;9.0;0.8436909121759173;0.8180860812682478;9.360260265897443;88.99922634012424;7.9853141584524145;0.0029787240115004016;0.8046099625986299;[GHSR, PTAFR, KIT]
GO:0038063;collagen-activated tyrosine kinase receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;57.50475921673876;7.474488534686424;0.0019246325400609058;0.7572456912631272;[COL1A1, SYK, COL4A2, COL4A1]
GO:1904303;positive regulation of maternal process involved in parturition;5.0;1.0;0.7902410118609202;9.628524252492122;118.0711512965144;9.777073627680469;0.003951735176756968;0.7902410118609202;[PTAFR]
GO:0042742;defense response to bacterium;6.0;0.7866048967936545;0.7164227609869718;9.193206181234276;69.6526388451159;4.021331414093558;0.0023312111388408135;0.5287713881179241;[, SERPINE1, HP, CXCL13, TNF, MPO, PYCARD, IGHG1, TRBC1, IL6R, SLC11A1, PRKCD, RNASE6, RNASE3, CLEC4D, SLPI, IL23A, CLEC4E, S100A9, S100A8, SEH1L, C5AR1, CFP, KLRK1, NLRP3, S100A12, S100A14, IGHA1, ELANE, DEFA4, PRG2, ISG15, AZU1, DEFA1, PPBP, LYZ, SELP, IL6, BCL3, IGKV3-20, MYD88, IGHM, CXCL6, HMGB2, GNLY, STAB1, CTSG, CD36, CAMP, HAVCR2, IL10, FCER1G, SYK, ANXA3, TLR1, FGR, IGHD, LTA, BPI, TLR6, TLR5, TLR4, LTF, TLR2, CEBPB, CEBPE, HIST1H2BK, NLRC4, NOD2, IGKC, CCL20, CARD9, NR1H4, CD4]
GO:0006015;5-phosphoribose 1-diphosphate biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;251.39073302494668;7.9853141584524145;0.008413821597373791;0.7592887026755414;[PYGL]
GO:0048298;positive regulation of isotype switching to IgA isotypes;11.0;1.0;0.9324289523296623;9.628524252492122;1407.9016349495496;8.16763571524637;0.04712120069255247;0.8501222226412654;[TGFB1, MSH2, TNFSF13, MLH1]
GO:0071285;cellular response to lithium ion;6.0;1.0;0.8231203125901445;9.628524252492122;77.8106912628645;7.212124270218933;0.002604253811492351;0.6919486831672181;[CEBPA, CDH1]
GO:0031668;cellular response to extracellular stimulus;4.0;0.5452700253111464;0.5226350126555732;7.377232453885626;45.163559484697416;4.334655917158676;0.0015115836913881548;0.47167450518560927;[EHMT2, TNC, SESN3, LAMP2, SKP2, POSTN, CYBB, SFRP2, RRAGD, SIK1, ATF3, SEH1L, ABCB4, FOXO1, HMOX1, GAS2L1, LYN, JUN, EIF2AK2, EIF2S1, NR4A2, COL1A1, BCL2, CDKN1A, PLEKHF1, LRRK2, KRT20, ASGR1, UPP1, AVPR1A, FOS, SIRT1, AES, PTGS2, AIF1, FYN, NR1H4, SIPA1, FOXA3, FOXA2]
GO:0032757;positive regulation of interleukin-8 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;5.948432231191374;0.002183412136085803;0.6273234135236593;[FCN1, SERPINE1, NOD2, TNF, PYCARD, FFAR2, CD58, CD14, ELANE, DDX58, F2R, TLR1, CD2, IL1B, TLR8, TLR7, TLR5, TLR4, CD244, TLR2]
GO:0072378;blood coagulation, fibrin clot formation;6.0;1.0;0.8231203125901445;9.628524252492122;55.78978942234946;8.16763571524637;0.0018672340444153065;0.7408135829017477;[F13A1, FBLN1]
GO:0071286;cellular response to magnesium ion;6.0;1.0;0.8231203125901445;9.628524252492122;77.8106912628645;7.9853141584524145;0.002604253811492351;0.7314896500084853;[FBP1]
GO:0016042;lipid catabolic process;4.0;0.5127202928476964;0.5063601464238482;6.883086519318291;43.14795622097559;4.114113147544524;0.0014441232640765526;0.4603959376912539;[GBA3, ABHD12, CYP1B1, PLBD1, SLC27A2, PLD4, PLA2G7, PLD3, ACAT1, PLCG1, RARRES3, CYP4F2, FUCA1, CYP4F3, SRD5A3, CYP4F12, ETFA, GM2A, ACADM, HIBCH, YWHAH, CYP4A11, EHHADH, PLCB1, HSD17B4, AOAH, CYP3A4, SPP1, PNPLA8, FABP1, SNX17, FABP7, PNPLA6]
GO:0031663;lipopolysaccharide-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;6.343086423195323;8.87013979980389E-4;0.647506047256038;[PTAFR, LY96, PTPN22, TNF, CCL5, AKT1, CCL2, CD14, LYN, TGFB1, PRKCE, IL18, MAPK14, NFKBIA, HCK, CD6, IL1B, TLR4, TLR2]
GO:0016045;detection of bacterium;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;95.72483819449377;7.697632086000634;0.0032038241876084527;0.7167775754447168;[NLRC4, CD1D, NOD2]
GO:0010744;positive regulation of macrophage derived foam cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;113.85781812010546;7.004484905440688;0.0038107187070962377;0.6813299963962409;[MSR1, PRKCH, AGTR1, IL18, CD36, NFKB1, PF4]
GO:0016046;detection of fungus;6.0;0.8653626801206646;0.7558016526504768;9.474373572664863;96.01252026694556;9.777073627680469;0.0032134526476763577;0.8231203125901445;[TLR4]
GO:0031666;positive regulation of lipopolysaccharide-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;344.2408759115043;7.697632086000634;0.011521432320083432;0.7445766281117727;[CD180, LY86, LY96, MIF]
GO:0032755;positive regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.94897299966192;5.395046993006588;0.0021737836760178982;0.5990232667078439;[IL1RN, TNF, PYCARD, IFIH1, CD36, IL6R, FCER1G, DDX58, F2R, EREG, TLR1, ADCYAP1, IL1A, IL1B, TLR8, TLR7, TLR6, TLR4, TLR2, PTAFR, TWIST1, NOD2, HSPD1, IL33, CARD9, LILRB2, MAPK13, IL6, MYD88, IL17A]
GO:0030334;regulation of cell migration;6.0;0.4770562410916853;0.5616484331359872;7.1128459440373675;36.74126027361157;3.1319826581748256;0.0012296969163702938;0.48329005138129355;[SERPINE1, ADARB1, MYLK, C3AR1, AKT1, CYP1B1, HOXA7, MEF2C, PRKCE, PADI2, PDGFA, FPR2, GATA3, THY1, PLA2G7, EPB41L5, KLRK1, FLRT2, PDGFD, PDGFC, HMOX1, NCKAP1L, S100A14, PLCG1, ELANE, LYN, JUN, JAG1, ACE, HACE1, JUP, PLK2, FN1, NR2F2, COL1A1, NOX4, SNAI2, GPR18, ARHGAP4, MMP28, TIMP1, ANXA1, ANXA3, SIRT1, F3, TMEFF2, PLCB1, HBEGF, ENG, PTAFR, PTGS2, GPNMB, NTF3, FLNA, CCL19, JAM3, CCL21, CCL20, SULF1, COL3A1, PF4, SEMA5B, PLXND1, ATP8A1, ITGA2B, CXCL13, TNF, SLC8A1, CXCL16, PYCARD, DACH1, PHLDA2, SEMA6A, IGFBP5, IGFBP3, F2R, TPM1, ADAM9, ADAM8, CD274, CSF1R, CD151, TACSTD2, CORO1A, CXCL10, CXCL11, DAB2, CXCL12, PTPRC, BCL2, PLXNB2, ITGB3, PIK3CD, CYR61, DUSP10, EMILIN1, ITGA4, XCL2, XCL1, CX3CR1, LRP1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, SEMA4B, TIE1, KLF4, IL1RN, SPARC, LGALS3, IL1R1, ACTN4, MIF, SFRP2, IL23A, PFN1, TRIB1, EPHA2, CCR1, TNFSF14, PPBP, PTK2, BST1, NRP1, PTPRR, NRP2, ECM1, CD40, PTPRK, EPB41L4B, RAC2, CTSH, CCR7, CCR6, CCR2, EDN1, GAB1, IL1A, CEACAM1, CEACAM6, IL1B, KIT, SGK1, SP100, AIF1, GNAI2, PAK1, CXCR3, CXCR2, PDPN, MPP1, CD74, IL33, PODN, DLC1, ETS1, PLAU, ARHGDIB, IL6R, PDGFRB, PDGFRA, POSTN, VCL, C5AR1, STAP1, TGFB2, TGFB1, SELP, VIL1, IL6, BMP2, NR4A3, DOCK5, CXCL6, CXCL9, DOCK4, MCTP1, TNFAIP6, LAMC2, CXCL1, CXCL3, CXCL2, CXCL5, MYOCD, DDX58, ARAP3, MMP9, DCN, FGR, GREM1, IFNG, LAMA4, LAMA3, LEF1, THBS1, EGF, LAMB1, MAPK14, SOD2, TEK]
GO:0030336;negative regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.20713857156096;158.04059951544355;4.3090134865453384;0.00528947663847651;0.5712825153487487;[IL1RN, SERPINE1, ADARB1, CXCL13, DACH1, ARHGDIB, CYP1B1, HOXA7, MEF2C, IGFBP5, IGFBP3, TPM1, MIF, SFRP2, PADI2, TRIB1, VCL, TACSTD2, THY1, KLRK1, STAP1, HMOX1, TGFB1, JAG1, JUP, NR2F2, CXCL12, BCL2, GPR18, PTPRR, MCTP1, PTPRK, ARHGAP4, DUSP10, MMP28, EMILIN1, TIMP1, MYOCD, ARAP3, DCN, GREM1, TMEFF2, PLCB1, ENG, CX3CR1, SP100, LRP1, THBS1, AIF1, CCL2, IL33, CCL21, TIE1, PODN, KLF4, SULF1, COL3A1, DLC1]
GO:0032753;positive regulation of interleukin-4 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.94897299966192;6.686031174322154;0.0021737836760178982;0.665044257777226;[CD86, IL33, CEBPB, PRG2, GATA3, CD3E, PRKCZ, CD40LG, CD28, RARA, NLRP3, PRKCQ, HAVCR2]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[SPARC, SERPINE1, MYLK, LGALS3, C3AR1, AKT1, IL1R1, PRKCE, ACTN4, IL23A, PFN1, PDGFA, FPR2, GATA3, THY1, PLA2G7, EPB41L5, PDGFD, PDGFC, HMOX1, NCKAP1L, S100A14, PLCG1, ELANE, LYN, CCR1, JUN, TNFSF14, PLK2, FN1, PPBP, PTK2, COL1A1, NOX4, SNAI2, NRP1, NRP2, CD40, EPB41L4B, RAC2, CTSH, CCR7, CCR6, CCR2, EDN1, ANXA1, ANXA3, GAB1, SIRT1, F3, IL1A, CEACAM6, IL1B, KIT, HBEGF, PTAFR, PTGS2, AIF1, GNAI2, PAK1, GPNMB, CXCR2, PDPN, NTF3, FLNA, CCL19, CD74, CCL21, CCL20, PF4, SEMA5B, ATP8A1, ITGA2B, CXCL13, TNF, ETS1, SLC8A1, CXCL16, PYCARD, PLAU, IL6R, PDGFRB, PDGFRA, POSTN, SEMA6A, IGFBP5, F2R, ADAM9, ADAM8, CD274, CSF1R, CD151, C5AR1, CORO1A, TGFB2, TGFB1, SELP, VIL1, CXCL10, CXCL11, IL6, BMP2, DAB2, CXCL12, PTPRC, NR4A3, BCL2, DOCK5, CXCL6, CXCL9, DOCK4, TNFAIP6, ITGB3, PIK3CD, LAMC2, CXCL1, CXCL3, CXCL2, CXCL5, CYR61, ITGA4, MMP9, FGR, IFNG, XCL2, XCL1, LEF1, THBS1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL1, EGF, SEMA4B, LAMB1, MAPK14, SOD2, TEK]
GO:0032754;positive regulation of interleukin-5 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;7.212124270218933;0.002183412136085803;0.6919486831672181;[IL33, RARA, NLRP3, GATA3, PRKCZ, IL17RB]
GO:0031665;negative regulation of lipopolysaccharide-mediated signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.582004236857228;344.71221365858594;7.212124270218933;0.011537207570301822;0.7197477358342742;[TNFAIP3, TRIB1, LILRA2, LTF]
GO:0042759;long-chain fatty acid biosynthetic process;9.0;0.7980440201809971;0.7952626352707877;9.372590878354922;458.549617088559;6.375876246018314;0.015347243016091356;0.722303232910233;[ELOVL6, PTGS2, CYP3A4, ALOX5, PLP1]
GO:1903223;positive regulation of oxidative stress-induced neuron death;9.0;0.9326813400603323;0.8625812952104552;9.582004236857228;363.38011971363295;8.390779266560578;0.012162005585939545;0.8253454670833372;[TLR6, TLR4]
GO:1904317;cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine;6.0;1.0;0.8231203125901445;9.628524252492122;456.1864936163678;9.777073627680469;0.015268151400150165;0.8231203125901445;[PTAFR]
GO:0009972;cytidine deamination;11.0;1.0;0.9324289523296623;9.628524252492122;2918.4586051188953;7.474488534686424;0.09767818307110789;0.8146746435927894;[CDA, APOBEC3A]
GO:1904798;positive regulation of core promoter binding;7.0;1.0;0.8509193652572005;9.628524252492122;62.59990527316089;7.9853141584524145;0.002095162493235609;0.7592887026755414;[IFNG, KLF4]
GO:0051222;positive regulation of protein transport;7.0;0.5960880403619941;0.6489633854381975;8.01908634005802;87.54714069787482;3.816068288057196;0.0029301240118465477;0.5460732749737691;[, SOX4, WLS, MED1, PRKCE, PRKCD, GOLPH3L, MIF, PDZK1, CFTR, TWIST1, GATA3, PRKCZ, SFN, CD14, JUP, FZD5, ACHE, ORM1, IFIH1, RAC2, CD38, FFAR2, CD34, HAVCR2, IL10, SYK, IL17RB, MMP12, TLR1, IL1A, IL1B, IGHD, TLR8, RHOU, TLR4, TLR2, PTGS2, PAK1, CD58, CCL19, IL33, NR1H2, NR1H4, NLRP12, CAMK1, IL17A, FCN1, CHRM1, TNF, PYCARD, CDH1, CLEC5A, POSTN, F2R, ADAM9, ADAM8, CLEC4E, BLK, CD274, CSF1R, RASGRP1, TMEM27, NLRP3, ECT2, MYH10, TGFB2, TGFB1, CRTAM, IL6, CDK1, ITGAM, LRRK2, ITGB2, PTPN22, CHUK, DDX58, FGR, IFNG, LRP1, NOD2, ABLIM3, FYN, MAPK14, CD2, CD244]
GO:0097421;liver regeneration;6.0;1.0;0.8231203125901445;9.628524252492122;47.21654787453615;6.250713103064308;0.0015802953652264606;0.6427820713687392;[IL10, CEBPB, PCNA, TGFB1, IHH, SULF2, NFKBIA, HMOX1, EZH2]
GO:0009968;negative regulation of signal transduction;6.0;0.43649654099988644;0.5413685830900877;6.680044863788677;140.65047919891595;2.686163805600486;0.0047074449615745265;0.460490854527945;[, PID1, SERPINE1, SLA2, PHB2, STMN1, AKT1, HOMER3, UBASH3A, PRKACB, DAPK1, PRKCD, PADI2, PRKCQ, ATF3, GATA3, THY1, ADAMTS12, GATA1, PRKCZ, FLRT2, FIGNL1, PRDM16, HMOX1, LYN, FZD1, SNAI2, EZH2, TGFB1I1, LRRC4, TIMP2, TIMP3, DUSP2, DUSP1, ARG1, FCRL3, BGN, PAWR, SIRT1, DUSP6, AES, MMP12, PXDN, LRRC19, PTGS2, FRZB, NR1H2, NR1H4, TMEM64, SULF1, SULF2, LGR4, PF4, RORA, TNF, CLU, PYCARD, SESN3, RUVBL2, MEN1, TLE4, RNF43, IGFBP5, CISH, IGFBP3, CSF1R, LY96, FOXO1, SOCS2, WFS1, TNFRSF10B, PTPRE, DAB2, CXCL12, PTPRC, BCL6, BCL3, BCL2, CCDC22, BCL2L1, LRRK2, FASLG, PTPN22, HHEX, LBH, DUSP10, EMILIN1, PVRIG, CX3CR1, PPP1R15A, LRP1, NLRC3, LRP2, CCL5, FYN, CSK, CTHRC1, TIE1, KLF4, PTPN6, IL1RN, LGALS3, PPP2R1A, DHX58, EPHB2, EPHB1, IL1R2, PAQR3, MIF, RUNX2, SFRP4, SFRP2, CDC34, SIK1, TRIB1, EPHA3, EPHA2, TWIST1, APCDD1, PKHD1, INPP5D, CD14, SLAMF1, EGR1, LIF, VNN1, CALM3, NRP1, PTPRR, ECM1, BRCA1, CD3E, STRADB, RHOH, GP1BA, IL1A, CEACAM1, BANK1, IL1B, KIT, TLR6, TLR4, YAP1, IFI6, LILRA2, GNAI2, CTNNA1, CD74, PODN, NLRP12, KIF26A, DLC1, NEDD4, FKBP1B, GRINA, RGS1, PDGFRB, PDGFRA, TSC2, HGS, HTRA1, FBLN1, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, CAV2, CAV1, ARHGAP25, NR4A2, NFKBIA, IL6, BMP2, FBN1, HMGB2, TNFAIP3, LRRTM4, NUP62, PTGIR, MYOCD, PLAUR, ARAP3, IRAK3, AXIN2, MMP9, DCN, DNM2, TGFBR3, GREM1, NDUFS3, ZMYND11, FBP1, PFDN5, LTF, BCL2A1, CLEC12B, TAF9, LEF1, THBS1, SNCA, EGF, MAPK14, SOD2, TEK]
GO:0010716;negative regulation of extracellular matrix disassembly;7.0;1.0;0.8509193652572005;9.628524252492122;86.13995449886744;8.390779266560578;0.002883026756151129;0.7800242071602487;[DPP4, CST3, TGFB1, FAP]
GO:0032509;endosome transport via multivesicular body sorting pathway;6.0;0.8436909121759173;0.7449657686781032;9.446202695698167;62.963525230995856;6.599019797332524;0.002107332525987629;0.6605944919115335;[SORT1]
GO:0032740;positive regulation of interleukin-17 production;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;65.23665507211369;7.212124270218933;0.002183412136085803;0.6919486831672181;[TGFB1, IL23A, IL18, PRKCQ, NOD2, LY9, MYD88]
GO:0010951;negative regulation of endopeptidase activity;10.0;0.7671156992804218;0.7987988615011312;9.446202695698167;500.3238742612354;4.2676852910524925;0.016745389809270216;0.6334906361130068;[PROS1, SERPINE1, SPINT2, AQP1, LAMP3, RPS6KA1, AKT1, APLP2, POR, SFRP2, SPINT1, SLPI, SERPING1, NAIP, C3, SFN, A2M, TNFSF14, TNFRSF10C, CRIM1, TNFRSF10B, DHCR24, VIL1, CD27, TNFAIP8, SERPINA1, TIMP2, TIMP3, TIMP1, CR1, SERPINB2, PLAUR, SERPINB9, TNFRSF1B, MMP9, PAX2, COL6A3, BIRC5, LTF, BIRC3, SERPINB10, CSTA, LEF1, IFI6, NLRC4, PTGS2, CST7, THBS1, CST3, SPOCK3, SNCA, KLF4, FABP1]
GO:0032741;positive regulation of interleukin-18 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.94897299966192;8.390779266560578;0.0021737836760178982;0.7522251544931926;[TLR2]
GO:0010711;negative regulation of collagen catabolic process;6.0;1.0;0.8231203125901445;9.628524252492122;104.12861204372116;9.777073627680469;0.0034850909354366545;0.8231203125901445;[CST3]
GO:1903232;melanosome assembly;7.0;1.0;0.8509193652572005;9.628524252492122;62.72328125453724;8.16763571524637;0.0020992917763011008;0.7686126355688037;[RAB32]
GO:0006470;protein dephosphorylation;7.0;0.7586651285174919;0.7302519295159464;9.223059144383958;177.1697810635027;4.458953633836253;0.005929713129744359;0.5789504614541361;[PPP2R1A, CDC25A, PTPRE, PTPRC, BCL2, PTPRR, PTPN22, PTPRK, DUSP10, DUSP2, PPP1R12A, DUSP1, DUSP6, LCK, PPP1R15A, TPTE, CPPED1, PPP1CA, PTPN6, PTPN7, PTPN4]
GO:0009743;response to carbohydrate;4.0;0.6347111282356054;0.5673555641178027;8.102467948997072;27.321196622860832;4.720827822332161;9.144158634865458E-4;0.49142335437501145;[SPARC, SLC8A1, CTGF, LGALS1, HNF4A, SOX4, MEN1, RMI1, HNF1B, PAX2, NME1, IL1B, COL6A2, CALCRL, PTGS2, THBS1, CST3, MAP2K6, LYN, EGR1, EIF2B3, TGFB1, MAPK13, LIN28A, FKBP1B, NOX4]
GO:1903238;positive regulation of leukocyte tethering or rolling;10.0;1.0;0.9152410118609203;9.628524252492122;440.9461040801303;8.390779266560578;0.014758069277832396;0.8443458537639685;[ITGA4, PTAFR, ELANE, CCR2]
GO:0007567;parturition;3.0;1.0;0.6981203125901445;9.628524252492122;32.8060485501291;7.57984905034425;0.0010979889214459554;0.585754145523778;[MAFF, PTAFR]
GO:0030316;osteoclast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;47.07409398820286;6.375876246018314;0.0015755275618510598;0.6491829203200885;[CSF1R, TGFB1, FCER1G, TFRC, TREM2, TNFRSF11A, GAB2, MAPK14, TNF, OSCAR, TYROBP, TNFSF11, JUNB, EPHA2]
GO:0032735;positive regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.311337724880743;0.002183412136085803;0.6458824173477649;[CD40, HSPD1, CCR7, CD36, CCL19, MAPK14, CD40LG, IFNG, IL23A, LTB, PLCB1, TLR4, TLR2]
GO:0098761;cellular response to interleukin-7;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;9.777073627680469;0.0027327542132076126;0.8231203125901445;[BTK]
GO:0032736;positive regulation of interleukin-13 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;7.069023426578259;0.002183412136085803;0.6846304993685643;[IL33, RARA, NLRP3, GATA3, PRKCZ, IL17RB]
GO:0031641;regulation of myelination;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.055147161688105;6.250713103064308;0.001407547928326502;0.6427820713687392;[TYMP, RARA, AKT1, WASF3]
GO:0032733;positive regulation of interleukin-10 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.375876246018314;0.002183412136085803;0.6491829203200885;[CD274, CD83, FCER1G, NOD2, PRKCZ, HSPD1, PYCARD, CD40LG, IL23A, BCL3, CD28, XCL1, TIGIT, TLR4, CD34, TLR2]
GO:0007252;I-kappaB phosphorylation;8.0;1.0;0.875;9.628524252492122;180.75330000196035;7.292166977892469;0.006049650283656873;0.747921758369865;[CHUK, TLR7, TLR4, TLR2]
GO:0090331;negative regulation of platelet aggregation;10.0;0.9326813400603323;0.8815816818910864;9.601125278304007;548.6740902153413;7.379178354882098;0.01836362802488484;0.7926125360964777;[CEACAM1, PRKCD, CD9]
GO:1904058;positive regulation of sensory perception of pain;8.0;1.0;0.875;9.628524252492122;66.22319046309637;8.16763571524637;0.0022164305877977837;0.7926932703116032;[PTAFR]
GO:0009435;NAD biosynthetic process;11.0;0.7980440201809971;0.8314509624201607;9.500690880982237;2002.0309936558642;5.825829909099042;0.06700617564674446;0.730362164809784;[PTGS2, HK3, KYNU, BPGM, KMO, PARP9]
GO:0042495;detection of triacyl bacterial lipopeptide;8.0;1.0;0.875;9.628524252492122;192.9668546023468;9.083926447120524;0.006458426964646296;0.839552420951524;[TLR1, TLR2]
GO:0046854;phosphatidylinositol phosphorylation;8.0;1.0;0.875;9.628524252492122;218.7418113453505;5.049685808968129;0.007321091570879569;0.6332411671050352;[CD86, CD80, PIK3CD, SLA2, FGF5, IMPA2, PDGFRB, PDGFRA, CISH, GAB1, TTC7B, VAV1, EREG, BTC, LCK, KIT, HBEGF, PDGFA, SOCS2, CD19, FYN, PIP5K1B, ICOS, TRAT1, EGF, KITLG, CD28]
GO:0090330;regulation of platelet aggregation;9.0;0.8259837884571596;0.8092325194088689;9.533214072687796;97.23557350837086;6.943860283624253;0.0032543871389904074;0.7513499630073597;[LYN, CEACAM1, SYK, PDPN, PRKCD, CD9, PRKCQ]
GO:0007257;activation of JUN kinase activity;14.0;1.0;0.9759193652572005;9.628524252492122;8640.54909511404;6.088194173566533;0.2891914022241413;0.7872698984233759;[TNFSF11, CCL19, MAP4K1, SYK, CD40LG, MDFIC, PKN1]
GO:0042496;detection of diacyl bacterial lipopeptide;8.0;1.0;0.875;9.628524252492122;192.9668546023468;9.083926447120524;0.006458426964646296;0.839552420951524;[TLR6, TLR2]
GO:0045762;positive regulation of adenylate cyclase activity;12.0;0.8933024483968273;0.8947715367885583;9.589303539338841;6276.064729494611;7.697632086000634;0.21005423840463325;0.8417775754447168;[LHCGR, TIMP2, TSHR]
GO:0007254;JNK cascade;11.0;1.0;0.9324289523296623;9.628524252492122;290.6144555783003;5.926926025970411;0.009726604292176047;0.735532224928036;[NOD2, TNF, TRIB1]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[NRP1, ECM1, CD40, SERPINE1, ITGB2, ADM, BRCA1, ETS1, AQP1, CDH5, C3AR1, CTSH, CYP1B1, ITGB8, CD34, IL10, PPP1R16B, GHSR, ANXA1, ANXA3, GAB1, CYBB, SIRT1, F3, GREM1, IL1A, SFRP2, IL1B, ADAM12, AGTR1, CHI3L1, ENG, CX3CR1, C5AR1, TWIST1, PTGS2, DLL1, THBS1, C3, CXCR2, HMOX1, PLCG1, JUP, PLK2, TNFSF12, KLF4, LRG1, TEK]
GO:0007016;cytoskeletal anchoring at plasma membrane;6.0;1.0;0.8231203125901445;9.628524252492122;66.89368938276097;7.474488534686424;0.002238871583229107;0.7053660038532718;[JUP, EPB41L3, TLN1]
GO:0046855;inositol phosphate dephosphorylation;8.0;0.9326813400603323;0.8413406700301662;9.590783924509275;336.6569207659842;7.138016298065211;0.011267604166479381;0.7400384854347593;[IMPA2]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[IHH, EDNRA, PDGFRA, TPM1, MSH2, TWIST1, GATA3, GATA1, EPB41L5, CCNB2, CCNB1, PLCG1, MYH10, STIL, EIF2S2, BMP2, MAFF, BCL2L1, PTPRR, TMEM100, HHEX, EDN1, RXRA, TIE1]
GO:0034620;cellular response to unfolded protein;6.0;0.9326813400603323;0.7894609826203107;9.5544162803384;123.17901887317109;6.8867018697843045;0.004122690907765296;0.6753065664753021;[HSPA6]
GO:0031116;positive regulation of microtubule polymerization;10.0;0.8933024483968273;0.861892236059334;9.589303539338841;431.61701704611926;6.518977089658987;0.014445833130437288;0.7486218033895181;[PAK1, PSRC1, FES]
GO:0032689;negative regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.343086423195323;0.002184000309729388;0.647506047256038;[IL10, CD274, CD96, IL33, NR1H4, LILRB1, INHBA, PDCD1LG2, GATA3, RARA, XCL1, TLR4, HAVCR2]
GO:0071805;potassium ion transmembrane transport;9.0;0.8259837884571596;0.8092325194088689;9.456673995565463;120.6235085317852;4.695669262696007;0.004037160276449102;0.636377369645515;[KCNK5, KCNG2, KCNE3, KCNE4, SLC1A3, KCNA5, AQP1, KCNMB3, KCNN3, KCNH1, SLC12A2, KCNH2, KCND2, SLC12A1, KCNJ15, KCNJ16, ATP1B2, ATP1B1, KCNQ1, FXYD2]
GO:0007263;nitric oxide mediated signal transduction;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;27.814661162170232;6.832634648514029;9.309316775279788E-4;0.7003406189322132;[FPR1, CD36]
GO:0007264;small GTPase mediated signal transduction;6.0;0.7369933605727446;0.6916169928765168;8.741221057491218;26.42836680105094;4.015022244900292;8.845336528452411E-4;0.5284487369119741;[CYFIP1, CELSR1, EPS8, GRAP2, ARHGDIA, ARHGDIB, RAB32, DOK2, DOK3, RAB31, AGTR1, RIN2, IQGAP3, RASGRP1, RASGRP4, HMOX1, JUN, HACE1, PLK2, DHCR24, ARHGAP30, COL1A2, BCL6, RGL4, RGL1, LAT, DOCK5, CDKN1A, DOCK4, ARHGAP6, ARHGAP4, RAC2, RALGPS2, ARHGEF12, CHUK, RHOG, RHOH, VAV1, RAB33B, CCNA2, RHOU, AIF1, RAB21, PAK1, PDPN, EPS8L1, EPS8L3, DNAJA3]
GO:0045773;positive regulation of axon extension;11.0;0.8933024483968273;0.8790801765280758;9.582004236857228;1257.908905926367;6.113511981550823;0.04210107903683872;0.7450742393735527;[CYFIP1, NRP1, FN1, PAK1, CXCL12, MAP1B]
GO:0046627;negative regulation of insulin receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.517298617381897;294.34753946768484;6.311337724880743;0.009851547250396369;0.6736814700148209;[PID1, CISH, PRKCD, TSC2, SLA2, PRKCZ, SOCS2, PTPRE, IL1B, PRKCQ]
GO:0001954;positive regulation of cell-matrix adhesion;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;50.25702962731741;5.926926025970411;0.0016820575532361247;0.6262235851885184;[NRP1, THY1, PRKCZ, EPB41L5, CCR7, CD36, JUP, CCL21, CEACAM6, NINJ1, TEK]
GO:0045780;positive regulation of bone resorption;7.0;1.0;0.8509193652572005;9.628524252492122;82.90338698468558;6.943860283624253;0.002774701754173115;0.7060287030842711;[TFRC, SYK, CA2, SPP1, TNFSF11, ADAM8, TNFRSF11A, TMEM64]
GO:0086091;regulation of heart rate by cardiac conduction;8.0;1.0;0.875;9.628524252492122;61.172773623059015;6.193554689224359;0.002047397681241798;0.6917386748366816;[DSP, KCNH2, CAMK2D, JUP, KCNE3, KCNQ1, CAV1, KCNA5]
GO:0010668;ectodermal cell differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;8.390779266560578;7.050676185779127E-4;0.6791048419030481;[ITGAM]
GO:0031100;animal organ regeneration;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;28.087648497102798;5.420364800990877;9.400683179555208E-4;0.5271977079954144;[CDKN1A, CEBPB, PCNA, C5AR1, IHH, ADM, ATIC, HMOX1, IL10, MED1, TGFB1, ANXA3, CAD, SULF2, TGFBR3, NFKBIA, CCNA2, CXCL12, NR4A3, CDK1, LCP1, EZH2]
GO:0018149;peptide cross-linking;7.0;0.6007507099811141;0.6512947202477576;8.117066748418225;151.15475272427284;5.69953618377475;0.005059013543235805;0.6423939107509793;[DSP, CSTA, ANXA1, EPB42, FN1, BGN, F13A1, THBS1, DCN, COL3A1, SPOCK3]
GO:0032436;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;11.0;0.8259837884571596;0.845420846558242;9.498471124243924;3778.5456327194074;5.334422371190153;0.12646452185682636;0.705231560468336;[LRRK2, CLU, AKT1, CBFA2T3, RNF144B, TRIB1, CEBPA, IL33, PLK2, CAV1, PLK1, DAB2]
GO:0034614;cellular response to reactive oxygen species;5.0;0.7671156992804218;0.6737988615011312;9.197741336399668;144.094088465717;5.076593261888053;0.004822699464687224;0.5498582273596049;[NCF1, TNFAIP3, PTPRK, ETS1, AQP1, IL18RAP, MYB, AKT1, CYP1B1, PDGFRA, ANXA1, CHUK, ARG1, TPM1, PRKCD, FOS, MMP9, SIRT1, PAX2, DNM2, CCNA2, BTK, PCNA, FOXO1, CST3, PDGFD, ECT2, JUN, KLF4, MAPK13, FABP1, IL6, CDK1, EZH2]
GO:0071800;podosome assembly;5.0;1.0;0.7902410118609202;9.628524252492122;81.13164658075348;7.697632086000634;0.00271540319731635;0.6838982747154925;[BIN2, NCF1, NCF1C]
GO:0071801;regulation of podosome assembly;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;64.45443428147517;7.069023426578259;0.002157231910176139;0.7124295520356204;[HCK, GSN, LCP1, TNF]
GO:0070508;cholesterol import;8.0;1.0;0.875;9.628524252492122;77.49126092049113;7.9853141584524145;0.0025935627654017587;0.7833693374183408;[CD36]
GO:1905167;positive regulation of lysosomal protein catabolic process;10.0;1.0;0.9152410118609203;9.628524252492122;1228.6477635104636;8.67846133901236;0.041121734933496905;0.8590579283277371;[LRP1, LRP2]
GO:0090314;positive regulation of protein targeting to membrane;10.0;0.9326813400603323;0.8815816818910864;9.587702257971866;497.0805077511855;6.343086423195323;0.016636837251019197;0.7396267465268138;[, ITGAM, ITGB2, PDZK1, PAK1, FYN]
GO:0048812;neuron projection morphogenesis;7.0;0.6547035408479693;0.6782711356811852;8.502512989635898;62.99970935475633;4.360973225476049;0.002108543576046295;0.5739397388140403;[ADARB1, STMN1, EPHB2, EPHB1, MNX1, MEF2A, MAP1B, SDC2, EPB41L3, NCKAP1L, GP5, PTK2, NR4A2, LRFN4, OGN, BCL2, NRP1, LRRK2, RAC2, DCC, STRADB, PAX2, DNM2, CDH11, SGK1, DSCAML1, SHANK3, NLGN1, LRP2, PAK1, NTF3, SLITRK6, FYN, LINGO1, POU4F1, WEE1]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[IL1RN, GOLT1B, TNF, LGALS1, AKT1, TNFSF11, TRIM25, WLS, PRKCE, F2R, CARD11, S100A12, HMOX1, ECT2, NDFIP2, PLK2, TNFRSF10B, CCDC22, MYD88, ECM1, CD40, SECTM1, FASLG, NUP62, CCR7, CD36, CHUK, ZDHHC17, IL1B, TLR6, LTF, BIRC3, NOD2, FLNA, FYN, CCL19, CD74, CCL21, CARD9, CD4, LTBR]
GO:0045786;negative regulation of cell cycle;5.0;0.5089359064165209;0.5447089650691808;7.0970975870692286;42.34575940812408;3.5270983854209863;0.0014172744586806725;0.47061698731819834;[EHMT2, SMC3, UXT, CHEK1, FBXO5, PRKACB, SOX4, MIF, RRAGD, AURKAIP1, GATA3, TP53BP2, SFN, BARD1, PLK2, PLK1, LIF, CDC6, NR2F2, ZWINT, STAG2, EZH2, TOP2A, CDKN1A, BTG2, PTPRK, BRCA1, BRCA2, BMI1, TIMP2, IL10, DUSP1, STRADB, GAS1, PCNA, PTGS2, GPNMB, CDKN2C, LILRB1, CENPF, FAP, SIPA1, MAD2L1, ZWILCH, GMNN, BUB1B, TNF, KNTC1, MEN1, MSH6, ADCYAP1, MSH2, MAD1L1, BLM, CUL5, CCNB1, NACC2, NAE1, GAS2L1, MAP2K6, FANCI, TGFB2, TGFB1, DHCR24, INHBA, NR4A1, BMP2, BCL6, CNOT3, JMY, CDK1, BCL2, BCL2L1, TNFAIP3, HHEX, TOPBP1, MYOCD, H2AFX, SMC1A, TFDP1, IFNG, DTL, PPP1R15A, CEBPA, THBS1, AURKB, RBBP8, E2F1, CCL2, BUB1, E2F7, RRM2, DONSON, MAPK14, KLF4, PML, WEE1, RAD51]
GO:0097190;apoptotic signaling pathway;5.0;0.6954798709641801;0.6379809473430103;8.529911963824013;23.17027026302992;4.145861845859104;7.75488093814194E-4;0.5022605794604473;[TNF, PYCARD, CYP1B1, IL6R, DAPK1, PRKCD, MSH6, MELK, MSH2, IFI27, LGALS12, BTK, EPHA2, CUL5, LY96, TNFRSF11A, TP53BP2, HMOX1, SFN, CD14, TGFB2, TGFB1, TNFSF12, CAV1, TNFRSF10C, TNFRSF10B, INHBA, JMY, BCL3, CD28, BCL2, CD27, CD24, BCL2L1, CDKN1A, CD40, FASLG, BRCA1, BRCA2, CD3E, CD38, DCC, PAWR, TNFRSF1B, SIRT1, IL1A, IFNG, IL1B, TLR4, PPP1R15A, CEBPB, BCL2A1, IFI6, PERP, E2F1, E2F2, CASP8AP2, IL33, SORT1, G0S2, GZMB, MLH1, POU4F1, PML, GZMH, CD5]
GO:0043124;negative regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.487551390376;6.063501560976162;0.008015432820232688;0.6850877518099798;[TNFAIP3, RORA, NLRC3, PYCARD, NR1H4, RHOH, SIRT1, NLRP12, CCDC22, ZMYND11]
GO:0046638;positive regulation of alpha-beta T cell differentiation;10.0;0.7671156992804218;0.7987988615011312;9.488762310116963;1285.3660192826185;5.970411137910149;0.04302004391107474;0.7205681151061569;[CD86, CD83, CD80, IHH, PRKCZ, HLX, MYB, NLRP3, NCKAP1L, CCL19, IL12RB1, ANXA1, SYK, IL18, ZAP70, IFNG, IL23A, RARA]
GO:0043129;surfactant homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;28.07196958697662;7.474488534686424;9.395435589437007E-4;0.7331650565203278;[CTSH]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[NRP1, ITGAM, ITGB5, ITGB4, ITGB3, ITGA2B, ITGB2, ITGAL, CTGF, ADAMTS1, ITGAX, ITGB8, ITGB7, ITGB6, FCER1G, SYK, ITGA4, VAV1, FGR, HCK, CEACAM1, TYROBP, ADAM9, ITGA7, TLN1, CDH17, TXK, THY1, PTK2, COL3A1, ZYX, PLP1, LAT]
GO:0034605;cellular response to heat;5.0;0.8436909121759173;0.712086467948879;9.260799472366804;50.43140892920004;5.666199763507158;0.0016878938715389536;0.5800107312719123;[CDKN1A, PTGS2, THBS1, HMOX1, LYN, HSPA6, MYOF, EIF2S1, CXCL10, IL1A, TFEC]
GO:0046641;positive regulation of alpha-beta T cell proliferation;10.0;0.8653626801206646;0.8479223519212526;9.54628615425515;937.8544877713971;6.8867018697843045;0.03138914569146771;0.7674272657460779;[BLM, SYK, IL18, CD3E, ZAP70, IL23A, CD28, XCL1, CCR2]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, JUNB, PRKCD, FPR1, GATA3, FLRT2, HMOX1, HLA-DQA2, HLA-DQA1, HLA-DRB4, FN1, COL1A2, HLA-DRB1, CDKN1A, LRRC4, TIMP1, JAK3, HLA-DPA1, ANXA1, SERPINB2, IFNGR1, GPR35, IFNGR2, BGN, FOS, SIRT1, F3, FCER2, PLCB1, HLA-DQB1, CCL13, LRRC19, PTAFR, PTGS2, ALOX5, STAT4, CCL19, CCL18, IL12RB1, IL12RB2, CCL23, CCL21, CCL20, HLA-DPB1, PF4, CSF3, CSF3R, F13A1, IL5RA, RORA, CXCL13, TNF, PYCARD, IGHG1, IL13RA2, IL13RA1, IFNA14, CISH, IFNA16, IFNA10, CSF1R, TNFRSF11A, FOXO1, SOCS2, TNFRSF17, IFNA21, TNFRSF10C, TNFRSF10B, NFKB1, CXCL10, CXCL11, CXCL12, BCL6, LCN2, BCL2, HLA-DRA, MYD88, BCL2L1, CIITA, ITGAM, ITGB2, PIK3CD, FASLG, TNFSF13B, ITGAX, CHUK, TNFRSF1B, IL3RA, XCL2, XCL1, BIRC5, LCP1, BIRC3, CX3CR1, CEBPA, CEBPD, NOD2, IL2RG, CCL8, CCL7, CCL5, CCL4, IL21R, CCL2, CCL1, FYN, FCGR1A, FCGR1B, PML, KLF6, IL2RB, PTPN6, IL1RN, IFI30, IFIT1, IFIT3, IFIT2, TNFSF11, TRIM25, RSAD2, ACSL1, IL1R1, IL1R2, FLT3LG, MIF, EREG, IFI27, IL23A, TWIST1, INPP5D, CCR10, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, LIF, PPBP, SDC1, CD27, IFNA5, IFNA4, IFNA7, CD40, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, IL10, SYK, IL18, GP1BA, GAB2, IL17RB, VAV1, HCK, IL1A, CEACAM1, IL1B, KIT, RHOU, SP100, CXCR5, IFI6, CXCR4, CXCR6, CXCR1, CXCR3, CXCR2, IL32, CD74, IL33, OSM, PODN, CD40LG, IL18R1, IL17A, CD86, CD80, MPL, IL18RAP, CCRL2, IL6R, PRTN3, CSF2RB, CSF2RA, TGFB1, VCAM1, ISG15, NFKBIA, IL6, IL7R, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, OASL, GHR, LRRTM4, MMP1, MMP2, IRAK3, MMP9, DCN, IFNG, OAS1, OAS3, LTA, IRF7, LTB, CAMK2D, SAMHD1, NCAM1, MX2, SOD2, CD4, LTBR]
GO:0010875;positive regulation of cholesterol efflux;9.0;1.0;0.896240625180289;9.628524252492122;184.0088741739662;7.069023426578259;0.0061586114213673755;0.757750811958709;[ABCA1, NFKBIA, LRP1, NR1H2, SIRT1]
GO:0010634;positive regulation of epithelial cell migration;8.0;0.7866048967936545;0.7683024483968273;9.383401794459138;242.52723865374625;4.901876304479318;0.00811716841739676;0.6256821821716325;[DOCK5, NRP1, NRP2, CD40, SPARC, ITGB3, ETS1, EPB41L4B, AKT1, CTSH, CCR6, EDN1, ANXA1, ANXA3, PRKCE, MMP9, SIRT1, IFNG, ADAM9, PFN1, HBEGF, GATA3, PTGS2, THBS1, EPB41L5, HMOX1, PLCG1, JUN, TGFB2, TGFB1, PLK2, VIL1, TEK]
GO:0018119;peptidyl-cysteine S-nitrosylation;9.0;0.9326813400603323;0.8625812952104552;9.574457031221845;309.97525888040974;7.9853141584524145;0.010374592955105913;0.8046099625986299;[S100A9, S100A8]
GO:0090322;regulation of superoxide metabolic process;6.0;0.7763722522362496;0.7113064387082693;9.176539128749065;28.861732253298378;6.343086423195323;9.659762046452353E-4;0.647506047256038;[TGFB1, ITGAM, GCH1, SYK, PRKCD, ITGB2, FPR2, TNF, GNAI2, BST1, CD36, CD177]
GO:0022617;extracellular matrix disassembly;5.0;0.8653626801206646;0.7229223519212526;9.377209824211215;37.09213040667776;5.69953618377475;0.0012414402239614005;0.581715557354699;[MMP1, MMP2, HTRA1, LAMC1, MMP8, MMP9, CTSS, MMP12, TIMP2, MMP19, CTSG, ADAM8, TIMP1, LCP1, A2M, ELANE]
GO:0046645;positive regulation of gamma-delta T cell activation;9.0;0.8653626801206646;0.8289219652406215;9.50592193039979;251.56717180496403;8.16763571524637;0.008419726844556379;0.8139338954918922;[SYK, LILRB1, NCKAP1L, NOD2]
GO:0008333;endosome to lysosome transport;6.0;0.8436909121759173;0.7449657686781032;9.36615998802463;62.67584315854233;5.769740442447999;0.0020977040659196657;0.618185107137305;[DENND3, ADRB2, CDX2, SORT1, VPS41]
GO:0007249;I-kappaB kinase/NF-kappaB signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;5.602686357784832;8.845336528452411E-4;0.6096419534788213;[TNF, AKT1, CHUK, BTK, TLR8, TLR7, TLR4, CARD11, BIRC3, LY96, NLRC3, CD14, CARD9, NFKB1, NFKB2, NFKBIA, BCL3]
GO:0001932;regulation of protein phosphorylation;8.0;0.49565848909023646;0.6228292445451182;7.636094087801916;109.02632868365667;2.531418560085934;0.00364901310371649;0.5044568628857964;[, PID1, ADARB1, PHB2, AKT1, PROK2, ROPN1L, PRKACB, PRKCE, PRKCD, PRKAR1B, ATF3, FPR1, PDGFA, FPR2, THY1, SLC30A10, IQGAP3, GATA1, PRKCZ, C3, FLRT2, PRKAR2B, PDGFD, PDGFC, S100A12, SFN, NCKAP1L, ELANE, LYN, FZD1, JUN, ACE, FZD5, PLK1, FN1, FZD8, EIF2AK2, CDC6, AZU1, NR2F2, NOX4, PKIG, NOX1, EZH2, CDKN1A, LRRC4, TIMP2, TIMP3, HAVCR2, DUSP2, GPR37, DUSP1, FCRL3, BGN, SIRT1, DUSP6, CKS2, PLCB1, HBEGF, ENG, CCL13, LRRC19, FAM129A, PTGS2, GPNMB, NTF3, DMD, CCL19, CCL18, CCL23, CDKN2C, CCL21, CCL20, CARD9, GTF2H1, ELP4, CENPE, PKN1, CSF3, CCNT2, NCF1, FMR1, TNF, CLU, CTGF, PYCARD, MEN1, IFNA14, MAP2K2, CISH, IFNA16, IGFBP3, F2R, CDC25A, ADCYAP1, ADAM9, ADAM8, IFNA10, CSF1R, BLM, TNFRSF11A, PKMYT1, FOXO1, SOCS2, PSAP, DRD4, IFNA21, MAP2K6, TNFRSF10B, CXCL10, DAB2, COPS5, PTPRC, CDK1, BCL2, PLXNB2, CSPG4, LAT, LRRK2, ITGB3, ITGB2, TREM2, PTPN22, CYR61, HHEX, DUSP10, EMILIN1, XCL2, XCL1, LCP2, CEBPA, NOD2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, CSK, TIE1, KLF4, PML, RAD50, PTPN6, FCGR2B, PPIL4, IL1RN, CCNH, HERC5, TCL1A, EDNRB, PPP2R1A, TNFSF11, EPHB2, EPHB1, ACSL1, SLC11A1, PAQR3, FLT3LG, MIF, EREG, SFRP2, IL23A, TRIB1, EPHA3, EPHA2, TGFA, TWIST1, PKHD1, SLAMF1, CCR1, EGR1, LIF, PTK2, BST1, MARCO, ID1, CD27, CALM3, CD24, IFNA5, IFNA4, NRP1, IFNA7, PTPRR, CD40, IFNA2, CD3E, IFNA8, RAC2, CCR7, CD36, MAP4K1, EDN1, SYK, STRADB, IL18, GP1BA, PARP9, CEACAM1, MDFIC, BANK1, IL1B, KIT, TLR8, TLR7, TLR6, TLR4, CXCR4, AIF1, GNAI2, PAK1, CD74, OSM, PODN, NLRP12, CD40LG, CAMK1, CD80, IL6R, PDGFRB, PDGFRA, TSC2, CCNE2, HGS, CCNE1, CALCA, C5AR1, FBLN1, ADRB2, RASGRP1, CCNB2, CCNB1, HRH4, STAP1, ECT2, TGFB2, TGFB1, CAV2, CAV1, INHBA, GH1, IL6, BMP2, GNAQ, TNFAIP3, GHR, GRM5, LRRTM4, NUP62, MYOCD, PLAUR, IRAK3, AXIN2, MMP9, DCN, FGR, CCNA2, GREM1, PSRC1, IFNG, NDUFS4, CHI3L1, PDE5A, ZMYND11, LTF, THBS1, SNCA, EGF, MAPK14, CD4, LTBR, TEK]
GO:0001934;positive regulation of protein phosphorylation;9.0;0.5833093054345528;0.6878952778975655;8.604019935977734;663.1129447749842;2.9039097934679514;0.02219379349871355;0.5447467070638558;[, PHB2, AKT1, PROK2, PRKACB, PRKCE, PRKCD, PRKAR1B, FPR1, PDGFA, FPR2, SLC30A10, IQGAP3, GATA1, PRKCZ, C3, PRKAR2B, PDGFD, PDGFC, S100A12, NCKAP1L, ELANE, LYN, FZD1, JUN, ACE, FZD5, PLK1, FZD8, EIF2AK2, CDC6, AZU1, NOX4, NOX1, EZH2, CDKN1A, TIMP2, HAVCR2, GPR37, FCRL3, SIRT1, DUSP6, CKS2, PLCB1, HBEGF, ENG, CCL13, FAM129A, PTGS2, GPNMB, NTF3, CCL19, CCL18, CCL23, CCL21, CCL20, CARD9, CENPE, PKN1, CSF3, CCNT2, NCF1, FMR1, TNF, CLU, CTGF, PYCARD, IFNA14, MAP2K2, IFNA16, IGFBP3, F2R, ADCYAP1, ADAM9, ADAM8, IFNA10, CSF1R, TNFRSF11A, PSAP, DRD4, IFNA21, MAP2K6, TNFRSF10B, DAB2, PTPRC, CDK1, BCL2, CSPG4, LAT, LRRK2, ITGB3, TREM2, PTPN22, CYR61, XCL2, XCL1, LCP2, NOD2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, CSK, TIE1, RAD50, FCGR2B, IL1RN, CCNH, TCL1A, EDNRB, TNFSF11, EPHB2, EPHB1, ACSL1, SLC11A1, FLT3LG, MIF, EREG, SFRP2, IL23A, EPHA3, EPHA2, TGFA, SLAMF1, CCR1, EGR1, LIF, PTK2, MARCO, CD27, CALM3, CD24, IFNA5, IFNA4, NRP1, IFNA7, CD40, IFNA2, CD3E, IFNA8, CCR7, CD36, MAP4K1, EDN1, SYK, STRADB, IL18, PARP9, MDFIC, BANK1, IL1B, KIT, TLR6, TLR4, CXCR4, AIF1, GNAI2, PAK1, CD74, OSM, CD40LG, CAMK1, CD80, IL6R, PDGFRB, PDGFRA, CALCA, C5AR1, ADRB2, RASGRP1, CCNB1, STAP1, ECT2, TGFB2, TGFB1, CAV2, CAV1, INHBA, GH1, IL6, BMP2, GHR, GRM5, PLAUR, AXIN2, MMP9, GREM1, PSRC1, IFNG, CHI3L1, PDE5A, LTF, THBS1, SNCA, EGF, MAPK14, CD4, LTBR, TEK]
GO:0010886;positive regulation of cholesterol storage;7.0;1.0;0.8509193652572005;9.628524252492122;69.4460343959197;7.8311634786251565;0.002324296273858149;0.7514054297404357;[MSR1, CD36]
GO:0032411;positive regulation of transporter activity;6.0;0.6347111282356054;0.6404758767079473;8.242229891372231;47.08415081846268;5.223196736079928;0.0015758641549092965;0.5902348365767605;[KCNE3, PTAFR, ADRB2, CTSS, JPH2, DMD, EPHB2, DRD4, PRKCD, ACTN4, ATP1B2, PDZK1, ATP1B1, SYNGR3, DNM2, EHD3, CALM3, SGK1, SHANK3, CFTR]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[IL1RN, CSF3R, PROS1, SIRPG, CXCL13, F11R, CXCL16, VPREB3, EPS8, LGALS3, VPREB1, EDNRB, C3AR1, TNFSF11, SIRPA, IL6R, SLC16A3, CD177, CXADR, ATP1B2, MIF, ATP1B1, CH25H, DOK2, PRTN3, ADAM8, S100A9, S100A8, GYPA, CALCA, SDC2, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, GATA3, CORO1A, NUP85, INPP5D, IGLV1-44, S100A12, NCKAP1L, PLCG1, IGHA1, ELANE, NKX2-3, LYN, CCR1, TGFB2, TGFB1, GPR15, CAV1, FN1, TNFRSF10B, AZU1, DEFA1, PPBP, GP6, SELE, COL1A1, SELP, CXCL10, CXCL11, IL6, COL1A2, SELL, SDC1, IGKV3-20, IGHM, CXCL6, CXCL9, ITGAM, ITGB3, ITGB2, PIK3CD, CXCL1, SLC7A11, CXCL3, ITGAL, CXCL2, TREM1, CXCL5, PDE4B, ITGAX, OLR1, FFAR2, CCR7, ITGB7, CCR6, CCR5, CD34, CCR2, IL10, ANXA1, FCER1G, SYK, ITGA4, MMP1, MMP9, VAV1, SLC7A5, ZAP70, HCK, CEACAM1, SLC7A7, SLC7A8, CEACAM6, LCK, SLC7A9, IL1B, CEACAM5, KIT, PECAM1, XCL2, XCL1, CEACAM8, CX3CR1, CCL13, CXCR5, CXCR4, CCL8, IGKC, CXCR1, CCL7, EPCAM, CCL5, CXCR3, TBX21, CXCR2, CCL4, CCL2, CCL1, FYN, CD58, CCL19, CCL18, JAM2, JAM3, CD74, CCL23, CCL21, CCL20, CD2, NLRP12, PTPN6, TEK, CD244, PF4]
GO:0007050;cell cycle arrest;6.0;0.811012628672052;0.7286266269261705;9.292052015870908;55.61614271062087;4.7664383335842135;0.0018614222452456451;0.5668761906316916;[CDKN1A, DUSP1, STRADB, MSH2, IFNG, RRAGD, GAS1, PPP1R15A, CUL5, THBS1, GAS2L1, MAP2K6, BARD1, TGFB2, TGFB1, CDKN2C, DHCR24, INHBA, PML, FAP, JMY]
GO:0043306;positive regulation of mast cell degranulation;11.0;0.8933024483968273;0.8790801765280758;9.584072489921288;1034.300036297698;7.212124270218933;0.03461709140528456;0.8012573229067359;[FGR, FCER1G, SYK, GAB2]
GO:0040037;negative regulation of fibroblast growth factor receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.517298617381897;298.26786127592857;7.004484905440688;0.00998275689325772;0.7091290490632969;[GATA3, SULF1, THBS1, SULF2]
GO:0045727;positive regulation of translation;8.0;0.6634067003016617;0.7067033501508309;9.123968241739727;1032.6861465930526;5.104244793218563;0.03456307596927652;0.6360313160968547;[FMR1, TNF, SOX4, PPP1R15A, PTAFR, FAM129A, THBS1, RXRA, CCL5, UPF3B, IL6, LIN28A, BCL3, CD28, EIF3E, EIF3D]
GO:0032494;response to peptidoglycan;5.0;0.8653626801206646;0.7229223519212526;9.461470167828956;77.33766349313319;7.379178354882098;0.002588421997736798;0.6676125360964777;[IL6, C5AR1, CARD9, NLRP3, TREM2, IRAK3, NOD2]
GO:0045963;negative regulation of dopamine metabolic process;8.0;0.9326813400603323;0.8413406700301662;9.574457031221845;288.50442548003474;8.390779266560578;0.0096559834836909;0.8041048419030481;[ITGAM, ITGB2, SNCA]
GO:0043542;endothelial cell migration;7.0;0.7980440201809971;0.7499413753476991;9.143016436710422;24.971868181253015;5.71663061713405;8.357859548042604E-4;0.6432681208679463;[NRP1, PLXND1, ITGB2, CXCL13, LOXL2, DPP4, CYP1B1, PRSS3, EGR3, TNFSF12, PTK2, GREM1, NR4A1, FAP, ID1, S100P]
GO:0043303;mast cell degranulation;9.0;1.0;0.896240625180289;9.628524252492122;196.3355458728175;7.138016298065211;0.006571174029843636;0.7612791106150483;[LAT2, NR4A3, KIT, PIK3CD, RASGRP1, LAT]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[F11R, TIAM2, DEPDC1B, RIN2, LLGL2, EPHA2, THY1, RACGAP1, NCKAP1L, A2M, JUN, EZH2, ARHGAP9, DENND1B, NRP1, CD40, ARHGAP6, ARHGAP4, CCR7, RHOG, GMIP, VAV1, DEPDC1, PLCB1, CCL13, NTF3, CCL19, CCL18, RANBP2, RANBP1, CCL23, CCL21, CCL20, DLC1, SIPA1, CXCL13, RGS1, ARHGDIA, ARHGDIB, F2R, TSC2, ADCYAP1, ACAP1, PRTN3, ARHGAP19, ARHGAP15, RASGRP1, ADAP2, ECT2, EVI5, CAV2, ARHGAP25, TBCK, ARHGAP30, GNAQ, ARHGAP11A, DOCK4, LRRK2, TAGAP, ARHGEF12, TBC1D9, ARAP3, ARAP1, AXIN2, ALDH1A1, XCL2, XCL1, ASAP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1]
GO:0043304;regulation of mast cell degranulation;10.0;0.7980440201809971;0.8142630219514189;9.523163736834295;224.79395709788088;6.409777797693995;0.007523651442639206;0.7430373465201421;[LYN, FCER1G, SYK, STXBP2, GAB2, FGR, FES, RAC2, HMOX1, IL13RA2]
GO:0002830;positive regulation of type 2 immune response;6.0;0.8933024483968273;0.7697715367885581;9.461470167828956;108.5833891387084;7.069023426578259;0.0036341883157667808;0.6846304993685643;[CD86, CD74, IL33, IL6, RSAD2, RARA, IL18, NLRP3, XCL1, GATA3, NOD2, PRKCZ]
GO:0032487;regulation of Rap protein signal transduction;9.0;1.0;0.896240625180289;9.628524252492122;48.758993290020136;8.67846133901236;0.0016319196251719597;0.8400575416471059;[TIMP2]
GO:0019048;modulation by virus of host morphology or physiology;6.0;0.5173302570349838;0.5817854411076364;7.2718719382278;41.653513925674126;6.193554689224359;0.0013941056253635594;0.6398589874268261;[RXRA, TGFB1, EIF2AK2, CD4, BCL2L1]
GO:0032481;positive regulation of type I interferon production;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;65.23665507211369;5.618190544320798;0.002183412136085803;0.610434838299289;[HMGB2, PTPN22, IFIH1, DHX58, CHUK, SYK, DDX58, MMP12, IRF7, TLR8, TLR7, TLR4, TLR2, HSPD1, CD14, NFKB1, NFKB2, MYD88]
GO:0032482;Rab protein signal transduction;8.0;1.0;0.875;9.628524252492122;29.60642063139588;5.500407508664414;9.9090025448413E-4;0.6562910957882058;[RAB21, RAB33B, RAB32, RAB31]
GO:0043552;positive regulation of phosphatidylinositol 3-kinase activity;11.0;0.9326813400603323;0.8987696223598284;9.597752593825367;732.6859750532908;6.375876246018314;0.024522340210466318;0.7584915600596062;[LYN, PDGFRB, PDGFRA, TGFB1, CCL21, FPR2, NOD2, PTK2, FGR, KIT, CCR7, TEK, CCL19]
GO:0043551;regulation of phosphatidylinositol 3-kinase activity;10.0;0.8259837884571596;0.8282329060895002;9.517298617381897;113.71851024663684;5.9928839937622085;0.0038060561979401893;0.7217173779995258;[LYN, PDGFRB, PDGFRA, TGFB1, CCL21, FPR2, NOD2, KLF4, PTK2, FGR, KIT, CCR7, TEK, CCL19]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, PSMD3, C3AR1, PRSS3, PRKCD, RNASE3, RNASE2, BIN2, PADI2, CFD, FPR1, FPR2, CFP, GNS, C3, S100A12, NCKAP1L, ELANE, S100A11, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, GRN, PTAFR, ALOX5, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, RAB31, ADAM8, SLC27A2, S100A9, S100A8, BRI3, HVCN1, GPR84, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, HPSE, ITGAM, ITGB2, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, FGL2, TTR, CPPED1, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, CD14, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CCT2, FCER1G, MME, RHOG, CEACAM1, CEACAM6, CEACAM8, TLR2, LILRA3, CST3, CXCR1, CXCR2, CD58, CCT8, GCA, LILRB2, LILRB3, QPCT, CD68, FCN1, MPO, PLAU, SIRPA, CD97, CHRNB4, CD93, CYBB, OSCAR, DOK3, TYROBP, PRTN3, VCL, PSMD14, C5AR1, MGAM, HSPA6, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, PLAUR, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0008156;negative regulation of DNA replication;8.0;0.7090535922965819;0.729526796148291;9.223059144383958;828.3435142391211;6.113511981550823;0.02772391196081998;0.6876452870438905;[SMARCAL1, BLM, GMNN, BRCA2, SMC3, S100A11, DONSON, CDC6, SMC1A, MSH6, STAG2, MSH2, BCL6]
GO:0043313;regulation of neutrophil degranulation;10.0;0.8933024483968273;0.861892236059334;9.537552474286395;150.84516981286367;7.8311634786251565;0.005048652081797471;0.8157270763441555;[ITGAM, SYK, PTAFR, ITGB2, CD177]
GO:0045736;negative regulation of cyclin-dependent protein serine/threonine kinase activity;12.0;0.8933024483968273;0.8947715367885583;9.585964638073326;2927.1185870500644;6.375876246018314;0.09796802487286638;0.7741829203200885;[CEBPA, CDKN1A, MYOCD, CDKN2C, PLK1, TNFAIP3, NR2F2, HHEX, MEN1]
GO:0097186;amelogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;26.73958370240551;7.474488534686424;8.949498024565515E-4;0.7053660038532718;[SLC24A4, CSF3R, ITGB4, PERP]
GO:0043315;positive regulation of neutrophil degranulation;11.0;1.0;0.9324289523296623;9.628524252492122;798.7725987099202;8.390779266560578;0.0267342000301538;0.8615337942327104;[ITGAM, PTAFR, ITGB2, CD177]
GO:0097178;ruffle assembly;6.0;1.0;0.8231203125901445;9.628524252492122;77.5241744012752;7.379178354882098;0.0025946643499833917;0.7004918368257019;[AIF1]
GO:0045980;negative regulation of nucleotide metabolic process;8.0;0.6547035408479693;0.7023517704239847;9.136047767394327;483.07628294740357;5.75172193694532;0.016168128449820685;0.6691433273378073;[CDA, P2RY13, GABBR1, PID1, HTR1E, GPR87, CBFA2T3, GNAI2, EDNRB, HRH4, FBP1, CCR2, SNCA]
GO:0001516;prostaglandin biosynthetic process;11.0;0.8933024483968273;0.8790801765280758;9.597752593825367;1037.183190875448;7.138016298065211;0.03471358799433119;0.7974674377644215;[CD74, EDN1, PNPLA8, MGST1, MIF, PTGS2, PTGS1]
GO:0002606;positive regulation of dendritic cell antigen processing and presentation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;55.28681003950749;7.8311634786251565;0.0018503997771236419;0.7236063770733796;[CD74, CCL21, SLC11A1, CCR7, CCL19, NOD2]
GO:0030299;intestinal cholesterol absorption;8.0;1.0;0.875;9.628524252492122;82.41160815185232;7.57984905034425;0.002758242359210401;0.7626338329336335;[CD36]
GO:2000601;positive regulation of Arp2/3 complex-mediated actin nucleation;13.0;1.0;0.9625549647676366;9.628524252492122;774.2616619260014;7.8311634786251565;0.025913841034406984;0.8630410292508717;[CYFIP1]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[IL1RN, CSF3, NCF1, SERPINE1, CXCL13, TNF, CTGF, CXCL16, FGF5, EFEMP1, PLAU, VSTM1, TNFSF11, FAM3D, EPHB2, PHLDA2, MED1, MEF2C, IFNA14, IFNA16, DAPK1, PRKCE, PRKCD, FLT3LG, MIF, EREG, BTC, ADCYAP1, SFRP2, IL23A, IFNA10, CALCA, TGFA, PDGFA, ADRB2, PDGFD, PDGFC, IFNA21, TGFB2, TGFB1, JAG1, TNFSF14, TNFSF12, TNFSF13, LIF, INHBA, PPBP, GH1, CXCL10, CXCL11, IL6, BMP2, CXCL12, PNOC, OGN, CD320, FBN1, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, SECTM1, CXCL1, FASLG, ADM, PRL, CXCL3, IFNA8, CXCL2, CXCL5, TNFSF13B, TIMP1, TNFSF12-TNFSF13, IL10, EDN1, IL18, GREM1, IL1A, IFNG, IL1B, LTA, XCL2, XCL1, LTB, SHANK3, HBEGF, CCL13, NLGN1, GRN, CLEC12B, RETN, TYMP, CCL8, TTR, GPNMB, CCL7, CCL5, NPY, CCL4, NTF3, SPP1, CCL2, CCL1, CCL19, CCL18, IL32, CMTM8, IL33, CCL23, CCL21, EGF, CCL20, OSM, KITLG, CD40LG, CMTM2, FCGR2B, PF4, IL17A]
GO:0033327;Leydig cell differentiation;4.0;1.0;0.75;9.628524252492122;40.68519770516384;7.379178354882098;0.0013616969528911006;0.6273715242355574;[PDGFRA, MGST1]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[CYFIP1, PLXND1, LST1, EPS8, TPM1, VRK1, CSF1R, EPB42, ARHGAP15, CORO1A, SPTA1, EPB41L3, MYH14, MYH10, FN1, PTK2, VIL1, FES, PLXNB2, ITGB2, ANXA1, RHOG, ARAP3, RHOH, ARAP1, FGR, HCK, KIT, ITGA7, RHOU, CCL13, FGD3, FGD4, CCL7, PDPN, CCL2, FYN, WASF3, DLC1]
GO:1904037;positive regulation of epithelial cell apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.148951172230236;105.42595785554589;6.375876246018314;0.0035285119322230004;0.701062607729944;[CD40, GSN, ITGA4, SORT1, FASLG, EIF2S1, THBS1, SFRP4, IL6, CD40LG, CCL2, PLCG1]
GO:0045742;positive regulation of epidermal growth factor receptor signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;233.1839134473908;6.280566066213989;0.0078044557311868065;0.6961884407023742;[NCF1, EGF, PLAUR, TGFA, FASLG, ARAP1, MMP9, EREG, NUP62, AKT1]
GO:0045740;positive regulation of DNA replication;8.0;0.7671156992804218;0.7585578496402109;9.427853557029971;747.3070825002359;6.166155715036245;0.025011695518573164;0.6903374900225189;[JUN, PCNA, EREG, CST3, DBF4, CDK1, E2F7]
GO:0045741;positive regulation of epidermal growth factor-activated receptor activity;12.0;0.9326813400603323;0.9144609826203107;9.611429819132821;2972.107935112762;7.292166977892469;0.09947377786474029;0.8210420709600095;[NCF1, EGF, TGFA, EREG]
GO:0007035;vacuolar acidification;12.0;0.9326813400603323;0.9144609826203107;9.57973408832269;182.53781204849716;6.686031174322154;0.006109376295897887;0.7900442577772261;[SLC11A1, DMXL2]
GO:0046835;carbohydrate phosphorylation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;67.30508528847182;6.518977089658987;0.002252640633960971;0.6565011041187423;[PFKFB4, HK3]
GO:0045747;positive regulation of Notch signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.56398573135455;187.6437959822434;5.926926025970411;0.006280268983073171;0.6540226378555745;[NOD2, DLL1, TSPAN5, TGFB2, JAG1, ELF3, KIT, MAML3]
GO:0060907;positive regulation of macrophage cytokine production;9.0;1.0;0.896240625180289;9.628524252492122;311.82526325162985;7.9853141584524145;0.010436510936514811;0.8046099625986299;[CD74, CD36]
GO:0001960;negative regulation of cytokine-mediated signaling pathway;7.0;0.7140352122741334;0.7079369713942671;8.965230035081857;244.80256319284138;5.8067817141283475;0.008193321482061134;0.6478784521606894;[ECM1, IL1RN, CCL5, STAP1, ARG1, NR1H2, IL1R2, CAV1, NR1H4, IRAK3, MMP12, IL6, PTPRC, PXDN, PADI2]
GO:0043330;response to exogenous dsRNA;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;30.956451235720028;5.970411137910149;0.0010360845638621964;0.6284474158353811;[IFNA5, COLEC12, IFNA4, IFNA7, IFNA14, IFNA16, DDX58, CAV1, IFNA2, CARD9, IRAK3, IFIT1, IFNA8, NFKBIA, IFIH1, IFNA21, IFNA10]
GO:1904044;response to aldosterone;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;94.91012926799756;8.16763571524637;0.0031765566130290556;0.7926932703116032;[CYBB]
GO:0030041;actin filament polymerization;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;66.55674193746657;6.409777797693995;0.0022275942554681166;0.6787156999164222;[GSN, ARHGAP6, AIF1, VIL1, WASF3]
GO:0045751;negative regulation of Toll signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;187.41437209568753;9.777073627680469;0.006272590372058239;0.8509193652572005;[NLRP12]
GO:0045994;positive regulation of translational initiation by iron;10.0;1.0;0.9152410118609203;9.628524252492122;1474.0558344206913;9.083926447120524;0.049335322213937396;0.8797934328124444;[RXRA, TNF]
GO:1990000;amyloid fibril formation;5.0;1.0;0.7902410118609202;9.628524252492122;65.1103285866179;7.697632086000634;0.0021791841023027143;0.6838982747154925;[GSN, CD36]
GO:0030032;lamellipodium assembly;6.0;0.8933024483968273;0.7697715367885581;9.533214072687796;78.21732158183345;6.311337724880743;0.002617863362324714;0.6458824173477649;[CYFIP1, ABLIM3, NUP85, KIT, VCL, WASF3, SH2B1]
GO:0002827;positive regulation of T-helper 1 type immune response;8.0;0.8933024483968273;0.8216512241984136;9.503361109538115;171.8650643746189;6.943860283624253;0.005752169036102488;0.7301093378270707;[ANXA1, SLC11A1, CD80, IL18, IL23A, HLX, XCL1, CCL19, IL12RB1, IL6R, CCR2]
GO:0030277;maintenance of gastrointestinal epithelium;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;27.01847773359639;7.004484905440688;9.042841346921778E-4;0.7091290490632969;[MUC13, NOD2, TLR4]
GO:0032695;negative regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;7.004484905440688;0.002184000309729388;0.6813299963962409;[IL10, LILRB1, IRAK3, THBS1, NFKB1, TLR8, TIGIT, JAK3, SLAMF1]
GO:0060761;negative regulation of response to cytokine stimulus;5.0;0.6954798709641801;0.6379809473430103;8.438940185618286;40.831621184480156;5.734022359845919;0.001366597614971242;0.5834791820027497;[ECM1, IL1RN, CCL5, STAP1, ARG1, NR1H2, IL1R2, CAV1, NR1H4, IRAK3, KLF4, AES, MMP12, IL6, PTPRC, PXDN, PADI2]
GO:0007098;centrosome cycle;4.0;1.0;0.75;9.628524252492122;37.692070457630365;6.088194173566533;0.0012615196775557923;0.5613505331661754;[PPP1R12A, PLK1, CETN3, HEPACAM2, TUBE1, BRCA1, UXT, FES, NUP62, CDK1]
GO:0050718;positive regulation of interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;998.8167007681584;6.518977089658987;0.033429496098039586;0.7658097438582601;[ORM1, FZD5, NOD2, PYCARD, NLRP12, TLR8, NLRP3, CCL19, TLR4]
GO:0061614;pri-miRNA transcription by RNA polymerase II;11.0;1.0;0.9324289523296623;9.628524252492122;587.6398479969114;7.57984905034425;0.019667776870928726;0.8200627852632958;[SPI1, KLF4, ETS1]
GO:0045124;regulation of bone resorption;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;23.47587490287836;6.139487467954083;7.857164060836016E-4;0.6370939872166814;[CSF1R, CALCA, TFRC, SYK, ITGB3, TNFAIP3, TNFRSF11A, TMEM64, IL6, CA2, INPP5D, SPP1, TNFSF11, CD38, CSK, ADAM8]
GO:0060528;secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development;7.0;1.0;0.8509193652572005;9.628524252492122;72.45322871866053;8.390779266560578;0.002424944361541102;0.7800242071602487;[RXRA]
GO:1901624;negative regulation of lymphocyte chemotaxis;10.0;0.8933024483968273;0.861892236059334;9.56398573135455;862.4577206283201;8.67846133901236;0.028865683747873985;0.8590579283277371;[KLRK1, PADI2, CCL2]
GO:0015707;nitrite transport;7.0;1.0;0.8509193652572005;9.628524252492122;31.194310375271012;9.777073627680469;0.0010440454952036402;0.8509193652572005;[SLC11A1]
GO:0050715;positive regulation of cytokine secretion;9.0;0.6913464685778243;0.7419138594692012;9.0689084645567;549.4808578036607;5.03214149931722;0.0183906298100222;0.6535845754738829;[FCN1, ORM1, LRRK2, PTPN22, TNF, PYCARD, IFIH1, CLEC5A, FFAR2, CD34, HAVCR2, IL10, POSTN, CHUK, SYK, DDX58, F2R, MIF, IL17RB, MMP12, TLR1, FGR, IL1A, IL1B, IGHD, TLR8, CLEC4E, TLR4, TLR2, CD274, CSF1R, TWIST1, GATA3, NOD2, PRKCZ, RASGRP1, NLRP3, CD58, CCL19, CD14, IL33, FZD5, CRTAM, MAPK14, CD2, NLRP12, CD244, IL17A]
GO:0032289;central nervous system myelin formation;6.0;1.0;0.8231203125901445;9.628524252492122;33.54444455821997;8.67846133901236;0.0011227023713234936;0.7669372290569613;[TLR2]
GO:0050713;negative regulation of interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;999.3037873052855;7.379178354882098;0.033445798446087804;0.8098004765652196;[NLRP3, PML]
GO:0050711;negative regulation of interleukin-1 secretion;10.0;0.8933024483968273;0.861892236059334;9.567899630675686;756.1696569975245;7.138016298065211;0.0253083179111982;0.7802794972956796;[NLRP12, IL1R2, NLRP3, PML]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[AKT1, MEF2A, MEF2C, PRKAR1B, AGTR1, FPR1, PDGFA, FPR2, GATA3, IQGAP3, PRKAR2B, SFN, LYN, ABCA1, JUN, HACE1, AZU1, COL1A2, ARHGAP6, ARHGAP4, JAK3, DUSP1, GMIP, SIRT1, DUSP6, PTAFR, STAT4, DMD, PKN1, LGR4, CTGF, SESN3, KCNH1, KCNH2, CISH, MSH6, ADCYAP1, MSH2, BLK, LY96, SOCS2, TNFRSF10B, BMX, CORO2A, NFKB1, NFKB2, LRRK2, PIK3CD, TNFRSF1B, LCP2, LCP1, DTL, BIRC3, PPP1R15A, IL2RG, CCL5, E2F1, CCL2, E2F2, FYN, E2F7, SH2B1, IL2RB, PTPN6, TNFSF11, PAQR3, MIF, EREG, BTC, BTK, TRIB1, RIN2, EPHA2, RACGAP1, CD14, PAG1, CCR1, PTK2, CALM3, RGL4, CD24, RGL1, CD40, CETN3, BRCA1, BRCA2, CCR9, RAC2, CTSH, CCR7, CCR6, CD36, CCR5, SPTAN1, CCR2, IL18, GAB2, LAT2, MC3R, IL1B, KIT, DEPDC1, YAP1, PCNA, GNAI2, PAK1, PERP, KITLG, FKBP1B, RAMP1, CD80, CELSR1, CCRL2, PDGFRB, PDGFRA, DOK2, DOK3, TYROBP, CARD11, CALCA, PSEN2, RASGRP1, RASGRP4, SPTA1, CCNB1, ECT2, VCAM1, GH1, GNAQ, TNFAIP3, GHR, GRM5, ARHGEF12, DDX58, IRAK3, CCNA2, NDUFS4, IRF7, SHANK3, BCL2A1, EPS8L1, EPS8L3, EGF, MAPK14, MAPK13, TEK, CYFIP1, EPS8, STMN1, CYP1B1, MED1, PRKCH, DAPK1, PRKCE, PRKCD, DEPDC1B, ADCY9, LGALS12, PRKCQ, PRKCZ, HMOX1, PLEK2, PLCG1, PLK2, PLK1, ITK, CDKN1A, BTG2, ADM, IFIH1, NFAM1, PAX2, CIT, PLCB1, HBEGF, GSN, CCL20, CARD9, POU4F1, IL5RA, TNF, SLC8A1, FGF5, PYCARD, GRAP2, STK32B, MEN1, LHCGR, MAP2K2, IGFBP5, DGKZ, NRBP1, RAB32, MELK, RAB31, CSF1R, CALCRL, CUL5, ITPR3, MAP2K6, DHCR24, BCL6, CNOT3, BCL3, CDK1, BCL2, CSPG4, LAT, BCL2L1, TREM1, CHUK, TFDP1, IL3RA, CX3CR1, CEBPB, NLRC3, NOD2, RAB21, PLN, PML, DNAJA3, CALML4, EDNRB, PPP2R1A, CHEK1, RPS6KA1, SOX4, PTGDR, TIAM2, SIK1, INPP5D, TP53BP2, CCR10, PRL, RALGPS2, MAP4K1, EDN1, STRADB, RHOG, RHOH, AVPR1A, GFRA3, VAV1, RAB33B, TLR8, TLR7, RHOU, SGK1, TLR4, GUCY2C, SP100, PTGER2, CXCR5, CXCR4, CXCR6, AIF1, CXCR1, CXCR3, CXCR2, PDPN, MLH1, CAMK4, CAMK1, SIPA1, SIRPG, ARHGDIA, ARHGDIB, TSC2, ATP1B1, CSF2RB, ADRB2, CSF2RA, TGFB1, SELE, NFKBIA, SELP, ARHGAP30, JMY, DOCK5, DOCK4, MCTP1, CXCL1, TMEM100, BLNK, PTGIR, TGFBR3, ZAP70, CAMK2D, NCAM1, TSHR]
GO:0071409;cellular response to cycloheximide;6.0;1.0;0.8231203125901445;9.628524252492122;692.5175601227966;8.67846133901236;0.023177939511969108;0.7669372290569613;[KLF4]
GO:0050728;negative regulation of inflammatory response;7.0;0.6729672293956388;0.6874029799550199;8.712233520617966;126.17514047852296;5.085725745451326;0.004222968401562039;0.6110036163900148;[TNFAIP6, TNFAIP3, RORA, ETS1, CDH5, DUSP10, IL10, GHSR, IL1R2, PRKCD, TNFRSF1B, ADCYAP1, CALCRL, NLRC3, GATA3, NT5E, NLRP3, ELANE, NR1H4, KLF4, NFKB1, NLRP12, TEK, FCGR2B]
GO:0034220;ion transmembrane transport;5.0;0.44800904580126355;0.514245534761552;6.183841758890227;26.332710660334534;2.96803432163749;8.813321279004005E-4;0.4420264250971726;[SLC35B3, AQP9, SLC4A1, SLC4A3, PHB2, AQP1, SCN1A, SLC6A16, SLC11A1, SLC6A15, PRKCE, CACNA2D3, SLC6A13, SLC6A12, CLDN4, COX7A2L, KCNQ1, CFTR, SLC22A4, TTYH3, TTYH2, SLC22A2, ATP5J, ATP5I, ATP5H, SLC30A10, ATP5O, ATP5L, GJC1, ANKH, KCNMB3, KCNN3, SCN3A, ABCA1, SLC6A6, FXYD2, SFXN3, FXYD6, NOX1, GABRB1, COX7B, CLIC3, GRIK3, SLC7A11, COX7C, JPH2, CCR7, CCR5, COX8A, KCND2, ZDHHC17, TMEM37, SLC7A5, SLC7A7, SLC7A8, SLC7A9, CLDN17, SGK1, CAPS2, SLC43A2, KCNA5, COX5B, COX5A, ANO10, SLC17A6, CCL19, GABRE, SLC17A1, SLC17A3, CCL21, SLC31A2, GABRA5, COX6C, FKBP1B, RHAG, KCNG2, STEAP3, STEAP4, ATP8A1, DENND5B, COX6A1, SLC8A1, BEST1, SLC26A11, SLC16A3, KCNH1, KCNH2, CHRNB4, SLC38A1, F2R, ATP11C, CYBB, ATP1B2, ATP1B1, ATP5J2, COX6B1, RHCE, KCNE3, CUL5, KCNE4, HVCN1, SLC41A2, SLC1A3, SLC38A11, ITPR3, CACNA1F, SLC1A6, SLC38A6, CYC1, SLC15A3, CLCA4, GRIA4, ATP8B2, PTPRC, SLC26A8, SLC26A7, SLC26A3, KCNK5, ATP2A3, SLC40A1, FASLG, ATP7B, SLC36A1, TRPC7, SLC13A1, TRPC3, TRPC1, NDUFS7, ASPH, LCK, XCL1, SLC24A2, SLC24A1, SLC24A4, SLC3A1, LRP2, ATP2C2, SLC5A10, SLC12A2, SLC35A3, NDUFA4, SLC12A1, KCNJ15, KCNJ16, SLC4A7, P2RX5, P2RX1]
GO:0050729;positive regulation of inflammatory response;7.0;0.657518819034173;0.679678774774287;8.587070377663961;125.85203775116636;4.973052582947213;0.0042121544440509905;0.6052415056197167;[SERPINE1, TNF, ETS1, TNFSF11, FFAR2, CCR7, CCR2, FCER1G, IL18, IL17RB, IL23A, IL1B, BTK, AGTR1, LTA, TLR10, TLR7, ADAM8, TLR6, TLR4, S100A9, S100A8, TLR2, SUCNR1, TNFRSF11A, NOD2, PTGS2, PLA2G7, C3, CNR1, CCL4, S100A12, CCL18, SNCA, IL33, CCL23, OSM, MAPK13, NFKBIA, NLRP12, IL6, CD6, CD28, MYD88, IL17A]
GO:0046469;platelet activating factor metabolic process;7.0;0.9326813400603323;0.8172600352873667;9.574457031221845;206.08016991717045;7.9853141584524145;0.0068973178270158595;0.7592887026755414;[LPCAT2, PLA2G7]
GO:0046466;membrane lipid catabolic process;6.0;0.7307253602413294;0.6884829927108091;9.176539128749065;159.2067488982067;6.409777797693995;0.005328506608851286;0.6509166472493662;[FUCA1, GBA3, GM2A, CYP1B1]
GO:1902961;positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process;11.0;1.0;0.9324289523296623;9.628524252492122;1348.57412674769;7.9853141584524145;0.04513556238432715;0.8407982897480031;[LYN]
GO:0061844;antimicrobial humoral immune response mediated by antimicrobial peptide;6.0;1.0;0.8231203125901445;9.628524252492122;44.28377145688295;5.682729065458369;0.0014821379778550245;0.6137353412716126;[CXCL6, CCL13, CXCL9, HIST1H2BK, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, GNLY, S100A12, CAMP, DEFA4, RNASE6, RNASE3, DEFA1, PPBP, CXCL10, CXCL11, S100A9, LTF, PF4]
GO:2000406;positive regulation of T cell migration;10.0;0.7980440201809971;0.8142630219514189;9.461470167828956;351.7821234142529;6.518977089658987;0.011773831087318304;0.7486218033895181;[TNFSF14, CCL21, ITGA4, CCL20, CXCL13, AIF1, PYCARD, CXCL10, CXCL12, CCL5, XCL2, XCL1, ADAM8, CCR2]
GO:0001798;positive regulation of type IIa hypersensitivity;12.0;0.9326813400603323;0.9144609826203107;9.606051396640064;1378.0251110012991;9.083926447120524;0.04612126032313042;0.9126727335416687;[C3, FCER1G]
GO:0045381;regulation of interleukin-18 biosynthetic process;7.0;0.8933024483968273;0.7975705894556142;9.517298617381897;154.99429437694414;9.777073627680469;0.005187519546987567;0.8509193652572005;[NLRP12]
GO:0001558;regulation of cell growth;5.0;0.5833093054345528;0.5818956645781967;7.6590836060266145;26.25041167864861;3.793137346993279;8.785776550476476E-4;0.4842222321850823;[CDA, CYFIP1, CPNE5, KIAA1109, PPP2R1A, DPYSL2, RPS6KA1, AKT1, SFRP2, MAP1B, AGTR1, PRKCQ, EPB41L3, SFN, FN1, FXYD2, NRP1, CDKN1A, ARHGAP4, ESM1, HNF4A, CD38, EDN1, AVPR1A, SIRT1, IL17RB, CEACAM1, SGK1, HBEGF, PAK1, FRZB, SPP1, CDKN2C, KIF26A, SIPA1, SEMA5B, CTGF, CXCL16, TNR, SEMA6A, IGFBP5, CISH, IGFBP3, S100A9, S100A8, HTRA1, SOCS2, IGFBP7, TGFB2, TGFB1, SYT2, CRIM1, INHBA, CXCL12, BCL6, BCL2, CYR61, TCHP, MYOCD, DCC, DNM2, GREM1, PSRC1, NDUFS3, FBP1, CAMK2D, TAF9, LEF1, RAB21, SEMA4B, PML]
GO:0002407;dendritic cell chemotaxis;7.0;0.8653626801206646;0.7836007053175329;9.485423408851448;93.27947089202779;6.8867018697843045;0.0031219799446826077;0.7031056191423581;[CCR1, CXCR1, CCL21, CCL5, CXCR2, CXCR4, CCR7, CCR6, CCL19, CCR5, CCR2]
GO:2000649;regulation of sodium ion transmembrane transporter activity;9.0;0.7140352122741334;0.7532582313173557;9.105276108727574;122.59439798633444;5.8650506222523235;0.004103124172807513;0.6961795867550195;[CAMK2D, DMD, DRD4, YWHAH, PRKCE, ACTN4, ATP1B1, DNM2, FXYD2, NEDD4, FXYD6]
GO:0030098;lymphocyte differentiation;5.0;0.6144040707577935;0.597443047239817;8.242229891372231;42.30537076970773;4.498958968449952;0.001415922687300292;0.5203179827304387;[SPI1, RORA, IKZF1, LGALS1, SOX4, TPD52, EOMES, IFNA14, RSAD2, IFNA16, FLT3LG, ATP11C, RUNX2, CLEC4D, MSH2, CD8A, CLEC4E, CARD11, IFNA10, BLM, TXK, TCF7, GATA3, CD79B, CD79A, NKX2-3, IFNA21, EGR1, TGFB1, VCAM1, BCL11B, FZD5, FZD8, BMX, PTPRC, MAFB, BCL6, BCL3, CD28, BCL2, IL7R, ITM2A, GPR18, IFNA5, IFNA4, ITK, IFNA7, IFNA2, PIK3CD, CD3G, PTPN22, CD3E, IFNA8, CD3D, LYL1, HHEX, BLNK, CCR9, CCR6, JAK3, IL10, CR2, ANXA1, FCER1G, ITGA4, NFAM1, RHOH, VAV1, ZAP70, LCK, KIT, CDH17, LEF1, DLL1, TBX21, CD4, KLF6, CD40LG, DNAJA3, FCGR2B, IL18R1]
GO:0050727;regulation of inflammatory response;6.0;0.5272636092234699;0.5867521172018795;7.400047131651798;31.586589572713706;3.8007227183825356;0.00105717472691369;0.517489449159909;[SERPINE1, EDNRB, C3AR1, TNFSF11, IL1R1, IL1R2, PRKCD, IL23A, BTK, AGTR1, SERPING1, CFB, CFH, CFI, GATA3, ADAMTS12, CFP, PLA2G7, C2, C3, C7, CD19, S100A12, A2M, ELANE, LYN, BST1, CD28, FFAR2, CCR7, CCR2, IL10, ANXA1, FCER1G, IL18, IL17RB, PSMA6, HCK, IL1B, TLR10, TLR7, TLR6, TLR4, TLR2, C1QB, C1QA, PTGS2, NT5E, IGKC, CCL18, IL33, CCL23, NR1H4, OSM, NLRP12, ZYX, IL17A, C1QC, PROS1, RORA, TNF, CLU, ETS1, CDH5, IGHG1, GHSR, ADCYAP1, FANCD2, ADAM8, S100A9, S100A8, SUCNR1, CALCRL, C5AR1, TNFRSF11A, IGLV1-44, NLRP3, SELE, NFKB1, NFKBIA, IL6, BCL6, IGKV3-20, MYD88, TNFAIP6, TNFAIP3, DUSP10, CR2, CR1, TNFRSF1B, LTA, XCL1, BIRC3, C1S, C1R, NLRC3, NOD2, CNR1, CCL5, CCL4, SNCA, MAPK14, KLF4, MAPK13, CD6, TEK, FCGR2B]
GO:0035548;negative regulation of interferon-beta secretion;10.0;1.0;0.9152410118609203;9.628524252492122;774.9330078742448;9.777073627680469;0.025936310379122567;0.9152410118609203;[LILRB1]
GO:0035307;positive regulation of protein dephosphorylation;9.0;0.811012628672052;0.801746939516315;9.464221201200845;660.9024749708963;6.063501560976162;0.022119811063664396;0.706328376990269;[PPP1R15A, PDGFRB, PPP1R16B, TGFB1, PPP1R12A, FCRL3, PRKCD, LILRB2, DLC1, CALM3]
GO:0071407;cellular response to organic cyclic compound;5.0;0.5310727365277519;0.5557773801247963;7.0299582842316;63.0333181336412;3.907776714546695;0.0021096684316296343;0.4900848947730398;[IL1RN, AQP9, IFIT1, AQP1, LGALS1, AKT1, CYP1B1, MED1, MEF2C, KCNQ1, CFTR, ABCB4, ABCA1, EGR1, JUP, COL1A1, ID1, NOX4, EZH2, GABRB1, BRCA1, IFIH1, IL10, EDN1, ANXA1, ARG1, IL18, IL1B, PTAFR, PTGS2, AIF1, GNAI1, CTNNA1, SPP1, P2RY13, POU4F1, TNC, RORA, TNF, SLC8A1, CDH1, RUVBL2, IGFBP5, ADCYAP1, BLM, FECH, FOXO1, CCNB1, OSBPL7, TGFB1, CAV1, INHBA, NFKB1, NFKBIA, BMP2, KIF18A, NR4A3, ALPL, SLC26A3, LRRK2, PDE4B, DDX58, DNM2, CCNA2, COLEC12, CEBPA, CEBPB, NOD2, P2RY6, CCL5, CCL2, SNCA, KLF4, RAD51, KLF5]
GO:0071404;cellular response to low-density lipoprotein particle stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;56.74958382123113;7.004484905440688;0.0018993574991869968;0.6813299963962409;[ABCA1, FCER1G, SYK, ITGB2, CD9, CD36]
GO:0032270;positive regulation of cellular protein metabolic process;7.0;0.47017759384120705;0.586008162177804;7.412950536487706;288.49227156764;2.455885070940991;0.00965557670318086;0.47651344199545814;[, AKT1, PRKACB, PRKAR1B, AGTR1, FPR1, PDGFA, FPR2, GATA3, SLC30A10, IQGAP3, GATA1, C3, PRKAR2B, PDGFD, PDGFC, LYN, JUN, FN1, EIF2AK2, AZU1, NOX4, NOX1, EZH2, GPR37, SIRT1, F3, DUSP6, CKS2, PTAFR, PTGS2, NTF3, CASP8AP2, CENPE, PSMC6, PSMC2, PKN1, CCNT2, NCF1, CTGF, RUVBL2, PPP1R16B, IFNA14, IFNA16, ADCYAP1, S100A9, S100A8, IFNA10, TNFRSF11A, IFNA21, TNFRSF10B, PTPRC, LRRK2, ITGB3, FASLG, PPP1R12A, TNFRSF1B, LCP2, BIRC3, PPP1R15A, LRP1, LRP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, TIE1, EIF3E, FCGR2B, EIF3D, CCNH, CDC20, TCL1A, TNFSF11, EPHB2, EPHB1, MIF, EREG, SFRP2, IFI27, TRIB1, EPHA3, EPHA2, TGFA, SLAMF1, CCR1, EGR1, PTK2, CD28, CD27, CALM3, CD24, NRP1, CD40, BRCA1, CD3E, BMI1, CTSH, CCR7, CD36, SYK, IL18, RNF144B, BANK1, IL1B, KIT, GNAI2, PAK1, RXRA, PERP, CD74, IL33, OSM, NLRP12, RAMP1, CD80, IL6R, PDGFRB, PDGFRA, PCOLCE, CALCA, PSMD14, RASGRP1, CCNB1, ECT2, CAV2, UBE2C, CAV1, INHBA, GH1, IL6, BMP2, TNFAIP3, GHR, GRM5, MMP9, GREM1, PSRC1, CHI3L1, EGF, MAPK14, CD4, TEK, PHB2, MYB, PROK2, DAPK1, PRKCE, PRKCD, PRKCZ, S100A12, NCKAP1L, ELANE, FZD1, NDFIP2, ACE, FZD5, PLK2, PLK1, FZD8, UPF3B, CDC6, CDKN1A, TIMP2, HAVCR2, FCRL3, PLCB1, HBEGF, ENG, CCL13, FAM129A, GPNMB, CCL19, CCL18, CCL23, GSN, CCL21, CCL20, NR1H2, CARD9, CSF3, FMR1, TNF, CLU, PYCARD, MAP2K2, IGFBP3, F2R, ADAM9, ADAM8, CSF1R, PSAP, DRD4, MAP2K6, FANCI, OSBPL7, WFS1, DAB2, BCL6, BCL3, CDK1, BCL2, CSPG4, CCDC22, LAT, TREM2, PTPN22, CYR61, CR1, ASPH, LCK, XCL2, XCL1, CEBPA, NLRC4, NOD2, CSK, KLF4, PML, RAD50, P2RX1, IL1RN, ANTXR1, EDNRB, SKP2, SOX7, SOX4, ACSL1, SLC11A1, FLT3LG, IL23A, AURKAIP1, LIF, MARCO, IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, MAP4K1, EDN1, STRADB, PARP9, CBFA2T3, MDFIC, TLR6, TLR4, CXCR4, AIF1, LILRB2, CD40LG, DLC1, CAMK1, C5AR1, FBLN1, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, NFKBIA, LIN28A, PLAUR, AXIN2, IFNG, PDE5A, LTF, THBS1, HSPD1, SNCA, HSPE1, LTBR]
GO:0090398;cellular senescence;4.0;0.8653626801206646;0.6826813400603323;9.446202695698167;55.136139509281044;6.343086423195323;0.0018453569700716361;0.5743857346658935;[CDKN1A, PRKCD, H2AFX, HMGA1, MAPK14, SIRT1, PML]
GO:0060548;negative regulation of cell death;5.0;0.5408746917014966;0.5606783577116685;7.270369308343265;41.94029430001592;2.875336421023895;0.0014037039064071987;0.4372858501489002;[SERPINE1, PHB2, AKT1, PROK2, IER3, MED1, MEF2C, PRKCH, DAPK1, PRKCD, CLDN7, PRKCQ, ABCB4, GATA3, SLC30A10, GATA1, PRKCZ, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, FZD1, JUN, PLK2, PLK1, EIF2AK2, AZU1, SNAI2, CDKN1A, BTG2, CHL1, TIMP1, JAK3, GPR37, ANXA1, SERPINB2, DUSP1, ANXA5, SERPINB9, SIRT1, PAX2, RARA, PTGS2, UNG, GPNMB, NTF3, FLNA, CCL19, CCL21, GABRA5, NR1H4, POU4F1, FABP1, PF4, CSF3, TNF, CLU, CTGF, LAMP3, CLEC5A, F2R, ADCYAP1, MSH2, ADAM8, CSF1R, BLM, CORO1A, FOXO1, SOCS2, PSAP, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, DAB2, CXCL12, COPS5, BCL6, BCL3, CDK1, BCL2, MYD88, BCL2L1, LRRK2, FHL2, FASLG, CYR61, TNFRSF1B, ADAMTS20, BIRC5, BIRC3, CX3CR1, CEBPB, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, DNAJA3, IL2RB, IL1RN, SLC46A2, IFIT3, AQP1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB2, EPHB1, SOX4, FLT3LG, HNF1B, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, PTK2, VNN1, ID1, CD28, CD27, NRP1, BRCA1, CTSH, CD38, CCR7, CCR5, CD34, IL10, EDN1, FCER1G, STRADB, HCK, RNF144B, IL1A, CEACAM6, IL1B, CEACAM5, KIT, YAP1, IFI6, AIF1, GNAI2, CST3, CXCR2, PDPN, CTNNA1, CD74, LILRB1, CD40LG, GRINA, MAD2L1, IHH, MPO, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, STIL, CBX4, CAV1, NR4A2, NFKBIA, VIL1, IL6, NR4A3, NAT8, IL7R, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, MYOCD, PLAUR, MMP9, GREM1, NDUFS3, IRF7, ZMYND11, LTF, BCL2A1, TAF9, LEF1, DLL1, THBS1, AURKB, HSPD1, SNCA, SOD2, TEK, NAA15]
GO:0048661;positive regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.45804869205661;5.433268205826786;0.002123883781187112;0.6009779013089371;[TNF, MYB, AKT1, SKP2, IL6R, PDGFRB, IL10, EDN1, IGFBP5, MMP2, IL18, MMP9, EREG, HBEGF, CALCRL, PTAFR, PTGS2, THBS1, AIF1, GNAI2, PAK1, CCL5, PDGFD, HMOX1, ELANE, JUN, IL6, NR4A3, NOX1]
GO:0050730;regulation of peptidyl-tyrosine phosphorylation;9.0;0.6873818243518346;0.7399315373562063;9.0689084645567;111.97076766282173;4.31748811353631;0.003747560826526104;0.6170371680902661;[CSF3, NCF1, CD80, PPP2R1A, IL6R, PRKCE, PRKCD, MIF, EREG, SFRP2, IL23A, CSF1R, TGFA, PDGFA, THY1, GATA1, PRKCZ, PDGFD, PDGFC, STAP1, LYN, TGFB1, ACE, CAV1, LIF, BST1, GH1, IL6, CSPG4, CD24, NRP1, CD40, ITGB3, IFNA2, ITGB2, TREM2, CD3E, GHR, GRM5, CD36, SYK, IL18, PARP9, GREM1, IFNG, BANK1, KIT, HBEGF, CCL5, NTF3, FYN, CD74, EGF, OSM, CD4, PTPN6]
GO:0001523;retinoid metabolic process;8.0;0.7671156992804218;0.7585578496402109;9.193206181234276;47.546147792504925;5.334422371190153;0.0015913267778602078;0.6478026081386739;[LRP1, SDC2, LRP2, SCPEP1, TTR, CYP1B1, DGAT2, HSPG2, ALDH1A1, SDC1]
GO:0070100;negative regulation of chemokine-mediated signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.577230958104572;306.6761070193533;8.16763571524637;0.010264173311360264;0.7926932703116032;[CCL5, PADI2]
GO:0071673;positive regulation of smooth muscle cell chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;372.1937940336002;8.67846133901236;0.012456991333636938;0.8400575416471059;[PDGFD, AIF1]
GO:1990822;basic amino acid transmembrane transport;10.0;0.7508913569872202;0.7906866903545304;9.277126365654233;267.5048622669104;7.697632086000634;0.008953147001327533;0.8088982747154926;[SLC7A7, SLC3A1]
GO:0048662;negative regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.58586787906956;5.970411137910149;0.0021281617743466354;0.6284474158353811;[CDKN1A, TNFAIP3, AIF1, CNN1, HMOX1, IL10, MEF2C, PTGIR, MYOCD, IGFBP5, IGFBP3, TPM1, KLF4, SOD2, IFNG, OGN, TRIB1]
GO:0071672;negative regulation of smooth muscle cell chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;373.36881743152423;8.390779266560578;0.012496318309313052;0.8253454670833372;[AIF1]
GO:0070588;calcium ion transmembrane transport;9.0;0.7140352122741334;0.7532582313173557;9.078477915572849;116.6808485568922;4.562137870071484;0.003905202995253044;0.629548568016852;[DENND5B, ATP2A3, FASLG, PHB2, SLC8A1, JPH2, CCR7, CCR5, TRPC7, TRPC3, TRPC1, PRKCE, F2R, CACNA2D3, TMEM37, LCK, XCL1, SLC24A2, SLC24A1, SLC24A4, CUL5, ITPR3, ATP2C2, CACNA1F, CCL19, CCL21, PTPRC, FKBP1B]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[NRP1, CD40, CSF3, NCF1, CD80, ITGB3, IFNA2, TREM2, CD3E, GHR, GRM5, CD36, IL6R, SYK, IL18, MIF, PARP9, EREG, GREM1, IFNG, BANK1, IL23A, KIT, HBEGF, CSF1R, TGFA, GATA1, CCL5, NTF3, STAP1, FYN, LYN, CD74, TGFB1, ACE, EGF, LIF, OSM, GH1, CD4, IL6, CSPG4, CD24]
GO:0050732;negative regulation of peptidyl-tyrosine phosphorylation;10.0;0.7980440201809971;0.8142630219514189;9.446202695698167;781.0212663083519;5.926926025970411;0.02614007890983527;0.7183442844592942;[THY1, PRKCZ, PPP2R1A, NTF3, CAV1, PRKCD, SFRP2, PTPN6]
GO:2000670;positive regulation of dendritic cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;128.63842847306384;8.67846133901236;0.004305412433924055;0.8400575416471059;[LYN]
GO:0034441;plasma lipoprotein particle oxidation;7.0;1.0;0.8509193652572005;9.628524252492122;83.38206178822108;9.777073627680469;0.0027907225690680937;0.8509193652572005;[PLA2G7]
GO:0034440;lipid oxidation;6.0;0.7436939687323844;0.6949672969563367;8.935377071932177;52.67621555484124;5.433268205826786;0.0017630255291043637;0.6009779013089371;[ETFA, ACADM, HIBCH, POR, EHHADH, SLC27A2, HSD17B4, PLA2G7, ACAT1, MAPK14]
GO:0000209;protein polyubiquitination;10.0;0.7671156992804218;0.7987988615011312;9.223059144383958;155.4032479663248;4.243684138952949;0.005201206855589802;0.6322632160784685;[HERC5, SKP2, FBXW2, CDC34, BARD1, HACE1, UBE2C, MARCH1, BCL2, TNFAIP3, BRCA1, RNF144B, DTL, RNF24, NEDD4]
GO:1901653;cellular response to peptide;6.0;0.6913464685778243;0.6687935468790567;8.798175950418692;225.6348642598113;4.473768719621393;0.007551795848581705;0.5519090529631041;[CYFIP1, AKT1, PRKACB, MEN1, GHSR, LHCGR, PRKCD, POR, ADCY9, RAB31, PRKAR1B, FPR2, ADRB2, SLC30A10, FOXO1, PRKAR2B, TGFB1, CAV1, CDC6, NFKB1, NR4A2, NR4A1, NR4A3, ID1, FBN1, PTPN22, GRM5, CD36, EDN1, ARG1, GLP2R, CCNA2, CEACAM1, TLR6, TLR4, LRP1, NOD2, PAK1, FYN, CSK, SORBS1, KLF4, TSHR, KLF1, KLF5, FCGR2B]
GO:0046488;phosphatidylinositol metabolic process;7.0;0.6835726970475526;0.6927057137809769;8.801845679307654;147.2037350013595;4.383446081328108;0.004926776535734991;0.5750890017074093;[CD86, CD80, SLA2, FGF5, PDGFRB, PDGFRA, CISH, TTC7B, EREG, BTC, PLBD1, CSF1R, PDGFA, SOCS2, CD19, INPP5D, PIP5K1B, ICOS, BMX, CD28, PIK3CD, IMPA2, GAB1, VAV1, LCK, KIT, PLCB1, HBEGF, FYN, TRAT1, EGF, MBOAT7, KITLG]
GO:0009267;cellular response to starvation;6.0;0.6369964171292115;0.6416185211547503;8.460919092337061;112.76702064936369;4.807260328104469;0.0037742106974044997;0.5689638293298743;[CDKN1A, PLEKHF1, EHMT2, LRRK2, KRT20, SESN3, LAMP2, UPP1, SIRT1, RRAGD, SIK1, ATF3, SEH1L, FOXO1, GAS2L1, JUN, EIF2AK2, EIF2S1, BCL2, FOXA3]
GO:0061621;canonical glycolysis;15.0;1.0;0.9883613244510648;9.628524252492122;17318.20443184688;6.558197802812269;0.5796247169618144;0.8237478650742711;[BPGM, HK3]
GO:0001782;B cell homeostasis;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;22.00128503895464;6.599019797332524;7.363632103827933E-4;0.6883935445785896;[LYN, MEF2C, TNFRSF13B, TNFAIP3, TNFSF13B, BCL2, NCKAP1L, PKN1]
GO:0061624;fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate;8.0;1.0;0.875;9.628524252492122;280.05413346487285;8.16763571524637;0.009373159814712501;0.7926932703116032;[ALDH1A1]
GO:0001774;microglial cell activation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;31.19674186509269;6.8867018697843045;0.001044126874979773;0.6753065664753021;[CX3CR1, IL33, JUN, ITGAM, ITGB2, FPR2, AZU1, CLU, AIF1, TLR8, TLR7, TLR6, TLR2, SNCA]
GO:1990830;cellular response to leukemia inhibitory factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[TFRC, TNFSF11, TRIM25, TLE4, PCOLCE, SIRT1, PADI2, KLF4, PML, BSPRY, KLF5]
GO:0048675;axon extension;5.0;0.8933024483968273;0.736892236059334;9.427853557029971;51.99108915072818;6.221725566191056;0.0017400949649324319;0.6084203466557585;[CYFIP1, NRP1, SEMA5B, NRP2, ALCAM, MAP1B, VCL]
GO:0070574;cadmium ion transmembrane transport;9.0;1.0;0.896240625180289;9.628524252492122;134.4975615453565;8.390779266560578;0.00450151234497627;0.8253454670833372;[SLC11A1]
GO:0071421;manganese ion transmembrane transport;9.0;0.8933024483968273;0.8428918493787028;9.4949928598676;98.82364420707664;8.390779266560578;0.003307538436105251;0.8253454670833372;[SLC11A1, SLC30A10]
GO:2000669;negative regulation of dendritic cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;128.74299079791163;7.8311634786251565;0.004308912040836728;0.7967266896635242;[CXCL12, CCL21, LILRB1, CCR7, CCL19]
GO:0015939;pantothenate metabolic process;7.0;0.8259837884571596;0.7639112594857803;9.437469015729413;165.9330644697462;8.16763571524637;0.005553630337739711;0.7686126355688037;[VNN1, VNN2, VNN3]
GO:0032498;detection of muramyl dipeptide;7.0;1.0;0.8509193652572005;9.628524252492122;223.28847168028474;9.777073627680469;0.007473264200561175;0.8509193652572005;[NOD2]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[CD86, IL1RN, CSF3, SPARC, CD80, SERPINE1, CXCL13, MPO, LOXL1, PYCARD, EDNRB, JUNB, GHSR, CD96, MEF2C, SLC11A1, CD180, F2R, KMO, SLPI, ADAM9, TRIB1, S100A8, CD274, ABCB4, C5AR1, MGST1, LY96, CSF2RB, TNFRSF11A, KLRK1, STAP1, NLRP3, S100A14, CD14, ELANE, ABCA1, JUN, VCAM1, DEFA4, TNFRSF10C, TNFRSF10B, DEFA1, PPBP, SELE, NFKB1, NFKB2, SELP, CXCL10, CXCL11, IL6, ALPL, CD27, CXCL6, CXCL9, CD40, HMGB2, TNFAIP3, CXCL1, TREM2, FASLG, PTPN22, ADM, CXCL3, CXCL2, CXCL5, ALAD, THBD, DUSP10, PDE4B, CTSG, CCR7, CD36, CCR5, HAVCR2, IL10, PTGIR, EDN1, CHUK, ARG1, IRAK3, PDCD1LG2, FOS, TNFRSF1B, DCN, IL1B, LTA, RARA, TLR4, CX3CR1, CEBPB, CEBPE, PTGER2, PTGS2, CNR1, CCL2, IL12RB2, SNCA, GCH1, CCL20, NR1H2, NR1H4, LILRB1, LILRB2, MAPK14, CD6, LTBR, PF4]
GO:0032497;detection of lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;150.00497270670016;8.390779266560578;0.005020531440782482;0.7522251544931926;[LY96, TREM2, TLR4]
GO:0010243;response to organonitrogen compound;4.0;0.45240132074476547;0.47620066037238273;6.234015858980763;25.42702214820504;3.12938525411714;8.510195484661687E-4;0.4100369074268474;[CYFIP1, AKT1, PRKACB, JUNB, MEF2C, PRKCE, PRKCD, ADCY9, PRKAR1B, UQCRC1, ABCB4, FPR2, SLC30A10, PRKAR2B, PDGFD, PDGFC, LYN, ABCA1, JUN, JAG1, JUP, CDC6, COL1A1, COL1A2, NOX4, EZH2, CDKN1A, GABRB1, BTG2, ADM, TIMP1, ANXA1, DUSP1, ARG1, TACR3, FOS, SIRT1, MMP19, PTAFR, PTGS2, GSN, CARD9, NR1H4, COL3A1, PSMC6, PSMC2, FOSB, TNF, SLC8A1, CTGF, SESN3, CDH1, MEN1, LHCGR, IGFBP5, RAB31, BLM, FOXO1, DRD4, EIF2B3, WFS1, NFKB1, CXCL12, CDK1, SLC26A3, MYD88, BCL2L1, LRRK2, ITGB2, TREM2, PTPN22, ALAD, THBD, HHEX, TRPC3, CHUK, CEBPB, LRP1, NOD2, PLN, FYN, CSK, KLF4, KLF1, P2RX5, RAD51, KLF5, P2RX1, FCGR2B, IL1RN, SPARC, AQP9, AQP1, EDNRB, TRIM25, EREG, POR, KCNQ1, RRAGD, NAIP, CFTR, MGST1, EGR1, EGR2, ID1, SDC1, CD40, BRCA1, CD36, IL10, EDN1, FCER1G, SYK, AVPR1A, NME1, CEACAM1, IL1B, TLR6, TLR4, TLR2, PCNA, AIF1, GNAI1, PAK1, CTNNA1, SORT1, SORBS1, GHSR, PDGFRA, CYBB, COL4A1, C5AR1, ADRB2, NLRP3, CYC1, TGFB1, CAV1, NR4A2, NFKBIA, NR4A1, IL6, NR4A3, SELL, COL5A2, FBN1, TNFAIP3, GRM5, KYNU, PDE4B, MMP2, GLP2R, CAD, IRAK3, DNM2, TGFBR3, CCNA2, NDUFS4, COL6A1, RETN, CNR1, SNCA, MAPK14, TSHR, MAPK13, CD9, TEK]
GO:0016601;Rac protein signal transduction;8.0;1.0;0.875;9.628524252492122;29.60642063139588;6.7325511899570465;9.9090025448413E-4;0.719302980950052;[CYFIP1, HACE1, RHOG, AIF1, EPS8, RAC2, RHOU]
GO:0032092;positive regulation of protein binding;5.0;0.7090535922965819;0.6447678080092112;8.529911963824013;32.707776742429765;5.311165509025885;0.0010946998524811438;0.5618542629869587;[NRP1, CSF3, PLXND1, LRRK2, MEN1, MEF2C, MMP9, LRP1, EPB41L5, CTHRC1, PLK2, CAV1, BMP2, RAN]
GO:0043388;positive regulation of DNA binding;5.0;0.7090535922965819;0.6447678080092112;8.578702127993445;32.525455185636034;5.825829909099042;0.0010885977140540058;0.5881742243410422;[HMGB2, TWIST1, GATA3, MYOCD, TGFB1, EGF, PLAUR, KLF4, MMP9, POU4F1, NME1, IFNG]
GO:0032091;negative regulation of protein binding;5.0;0.6997970393407541;0.6401395315312973;8.48339194818912;32.716075545242866;5.171903441692378;0.0010949776059428606;0.5547323943871747;[LRRK2, CTSZ, IFIT1, IFIT2, RUVBL2, STMN1, AKT1, IL10, ITGA4, PRKCD, AES, SLPI, LEF1, ADRB2, AURKB, EPB41L5, CCL23, CAV1, EIF2S1, PPP1CA, DAB2, ID1, CAMK1]
GO:0060729;intestinal epithelial structure maintenance;8.0;1.0;0.875;9.628524252492122;27.01847773359651;8.390779266560578;9.042841346921817E-4;0.8041048419030481;[TLR4]
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.8653626801206646;0.8808016526504769;9.556203590912496;734.4861809891323;5.277263957350204;0.024582591483058774;0.7179998367869053;[TNFAIP8, AQP1, LAMP3, RPS6KA1, AKT1, PLAUR, SERPINB9, TNFRSF1B, MMP9, PAX2, POR, SFRP2, BIRC5, NAIP, BIRC3, LEF1, IFI6, NLRC4, PTGS2, THBS1, SFN, SNCA, TNFSF14, TNFRSF10C, TNFRSF10B, DHCR24, KLF4, FABP1, VIL1, CD27]
GO:0035357;peroxisome proliferator activated receptor signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;25.568165535828406;7.697632086000634;8.557434906291208E-4;0.7167775754447168;[MED1, RXRA, ACTN4]
GO:0032088;negative regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.61713652769816;5.420364800990877;0.009358533920496976;0.725318020585559;[TNFAIP3, PYCARD, CYP1B1, HAVCR2, IL10, CHUK, IRAK3, SIRT1, NLRC3, PKHD1, NLRP3, NR1H4, KLF4, NFKBIA, NLRP12, CCDC22]
GO:0002691;regulation of cellular extravasation;8.0;0.6799073451904818;0.7149536725952409;8.890925309361343;53.02995074112654;6.599019797332524;0.0017748647274483335;0.712474179321389;[CCL21, ITGA4, IL1R1, PTAFR, THY1, BST1, IL1A, CXCL12, PDGFD, ADAM8, PLCB1, ELANE, CCR2]
GO:0045579;positive regulation of B cell differentiation;9.0;0.8436909121759173;0.8180860812682478;9.503361109538115;803.2041625246294;7.212124270218933;0.026882520482883615;0.7650689957573628;[SYK, INPP5D, BTK, ATP11C, CD27, NCKAP1L]
GO:1900745;positive regulation of p38MAPK cascade;12.0;1.0;0.9481203125901445;9.628524252492122;1761.632567075866;6.7325511899570465;0.05896025665364957;0.7924232935401965;[NCF1, BMP2, IL1B]
GO:0046427;positive regulation of JAK-STAT cascade;9.0;0.8933024483968273;0.8428918493787028;9.52844079393514;286.6013214379199;5.459585514144159;0.009592288304083759;0.675444082270312;[CSF1R, CD40, IFNA2, PRL, GHR, CCL5, CYP1B1, FYN, IL6R, LYN, F2R, LIF, IL18, OSM, PARP9, GH1, IL6, IFNG, IL23A, KIT]
GO:0045342;MHC class II biosynthetic process;5.0;1.0;0.7902410118609202;9.628524252492122;39.16312370347755;9.777073627680469;0.0013107545058323288;0.7902410118609202;[SLC11A1]
GO:0006809;nitric oxide biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;241.09966064176743;7.212124270218933;0.008069388666072628;0.6919486831672181;[GCH1, AKT1, CYP1B1, RORA]
GO:0032079;positive regulation of endodeoxyribonuclease activity;9.0;1.0;0.896240625180289;9.628524252492122;975.1149925155983;8.390779266560578;0.03263622125297896;0.8253454670833372;[PRKCD, AKT1]
GO:0035589;G-protein coupled purinergic nucleotide receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;82.06132384088221;7.069023426578259;0.0027465186585576445;0.7365101867784198;[P2RY13, P2RY6, P2RY14, P2RY2, GPR87, PTAFR, GPR171]
GO:0045588;positive regulation of gamma-delta T cell differentiation;10.0;1.0;0.9152410118609203;9.628524252492122;1283.265958453736;8.67846133901236;0.04294975676506408;0.8590579283277371;[SYK, NCKAP1L]
GO:0045347;negative regulation of MHC class II biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.30203964950672;8.16763571524637;0.0049300667038400395;0.7686126355688037;[IL10, SPI1, PF4]
GO:0045345;positive regulation of MHC class I biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.28763043943843;7.9853141584524145;0.0049295844405465;0.7592887026755414;[CIITA, NLRP12, PML]
GO:0045591;positive regulation of regulatory T cell differentiation;10.0;0.8933024483968273;0.861892236059334;9.60254876608886;997.8066164740876;7.292166977892469;0.03339568948573388;0.7881627702307852;[TGFB1, DUSP10, BCL6, IFNG, LILRB2]
GO:0043171;peptide catabolic process;6.0;0.7192862368539868;0.682763431017138;8.971744716103052;139.83704318034597;6.280566066213989;0.0046802199900778775;0.6443087532925187;[ENPEP, ACE, TRHDE, ANPEP, CTSH]
GO:0070542;response to fatty acid;5.0;0.6696747006330769;0.6250783621774587;8.578702127993445;43.78950961223322;5.382624473008031;0.0014655954787213788;0.5655086777281872;[PID1, TNC, CTGF, ALAD, AKT1, FFAR2, CCR7, CD36, PTGDR, EDN1, DGAT2, ACSL1, PRKCE, NME1, TGFBR3, IL1B, TLR2, PTGER2, PTAFR, PTGS2, P2RY6, CCNB1, E2F1, CCL19, CCL21, NR1H4]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[PCNA, TNFAIP3, ETS1, FOXO1, AQP1, CST3, IL18RAP, PDGFD, MYB, CYP1B1, ECT2, ANXA1, ARG1, PRKCD, KLF4, SIRT1, PAX2, MAPK13, FABP1, IL6, CDK1, EZH2]
GO:0070543;response to linoleic acid;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;46.1874048850311;9.083926447120524;0.0015458508755362855;0.7876727335416686;[CD36]
GO:0015722;canalicular bile acid transport;10.0;1.0;0.9152410118609203;9.628524252492122;105.66982015532285;8.390779266560578;0.003536673783934714;0.8443458537639685;[ABCC3, AQP9]
GO:0070304;positive regulation of stress-activated protein kinase signaling cascade;8.0;0.7866048967936545;0.7683024483968273;9.394909401310617;268.25740884697916;4.746635706288034;0.008978334058114483;0.6177431707607042;[IL1RN, NCF1, TNF, CTGF, PYCARD, TNFSF11, CCR7, MAP4K1, EDN1, SYK, MDFIC, IL1B, TLR6, PLCB1, TNFRSF11A, NOD2, RASGRP1, PAK1, CCL19, SLAMF1, LYN, TGFB2, FZD5, CCL21, CARD9, FZD8, EIF2AK2, BMP2, CD40LG, CD27, PKN1, LTBR, FCGR2B, NOX1]
GO:0015721;bile acid and bile salt transport;9.0;0.9326813400603323;0.8625812952104552;9.5544162803384;89.96332036720499;6.375876246018314;0.003010991370958501;0.722303232910233;[ABCC3, SLC10A2, AQP9, NR1H4, CEACAM1, RXRA, SLCO2B1]
GO:0050707;regulation of cytokine secretion;8.0;0.5887823193610073;0.6693911596805037;8.358061706897352;114.42085987655861;4.647174912757396;0.003829563207980042;0.6126567411541474;[FCN1, TNF, PYCARD, CLEC5A, GHSR, POSTN, IL1R2, F2R, MIF, CLEC4E, CD274, CSF1R, TWIST1, GATA3, PRKCZ, RASGRP1, NLRP3, CD14, LYN, FZD5, CRTAM, FN1, ORM1, LRRK2, IFNA2, PTPN22, LRRC32, IFIH1, FFAR2, CCR7, CD34, HAVCR2, IL10, ANXA1, CHUK, SYK, DDX58, IL17RB, MMP12, TLR1, FGR, IL1A, BANK1, IL1B, IGHD, TLR8, TLR10, TLR6, TLR5, TLR4, TLR2, NOD2, CD58, CCL19, IL33, NR1H4, LILRB1, MAPK14, PML, CD2, NLRP12, FCGR2B, LGR4, CD244, IL17A]
GO:0044267;cellular protein metabolic process;5.0;0.3358520568840654;0.45816704030295297;5.574370570853267;80.86766357206795;1.6585685600933726;0.0027065679235849286;0.3750602851554211;[, POP5, SPI1, SLA2, AKT1, PRKACB, CDCA3, PDGFA, GATA3, FN1, EIF2AK2, JAK3, DUSP2, DUSP1, BGN, DUSP6, SPP1, IL12RB2, COL3A1, PKN1, EFEMP1, KCNH1, KCNH2, CISH, FBXW2, CDC25A, BLK, PKMYT1, NAE1, BMX, HM13, IL2RG, EIF4H, FYN, IL2RB, EIF3F, CDC20, HERC5, C1GALT1C1, LGALS1, TNFSF11, TRIM25, SNRPD3, ALG8, BTC, CDC34, BTK, TRIB1, NAIP, EPB42, SDC2, GSPT1, EGR2, PTK2, MUC13, MUC15, SPTAN1, SYK, IL18, RNF144B, IL1B, KIT, PCNA, IL33, KITLG, NDUFAB1, BUB1B, LOXL1, LOXL2, MUC3B, UBE2C, NAT8, UBE2M, FBN1, TNFAIP3, GHR, CAD, IRAK3, SHANK3, SPOCK3, TEK, PRKCH, PRKCE, PRKCD, HMBS, PRKCQ, PRKCZ, PRDM16, ST3GAL6, IGHA1, BARD1, PLK2, PLK1, BTG2, ASGR1, ASGR2, IFIH1, TIMP1, CIT, RARA, USP1, GSN, NR1H4, ELP4, NUCB1, TNC, IL5RA, TNF, FGF5, LAMP2, MAP2K2, VRK1, NRBP1, FKBP3, MAP2K6, COPS5, P4HA2, BCL2, CCDC22, LAT, GAL3ST1, CYR61, LCK, TPTE, DENND3, NLRC4, NOD2, TTR, CSK, PML, CPPED1, PPIL4, PPP2R1A, RPS6KA1, ESCO2, POR, SIK1, CFTR, TXK, LIF, PRL, STRADB, GFRA3, PARP9, ZDHHC17, HCK, TLR7, TLR4, TLR2, GUCY2C, CSTA, CST3, QPCT, LOX, NLRP3, CBX4, EIF2S1, KDM5D, DCN, ZAP70, LTF, HIST1H2BK, LEF1, THBS1, BUB1, SNCA, WEE1, EHMT2, MYLK, KRTCAP2, PSMD3, MEF2A, MEF2C, HSPG2, PRKAR1B, PADI2, SPARCL1, PADI4, UQCRC2, THY1, IQGAP3, C3, LYN, ABCA1, HACE1, LYZ, BHMT, EZH2, ACTL6A, SIRT1, F5, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, FSTL1, USP9Y, PSMC6, PSMC2, CCNT2, F13A1, RUVBL2, RUVBL1, AP2M1, S100A9, S100A8, FOXO1, SOCS2, NFKB1, PTPRE, PTPRC, ST6GALNAC2, LRRK2, PIK3CD, UTY, DSP, PPP1R12A, BIRC5, DTL, BIRC3, PPP1R15A, CCL8, CCL5, CCL2, NDUFA7, TIE1, PTPN6, PTPN7, PTPN4, CCNH, EPHB2, EPHB1, PAQR3, EREG, MXRA8, ALPK2, EPHA3, EPHA2, TF, PTPRR, FKBP14, SUV39H1, PTPRK, BRCA1, BRCA2, BMI1, CTSH, CTSG, CCR5, PDZRN3, PAK1, PRKY, PPP1CA, NEDD4, FKBP1B, GXYLT2, PDGFRB, PDGFRA, CCNE1, CALCA, KLHL14, PSMD14, PSEN2, RASGRP1, RASGRP4, FUT4, FUT3, SPTA1, CCNB1, ISG15, CLK4, CLK1, IL6, BMP2, LAMC1, MMP1, DDX58, MMP2, CCNA2, VCAN, TAF9, AURKB, GALNT7, GALNT6, EGF, LAMB1, MAPK14, MAPK13, TAF5, NAA15, MED1, DAPK1, CDK14, ITK, SERPINA1, ANXA1, HBEGF, FAM105A, RNF130, GTF2H1, CHRM1, ABHD12, GRAP2, MACROD2, STK32B, MEN1, RNF43, IGFBP5, IGFBP3, MELK, CSF1R, CUL5, NACC2, IGFBP7, WFS1, MARCH3, MARCH1, CDK1, PTPN22, DUSP10, CHUK, ASPH, IL3RA, RNF24, CHEK1, SKP2, BCL11A, MAP4K1, B3GNT5, FAM20C, SGK1, RANBP2, CAMK4, CAMK1, GALNT14, ARID4A, ARID4B, FBL, APLP2, MATK, CSF2RB, ADRB2, DTX3, CSF2RA, TGFB2, TGFB1, NFKBIA, FES, TGFBI, TGFBR3, FGR, EHHADH, CAMK2D, NCAM1]
GO:0045599;negative regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.62387697121986;5.948432231191374;0.0038363580074348307;0.6273234135236593;[TGFB1I1, RORA, GATA3, TNF, FOXO1, E2F1, TGFB1, JAG1, SORT1, SIRT1, IL6]
GO:0044027;hypermethylation of CpG island;9.0;1.0;0.896240625180289;9.628524252492122;74.95921705947427;9.083926447120524;0.002508817536065054;0.8607930461318132;[SPI1]
GO:0045113;regulation of integrin biosynthetic process;6.0;0.8259837884571596;0.7361122068187242;9.446202695698167;47.68886481839192;8.16763571524637;0.001596103388279661;0.7408135829017477;[TMEFF2, TGFB2, S100A9, NOX1]
GO:0045356;positive regulation of interferon-alpha biosynthetic process;8.0;1.0;0.875;9.628524252492122;855.4349480558234;8.390779266560578;0.0286306378699575;0.8041048419030481;[TLR8, TLR7]
GO:0002430;complement receptor mediated signaling pathway;9.0;0.9326813400603323;0.8625812952104552;9.57973408832269;218.73839564357212;7.212124270218933;0.007320977250414979;0.7650689957573628;[CR2, CR1, C5AR1, FPR1, C3AR1, FPR3, FPR2]
GO:0046209;nitric oxide metabolic process;5.0;0.8933024483968273;0.736892236059334;9.474373572664863;82.70267162507076;6.943860283624253;0.002767983991718903;0.6453503496879909;[POR, GCH1, AKT1, CYP1B1, RORA, TLR6, TLR2]
GO:0002431;Fc receptor mediated stimulatory signaling pathway;9.0;0.8933024483968273;0.8428918493787028;9.533214072687796;218.73839564357212;4.87179884924204;0.007320977250414979;0.6453846448923425;[CYFIP1, CD3G, IGHG1, FCGR3A, FCER1G, SYK, PRKCE, PRKCD, VAV1, FGR, HCK, PAK1, IGKC, IGLV1-44, NCKAP1L, FYN, PLCG1, FCGR1A, LYN, PTK2, FCGR2A, NR4A3, CD247, FCGR2B, IGKV3-20]
GO:0045359;positive regulation of interferon-beta biosynthetic process;8.0;1.0;0.875;9.628524252492122;855.4349480558234;7.8311634786251565;0.0286306378699575;0.7754860644832351;[TLR8, TLR7]
GO:0060732;positive regulation of inositol phosphate biosynthetic process;8.0;0.9326813400603323;0.8413406700301662;9.59462270081644;800.1222801547256;7.212124270218933;0.026779372653476994;0.7438283705770736;[LHCGR, PTAFR, CD244, SNCA]
GO:1902943;positive regulation of voltage-gated chloride channel activity;10.0;1.0;0.9152410118609203;9.628524252492122;1152.1971065561047;9.083926447120524;0.03856300024635883;0.8797934328124444;[PTAFR, CFTR]
GO:0002674;negative regulation of acute inflammatory response;8.0;0.7369933605727446;0.7434966802863723;9.132087366178231;164.84175655116067;7.292166977892469;0.005517105243818016;0.747921758369865;[ADCYAP1, NLRP3, FCGR2B]
GO:0002666;positive regulation of T cell tolerance induction;7.0;0.8653626801206646;0.7836007053175329;9.4949928598676;165.82106058012107;7.8311634786251565;0.005549881668350914;0.7514054297404357;[LILRB2, CD3E]
GO:0001578;microtubule bundle formation;6.0;0.8436909121759173;0.7449657686781032;9.310070521373587;33.1981629444775;5.8067817141283475;0.0011111126373447525;0.6200793994936333;[PLK1, NAV1, PSRC1, FES, PRC1, MAP1B]
GO:0050702;interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;137.76275822249997;7.697632086000634;0.004610795539274035;0.8260862151842345;[ABCA1, NLRC4, CD36, TLR6, TLR4]
GO:0036413;histone H3-R26 citrullination;11.0;1.0;0.9324289523296623;9.628524252492122;343.59953251902647;9.083926447120524;0.011499967133908778;0.8969813732811862;[PADI2, PADI4]
GO:0050701;interleukin-1 secretion;10.0;0.8933024483968273;0.861892236059334;9.523163736834295;137.06961104194002;7.474488534686424;0.004587596526932657;0.7974867031240476;[ABCA1, NLRP3, NLRC4, CD36, TLR6, TLR4]
GO:0016525;negative regulation of angiogenesis;8.0;0.811012628672052;0.780506314336026;9.32314260294094;151.1079732353669;5.192106149009898;0.005057447875840929;0.6405245499179943;[SPARC, SERPINE1, FASLG, PRL, HHEX, STAB1, EMILIN1, HOXA5, CCR2, SEMA6A, HSPG2, DCN, COL4A2, HGS, CX3CR1, THBS2, THBS1, E2F2, TGFB2, PLK2, TIE1, KLF4, SULF1, PML, CXCL10, TEK, PF4]
GO:0060009;Sertoli cell development;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;53.96940310801817;7.138016298065211;0.0018063073527159576;0.6552794972956795;[CST3, ARID4A, FLNA, SDC1, ARID4B]
GO:1903765;negative regulation of potassium ion export across plasma membrane;11.0;1.0;0.9324289523296623;9.628524252492122;488.145687169157;9.777073627680469;0.01633779684695517;0.9324289523296623;[KCNE3]
GO:1900017;positive regulation of cytokine production involved in inflammatory response;8.0;1.0;0.875;9.628524252492122;226.66426644256094;7.004484905440688;0.0075862490132365176;0.7332096838060964;[CD6, TLR6, NOD2, TLR4, MYD88, IL17A]
GO:0006957;complement activation, alternative pathway;8.0;1.0;0.875;9.628524252492122;200.06168254027287;7.212124270218933;0.006695884470798082;0.7438283705770736;[CFD, C3, CFH, C7, CFP, CFB]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[, LRRK2, TNF, GHR, PROK2, TNFSF11, MAP4K1, MAP2K2, SYK, DUSP6, MDFIC, IL1B, KIT, TLR4, C5AR1, FPR1, CXCR4, TGFA, NOD2, IQGAP3, THBS1, NTF3, CCL19, DRD4, MAP2K6, CD74, EGF, MAPK14, BMP2, CD40LG, CDK1, CSPG4, PKN1]
GO:0050672;negative regulation of lymphocyte proliferation;8.0;0.7436939687323844;0.7468469843661922;9.271849308553389;262.9542115637972;5.514393750639154;0.008800840817614076;0.6570063528532206;[CD86, CD274, CEBPB, TNFRSF13B, CD80, LST1, IHH, LRRC32, GPNMB, INPP5D, CTLA4, HAVCR2, LYN, IL10, TGFB1, ARG1, PAWR, LILRB1, PDCD1LG2, LILRB2, BTK, XCL1, PTPN6, MNDA, PDE5A, PKN1, FCGR2B, MAD1L1]
GO:0050679;positive regulation of epithelial cell proliferation;6.0;0.7192862368539868;0.682763431017138;8.647694999480395;65.06748660449396;4.584116776790259;0.002177750219716307;0.5575522577384293;[NRP1, NRP2, ECM1, ITGB3, HMGB2, IHH, TNFAIP3, LAMC1, CDH3, AKT1, IL10, PPP1R16B, GHSR, MED1, ITGA4, ARG1, SIRT1, F3, PAX2, NME1, MMP12, AGTR1, C5AR1, HTRA1, TGFA, TWIST1, NOD2, IQGAP3, CCL5, HMOX1, PLCG1, JUN, TGFB1, EGR3, CAV2, TNFSF12, LAMB1, NR4A1, BMP2, LRG1, CXCL12, NR4A3, ID1, TEK]
GO:2000010;positive regulation of protein localization to cell surface;7.0;1.0;0.8509193652572005;9.628524252492122;73.70707873031733;7.004484905440688;0.002466909593039506;0.7091290490632969;[FCER1G, TNF, AKT1, CD247]
GO:2000251;positive regulation of actin cytoskeleton reorganization;9.0;1.0;0.896240625180289;9.628524252492122;130.7363647434596;6.8867018697843045;0.004375628472874139;0.7484268790654467;[NRP1, HCK, CSF3, FES, NTF3, STAP1, TEK]
GO:1900029;positive regulation of ruffle assembly;9.0;1.0;0.896240625180289;9.628524252492122;200.30665838708023;7.138016298065211;0.006704083591926775;0.7612791106150483;[EPS8, CYFIP1, NLGN1, EPS8L1, EPS8L3, PFN1]
GO:0002374;cytokine secretion involved in immune response;10.0;1.0;0.9152410118609203;9.628524252492122;137.06961104194002;8.67846133901236;0.004587596526932657;0.8590579283277371;[NLRP3, NOD2, TLR2]
GO:0006974;cellular response to DNA damage stimulus;4.0;0.5696777571895439;0.534838878594772;7.469040003138749;28.997869804256865;3.161008442547652;9.705326059599744E-4;0.4116541187538124;[SMC3, AKT1, CDCA5, HMOX1, SFN, BARD1, LYN, PLK2, PLK1, CDKN1A, BTG2, CHAF1B, CHAF1A, CTLA4, ACTL6A, SIRT1, UNG, USP1, PMS1, GTF2H1, FMR1, TNF, PYCARD, RUVBL2, RUVBL1, MACROD2, MEN1, MSH6, MSH2, BLM, CUL5, FOXO1, MAP2K6, FANCI, FANCG, COPS5, BCL6, CNOT3, BCL3, CDK1, BCL2, BCL2L1, MCM7, EXO1, RFC5, RFC3, RFC4, RFC1, RFC2, SMC1A, TNFRSF1B, TFDP1, DTL, PPP1R15A, RBBP8, POLR2E, E2F1, POLR2I, POLR2J, E2F7, POLR2K, POLR2L, DONSON, PML, RAD50, RAD51, MNDA, SMARCAL1, CCNH, CHEK1, TRIM25, SOX4, ESCO2, MIF, EPHA2, POLA1, TOP2A, FEN1, SUV39H1, BRCA1, BRCA2, PARP9, RAD51C, SGK1, YAP1, SP100, PCNA, RAD54B, RAD54L, GINS2, RPA1, MLH1, RPA3, NEDD4, DCLRE1A, LIG1, FANCD2, PSMD14, CCNB1, HMGA1, ISG15, JMY, TOPBP1, H2AFX, IRF7, BCL2A1, TAF9, POLD3, POLD1, MAPK14, POLE2]
GO:0071361;cellular response to ethanol;6.0;1.0;0.8231203125901445;9.628524252492122;330.81194821622347;7.138016298065211;0.011071978195372667;0.6881587980249038;[SPI1, CCL7, PRKCE, CYBB]
GO:0002369;T cell cytokine production;6.0;0.8653626801206646;0.7558016526504768;9.4949928598676;52.63383953837513;7.379178354882098;0.0017616072419691818;0.7004918368257019;[DENND1B, IL18RAP, SLC11A1, IL18]
GO:0051770;positive regulation of nitric-oxide synthase biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.28763043943843;7.069023426578259;0.0049295844405465;0.7124295520356204;[CCL20, LRRK2, NOD2, FCER2, CCL2, TLR4, TLR2, MAP2K6]
GO:0071363;cellular response to growth factor stimulus;5.0;0.7671156992804218;0.6737988615011312;8.935377071932177;60.394260804020476;4.247644540169047;0.0020213415578046274;0.5074657511808371;[SPARC, SPINT2, AKT1, PDGFRB, MED1, MEF2C, POSTN, RUNX2, SPINT1, COL4A2, CALCA, TWIST1, GATA3, ADAMTS12, EPB41L5, PDGFD, PLCG1, TGFB1, EGR3, VCAM1, CAV1, COL1A1, VIL1, NR4A1, BMP2, ID1, NOX4, SNAI2, FBN1, NRP1, MCM7, TMEM100, IL10, EDN1, ANXA1, ARG1, CAD, TNFRSF1B, PAX2, CCNA2, XCL1, GAS1, CX3CR1, DTYMK, THBS1, CCL5, E2F1, CCL2, FYN, SNCA, MAPK14, KLF4]
GO:2000484;positive regulation of interleukin-8 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.5029195149353;7.069023426578259;0.02521906460756386;0.7767511986393403;[FCN1, F2R, TLR1, CD2, PYCARD, FFAR2, CD58, CD14, CD244, TLR2]
GO:2000249;regulation of actin cytoskeleton reorganization;8.0;0.8933024483968273;0.8216512241984136;9.427853557029971;36.19570401534177;6.221725566191056;0.0012114376393747596;0.6931793347948383;[NRP1, PDGFRA, CSF1R, CSF3, TGFB1, F11R, HCK, FES, ARHGDIA, NTF3, ARHGDIB, STAP1, TEK]
GO:1900271;regulation of long-term synaptic potentiation;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;41.65758488823441;6.193554689224359;0.0013942418768168238;0.6917386748366816;[CX3CR1, LILRB2, NRGN, EPHB2, SHANK3]
GO:1900273;positive regulation of long-term synaptic potentiation;9.0;1.0;0.896240625180289;9.628524252492122;146.46287151967024;6.832634648514029;0.004901980501736697;0.7456618788553018;[EPHB2, SHANK3, NRGN]
GO:0042832;defense response to protozoan;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;69.6526388451159;6.832634648514029;0.0023312111388408135;0.6725415662651573;[IL10, CD40, ARG1, SLC11A1, DEFA1, CLEC7A, BCL3, PF4]
GO:0002576;platelet degranulation;8.0;1.0;0.875;9.628524252492122;39.85546922145481;4.956792062075433;0.0013339266872485146;0.6284905765689417;[ORM1, ECM1, SERPINA1, SPARC, PROS1, ITGB3, ITGA2B, SERPINE1, F13A1, CTSW, CLU, LAMP2, TIMP3, CD36, TIMP1, VWF, ACTN1, APLP2, ANXA5, ACTN4, F5, MMRN1, PECAM1, SERPING1, TLN1, VCL, CFD, STXBP2, PDGFA, THBS1, PSAP, FLNA, A2M, LYN, TGFB2, TGFB1, EGF, PCDH7, FN1, LHFPL2, PPBP, SELP, TF, CD9, PF4]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[IL5RA, TNF, FGF5, TNFSF11, MEN1, PDGFRB, MEF2A, PDGFRA, MED1, MEF2C, MAP2K2, PAQR3, EREG, BTC, TRIB1, PDGFA, CSF2RB, IQGAP3, CSF2RA, RASGRP1, RASGRP4, SPTA1, MAP2K6, TGFB1, PTK2, NFKB1, LAT, LRRK2, CTSH, CCR5, SPTAN1, JAK3, MAP4K1, CHUK, STRADB, IL18, GFRA3, DUSP6, IL1B, KIT, IL3RA, SHANK3, HBEGF, CAMK2D, NOD2, IL2RG, CCL5, CCL2, NCAM1, FYN, EGF, MAPK14, MAPK13, KITLG, IL2RB, TEK]
GO:0048384;retinoic acid receptor signaling pathway;6.0;0.7866048967936545;0.7164227609869718;8.935377071932177;25.568165535828406;7.004484905440688;8.557434906291208E-4;0.6813299963962409;[RXRA, NR1H2, RARA, ACTN4, PML]
GO:0002578;negative regulation of antigen processing and presentation;5.0;0.6913464685778243;0.6359142461498324;8.48339194818912;38.82783361315856;7.8311634786251565;0.0012995326482508427;0.6907270763441554;[LILRB2, FCGR2B, HLA-DOA, HLA-DOB, THBS1]
GO:0051781;positive regulation of cell division;5.0;0.6763753087927167;0.6284286662572787;8.438940185618286;42.28939918509474;5.358233019883872;0.0014153881327367882;0.5642612976810992;[CXCR5, TGFA, PDGFA, AURKB, FGF5, LBH, RACGAP1, PDGFD, NUP62, PDGFC, ECT2, SVIL, TGFB2, TGFB1, PRKCE, TAS2R13, OSM, CDC6, PPBP, CIT, EREG, BTC, IL1A, IL1B]
GO:0071398;cellular response to fatty acid;6.0;0.7369933605727446;0.6916169928765168;9.004369943419128;203.00017448222317;5.8067817141283475;0.006794233151624104;0.6200793994936333;[PID1, PTGER2, PTAFR, TNC, P2RY6, CCNB1, E2F1, AKT1, FFAR2, PTGDR, EDN1, DGAT2, PRKCE, NR1H4, NME1, IL1B]
GO:0048146;positive regulation of fibroblast proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.74573076450893;5.825829909099042;0.0021335122412550348;0.6210535250702663;[CDKN1A, PDGFA, BMI1, AQP1, CCNB1, PDGFD, MYB, PDGFC, E2F1, PDGFRB, PDGFRA, CD74, JUN, TGFB1, FN1, CDC6, MIF, PML, EREG, BTC, CCNA2, NDUFS4]
GO:0034162;toll-like receptor 9 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;7.004484905440688;0.013811191226989502;0.8063299963962409;[UNC93B1, NR1H4, TLR8, TLR7, MYD88, HAVCR2]
GO:0033077;T cell differentiation in thymus;7.0;0.8653626801206646;0.7836007053175329;9.420884887713877;66.99450330244977;6.481236761676141;0.002242245734394454;0.6823701146576509;[BCL11B, FZD5, FZD8, MAFB, DNAJA3, BCL2, CCR6]
GO:0060252;positive regulation of glial cell proliferation;9.0;0.8933024483968273;0.8428918493787028;9.587702257971866;465.4406966640378;7.292166977892469;0.015577881247913653;0.769162383550154;[LYN, PRKCH, MYB, LTA]
GO:1904646;cellular response to amyloid-beta;7.0;1.0;0.8509193652572005;9.628524252492122;273.93391051768003;6.518977089658987;0.009168321460513012;0.6843001567857983;[LRP1, FPR2, ADRB2, GRM5, CD36, TLR6, FCGR2B, TLR4]
GO:0070294;renal sodium ion absorption;9.0;0.9326813400603323;0.8625812952104552;9.55953138100517;61.19261611586542;8.390779266560578;0.002048061791618944;0.8253454670833372;[SGK1]
GO:0097755;positive regulation of blood vessel diameter;7.0;0.7508913569872202;0.7263650437508107;9.0689084645567;39.67967046252893;5.845247994956144;0.0013280428609958766;0.6498456195510879;[DOCK5, CALCA, DOCK4, GCH1, PTAFR, ADM, ADRB2, SOD2, ADCYAP1, SCPEP1, EDNRB, HMOX1, PTGDR]
GO:0034158;toll-like receptor 8 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;9.777073627680469;0.013811191226989502;0.9481203125901445;[TLR8]
GO:0036336;dendritic cell migration;6.0;0.8436909121759173;0.7449657686781032;9.405380701177911;29.137022145890857;6.7325511899570465;9.751899096054872E-4;0.6674232935401965;[CCR1, CCL21, CXCR4, EPS8, NLRP12, CXCR1, CCL5, CXCR2, CCR7, CCR6, CCL19, CCR5, CCR2]
GO:0051798;positive regulation of hair follicle development;6.0;0.8259837884571596;0.7361122068187242;9.377209824211215;137.70877785042182;7.292166977892469;0.004608988864799761;0.6960420709600095;[TGFB2, HPSE, TNF]
GO:0055096;low-density lipoprotein particle mediated signaling;6.0;1.0;0.8231203125901445;9.628524252492122;23.86341744358871;8.67846133901236;7.986871061555342E-4;0.7669372290569613;[CD36]
GO:0038110;interleukin-2-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.379178354882098;0.00101047745553359;0.728290889492758;[SYK, IL2RB, IL2RG, JAK3]
GO:1900454;positive regulation of long term synaptic depression;9.0;1.0;0.896240625180289;9.628524252492122;54.16329535062315;8.16763571524637;0.0018127967515842568;0.8139338954918922;[LILRB2]
GO:0006520;cellular amino acid metabolic process;6.0;0.406884124246779;0.526562374713534;6.526182243879872;77.81072980309767;4.002522082136061;0.0026042551013992716;0.5278094780068945;[CPOX, HNMT, MCCC2, KMO, UPB1, MTHFD1, PADI4, GMPS, SLC1A3, GLYAT, ACMSD, ACAT1, AGXT2, SLC6A6, HAL, ALDH6A1, BHMT, P4HA2, NOX4, ALDH18A1, SERINC5, HIBADH, DPYS, PFAS, GHR, HNF4A, KYNU, HIBCH, ARG1, BHMT2, CAD, PRODH2, SLC7A5, SLC7A7, SLC7A8, DPYD, BCAT1, GART, SLC3A1, SLC25A21, AGMAT]
GO:0060687;regulation of branching involved in prostate gland morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;105.64673904754125;7.8311634786251565;0.003535901280028912;0.7236063770733796;[RXRA]
GO:0030866;cortical actin cytoskeleton organization;6.0;0.7671156992804218;0.7066781622303554;9.117698628726131;53.946853691669205;6.088194173566533;0.0018055526440439148;0.63447084575632;[TNF, RACGAP1, EPB41L3, NCKAP1L, PLS1, VIL1, TLN1, LLGL2]
GO:0050872;white fat cell differentiation;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;21.75937296335754;7.292166977892469;7.282666309192915E-4;0.6631627702307852;[CEBPA, PRDM16, SIRT1]
GO:0050873;brown fat cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;21.75937296335754;6.444869117505266;7.282666309192915E-4;0.6198319182472036;[CEBPA, CEBPB, LAMB3, ADRB2, PTGS2, ALDH6A1, LRG1, PRDM16]
GO:0050870;positive regulation of T cell activation;8.0;0.6260725219892441;0.688036260994622;8.781226392104918;216.0655637178415;4.493869898942481;0.007231519971253338;0.6048167156182404;[CD86, CD83, TFRC, CD80, SIRPG, IHH, PYCARD, LGALS1, GRAP2, MYB, AKT1, TNFSF11, SIRPA, IL6R, ICOSLG, IL23A, PRKCQ, ADAM8, CARD11, CD274, BLM, HHLA2, GATA3, CD1D, THY1, CORO1A, PRKCZ, RASGRP1, DPP4, KLRK1, BTLA, NLRP3, NCKAP1L, ICOS, LYN, TGFB1, EGR3, VCAM1, TNFSF14, CAV1, IL6, VNN1, PTPRC, BCL6, CD28, CD27, CD24, IL7R, CD3E, SIRPB1, TNFSF13B, DUSP10, CTLA4, CCR7, JAK3, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, IL18, PDCD1LG2, VAV1, ZAP70, IFNG, LCK, IL1B, RARA, XCL1, NOD2, AIF1, HSPD1, PAK1, HLA-DMB, HLX, CCL5, CCL2, FYN, CSK, CCL19, IL12RB1, CD74, CCL21, LILRB1, LILRB2, CD4, CD40LG, CD6, CD5, DNAJA3, HLA-DPB1, PTPN6]
GO:0031954;positive regulation of protein autophosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;6.481236761676141;0.026061291479152104;0.7466917612613706;[ACE, SYK, PDGFA, GREM1, RAD50, GPNMB, PDGFD, PDGFC, CALM3]
GO:0050871;positive regulation of B cell activation;8.0;0.7436939687323844;0.7468469843661922;9.117698628726131;160.32529438548238;4.695669262696007;0.00536594331968482;0.6151367444652258;[, IGHM, CDKN1A, CD40, TFRC, TNFSF13B, IGHG1, TRBC1, CD38, MEF2C, SYK, FCRL3, ATP11C, MIF, MSH6, MSH2, BTK, IGHD, CARD11, NOD2, UNG, IGKC, INPP5D, TBX21, NCKAP1L, IGHA1, CD74, TGFB1, TNFSF13, MLH1, BST1, IL6, PTPRC, BCL6, CD28, BCL2, CD27, CD320]
GO:0051969;regulation of transmission of nerve impulse;6.0;0.811012628672052;0.7286266269261705;9.34084218004034;42.49049401117059;7.004484905440688;0.0014221185955919531;0.6813299963962409;[GHSR, CHRNB4, GPR35, FMR1, TNR, AVPR1A, TYMP]
GO:0016572;histone phosphorylation;8.0;0.7090535922965819;0.729526796148291;9.195660170195843;367.80445225036385;6.444869117505266;0.012310084014303157;0.7045909063862833;[PRKCD, VRK1, AURKB, CCNA2, CCNB1, CHEK1, CDK1, PKN1]
GO:0031953;negative regulation of protein autophosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;780.3281191277907;7.379178354882098;0.026116879897493853;0.7926125360964777;[NLRP12, JUN, CAV1, ENG]
GO:0051964;negative regulation of synapse assembly;7.0;0.8259837884571596;0.7639112594857803;9.437469015729413;219.30269939314178;7.9853141584524145;0.007339863989072673;0.7592887026755414;[ROBO2, PTK2, TLR2]
GO:1904823;purine nucleobase transmembrane transport;7.0;0.8436909121759173;0.7727648213451592;9.36615998802463;77.53080622993028;8.67846133901236;0.002594886311320219;0.7947362817240173;[AQP9, SLC28A1]
GO:1900223;positive regulation of amyloid-beta clearance;5.0;1.0;0.7902410118609202;9.628524252492122;41.03658450598229;7.9853141584524145;0.001373457552886905;0.6986103492792611;[LRP1]
GO:0002175;protein localization to paranode region of axon;5.0;1.0;0.7902410118609202;9.628524252492122;40.92839637806193;8.390779266560578;0.0013698365936084043;0.7193458537639684;[EPB41L3]
GO:1903974;positive regulation of cellular response to macrophage colony-stimulating factor stimulus;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;111.61630484940933;8.67846133901236;0.0037356972751570123;0.7947362817240173;[TLR4, TLR2]
GO:1900227;positive regulation of NLRP3 inflammasome complex assembly;7.0;1.0;0.8509193652572005;9.628524252492122;140.3817219977405;7.9853141584524145;0.004698449899916962;0.7592887026755414;[CD36, TLR6, TLR4]
GO:0007616;long-term memory;7.0;1.0;0.8509193652572005;9.628524252492122;22.22653164046661;6.221725566191056;7.439020114266185E-4;0.6690987000520388;[PRKCZ, CAMK4, SGK1]
GO:0051973;positive regulation of telomerase activity;9.0;0.9326813400603323;0.8625812952104552;9.600353375525426;952.4250073221435;6.193554689224359;0.031876807868214944;0.7129793000169707;[AURKB, CCT4, CCT2, KLF4, GRHL2, GREM1, PRKCQ]
GO:0071320;cellular response to cAMP;7.0;1.0;0.8509193652572005;9.628524252492122;327.37290077043656;5.825829909099042;0.01095687637230394;0.6488525777373224;[IGFBP5, PTAFR, AQP9, SLC8A1, AQP1, KCNQ1, NOX4, SLC26A3, CFTR]
GO:0072657;protein localization to membrane;5.0;0.5756379274792419;0.5780599756005412;7.585450354983161;29.829169826127035;3.7017275965917853;9.983554695705216E-4;0.4795475332985618;[F11R, GOLPH3L, THY1, PRKCZ, EPB41L3, TSPAN5, JUP, EHD3, CD24, LRRC4, TRAM2, FCER1G, FLNA, RAMP1, NCF1, TNF, CDH1, TTC7B, ATP1B1, RAB32, RAB31, HGS, PKP3, LIN7A, NUP155, CAV1, REEP1, PLEKHF1, ITGB2, ITGAL, ITGB7, ITGA4, NUP54, SHANK3, NLGN1, TSPAN33, TSPAN15, DNAJA3]
GO:0030851;granulocyte differentiation;6.0;0.8653626801206646;0.7558016526504768;9.310070521373587;47.07409398820286;7.069023426578259;0.0015755275618510598;0.6846304993685643;[CEBPA, CSF3, SPI1, CEBPE, LEF1, CBFA2T3, GATA1]
GO:0072659;protein localization to plasma membrane;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.42666064804821;4.677207199856271;0.002189771451718415;0.5623129063031725;[PLEKHF1, F11R, TNF, CDH1, FCER1G, GOLPH3L, TTC7B, ATP1B1, RAB31, PKP3, TSPAN33, PRKCZ, EPB41L3, FLNA, TSPAN5, JUP, TSPAN15, EHD3, RAMP1]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[AKT1, MED1, CDCA3, BARD1, HACE1, PLK1, SIRT1, RNF130, RNF43, CISH, FBXW2, CUL5, SOCS2, MARCH3, MARCH1, BCL2, BIRC5, DTL, BIRC3, NLRC4, RNF24, CDC20, HERC5, TRIM25, SKP2, CDC34, NAIP, BRCA1, BMI1, RNF144B, PDZRN3, PCNA, NEDD4, KLHL14, DTX3, UBE2C, UBE2M, TNFAIP3, HIST1H2BK]
GO:0036151;phosphatidylcholine acyl-chain remodeling;8.0;1.0;0.875;9.628524252492122;185.56639978848355;6.481236761676141;0.0062107404020032226;0.7064507494004503;[PNPLA8, LPCAT2, MBOAT2, PLBD1]
GO:0036152;phosphatidylethanolamine acyl-chain remodeling;8.0;1.0;0.875;9.628524252492122;185.56639978848355;6.518977089658987;0.0062107404020032226;0.7083807915285978;[RARRES3, PNPLA8, MBOAT2, PLBD1]
GO:1903980;positive regulation of microglial cell activation;8.0;1.0;0.875;9.628524252492122;155.50143499853152;7.697632086000634;0.005204493087195169;0.7686572628545723;[ITGAM, LRRK2, ITGB2, STAP1]
GO:1902895;positive regulation of pri-miRNA transcription by RNA polymerase II;12.0;1.0;0.9481203125901445;9.628524252492122;1721.2385553242598;6.599019797332524;0.0576083054325737;0.7855944919115336;[JUN, TGFB2, BMP2, TGFB1, KLF5, SPI1, PRL, FOS]
GO:1903507;negative regulation of nucleic acid-templated transcription;9.0;0.5547065974044363;0.6735939238825073;8.375761283996754;898.5514994986271;2.646975117554892;0.030073710044371104;0.5316070557889775;[SPI1, EHMT2, SLA2, PHB2, MYB, HOXA2, HOXA7, JUNB, MEF2A, MED1, MEF2C, HOXB4, HOXB3, ATF3, GATA3, GATA1, PRDM16, HESX1, ELANE, FZD1, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, BTG2, PAWR, PAX5, SIRT1, PAX2, AES, MMP12, RARA, PLCB1, NR1I2, ASCL2, BTAF1, FLNA, CASP8AP2, NR1H2, NR1H4, POU4F1, CENPF, FOSB, LGR4, GMNN, TNF, DACH1, RUVBL2, MEN1, TLE4, AEBP1, FOXO1, NACC2, ZNF423, WFS1, NFKB1, NFKB2, DAB2, BCL6, BCL3, CIITA, FHL2, FASLG, HHEX, EMILIN1, RFC1, PEG3, XCL1, BIRC5, CEBPA, CEBPB, RBBP8, E2F1, E2F7, PRRX1, KLF4, PML, KLF8, KLF5, DNAJA3, IKZF1, UXT, ZNF608, EDNRB, DPF3, SOX7, SOX4, HNF1B, RUNX2, EREG, NIF3L1, SFRP2, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H1, IFNA2, PTPRK, BRCA1, BMI1, XPO1, CD38, CD36, EDN1, PARP9, CBFA2T3, MDFIC, IL1B, TFEC, DEPDC1, YAP1, SP100, SATB2, PURA, RXRA, CDX2, NEDD4, ARID4A, LOXL2, CHCHD3, BASP1, EOMES, CCNE1, CALCA, TCF7, TGFB1, CBX4, VDR, CAV1, HMGA1, NR4A2, BMP2, NR4A3, FEV, MXD1, CREBZF, HMGB2, MYOCD, KLF12, H2AFX, GREM1, IFNG, ELF3, IRF7, ZMYND11, FBP1, PFDN5, LEF1, AURKB, TBX21, SNCA, MEIS2]
GO:0045078;positive regulation of interferon-gamma biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.212124270218933;0.027942676825076673;0.7438283705770736;[TLR8, TLR7]
GO:0045077;negative regulation of interferon-gamma biosynthetic process;8.0;1.0;0.875;9.628524252492122;836.0204953067102;8.390779266560578;0.027980853608317785;0.8041048419030481;[LILRB1, INHBA]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[PID1, RORA, BRCA1, PYCARD, TCL1A, AKT1, EDN1, POSTN, CHUK, SIRT1, XCL2, CHI3L1, XCL1, CCL13, CEBPA, CALCA, GATA3, ADAMTS12, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, CCL23, VCAM1, CCL21, CCL20, MAPK14, NFKB1, COL1A1]
GO:0016311;dephosphorylation;5.0;0.6835726970475526;0.6320273603846966;8.32924126836186;24.405590426795786;4.076630054289783;8.168331479794688E-4;0.4987200624199847;[PPP2R1A, CDC25A, PFKFB4, INPP5D, PTPRE, PTPRC, BCL2, ALPL, PTPRR, PTPN22, PTPRK, DUSP10, IMPA2, DUSP2, PPP1R12A, DUSP1, DUSP6, LCK, ACPP, FBP1, PPP1R15A, TPTE, NT5E, SGPP2, CPPED1, PPP1CA, PTPN6, PTPN7, PTPN4]
GO:0036149;phosphatidylinositol acyl-chain remodeling;8.0;1.0;0.875;9.628524252492122;149.40095957869912;6.943860283624253;0.005000315664964811;0.7301093378270707;[MBOAT7, PLBD1]
GO:0016554;cytidine to uridine editing;9.0;1.0;0.896240625180289;9.628524252492122;133.9430579393504;7.292166977892469;0.0044829536083040925;0.769162383550154;[RBM47, APOBEC3A]
GO:0019805;quinolinate biosynthetic process;8.0;1.0;0.875;9.628524252492122;691.6482702327052;8.67846133901236;0.023148845161657855;0.8188169164668168;[KYNU, KMO]
GO:0140052;cellular response to oxidised low-density lipoprotein particle stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;56.74958382123113;8.16763571524637;0.0018993574991869968;0.7408135829017477;[CD36, TLR6, TLR4, MYD88]
GO:0060453;regulation of gastric acid secretion;6.0;0.8259837884571596;0.7361122068187242;9.427853557029971;33.403759553966054;7.379178354882098;0.0011179937708393987;0.7004918368257019;[KCNQ1, SGK1]
GO:1904845;cellular response to L-glutamine;7.0;1.0;0.8509193652572005;9.628524252492122;543.0623632319648;8.67846133901236;0.01817580857297763;0.7947362817240173;[CYBB]
GO:1900006;positive regulation of dendrite development;10.0;0.8653626801206646;0.8479223519212526;9.59462270081644;582.4293208864839;5.557565922504363;0.01949338521771267;0.6994551915910392;[CYFIP1, NLGN1, FMR1, RAB21, CAMK1, SHANK3, EZH2]
GO:0061304;retinal blood vessel morphogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;25.965694757875163;8.16763571524637;8.690484359379531E-4;0.7079342821725234;[COL4A1, CYP1B1]
GO:0050663;cytokine secretion;9.0;0.6056485694559711;0.6990649099082746;8.227631091951078;133.331941423656;5.9928839937622085;0.004462500088492957;0.7027169913188946;[NLRC4, GATA3, NOD2, NLRP3, S100A12, CCR7, ITGB6, CD36, CCL19, LYN, ABCA1, NR1H4, LILRB1, CHI3L1, LCP2, TLR6, TLR4, CARD11, TLR2]
GO:0045086;positive regulation of interleukin-2 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.292166977892469;0.027942676825076673;0.747921758369865;[CD86, IL1A, CD4, CD80, IL1B, CD28, PRKCQ, CD3E, CARD11]
GO:0045084;positive regulation of interleukin-12 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;8.16763571524637;0.027942676825076673;0.7926932703116032;[LTB, TLR4]
GO:0030837;negative regulation of actin filament polymerization;11.0;0.8436909121759173;0.8542744084176208;9.536150932361107;433.7598075732239;5.8067817141283475;0.014517550400993206;0.7293880392331511;[LMOD1, CAPG, EPS8, SPTA1, SPTAN1, TMOD1, GSN, PRKCD, VIL1, PFN1]
GO:0045089;positive regulation of innate immune response;7.0;0.5408746917014966;0.6213567111079488;7.77894521237524;173.7808589209889;4.201124524534153;0.005816288955466338;0.5657650688141469;[FCN1, CLEC10A, ICAM2, ICAM3, PYCARD, IL18RAP, DHX58, PRKACB, MED1, LAG3, RSAD2, PRKCE, CD180, PRKCD, MUC3B, EREG, CLEC4A, CLEC4D, BTK, ADAM8, CLEC4E, S100A9, S100A8, CARD11, TXK, LY96, CD1D, DDX60, RASGRP1, KLRK1, CLEC7A, S100A14, CD14, MAP2K6, LYN, CAV1, SH2D1A, CRTAM, NFKB1, NFKBIA, MARCO, MYD88, ITGAM, ITGB2, HMGB2, TNFAIP3, PTPN22, CTSS, IFIH1, MUC13, FFAR2, MUC15, CD36, HAVCR2, FCER1G, CHUK, SYK, DDX58, MMP2, IRAK3, PARP9, VAV1, MMP12, TLR1, HCK, PLSCR1, IRF7, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, LTF, TLR2, COLEC12, UNC93B1, NLRC4, NOD2, LILRA2, HSPD1, PAK1, CCL5, FYN, CARD9, NR1H4]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, CLEC10A, ADARB1, SLA2, HERC5, LGALS3, TRBC1, DHX58, TRIM25, RNASE6, RNASE3, MIF, SLPI, IL23A, BTK, SERPING1, PADI4, TRIM10, NAIP, CFB, CFD, CFH, TXK, CFI, GATA3, CD1D, CFP, LY9, C2, C3, KLRK1, C7, SLAMF7, S100A12, CD14, IGHA1, SLAMF1, LYN, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, EIF2AK2, PTK2, MARCO, VNN1, APOBEC3A, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, IFIH1, JAK3, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, IL18, PARP9, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA2, LILRA5, IGKC, CARD9, NR1H4, KIR3DL1, LGR4, C1QC, FCN1, NCF1, NCF2, CLU, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, MATK, CYBB, CLEC4A, CLEC4D, TYROBP, CLEC4E, S100A9, S100A8, IFNA10, BLK, CSF1R, LY96, DDX60, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, LY86, DEFA1, BMX, NFKB1, NFKB2, FES, LCN2, KLRD1, SERINC5, ITGAM, KIR3DS1, CRISP3, HMGB2, PIK3CD, TREM2, TREM1, SIRPB1, CR2, CR1, CHUK, DDX58, FGR, ZAP70, LCK, IRF7, LTF, COLEC12, C1S, UNC93B1, C1R, HIST1H2BK, NLRC4, NOD2, FYN, CSK, MX2, GZMB, PML, GZMM, CD6, PTX3, PTPN6, CD244]
GO:0006749;glutathione metabolic process;6.0;0.8436909121759173;0.7449657686781032;9.360260265897443;147.28945980206763;5.71663061713405;0.0049296456676673804;0.6154690682008903;[MGST1, EEF1G, NAT8]
GO:0006508;proteolysis;5.0;0.5517781253862416;0.5661300745540411;7.338517941704937;47.85814540089318;2.5985281439167696;0.001601769057033345;0.42312986198474045;[, PSMD3, PRSS3, UQCRC1, PRKCQ, UQCRC2, CFB, CFD, ENPEP, CFI, GATA3, ADAMTS12, CFP, C2, C3, ELANE, BARD1, ST14, ACE, HACE1, PLK1, AZU1, TGFB1I1, IFIH1, MMP28, OLR1, ACTL6A, SIRT1, F3, MMP12, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, MMP19, FAM105A, ADAM28, USP1, USP9Y, F11, PSMC6, PSMC2, APEH, IGHG1, RUVBL1, RNF43, FBXW2, CDC25A, ADAM2, ADAM9, ADAM8, ADAM7, CUL5, AEBP1, TMEM27, IGLV1-44, CLCA4, WFS1, DHCR24, NFKB1, COPS5, CDK1, SCPEP1, ADAMTS1, ADAMTS20, ASPH, MEP1A, DTL, BIRC3, C1S, C1R, HM13, FGL2, RNF24, GZMA, GZMB, PML, GZMH, GZMK, GZMM, EIF3F, CDC20, ANPEP, TRIM25, SKP2, CDC34, CFTR, CTSZ, CTSW, BRCA1, PCSK6, CTSS, CTSH, CTSG, CTSB, MME, RNF144B, C1QB, C1QA, CD5L, TMPRSS2, IGKC, PERP, RANBP2, RANBP1, IL33, GCA, FAP, NEDD4, MAD2L1, C1QC, FCN1, IHH, BUB1B, PLAU, PCOLCE, ADAM12, PRTN3, PSMD14, PSEN2, HTRA1, ADRB2, TRHDE, DPP4, CCNB1, NLRP3, TGFB1, UBE2C, ISG15, NFKBIA, IGKV3-20, TNFAIP3, MMP1, DDX58, MMP2, MMP8, MMP9, CCNA2, LTF, AURKB, TBX21, NRIP3, CPVL, RBMX]
GO:0045088;regulation of innate immune response;6.0;0.4673148936341128;0.556777759407201;6.780712109014753;42.469229973879315;3.8881956693475885;0.0014214069074002054;0.52196281994017;[CLEC10A, ICAM2, ICAM3, DHX58, PRKACB, MED1, RSAD2, PRKCE, PRKCD, EREG, BTK, SERPING1, TXK, CD1D, KLRK1, S100A14, CD14, A2M, LYN, SH2D1A, MARCO, CTSS, IFIH1, MUC13, FFAR2, MUC15, CD36, HAVCR2, FCER1G, SYK, ARG1, IFNGR1, FCRL3, IFNGR2, SERPINB9, PARP9, VAV1, MMP12, TLR1, NCR1, HCK, CEACAM1, PLSCR1, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, LILRA2, PAK1, NR1H2, CARD9, NR1H4, LILRB1, LGR4, FCN1, PYCARD, IL18RAP, CD96, LAG3, CD180, MUC3B, CLEC4A, CLEC4D, ADAM8, CLEC4E, S100A9, S100A8, CARD11, LY96, DDX60, RASGRP1, CLEC7A, MAP2K6, CAV1, CRTAM, NFKB1, NFKBIA, MYD88, ITGAM, ITGB2, HMGB2, TNFAIP3, PTPN22, DUSP10, CR1, CHUK, DDX58, MMP2, IRAK3, FGR, IFNG, IRF7, LTF, BIRC3, COLEC12, UNC93B1, CLEC12B, NLRC3, NLRC4, NOD2, SAMHD1, HSPD1, CCL5, FYN, PTPN6, FCGR2B]
GO:0030838;positive regulation of actin filament polymerization;11.0;0.7866048967936545;0.8257314007264895;9.456673995565463;459.92540939869633;5.2552850506314295;0.01539328954657896;0.7011844742147011;[CYFIP1, CSF3, LMOD1, PYCARD, CCR7, PRKCE, HCK, PFN1, NCKAP1L, VASP, GSN, CCL21, VIL1, JMY]
GO:0070498;interleukin-1-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.845247994956144;0.00101047745553359;0.6498456195510879;[IL1RN, NOD2, EGR1, CHUK, IL1R1, IL1R2, IRAK3, NFKB1, NFKBIA, IL1A, IL1B, PLCB1, MYD88]
GO:0071345;cellular response to cytokine stimulus;5.0;0.6729672293956388;0.6267246265587396;8.214830917184116;61.59823360834823;3.805811787890007;0.0020616374440603005;0.48487040368196277;[PID1, TFRC, IFIT1, IFIT3, IFIT2, TCL1A, AKT1, TNFSF11, TRIM25, DAPK1, CDC34, BTK, PADI2, STXBP2, GATA3, ADAMTS12, ST3GAL6, EGR1, COL1A1, CD40, BRCA1, CCR7, HLA-DPA1, EDN1, MME, ARG1, SIRT1, TLR4, TLR2, CCL13, CXCR4, AIF1, CD58, CCL19, CCL18, IL12RB1, CCL23, GSN, CCL21, CCL20, POU4F1, NLRP12, ZYX, IL18R1, IL17A, CSF3, RORA, PYCARD, TLE4, POSTN, PCOLCE, KMO, KIF16B, CSF1R, CALCA, TCF7, CSF2RB, CORO1A, VCAM1, NFKB1, BSPRY, ALAD, CHUK, ITGA4, IL3RA, XCL2, CHI3L1, XCL1, MCM2, CEBPA, CEBPB, LEF1, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, MAPK14, KLF4, PML, MAPK13, CD4, KLF5, IMPDH2, PTPN6, PTPN7, PTPN4, RBMX]
GO:0071346;cellular response to interferon-gamma;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[HLA-DPA1, EDN1, DAPK1, KIF16B, XCL2, XCL1, TLR4, TLR2, CCL13, STXBP2, AIF1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, IL12RB1, CCL23, GSN, CCL21, CCL20, ZYX]
GO:0050665;hydrogen peroxide biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;211.45566258744057;7.697632086000634;0.0070772307290604825;0.7167775754447168;[CYBB]
GO:1902036;regulation of hematopoietic stem cell differentiation;7.0;0.8933024483968273;0.7975705894556142;9.474373572664863;97.61516402498306;6.558197802812269;0.003267091691972132;0.6863059058804069;[YAP1, LMO2, EIF2AK2, GATA3, GATA1, MYB]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[, NUP107, TFRC, AKT1, WLS, GATA3, LYN, ABCA1, COL1A1, MMP12, CENPF, SNX17, GOPC, NCF1, CSE1L, AP2M1, ADCYAP1, ACAP1, SLC27A2, LIN7A, EVI5, TNFSF13B, ITGB6, ARL4C, LCP2, LRP1, LRP2, GOLPH3L, HNF1B, ACTN4, MSR1, EGR2, POLA2, TF, CD24, CD3G, AKAP12, CCR7, CD36, SYK, NAPA, HSD17B4, STX11, CD74, NEDD4, FKBP1B, RAMP1, SCARB2, CARD11, ECT2, NUP155, NASP, NUP62, YWHAH, NUP133, TBC1D9, CHI3L1, NUP54, MX2, NUP35, RAN, PHB2, HOMER3, CUBN, NUP85, S100A12, NUP88, EHD3, DENND1B, ANXA1, CCL19, NR1H4, TNF, CLU, LAMP2, TAP1, RAB32, RAB31, CALCRL, SLC15A3, DAB2, BCL6, BCL3, CCDC22, NLGN1, UNC93B1, NLRC4, NOD2, RAB21, PML, VPS41, IL1RN, IFIT1, ARFIP1, STXBP2, AHCTF1, TRAM2, XPO1, TMED6, STRADB, ZDHHC17, RAB33B, TLR6, TLR4, TLR2, RANBP2, RANBP1, LILRB1, RANBP6, CD40LG, NUPL2, STEAP3, GOLT1B, TSC2, ATP1B1, HGS, COPB2, SUCNR1, NLRP3, TGFB1, LRP1B, NFKBIA, TBCK, KIF18A, DNM2, IFNG, EHHADH, HSPD1]
GO:0010813;neuropeptide catabolic process;7.0;0.9326813400603323;0.8172600352873667;9.56398573135455;142.40199253781023;9.083926447120524;0.004766066536767652;0.8154717862087246;[CTSH]
GO:0010815;bradykinin catabolic process;7.0;1.0;0.8509193652572005;9.628524252492122;198.73492378151718;8.16763571524637;0.00665147904914789;0.7686126355688037;[CTSH]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[KIF11, IFI30, CTSS, HLA-DOA, HLA-DOB, AP2M1, HLA-DPA1, LAG3, FCER1G, DNM2, KIF2C, HLA-DQB1, HLA-DMA, HLA-DMB, RACGAP1, HLA-DQA2, HLA-DQA1, CD74, HLA-DRB4, CENPE, KIF18A, KIF26A, HLA-DPB1, HLA-DRA, FCGR2B, HLA-DRB1]
GO:0090502;RNA phosphodiester bond hydrolysis, endonucleolytic;8.0;0.6799073451904818;0.7149536725952409;8.878218658092228;231.13671471601307;5.395046993006588;0.007735937832006836;0.6509029541176994;[POP5, FEN1, EXO1, RNASE2]
GO:2001186;negative regulation of CD8-positive, alpha-beta T cell activation;10.0;0.8933024483968273;0.861892236059334;9.551563211355994;305.21353058757757;8.16763571524637;0.010215222194422061;0.8329342821725234;[CD274, LILRB1]
GO:2001180;negative regulation of interleukin-10 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.9724324201893;8.67846133901236;0.02523477878196853;0.8590579283277371;[LILRB1]
GO:0038145;macrophage colony-stimulating factor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;8.67846133901236;0.00101047745553359;0.7947362817240173;[CSF1R]
GO:1902287;semaphorin-plexin signaling pathway involved in axon guidance;8.0;1.0;0.875;9.628524252492122;28.581916314885376;7.292166977892469;9.566110170045473E-4;0.747921758369865;[NRP1, PLXND1, PLXNB2]
GO:2001183;negative regulation of interleukin-12 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.9724324201893;8.67846133901236;0.02523477878196853;0.8590579283277371;[TLR8, LILRB1]
GO:0045930;negative regulation of mitotic cell cycle;6.0;0.5833093054345528;0.6147749653074209;7.836764783264067;61.236897459641845;4.271742091748107;0.0020495438483445192;0.5415774018184651;[ZWILCH, BUB1B, TNF, CHEK1, KNTC1, SOX4, MSH6, MSH2, AURKAIP1, MAD1L1, BLM, CCNB1, NACC2, SFN, NAE1, FANCI, TGFB1, PLK2, PLK1, CDC6, ZWINT, BCL6, CNOT3, CDK1, BCL2, EZH2, BCL2L1, TOP2A, CDKN1A, BTG2, BRCA1, TIMP2, TOPBP1, IL10, DUSP1, TFDP1, GAS1, PCNA, AURKB, GPNMB, E2F1, CCL2, BUB1, E2F7, DONSON, KLF4, PML, WEE1, CENPF, FAP, MAD2L1]
GO:0006337;nucleosome disassembly;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;96.25424468242052;6.832634648514029;0.0032215429463244545;0.6725415662651573;[NFE2, SMARCD3, HMGA1]
GO:0032836;glomerular basement membrane development;5.0;0.8933024483968273;0.736892236059334;9.405380701177911;30.929431176690045;7.474488534686424;0.0010351802268029372;0.6724867031240476;[SULF1, NID1, SULF2]
GO:0030890;positive regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.1565706318756;6.063501560976162;0.016940604907709607;0.706328376990269;[CDKN1A, CD40, TFRC, TNFSF13B, CD38, NCKAP1L, CD74, MEF2C, FCRL3, MIF, MSH6, BST1, PTPRC, BCL6, BCL2, CARD11, CD320]
GO:0016125;sterol metabolic process;5.0;0.7090535922965819;0.6447678080092112;8.712233520617966;52.055674199354506;4.901876304479318;0.001742256568387185;0.5409231940325527;[CYP1B1, CUBN, CH25H, CFTR, CEBPA, RXRA, ABCA1, DHCR24, SNX17]
GO:0019858;cytosine metabolic process;8.0;0.8933024483968273;0.8216512241984136;9.523163736834295;228.61631376470658;9.083926447120524;0.007651582280380199;0.839552420951524;[CDA]
GO:2001198;regulation of dendritic cell differentiation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;68.77525917473399;7.474488534686424;0.0023018460308635697;0.7331650565203278;[TMEM176B, TMEM176A, LILRB1, LILRB2, FCGR2B]
GO:2001193;positive regulation of gamma-delta T cell activation involved in immune response;10.0;1.0;0.9152410118609203;9.628524252492122;449.64974642203094;9.777073627680469;0.01504937235424625;0.9152410118609203;[LILRB1]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, JUNB, HOXA5, MEF2A, MED1, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, ATF3, HOXB5, GATA3, GATA1, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, HOXC10, PAX5, FOS, SIRT1, PAX2, MMP12, PLSCR1, RARA, ENG, NR1I2, EPCAM, STAT4, NR1H2, ATAD2, NR1H4, GTF2H1, POU4F1, PSMC6, PSMC2, FOSB, PF4, CSF3, CCNT2, PLXND1, RORA, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, NFKB1, NFKB2, CXCL10, COPS5, MAFB, MAFF, BCL3, CIITA, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPA, CEBPB, CEBPD, CEBPE, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, PRRX1, KLF4, PML, KLF1, KLF6, KLF5, POU2AF1, CCNH, IKZF1, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, HNF1B, RUNX2, SFRP2, IL23A, BEX1, TXK, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, CD28, TOP2A, CD40, HNF4G, PRL, BRCA1, CD3D, HNF4A, IL10, EDN1, IL18, RGMA, IL1A, IL1B, TFEC, TLR4, TLR2, YAP1, SATB2, RXRA, IL33, CDX1, OSM, LILRB1, GRHL2, CAMK1, FOXA3, IL17A, FOXA2, IHH, ARID4A, ARID4B, ETS1, HOXA10, EOMES, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYBL1, MYOCD, KLF13, DDX58, CKAP2, ETV1, DCN, GREM1, ELF3, IRF7, TAF9, LEF1, DLL1, LUM, MAPK14, MEIS2, MEIS1, RBMX]
GO:0045945;positive regulation of transcription by RNA polymerase III;11.0;1.0;0.9324289523296623;9.628524252492122;1460.8767565828284;7.379178354882098;0.04889423033910414;0.8098004765652196;[CEBPA]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[NRP1, BTG2, CHL1, MEF2C, F2R, MSH2, ADAM8, NAIP, CEBPB, LRP1, C5AR1, SLC30A10, CORO1A, NTF3, CCL2, HMOX1, FYN, SNCA, JUN, WFS1, GABRA5, SOD2, POU4F1, NR4A2, NR4A3, BCL2, BCL2L1]
GO:0051388;positive regulation of neurotrophin TRK receptor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;213.0397923327438;8.16763571524637;0.0071302501260115695;0.7686126355688037;[CYFIP1]
GO:0030889;negative regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.3396801226706;7.004484905440688;0.016946733417578675;0.7544503089863854;[LYN, IL10, TNFRSF13B, PAWR, INPP5D, BTK, CTLA4, MNDA, PKN1, FCGR2B]
GO:0051384;response to glucocorticoid;7.0;0.7671156992804218;0.7344772148974115;9.223059144383958;62.73690238121479;4.800339885259895;0.00209974766315278;0.5964089702280253;[CDKN1A, IL1RN, SPARC, ADM, TNF, AQP1, ALAD, IL10, GHSR, EDN1, ANXA1, DUSP1, ANXA3, ARG1, CAD, AVPR1A, FOS, ADCYAP1, IL1B, ADAM9, ACSBG1, PCNA, FECH, ABCB4, PTAFR, PTGS2, AIF1, FOXO1, IGFBP7, TGFB1, IL6, BCL2, ALPL, SDC1, FOSB]
GO:2001189;negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell;9.0;1.0;0.896240625180289;9.628524252492122;430.8793777811617;8.67846133901236;0.014421145008071396;0.8400575416471059;[LGALS3, LILRB1, HAVCR2]
GO:0016358;dendrite development;6.0;0.8259837884571596;0.7361122068187242;9.260799472366804;32.63417926892749;6.343086423195323;0.0010922366112764486;0.647506047256038;[NRP1, LST1, CD3E, MAP1B]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[CDC20, RUVBL1, PSMD3, SKP2, CDC25A, CFTR, PSMD14, ADRB2, GATA3, NLRP3, BARD1, NFKBIA, COPS5, CDK1, TNFAIP3, BRCA1, IFIH1, DDX58, ACTL6A, PSMA5, CCNA2, PSMA6, PSMA3, PSMA4, PSMA2, BIRC3, FAM105A, USP1, IL33, USP9Y, PSMC6, PSMC2, EIF3F]
GO:0038124;toll-like receptor TLR6:TLR2 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;8.390779266560578;0.013811191226989502;0.8772251544931927;[CD36, TLR6, CD14, TLR2]
GO:0038123;toll-like receptor TLR1:TLR2 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;8.67846133901236;0.013811191226989502;0.8919372290569614;[TLR1, CD14, TLR2]
GO:0045953;negative regulation of natural killer cell mediated cytotoxicity;9.0;0.8653626801206646;0.8289219652406215;9.526741558182179;431.6560499367194;7.379178354882098;0.014447139526158352;0.7736121494158466;[CEACAM1, CLEC12B, LILRB1, SERPINB9, HAVCR2]
GO:0051156;glucose 6-phosphate metabolic process;5.0;0.8653626801206646;0.7229223519212526;9.34084218004034;72.82688802824934;6.686031174322154;0.0024374504023614934;0.6321649570480018;[PGD, HK3]
GO:0006548;histidine catabolic process;9.0;0.7980440201809971;0.7952626352707877;9.441312710403976;962.5341159731809;7.697632086000634;0.03221515063715804;0.7898978880348613;[HAL, HNMT]
GO:0010803;regulation of tumor necrosis factor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;58.00234281560482;5.734022359845919;0.001941286215318787;0.64415753539903;[TNFAIP3, TNF, PYCARD, CHUK, SYK, NR1H4, TRAF1, BIRC3]
GO:2001199;negative regulation of dendritic cell differentiation;8.0;1.0;0.875;9.628524252492122;349.4674446787805;7.9853141584524145;0.01169636087311766;0.7833693374183408;[TMEM176B, TMEM176A, LILRB1, FCGR2B]
GO:0018108;peptidyl-tyrosine phosphorylation;9.0;0.811012628672052;0.801746939516315;9.414950152194063;338.33129968976414;4.530049555519983;0.011323644122215096;0.627907570118429;[IL5RA, SLA2, FGF5, EFEMP1, GRAP2, EPHB2, EPHB1, PDGFRB, PDGFRA, MAP2K2, PRKCD, MATK, EREG, BTC, MELK, BTK, EPHA3, EPHA2, BLK, CSF1R, TXK, CSF2RB, CSF2RA, MAP2K6, LYN, LIF, EIF2AK2, BMX, CLK4, PTK2, CLK1, FES, ITK, GHR, JAK3, SYK, FGR, ZAP70, HCK, LCK, KIT, IL3RA, HBEGF, FYN, CSK, IL12RB2, EGF, TIE1, WEE1, PTPN6, TEK]
GO:1902475;L-alpha-amino acid transmembrane transport;10.0;0.6181399273706679;0.7243109755462542;8.529911963824013;268.42115299878213;6.063501560976162;0.00898381442751516;0.7253287636709003;[SLC38A1, SLC43A2, SLC1A3, SLC7A11, SLC1A6, SLC7A5, SLC7A7, SLC7A8, SLC17A6]
GO:1901387;positive regulation of voltage-gated calcium channel activity;11.0;0.9326813400603323;0.8987696223598284;9.597752593825367;1442.0152551110536;7.474488534686424;0.0482629528590931;0.8146746435927894;[EHD3, KCNE3]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[EHF, SPI1, CCNH, SPIB, MYB, HOXA7, JUNB, HOXA5, SOX4, MEF2A, MED1, MEF2C, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, TXK, GATA3, GATA1, NHLH2, EGR1, EGR2, JUN, BCL11B, TGFB1I1, BRCA1, HOXC10, PAX5, FOS, SIRT1, PAX2, PLSCR1, TFEC, SATB2, FLNA, CDX2, CDX1, GTF2H1, GRHL2, POU4F1, FOSB, CCNT2, ARID4A, ETS1, HOXA10, LMO2, C5AR1, HMGA1, NFKB1, NFKB2, COPS5, MAFB, FEV, MAFF, MYBL1, MYOCD, KLF13, ETV1, TFDP1, ELF3, IRF7, CREB5, CEBPA, CEBPB, CEBPD, CEBPE, TAF9, LEF1, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, PRRX1, KLF4, MEIS2, MEIS1, KLF6, KLF5, POU2AF1, TAF5, RBMX]
GO:0038195;urokinase plasminogen activator signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;9.083926447120524;8.87013979980389E-4;0.7876727335416686;[PLAUR]
GO:0008306;associative learning;7.0;0.8436909121759173;0.7727648213451592;9.223059144383958;22.449675191779697;5.459585514144159;7.513704252729093E-4;0.6301228223472235;[BTG2, NRGN, TNR, GABRA5, FOS, MEIS2, ADAM2, KIT]
GO:0006367;transcription initiation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;4.629579150867016;0.015969835568764485;0.6329975182530758;[CCNH, RORA, NR3C2, CTGF, MED1, NRBP1, RUNX2, MAML3, MAZ, VDR, NR4A2, NR4A1, NR4A3, TCF4, CDKN1A, HNF4G, HNF4A, MED23, RARA, YAP1, TAF9, NR1I2, RXRA, POLR2E, E2F2, POLR2I, POLR2J, POLR2K, POLR2L, NR1H2, NR1H4, GTF2H1, TAF5]
GO:0019441;tryptophan catabolic process to kynurenine;10.0;1.0;0.9152410118609203;9.628524252492122;2139.3361475978627;8.16763571524637;0.07160165558256723;0.8329342821725234;[KYNU]
GO:0019442;tryptophan catabolic process to acetyl-CoA;10.0;1.0;0.9152410118609203;9.628524252492122;2054.5202981753127;9.083926447120524;0.06876294543170325;0.8797934328124444;[KYNU]
GO:0030224;monocyte differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;69.52661413212034;7.004484905440688;0.0023269932051117304;0.6813299963962409;[CSF1R, MED1, MEF2C, JUN]
GO:0030225;macrophage differentiation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;47.07409398820286;6.8867018697843045;0.0015755275618510598;0.6753065664753021;[CSF1R, CEBPA, CSF3, SPI1, CEBPE, MMP9, SIRT1, NKX2-3]
GO:0000821;regulation of arginine metabolic process;8.0;0.7763722522362496;0.7631861261181248;9.303101852057495;103.95066091928724;9.083926447120524;0.003479135071447466;0.839552420951524;[SLC7A7]
GO:0009404;toxin metabolic process;3.0;0.5720181185523628;0.484129371866326;7.2867184463447945;27.61873557695172;6.686031174322154;9.243742245122942E-4;0.5400442577772261;[CYP1B1]
GO:0038180;nerve growth factor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;27.195621953761602;7.292166977892469;9.102129923216596E-4;0.7238411236270654;[SORT1, NTF3, CORO1A]
GO:0010629;negative regulation of gene expression;6.0;0.471430776349301;0.558835700764795;6.738152494595957;59.04642522059629;2.349334787147576;0.001976230713800692;0.44326540286011196;[SPI1, EHMT2, SLA2, AKT1, MEF2A, MEF2C, ATF3, GATA3, IQGAP3, GATA1, HESX1, JUN, EIF2AK2, NR2F2, PKIG, EZH2, SIRT1, MMP12, BTAF1, FLNA, CENPF, LGR4, GMNN, CTGF, FOXO1, ZNF423, NFKB1, NFKB2, CIITA, LRRK2, FHL2, PIK3CD, FASLG, HHEX, ITGB8, PEG3, BIRC5, BIRC3, E2F1, FYN, E2F7, PRRX1, EIF3E, IKZF1, UXT, HNF1B, MIF, EREG, SFRP2, IFI27, KCNQ1, NAIP, GSPT1, PCBP3, A2M, CCR1, EGR1, MSR1, ID1, CD28, SUV39H1, CTSZ, PTPRK, BRCA1, CD3E, BMI1, CD38, CD36, CD34, BANK1, IL1B, DEPDC1, SATB2, RXRA, NEDD4, LOXL2, EOMES, CCNE1, CALCA, TCF7, CCNB1, VDR, CAV1, HMGA1, BMP2, MXD1, HMGB2, MYOCD, GREM1, ELF3, IRF7, FBP1, AURKB, TBX21, SERPINE1, PHB2, MYB, HOXA2, HOXA7, JUNB, MED1, DAPK1, HOXB4, HOXB3, SERPING1, PRDM16, ELANE, BARD1, FZD1, NDFIP2, PLK1, FZD8, UPF3B, SNAI2, CDKN1A, BTG2, HAVCR2, PAWR, PAX5, PAX2, AES, RARA, GAS1, PLCB1, ENG, NR1I2, ASCL2, NR1H2, NR1H4, POU4F1, FOSB, FMR1, TNF, DACH1, MEN1, TLE4, MAP2K2, IGFBP5, AEBP1, NACC2, WFS1, LSM5, LSM3, DAB2, BCL6, CNOT3, BCL3, PTPN22, EMILIN1, CR1, RFC1, PTBP2, XCL1, CEBPA, CEBPB, NLRC4, RBBP8, ZNF503, KLF4, PML, KLF8, KLF5, DNAJA3, ZNF608, EDNRB, PPP2R1A, MAGOH, DPF3, SOX7, SOX4, IL1R2, RUNX2, TWIST1, BCL11A, IFNA2, XPO1, EDN1, PARP9, CBFA2T3, NME1, MDFIC, SP100, AIF1, PURA, CDX2, MLH1, ARID4A, CHCHD3, BASP1, TGFB2, TGFB1, CBX4, EIF2S1, NR4A2, LIN28A, NR4A3, CREBZF, KLF12, H2AFX, IFNG, PFDN5, LEF1, THBS1, SNCA, MEIS2, RBMX]
GO:0030216;keratinocyte differentiation;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;25.58801435984686;5.486614186532078;8.564078129062366E-4;0.6037060172430475;[DSP, YAP1, MED1, ST14, CSTA, JAG1, ANXA1, EREG, ADAM9, EPHA2]
GO:0070072;vacuolar proton-transporting V-type ATPase complex assembly;8.0;1.0;0.875;9.628524252492122;45.210214189519135;7.474488534686424;0.0015131451823720294;0.7572456912631272;[DMXL2]
GO:0007218;neuropeptide signaling pathway;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;26.976932752798508;5.123113277522946;9.028936615729279E-4;0.5851165638517994;[CALCA, SORT1, NPY1R, GPR84, SORCS3, LTB4R, ADCYAP1, NPY, PNOC, PROK2, GPR19]
GO:0030218;erythrocyte differentiation;5.0;0.8436909121759173;0.712086467948879;9.117698628726131;22.675663695230284;5.885253329569843;7.589340571069517E-4;0.5912131408273906;[ALAS2, SPI1, GATA3, IKZF1, GATA1, AHSP, JAK3, LYN, INHBA, KLF1, TGFBR3, KIT, ACIN1, TRIM10]
GO:0007219;Notch signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;4.99795013456894;8.87013979980389E-4;0.5787157149004503;[TMEM100, HHEX, HNF1B, FCER2, MAML3, CEBPA, PSEN2, KCNA5, DTX3, DLL1, PLN, GMDS, PERP, S1PR3, ZNF423, TGFB1, JAG1, NR1H4, KRT19, BMP2, SNAI2]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, IQGAP3, GATA1, C3, JUN, JAG1, JUP, FN1, AZU1, NR2F2, COL1A1, LRRC32, HOXC10, FOS, SIRT1, MMP12, PLSCR1, CKS2, PTAFR, STAT4, SPP1, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, NCF1, RORA, CTGF, RUVBL2, ADCYAP1, PKP3, BLM, FOXO1, ZNF423, NFKB1, NFKB2, CXCL10, MYD88, CIITA, FHL2, PIK3CD, HHEX, ITGB8, PPP1R12A, PEG3, PPP1R15A, CCL5, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, EIF3E, EIF3D, CCNH, IKZF1, TNFSF11, EPHB2, HNF1B, SFRP4, SFRP2, EGR1, EGR2, EGR3, ID1, CD28, CD40, HNF4G, BRCA1, BRCA2, CD3E, CD3D, HNF4A, CTSH, CD38, CD36, CD34, IL10, IL18, RGMA, IL1A, IL1B, KIT, YAP1, SATB2, RXRA, CD74, IL33, OSM, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, ETS1, ACTG2, EOMES, CCNE1, CCNB1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, NAT8, TCF4, IL7R, HMGB2, ARHGEF10L, LYL1, NUP62, MYBL1, YWHAH, MYOCD, DDX58, ETV1, ACTA2, CCNA2, GREM1, PSRC1, ELF3, IRF7, CREB5, TAF9, TBX21, RBM38, EGF, MAPK14, CD4, NAA15, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB5, NUP85, PRDM16, NKX2-3, FZD1, NFE2, FZD5, FZD8, UPF3B, TGFB1I1, PAWR, SERPINB9, PAX5, PAX2, RARA, PLCB1, ENG, NR1I2, FAM129A, EPCAM, GSN, NR1H2, NR1H4, GTF2H1, POU4F1, PLP1, FOSB, PF4, CSF3, PLXND1, FMR1, TNC, TNF, CLU, CDH3, CDH1, LAMP3, MEN1, MAP2K2, F2R, ADAM2, ADAM8, DAB2, COPS5, MAFB, MAFF, BCL3, CDK1, PTPN22, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, CEBPA, CEBPB, SMARCD3, CEBPD, CEBPE, NOD2, ABLIM3, POLR2E, POLR2K, POLR2L, KLF4, PML, KLF1, KLF6, KLF5, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, NIF3L1, IL23A, BEX1, TXK, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EPB41L4B, EDN1, RHOG, PARP9, MDFIC, TFEC, TLR6, TLR4, TLR2, SP100, CDX2, CDX1, LILRB1, GRHL2, CAMK4, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, LMO2, HGS, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, FEV, SLC40A1, KLF13, CKAP2, AXIN2, DCN, DNM2, IFNG, LEF1, DLL1, THBS1, LUM, MEIS2, MEIS1, RBMX]
GO:0019674;NAD metabolic process;10.0;0.7369933605727446;0.7837376921472926;9.33127272902419;293.8575721815232;5.54296712308321;0.009835148486270468;0.6987086083097278;[PTGS2, HK3, NT5E, KYNU, CD38, BPGM, KMO, PARP9, BST1]
GO:0001913;T cell mediated cytotoxicity;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;37.17052405245288;7.292166977892469;0.001244063988735793;0.6960420709600095;[CTSH]
GO:0010863;positive regulation of phospholipase C activity;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;83.73920694943958;6.139487467954083;0.0028026758962042993;0.6889736746265369;[PDGFRB, ITK, PDGFRA, TXK, C5AR1, PTAFR, AVPR1A, SELE, RASGRP4, EDNRA, GNA15, GNAQ, KIT, PLCG1]
GO:0032870;cellular response to hormone stimulus;5.0;0.6039883530135606;0.5922351883677006;7.932074963068391;80.94247679971589;3.9540277321974506;0.0027090718549867714;0.49245017396659174;[CYFIP1, PID1, TNC, AQP1, RUVBL2, AKT1, PRKACB, JUNB, PTGDR, MEN1, GHSR, MED1, LHCGR, MEF2C, PRKCE, PRKCD, LMO2, ADCYAP1, POR, ADCY9, RAB31, PRKAR1B, SIK1, FECH, ABCB4, SLC30A10, GATA1, FOXO1, SOCS2, PRKAR2B, IGFBP7, GAS2L1, JUN, TGFB1, CAV1, CDC6, INHBA, NFKB1, NR4A2, NR4A1, KIF18A, NR4A3, FBN1, ROBO2, CTSS, GHR, CTSH, CTSB, IL10, EDN1, ANXA1, DUSP1, ARG1, GLP2R, AVPR1A, FOS, CCNA2, CEACAM1, KIT, PTGER2, AIF1, P2RY6, PAK1, SPP1, FYN, CSK, SORBS1, POU4F1, TSHR, FOSB, RAMP1]
GO:0001915;negative regulation of T cell mediated cytotoxicity;9.0;0.8933024483968273;0.8428918493787028;9.557065288509976;365.562885098783;7.9853141584524145;0.012235060779019208;0.8046099625986299;[CEACAM1, PTPRC, LILRB1, FCGR2B, IL7R]
GO:0001916;positive regulation of T cell mediated cytotoxicity;9.0;0.8653626801206646;0.8289219652406215;9.523163736834295;365.14378084230765;6.518977089658987;0.012221033736724321;0.7296214167088868;[CD1E, CD1D, CD1C, CD1B, CD1A, IL23A, XCL1, IL12RB1]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[, AKT1, STK32B, MAP2K2, PRKCH, PRKCE, PRKCD, VRK1, PRKCQ, PRKCZ, CCNB1, PLK2, PLK1, CLK1, CDK1, BCL2, LRRK2, MAP4K1, CHUK, SYK, SGK1, CAMK2D, AURKB, MAPK14, MAPK13, CAMK4, PKN1, CAMK1]
GO:0018107;peptidyl-threonine phosphorylation;9.0;0.7671156992804218;0.7797984748205;9.305750860229072;337.99482745314367;5.395046993006588;0.011312382699260763;0.6721435792979885;[LRRK2, CHEK1, AKT1, PRKCD, CAD, VRK1, CAMK2D, CLK1, CDK1, BCL2, PKN1, CAMK1]
GO:0043966;histone H3 acetylation;12.0;0.7671156992804218;0.8316781622303555;9.3498108500231;659.4528027923784;5.926926025970411;0.022071291840469662;0.7512235851885185;[SPI1, TAF9, LEF1, ELP4, BRCA2]
GO:0038178;complement component C5a signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;245.7153283963706;9.083926447120524;0.008223870911987907;0.8797934328124444;[C5AR1]
GO:0045907;positive regulation of vasoconstriction;8.0;0.8933024483968273;0.8216512241984136;9.57973408832269;103.52331479149503;6.280566066213989;0.003464832181136806;0.6961884407023742;[CAV1, PTAFR, F2R, AVPR1A, PTGS2, AKT1, CD38]
GO:0009615;response to virus;5.0;0.7436939687323844;0.6620879962271125;8.801845679307654;27.267803904038782;4.174954806800768;9.126288572378991E-4;0.503748394835965;[CHRM2, FMR1, PRF1, ADARB1, IFIT1, TNF, CLU, IFIT3, IFIT2, PYCARD, HERC5, STMN1, DHX58, TRIM25, IFNA14, RSAD2, IFNA16, RNASE6, RNASE2, IL23A, IFNA10, GATA3, DDX60, NLRP3, IFNA21, HMGA1, EIF2AK2, ISG15, AZU1, DEFA1, CXCL10, IL6, CXCL12, PTPRC, BCL3, BCL2, SERINC5, APOBEC3A, BCL2L1, IFNA5, CREBZF, IFNA4, IFNA7, CXCL9, CD40, IFNA2, IFNA8, OASL, IFIH1, CHUK, IFNGR1, DDX58, IFNGR2, IRAK3, PARP9, MMP12, ACTA2, EEF1G, FGR, PLSCR1, IFNG, OAS1, PSMA2, OAS3, IRF7, TLR8, XCL1, TLR7, ZMYND11, UNC93B1, CXCR4, SAMHD1, CCL8, CCL5, TBX21, CCL4, CCL19, CCT5, IL33, MX2, CARD9, LILRB1, MAPK14, PML]
GO:0032869;cellular response to insulin stimulus;8.0;1.0;0.875;9.628524252492122;462.69925393661634;5.334422371190153;0.015486127626965131;0.6478026081386739;[CYFIP1, AKT1, GHSR, CEACAM1, RAB31, FOXO1, PAK1, SORBS1]
GO:0030206;chondroitin sulfate biosynthetic process;8.0;1.0;0.875;9.628524252492122;416.1007025877491;6.558197802812269;0.013926516049292044;0.7103865406232063;[BGN, DCN, VCAN, DSE, CHST15, CSPG4]
GO:0030449;regulation of complement activation;8.0;0.6873818243518346;0.7186909121759173;9.298282565621545;245.7676390307622;5.076593261888053;0.008225621701844479;0.6346172154986847;[C1QB, C1QA, CFH, C1S, C1R, PROS1, C5AR1, CFI, CFP, CLU, C2, C3, IGHG1, IGKC, C7, CD19, IGLV1-44, C3AR1, A2M, CR2, CR1, SERPING1, IGKV3-20, CFB, C1QC]
GO:0032868;response to insulin;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;4.800339885259895;0.0024778305216419678;0.5964089702280253;[CYFIP1, ADM, SESN3, AKT1, IL10, GHSR, CAD, SIRT1, CEACAM1, RAB31, TLR2, RETN, FOXO1, PAK1, PLN, LYN, EGR1, EGR2, SORT1, SORBS1]
GO:0009609;response to symbiotic bacterium;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;57.42597956597373;9.083926447120524;0.0019219958560468828;0.7876727335416686;[PTAFR]
GO:0060070;canonical Wnt signaling pathway;8.0;0.6729672293956388;0.7114836146978194;8.391761625343195;31.415129658942366;5.233778845410465;0.0010514361179036673;0.6426556935498979;[LRRK2, LEF1, TCF7, GATA3, CDH3, FRZB, SOX4, FZD1, FZD5, EGF, FZD8, TMEM64, KLF4, NR4A2, SFRP4, HOXB9, SFRP2, SDC1, SNAI2, LGR4]
GO:0030200;heparan sulfate proteoglycan catabolic process;8.0;1.0;0.875;9.628524252492122;576.1643235394821;8.67846133901236;0.019283701394640074;0.8188169164668168;[HPSE]
GO:0030201;heparan sulfate proteoglycan metabolic process;7.0;0.8436909121759173;0.7727648213451592;9.377209824211215;98.46140010755443;6.481236761676141;0.003295414452092766;0.6823701146576509;[HS3ST3B1, SULF1, SULF2, NDST3, DSE, HPSE]
GO:0031532;actin cytoskeleton reorganization;6.0;1.0;0.8231203125901445;9.628524252492122;32.01253927882412;5.788089581116195;0.001071430880247358;0.6191234829421188;[NRP1, ANTXR1, PRKCZ, PAK1, FLNA, CXADR, ANXA1, GAB1, KIT, S100A9]
GO:1902260;negative regulation of delayed rectifier potassium channel activity;12.0;1.0;0.9481203125901445;9.628524252492122;1503.3881939300709;7.8311634786251565;0.05031704988930664;0.8486063770733797;[KCNE3]
GO:1900087;positive regulation of G1/S transition of mitotic cell cycle;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;354.40743100732976;6.409777797693995;0.011861697769835146;0.7240369598395108;[ANXA1, KCNA5, CDC6, AIF1, PLCB1]
GO:0045919;positive regulation of cytolysis;5.0;0.8436909121759173;0.712086467948879;9.377209824211215;41.08542638077049;7.379178354882098;0.0013750922464812324;0.6676125360964777;[LILRB1]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[SPI1, SPIB, MNX1, MEF2A, MEF2C, PADI4, ATF3, CDCA7, GATA3, GATA1, HESX1, JUN, HACE1, EIF2AK2, NR2F2, EZH2, HOXC10, CHAF1B, ACTL6A, FOS, SIRT1, PLSCR1, STAT4, FLNA, ZNF467, CASP8AP2, ATAD2, PKN1, CCNT2, RUVBL2, RUVBL1, FOXO1, ZNF423, NFKB1, NFKB2, CIITA, FHL2, FASLG, HHEX, BIRC5, E2F1, E2F5, E2F7, PRRX1, POU2AF1, CCNH, IKZF1, UXT, HNF1B, EREG, BTK, ZNF700, EGR1, EGR2, EGR3, ID1, SUV39H1, BRCA1, BMI1, DEPDC1, SATB2, IL33, FOXA3, FOXA2, ETS1, LOXL2, EOMES, TCF7, HMGA1, MXD1, HMGB2, AFF3, LYL1, NUP62, MYBL1, MYOCD, ETV1, ELF3, IRF7, ZMYND11, CREB5, TAF9, TBX21, MAPK14, MAPK13, TAF5, NAA15, EHF, PHB2, HOXA9, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, HOXA4, MED1, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB6, HOXB5, PRDM16, NKX2-3, NFE2, SNAI2, BTG2, TGFB1I1, ZNF367, BRD2, PAWR, PAX5, PAX2, AES, ASCL2, GTF2H1, POU4F1, FOSB, MEN1, TLE4, AEBP1, NACC2, MAP2K6, HOPX, COPS5, MAFB, BCL6, CNOT3, MAFF, BCL3, LBH, RFC1, TFDP1, CEBPA, CEBPB, SMARCD3, CEBPD, CEBPE, ABLIM3, POLR2E, ZNF503, POLR2I, POLR2J, POLR2K, POLR2L, IRX3, KLF4, PML, KLF1, KLF8, KLF6, KLF5, MNDA, ZNF608, DPF3, SOX7, SOX4, EBF1, TXK, TWIST1, NHLH2, BCL11B, BCL11A, CBFA2T3, MDFIC, TFEC, SP100, PURA, CDX2, CDX1, GRHL2, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, LMO2, COL4A2, C5AR1, NLRP3, CBX4, NR4A2, FEV, CREBZF, KDM5D, KLF12, KLF13, LTF, LEF1, HLX, MEIS2, MEIS1, RBMX]
GO:1900086;positive regulation of peptidyl-tyrosine autophosphorylation;11.0;1.0;0.9324289523296623;9.628524252492122;1786.9389585583017;8.16763571524637;0.05980723880229299;0.8501222226412654;[GREM1, ACE, SYK]
GO:1902023;L-arginine transport;11.0;0.8259837884571596;0.845420846558242;9.417215158824915;169.89972840006223;8.16763571524637;0.00568639100972162;0.8501222226412654;[SLC11A1]
GO:0007202;activation of phospholipase C activity;9.0;1.0;0.896240625180289;9.628524252492122;83.73920694944017;6.444869117505266;0.0028026758962043192;0.7258315315665724;[ITK, TXK, C5AR1, AVPR1A, SELE, RASGRP4, EDNRA, GNA15, GNAQ, PLCG1]
GO:0006355;regulation of transcription, DNA-templated;9.0;0.4043225613388953;0.5984019058497367;6.838723401371219;245.35026186902695;1.5478292109445575;0.008211652463856259;0.4753966830094131;[NUP107, SPI1, SLA2, SPIB, AKT1, MNX1, ATF3, CDCA7, GATA3, GATA1, JUN, JAG1, JUP, EIF2AK2, NR2F2, PKIG, HOXC10, CHAF1B, FOS, MMP12, MED23, PLSCR1, PTAFR, SPP1, ZNF467, CASP8AP2, ATAD2, NOC3L, CENPF, PKN1, LGR4, GMNN, EFEMP1, BLM, ZNF423, CIITA, ITGB2, HHEX, E2F1, E2F2, E2F5, E2F7, POU2AF1, SMARCAL1, IKZF1, TNFSF11, TRIM25, FBXO5, BTK, TRIB1, TGFA, PKHD1, EGR1, EGR2, EGR3, POLA1, ECM1, IL10, SYK, IL18, IL1A, IL1B, KIT, DEPDC1, YAP1, PCNA, IL33, OSM, ETS1, NR3C2, LOXL2, CARD11, TCF7, HTRA1, CAV1, TCF4, MXD1, FBN1, TNFAIP3, LYL1, MYBL1, MYOCD, NUP133, IRAK3, ETV1, GREM1, ELF3, ZMYND11, FBP1, TBX21, RRM2, CD4, PHB2, PRKCH, PRKCQ, PRKCZ, NUP85, PRDM16, HMOX1, NFE2, PLK1, SNAI2, CDKN1A, BTG2, ZNF367, RARA, NR1I2, ASCL2, EPCAM, NR1H2, NR1H4, ELP4, FOSB, PF4, CSF3, PLXND1, TNF, CLU, TLE4, MAP2K2, AEBP1, MAP2K6, DAB2, COPS5, BCL6, BCL3, CCDC22, SLC26A3, CYR61, LBH, EMILIN1, RFC1, TFDP1, XCL1, CEBPA, CEBPB, CEBPD, CEBPE, NLRC3, NLRC4, NOD2, ABLIM3, POLR2K, POLR2L, PML, DNAJA3, PPIL4, PPP2R1A, RPS6KA1, FLT3LG, NIF3L1, IL23A, SIK1, TXK, TWIST1, LIF, TOP2A, AHCTF1, IFNA2, PRL, XPO1, EDN1, PARP9, CBFA2T3, VAV1, MLF2, HCK, TLR6, TLR4, TLR2, PURA, GRHL2, CD40LG, HOXA11, HOXA10, LMO2, FANCD2, NLRP3, CBX4, KDM5D, SLC40A1, H2AFX, DCN, DNM2, PFDN5, LTF, LEF1, HLX, SNCA, LUM, RBMX, PID1, EHMT2, MEF2A, MEF2C, PADI2, PADI4, HESX1, HACE1, COL1A1, EZH2, ACTL6A, SIRT1, PSMA6, CKS2, FSTL1, BTAF1, STAT4, FLNA, USP9Y, PSMC6, PSMC2, CCNT2, NCF1, RORA, RUVBL2, RUVBL1, ADCYAP1, S100A9, S100A8, MAZ, TNFRSF11A, FOXO1, NFKB1, NFKB2, CXCL10, MYD88, FHL2, FASLG, PPP1R12A, PEG3, BIRC5, BDP1, LRP2, PRRX1, CCNH, UXT, TMPO, HNF1B, EREG, SFRP4, SFRP2, IFI27, PCBP3, ZNF700, OR7D2, ID1, CD28, CD40, SUV39H1, HNF4G, PTPRK, BRCA1, BRCA2, PCSK6, BMI1, CD3D, HNF4A, CD38, CD36, RGMA, SATB2, RXRA, CD74, NLRP12, NEDD4, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, EOMES, CCNE1, CALCA, VDR, HMGA1, INHBA, IL6, BMP2, HMGB2, ARHGEF10L, AFF3, NUP62, YWHAH, DDX58, CCNA2, PSRC1, IRF7, CREB5, TAF9, AURKB, EGF, MAPK14, SOD2, MAPK13, NUP35, TAF5, NAA15, RAN, EHF, SERPINE1, HOXA9, MYB, HOXA3, HOXA2, CYP1B1, HOXA7, JUNB, HOXA5, HOXA4, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB6, HOXB5, S100A12, ELANE, NKX2-3, FZD1, FZD5, FZD8, CDC6, TGFB1I1, HAVCR2, BRD2, ANXA3, NFAM1, PAWR, PAX5, PAX2, AES, PLCB1, ENG, GTF2H1, SULF1, POU4F1, PYCARD, DACH1, CDH1, MEN1, F2R, ADAM8, NACC2, WFS1, HOPX, MAFB, CNOT3, MAFF, CHUK, TRAF1, SMARCD3, RBBP8, ZNF503, IRX3, KLF4, KLF1, KLF8, KLF6, KLF5, MNDA, ZNF608, EDNRB, CHEK1, DPF3, SOX7, SOX4, SLC11A1, EBF1, RUNX2, PFN1, BEX1, SP140, NHLH2, BCL11B, BCL11A, RHOG, RHOH, MDFIC, TFEC, SGK1, SP100, CDX2, CDX1, LILRB1, CAMK4, CAMK1, ARID4A, ARID4B, CHCHD3, BASP1, ADRB2, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, FEV, JMY, CREBZF, TMEM100, KLF12, KLF13, CKAP2, TGFBR3, IFNG, CAMK2D, DLL1, HSPD1, MEIS2, MEIS1]
GO:0007200;phospholipase C-activating G-protein coupled receptor signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.976932752798508;5.288437257948329;9.028936615729279E-4;0.5935712398991049;[CHRM2, LHCGR, CHRM1, C5AR1, F2R, FPR1, FPR3, FPR2, GPR84, NMBR, LTB4R, MC3R, GRM5, P2RY6, GNA15, EDNRB, P2RY2, GNAQ, CXCR2, C3AR1, AGTR1, F2RL3]
GO:0006111;regulation of gluconeogenesis;8.0;0.8259837884571596;0.7879918942285797;9.420884887713877;92.65639547924356;6.113511981550823;0.0031011261713481853;0.6876452870438905;[DGAT2, FOXO1, SIK1, FBP1]
GO:0007205;protein kinase C-activating G-protein coupled receptor signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.976932752798508;6.444869117505266;9.028936615729279E-4;0.6527112189764278;[EDN1, CHRM1, LRP1, CISH, F2R, AZU1, DGKZ]
GO:0007204;positive regulation of cytosolic calcium ion concentration;11.0;0.6835726970475526;0.7742153008534385;9.097896001429952;290.3013502407617;4.174954806800768;0.00971612493830514;0.645936335304707;[CXCL13, SLC8A1, EDNRA, EDNRB, CCRL2, C3AR1, PROK2, PTGDR, PDGFRA, PRKCE, F2R, ADCYAP1, AGTR1, CALCA, C5AR1, FPR1, FPR3, ITPR3, FPR2, THY1, CD19, HRH4, PLCG1, CCR10, CCR1, CAV1, CXCL10, CXCL11, PTPRC, CALM3, CD24, GPR18, CXCL9, FASLG, ADM, JPH2, CCR9, CD38, CCR7, CCR6, CD36, CCR5, CCR2, CD52, PTGIR, EDN1, TRPC3, GPR35, TRPC1, AVPR1A, LCK, IL1B, XCL1, CX3CR1, PTGER2, CXCR5, CXCR4, CXCR6, GNA15, CXCR1, CXCR3, CXCR2, S1PR3, CCL1, CCL19, GPR157, SNCA, CCL21, GPR6, P2RX5, CD4, FKBP1B, F2RL3]
GO:0006357;regulation of transcription by RNA polymerase II;10.0;0.43649654099988644;0.6334892823608635;7.109131426632953;248.56913769389934;1.8913682364374496;0.008319385340914571;0.5119656714299493;[PID1, SPI1, EHMT2, SLA2, SPIB, AKT1, MNX1, MEF2A, MEF2C, ATF3, GATA3, GATA1, HESX1, JUN, JAG1, JUP, NR2F2, PKIG, EZH2, HOXC10, ACTL6A, FOS, SIRT1, MMP12, MED23, PLSCR1, CKS2, PTAFR, FSTL1, STAT4, ZNF467, USP9Y, ATAD2, NOC3L, PSMC6, PSMC2, PKN1, CCNT2, RORA, RUVBL2, RUVBL1, ADCYAP1, MAZ, FOXO1, ZNF423, NFKB1, NFKB2, CXCL10, CIITA, FHL2, FASLG, HHEX, PPP1R12A, PEG3, LRP2, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, SMARCAL1, CCNH, IKZF1, UXT, TNFSF11, HNF1B, SFRP4, SFRP2, IFI27, TGFA, PCBP3, ZNF700, EGR1, EGR2, EGR3, ID1, CD28, ECM1, CD40, SUV39H1, HNF4G, BRCA1, PCSK6, BMI1, CD3D, HNF4A, CD36, IL10, IL18, RGMA, IL1A, IL1B, KIT, YAP1, SATB2, RXRA, IL33, OSM, NEDD4, FOXA3, IL17A, FOXA2, IHH, ETS1, NR3C2, LOXL2, EOMES, CCNE1, TCF7, HTRA1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, TCF4, MXD1, FBN1, HMGB2, ARHGEF10L, LYL1, MYBL1, MYOCD, DDX58, ETV1, GREM1, ELF3, IRF7, ZMYND11, FBP1, CREB5, TAF9, AURKB, TBX21, MAPK14, SOD2, EHF, SERPINE1, HOXA9, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, HOXA4, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB6, HOXB5, PRDM16, HMOX1, ELANE, NKX2-3, FZD1, NFE2, FZD5, PLK1, FZD8, SNAI2, CDKN1A, BTG2, ZNF367, HAVCR2, BRD2, PAWR, PAX5, PAX2, AES, RARA, ENG, NR1I2, ASCL2, EPCAM, NR1H2, NR1H4, GTF2H1, ELP4, SULF1, POU4F1, FOSB, PF4, CSF3, PLXND1, TNF, DACH1, MEN1, TLE4, AEBP1, NACC2, WFS1, HOPX, COPS5, MAFB, BCL6, MAFF, BCL3, CYR61, RFC1, CHUK, TFDP1, CEBPA, CEBPB, SMARCD3, CEBPD, CEBPE, NOD2, ABLIM3, RBBP8, IRX3, KLF4, PML, KLF1, KLF8, KLF6, KLF5, DNAJA3, PPIL4, ZNF608, EDNRB, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, IL23A, PFN1, BEX1, TXK, TWIST1, NHLH2, BCL11B, BCL11A, LIF, TOP2A, AHCTF1, PRL, XPO1, EDN1, PARP9, TFEC, TLR4, TLR2, SP100, PURA, CDX2, CDX1, LILRB1, GRHL2, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, CBX4, NR4A2, NFKBIA, NR4A1, NR4A3, FEV, JMY, CREBZF, KDM5D, SLC40A1, TMEM100, KLF12, KLF13, CKAP2, DCN, TGFBR3, IFNG, CAMK2D, LEF1, DLL1, HSPD1, HLX, SNCA, LUM, MEIS2, MEIS1, RBMX]
GO:0010848;regulation of chromatin disassembly;9.0;1.0;0.896240625180289;9.628524252492122;25.33440588765447;9.083926447120524;8.479197655747641E-4;0.8607930461318132;[PADI2]
GO:0070098;chemokine-mediated signaling pathway;7.0;0.7307253602413294;0.7162820453778652;8.999915593069748;30.19135422731818;5.459585514144159;0.00101047745553359;0.6301228223472235;[CX3CR1, CXCL6, CCL13, CXCL9, CXCR5, MPL, CXCR4, CXCL1, CXCR6, CXCL13, CXCL3, CXCL2, CXCL5, CCL8, CXCR1, CCL7, CCL5, CXCR3, CXCR2, CCRL2, CCL4, CCR9, CCL2, CCL1, CCR7, CCR6, CCL19, CCR5, CCL18, CCR10, CCR2, CCR1, CCL23, CCL21, CCL20, GPR35, PPBP, CXCL10, CXCL11, CXCL12, XCL2, XCL1, PF4]
GO:0009790;embryo development;4.0;0.7980440201809971;0.6490220100904985;9.040737587590003;21.10990084630072;4.5143834387755835;7.065293836483571E-4;0.4808657789992824;[IHH, EDNRA, PDGFRA, TPM1, MSH2, TWIST1, GATA3, GATA1, EPB41L5, CCNB2, CCNB1, PDGFC, PLCG1, MYH10, TGFB2, STIL, EIF2S2, BMP2, MAFF, BCL2L1, PTPRR, BRCA1, TMEM100, HHEX, EDN1, RXRA, TIE1]
GO:0045409;negative regulation of interleukin-6 biosynthetic process;8.0;1.0;0.875;9.628524252492122;835.4451311618078;8.16763571524637;0.027961596688182013;0.7926932703116032;[GHSR, NLRP12, INPP5D]
GO:1905025;negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential;12.0;0.9326813400603323;0.9144609826203107;9.607904965289386;975.4476452163691;9.777073627680469;0.03264735483950576;0.9481203125901445;[KCNE3]
GO:0032570;response to progesterone;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;105.99106082751567;6.166155715036245;0.0035474254201351726;0.6384578026126634;[YAP1, GABRB1, TGFB2, TGFB1, CAV1, PTGER2, FOS, THBS1, CLDN4, FOSB, CD38, TLR2]
GO:0045401;positive regulation of interleukin-3 biosynthetic process;8.0;1.0;0.875;9.628524252492122;833.6113263844036;9.777073627680469;0.027900220892599446;0.875;[SYK]
GO:0045647;negative regulation of erythrocyte differentiation;8.0;0.9326813400603323;0.8413406700301662;9.582004236857228;359.6763559852469;7.697632086000634;0.012038043947121413;0.7686572628545723;[KLF13, MAFB, HOXA5]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[TNF, CLU, PYCARD, TNFSF11, TRIM25, PRKCH, BTK, PRKCQ, ADAM8, S100A9, S100A8, CARD11, TNFRSF11A, PRKCZ, NLRP3, S100A12, TGFB1, EIF2AK2, NFKB1, NFKB2, MYD88, CD40, ITGB2, CD36, CHUK, IL18, IRAK3, TRAF1, GREM1, PSMA6, IL1B, TLR6, TLR4, LTF, TLR2, NLRC4, NOD2, CD40LG]
GO:0045404;positive regulation of interleukin-4 biosynthetic process;8.0;1.0;0.875;9.628524252492122;833.6113263844036;9.083926447120524;0.027900220892599446;0.839552420951524;[CD86]
GO:0045646;regulation of erythrocyte differentiation;7.0;0.7980440201809971;0.7499413753476991;9.34084218004034;77.59787612007705;5.9928839937622085;0.002597131080184449;0.6573957313958061;[SPI1, HMGB2, GATA1, ETS1, INPP5D, NCKAP1L, HOXA5, LYN, MED1, KLF13, ISG15, INHBA, MAPK14, MAFB]
GO:0051090;regulation of DNA binding transcription factor activity;10.0;0.7192862368539868;0.7748841302879137;9.223059144383958;255.33763090554476;3.793137346993279;0.00854592071745993;0.6092222321850824;[PHB2, AKT1, TNFSF11, CYP1B1, TRIM25, PRKCH, SFRP4, BTK, SIK1, PRKCQ, TRIB1, BEX1, TWIST1, PRKCZ, PKHD1, NHLH2, S100A12, HMOX1, FZD1, JUN, JUP, EIF2AK2, ID1, EZH2, CD40, CD36, HAVCR2, IL10, EDN1, SYK, ANXA3, NFAM1, IL18, FOS, SIRT1, PSMA6, HCK, IL1B, KIT, TLR6, SGK1, TLR4, TLR2, SP100, FLNA, NR1H4, POU4F1, NLRP12, CD40LG, FOXA2, CSF3, TNF, CLU, PYCARD, MEN1, FANCD2, ADAM8, S100A9, S100A8, CARD11, TNFRSF11A, NLRP3, TGFB1, WFS1, NFKB1, NFKB2, NFKBIA, IL6, COPS5, JMY, CCDC22, MYD88, CREBZF, ITGB2, TNFAIP3, MYOCD, CHUK, DDX58, IRAK3, TRAF1, GREM1, XCL1, LTF, NLRC3, NLRC4, NOD2, KLF4]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, GATA1, JUN, JAG1, JUP, NR2F2, COL1A1, HOXC10, FOS, SIRT1, MMP12, PLSCR1, CKS2, STAT4, SPP1, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, NCF1, RORA, RUVBL2, ADCYAP1, BLM, FOXO1, ZNF423, NFKB1, NFKB2, CXCL10, CIITA, FHL2, HHEX, PPP1R12A, PEG3, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, CCNH, IKZF1, TNFSF11, HNF1B, SFRP2, EGR1, EGR2, EGR3, CD28, CD40, HNF4G, BRCA1, BRCA2, CD3D, HNF4A, CD38, IL10, IL18, RGMA, IL1A, IL1B, YAP1, SATB2, RXRA, CD74, IL33, OSM, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, ETS1, EOMES, CCNE1, VDR, HMGA1, INHBA, IL6, BMP2, TCF4, HMGB2, ARHGEF10L, LYL1, NUP62, MYBL1, YWHAH, MYOCD, DDX58, ETV1, CCNA2, GREM1, PSRC1, ELF3, IRF7, CREB5, TAF9, TBX21, EGF, MAPK14, CD4, NAA15, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB5, NUP85, PRDM16, NKX2-3, FZD1, NFE2, FZD5, FZD8, TGFB1I1, PAX5, PAX2, RARA, PLCB1, ENG, NR1I2, EPCAM, NR1H2, NR1H4, GTF2H1, POU4F1, FOSB, PF4, CSF3, PLXND1, TNF, CDH1, MEN1, MAP2K2, F2R, DAB2, COPS5, MAFB, MAFF, BCL3, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, CEBPA, CEBPB, SMARCD3, CEBPD, CEBPE, NOD2, ABLIM3, KLF4, PML, KLF1, KLF6, KLF5, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, NIF3L1, IL23A, BEX1, TXK, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EDN1, RHOG, PARP9, MDFIC, TFEC, TLR4, TLR2, SP100, CDX2, CDX1, LILRB1, GRHL2, CAMK4, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, NR4A3, SLC40A1, KLF13, CKAP2, DCN, DNM2, LEF1, DLL1, LUM, MEIS2, MEIS1, RBMX]
GO:0017186;peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase;9.0;1.0;0.896240625180289;9.628524252492122;156.5483802706234;9.083926447120524;0.005239533403262511;0.8607930461318132;[QPCT]
GO:0018279;protein N-linked glycosylation via asparagine;9.0;0.8653626801206646;0.8289219652406215;9.4949928598676;334.83267440717236;6.113511981550823;0.011206548282565083;0.7088859122241795;[ST6GALNAC2, ASGR1, ASGR2, ST3GAL6]
GO:0030388;fructose 1,6-bisphosphate metabolic process;5.0;1.0;0.7902410118609202;9.628524252492122;72.82688802824934;7.8311634786251565;0.0024374504023614934;0.6907270763441554;[FBP1]
GO:0070839;divalent metal ion export;8.0;0.8933024483968273;0.8216512241984136;9.427853557029971;35.67391733828006;9.083926447120524;0.001193973908871026;0.839552420951524;[SLC11A1, SLC40A1]
GO:1905039;carboxylic acid transmembrane transport;8.0;0.520066220968634;0.635033110484317;7.642608768823109;124.81757766331765;5.067543426368135;0.00417753199586433;0.6341544064893356;[AQP9, SLC7A11, SLC16A3, SLC36A1, SLC38A1, SLC6A16, SLC6A15, SLC6A12, SLC7A5, SLC7A7, SLC7A8, SLC7A9, SLC43A2, SLC1A3, SLC3A1, SLC38A11, LRP2, SLC1A6, SLC38A6, SLC17A6, SLC6A6]
GO:0065003;protein-containing complex assembly;4.0;0.45485133202666184;0.4774256660133309;6.058991556010752;36.471478728154885;2.4440506132939883;0.0012206675708314864;0.3749888620238313;[, NUP107, PRKACB, CLDN3, PADI4, PDGFC, ABCA1, JUP, FN1, COL1A1, COL1A2, HLA-DRB1, ACHE, DPYS, ARHGAP6, CHAF1B, CHAF1A, KCND2, ARG1, F5, SLC7A7, SLC7A9, KCNA5, CENPA, HLA-DMA, HLA-DMB, DMD, CENPE, CENPF, CENPH, CENPI, CENPK, CENPL, CENPM, GOPC, CENPN, CENPO, KCNG2, NCF1, GMNN, RUVBL2, RUVBL1, OLFM4, BLM, UQCRB, LIN7A, ACAT1, CXCL12, DMXL2, HLA-DRA, LRRK2, ALAD, VBP1, NDUFC2, ACPP, BDP1, BIRC3, NDUFB7, NDUFB6, HM13, NDUFB4, NDUFB3, NDUFB2, NDUFB1, CCL5, EIF4H, NDUFA8, NDUFA7, NDUFA6, NDUFA3, NDUFA2, IL2RB, CD247, EIF3D, CCNH, PRF1, IKZF1, TCL1A, SNRPD2, SNRPD1, TNFSF11, FBXO5, SNRPD3, HNF1B, MIF, KCTD12, KCTD15, TGFA, PTK2, CD40, CTSZ, CD3G, CD3E, CD3D, CCT3, CCT2, FCER1G, YAP1, NAPA, MIS12, CAPG, RXRA, CCT8, CD74, GCH1, RPA1, RPA3, NDUFAB1, NDUFB10, NDUFB11, TCF7, RASGRP1, CCNB1, H1FX, ECT2, CAV2, UBE2C, CAV1, HMGA1, VIL1, NASP, TCF4, HMGB2, TNFAIP3, LAMC1, NUP62, GREM1, NDUFS8, NDUFS7, NDUFS6, NDUFS4, NDUFS3, NUP54, FBP1, TAF9, SAMHD1, RRM1, EGF, MX2, SOD2, TTC19, TEK, CDA, BIN2, NUP205, PRKCZ, ACMSD, HMOX1, NCKAP1L, EHD3, SERPINA1, TK1, BRD2, GSN, GTF2H1, TNF, CLU, DACH1, MEN1, TLE4, SNRPG, SNRPE, SNRPF, ITPR3, NACC2, LSM3, HOPX, CDK1, EMILIN1, ADSL, VWF, TRAF1, PTBP2, MCM2, NLGN1, NLRC4, NOD2, PLN, WASF3, PML, MARCKS, RAD51, P2RX1, IMPDH2, PPP2R1A, MCCC2, COX7A2L, TLN1, MGST1, CD79B, CD79A, VASP, AHCTF1, RAD51C, UQCR10, AIF1, CTNNA1, NDUFA11, KNTC1, CHRNB4, NCF1C, ADRB2, NLRP3, MYH11, TGFB1, EIF2S1, H2AFX, AXIN2, DNM2, TGFBR3, COL6A2, COL6A1, COLEC12, CAMK2D, HIST1H2BK, LEF1, HSPD1, REPS2, RBMX]
GO:0046985;positive regulation of hemoglobin biosynthetic process;8.0;1.0;0.875;9.628524252492122;545.056182040423;8.67846133901236;0.018242539894176294;0.8188169164668168;[KLF4]
GO:0045652;regulation of megakaryocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;68.9575807315309;5.845247994956144;0.0023079481692908138;0.6498456195510879;[ITGA2B, HMGB2, THBS1, GATA1, NFE2, MEF2C, GP1BA, NR4A3, PRKCQ, MYL9, PF4]
GO:0045410;positive regulation of interleukin-6 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.3044735649636;7.8311634786251565;0.02792341990494083;0.7754860644832351;[TLR1, IL1B, PTAFR, TLR6, EREG]
GO:0045416;positive regulation of interleukin-8 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.474488534686424;0.027942676825076673;0.7572456912631272;[TLR8, TLR7, TLR4, TNF, ELANE]
GO:0045415;negative regulation of interleukin-8 biosynthetic process;8.0;1.0;0.875;9.628524252492122;836.0204953067102;8.390779266560578;0.027980853608317785;0.8041048419030481;[BCL3, KLF4, ELANE]
GO:1990776;response to angiotensin;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;7.138016298065211;0.0024778305216419678;0.7159578506919597;[PRKCD, CYBB, CDC6, PTGS2, SLC30A10, NFKB1]
GO:0043242;negative regulation of protein complex disassembly;6.0;0.7248374789738407;0.6855390520770648;8.83001655627435;65.72942481560547;5.572381008289503;0.002199904695936496;0.6080921364962873;[LMOD1, CAPG, TNF, EPS8, SPTA1, SPTAN1, TMOD1, GSN, CKAP2, IRAK3, VIL1]
GO:0014902;myotube differentiation;6.0;0.8653626801206646;0.7558016526504768;9.377209824211215;22.452520143917486;7.379178354882098;7.514656432606705E-4;0.7004918368257019;[MEF2C, SORT1, AVPR1A]
GO:0010543;regulation of platelet activation;8.0;0.7866048967936545;0.7683024483968273;9.510741216835738;81.8829764000265;6.343086423195323;0.0027405495302144796;0.6993857346658935;[LYN, PDGFRA, FCER1G, SYK, TXK, PRKCD, PDGFA, SELP, THBD, CEACAM1, PDPN, CD9, PRKCQ, TLR4]
GO:0045429;positive regulation of nitric oxide biosynthetic process;8.0;1.0;0.875;9.628524252492122;658.6394256443023;6.166155715036245;0.02204406883931546;0.6903374900225189;[ITGB2, PTGS2, TNF, CLU, AIF1, KLRK1, AKT1, CD36, EDN1, AGXT2, KLF4, DNM2, IFNG, IL1B, PTX3, TLR6, TLR4]
GO:0006021;inositol biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;310.2505467811778;8.390779266560578;0.010383806593401594;0.7800242071602487;[IMPA2]
GO:1905049;negative regulation of metallopeptidase activity;10.0;0.8933024483968273;0.861892236059334;9.59573442966913;499.6307270806722;7.9853141584524145;0.016722190796928726;0.8236103492792612;[TIMP2, TIMP3, TIMP1]
GO:0038095;Fc-epsilon receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.989581884898423;0.002626513627734276;0.6301674496329921;[ITK, GRAP2, FCER1A, FCER1G, CHUK, SYK, FOS, GAB2, VAV1, LAT2, BTK, PRKCQ, LCP2, CARD11, PAK1, IGKC, IGLV1-44, PLCG1, LYN, JUN, NFKB1, NR4A3, IGKV3-20, LAT]
GO:0008203;cholesterol metabolic process;6.0;0.7980440201809971;0.722142322680643;9.223059144383958;82.64786032185484;5.058574756385375;0.0027661495067272364;0.581816060879476;[CUBN, CH25H, CFTR, CEBPA, RXRA, ABCA1, DHCR24, SNX17]
GO:0038094;Fc-gamma receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.857092701852345;0.002626513627734276;0.6233919466506386;[CYFIP1, CD3G, IGHG1, FCGR3A, FCGRT, FCER1G, SYK, PRKCE, PRKCD, VAV1, FGR, HCK, CLEC4D, CLEC4E, PAK1, IGKC, IGLV1-44, NCKAP1L, FYN, PLCG1, FCGR1A, LYN, PTK2, FCGR2A, CD247, FCGR2B, IGKV3-20]
GO:0043001;Golgi to plasma membrane protein transport;8.0;0.9326813400603323;0.8413406700301662;9.589303539338841;211.1766051690936;6.481236761676141;0.00706789092840378;0.7064507494004503;[GOLPH3L, RAB31]
GO:0045666;positive regulation of neuron differentiation;8.0;0.6181399273706679;0.684069963685334;8.712233520617966;337.32148776029015;3.9481280100702625;0.011289846625707336;0.576907450041722;[SCARB2, CYFIP1, CPNE5, PLXND1, FMR1, ARHGDIA, MEF2C, ADCYAP1, MAP1B, S100A9, EPHA3, SOCS2, ECT2, LYN, FZD1, SYT2, FN1, BMP2, CXCL12, LIN28A, BCL6, FES, BCL2, PLXNB2, TCF4, EZH2, ROBO2, NRP1, TIMP2, NME1, RARA, SHANK3, NLGN1, RAB21, PAK1, CNR1, FYN, IRX3, FKBP1B, CAMK1]
GO:0043488;regulation of mRNA stability;9.0;0.7436939687323844;0.7680876095464813;9.240758721483358;282.23354693635815;4.989581884898423;0.009446102822258332;0.6514080748132811;[FMR1, XPO1, AKT1, SLC11A1, PRKCD, AXIN2, E2F1, RBM38, TNFSF13, MAPK14, MYD88]
GO:0038096;Fc-gamma receptor signaling pathway involved in phagocytosis;10.0;1.0;0.9152410118609203;9.628524252492122;384.64074149301706;4.886724499458715;0.01287357946357817;0.6651483300191682;[CYFIP1, CD3G, IGHG1, FCGR3A, SYK, PRKCE, PRKCD, VAV1, FGR, HCK, PAK1, IGKC, IGLV1-44, NCKAP1L, FYN, PLCG1, FCGR1A, LYN, PTK2, FCGR2A, CD247, FCGR2B, IGKV3-20]
GO:0042157;lipoprotein metabolic process;5.0;0.7586651285174919;0.6695735761196662;8.999915593069748;47.85814540089318;6.221725566191056;0.001601769057033345;0.6084203466557585;[LRP1, ABHD12]
GO:0045669;positive regulation of osteoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;169.86351353303945;5.734022359845919;0.005685178930713632;0.6163584827319739;[CEBPA, CEBPB, CYR61, IL6R, CTHRC1, MEF2C, JAG1, RUNX2, IL6, BMP2, SFRP2, FAM20C, LTF]
GO:0045425;positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process;8.0;1.0;0.875;9.628524252492122;833.6113263844036;9.083926447120524;0.027900220892599446;0.839552420951524;[SYK, CD80]
GO:0038093;Fc receptor signaling pathway;7.0;0.8436909121759173;0.7727648213451592;9.474373572664863;77.78262967477835;4.556717802602145;0.0026033146153928975;0.5839501255913225;[CYFIP1, IGHG1, FCGRT, GRAP2, PRKCE, PRKCD, CLEC4D, BTK, PRKCQ, CLEC4E, CARD11, IGLV1-44, NCKAP1L, PLCG1, LYN, JUN, PTK2, NFKB1, NR4A3, IGKV3-20, LAT, ITK, CD3G, FCGR3A, FCER1A, FCER1G, CHUK, SYK, FOS, GAB2, VAV1, LAT2, FGR, HCK, KIT, LCP2, PAK1, IGKC, FYN, FCGR1A, FCGR1B, FCGR2A, CD247, FCGR2B]
GO:0006027;glycosaminoglycan catabolic process;6.0;0.7866048967936545;0.7164227609869718;9.245532000236016;234.16675596998346;5.618190544320798;0.00783735058591714;0.610434838299289;[SDC2, GNS, PKHD1, TGFB1, LUM, FUCA1, OMD, BGN, HSPG2, DCN, VCAN, OGN, SDC1, CSPG4, HPSE]
GO:0097067;cellular response to thyroid hormone stimulus;6.0;0.8933024483968273;0.7697715367885581;9.485423408851448;110.48347060425422;7.004484905440688;0.003697782332456301;0.6813299963962409;[GHSR, MED1, KIT, LMO2, CTSH, GAS2L1, GATA1, CTSS, CTSB]
GO:0045672;positive regulation of osteoclast differentiation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;840.7838216260375;6.599019797332524;0.0281402778535103;0.7337148045016781;[CCR1, TMEM64, FOS, TNF, POU4F1, IFNG, IL23A, CA2, TNFSF11, IL17A]
GO:0043011;myeloid dendritic cell differentiation;6.0;0.8933024483968273;0.7697715367885581;9.4949928598676;91.1712242271392;6.8867018697843045;0.003051418826107602;0.6753065664753021;[TGFB1, SPI1, CAMK4, LTBR]
GO:0010759;positive regulation of macrophage chemotaxis;10.0;1.0;0.9152410118609203;9.628524252492122;998.0472698001994;7.292166977892469;0.033403743935984914;0.7881627702307852;[CCL5, C5AR1, C3AR1, MAPK14, THBS1]
GO:0045671;negative regulation of osteoclast differentiation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;842.5336305879634;6.481236761676141;0.028198842384740134;0.7276913745807394;[LILRB1, LILRB3, MAFB, INPP5D, TLR4, LTF, FBN1]
GO:0001805;positive regulation of type III hypersensitivity;11.0;1.0;0.9324289523296623;9.628524252492122;1205.6585476054483;9.083926447120524;0.04035230656610712;0.8969813732811862;[FCER1G, BTK]
GO:0033630;positive regulation of cell adhesion mediated by integrin;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;34.61675044652454;6.943860283624253;0.0011585914843924019;0.6453503496879909;[TGFB2, SFRP2, SYK, CCL21, CCL5, ADAM9, NCKAP1L, PTPN6, CXCL13]
GO:0008210;estrogen metabolic process;6.0;0.8933024483968273;0.7697715367885581;9.4949928598676;78.56989776551285;6.599019797332524;0.002629663769894499;0.6605944919115335;[PDGFRA, HSD17B4, CYP1B1]
GO:0090200;positive regulation of release of cytochrome c from mitochondria;9.0;1.0;0.896240625180289;9.628524252492122;472.23248408711356;6.409777797693995;0.015805196260752157;0.7240369598395108;[BIK, PLAUR, MMP9, PYCARD]
GO:0038083;peptidyl-tyrosine autophosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;522.6399477532146;5.905872616772578;0.017492288705884526;0.7172676121338334;[BLK, ITK, TXK, SLA2, GRAP2, FYN, CSK, JAK3, LYN, SYK, MATK, BMX, PTK2, FGR, ZAP70, HCK, LCK, FES, BTK]
GO:0042167;heme catabolic process;7.0;0.8259837884571596;0.7639112594857803;9.464221201200845;638.5210787907555;7.8311634786251565;0.02137072587546392;0.7514054297404357;[BLVRB, HMOX1]
GO:0061903;positive regulation of 1-phosphatidylinositol-3-kinase activity;12.0;1.0;0.9481203125901445;9.628524252492122;1772.7488086408737;9.083926447120524;0.05933230725486248;0.9126727335416687;[FPR2]
GO:0043017;positive regulation of lymphotoxin A biosynthetic process;8.0;1.0;0.875;9.628524252492122;856.0759792352393;9.777073627680469;0.028652092606641942;0.875;[CD86]
GO:0033629;negative regulation of cell adhesion mediated by integrin;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;51.31823397956752;7.474488534686424;0.0017175751078840245;0.7053660038532718;[SERPINE1, CYP1B1, SNAI2]
GO:0001812;positive regulation of type I hypersensitivity;11.0;1.0;0.9324289523296623;9.628524252492122;1109.5695898802176;9.083926447120524;0.0371362956254912;0.8969813732811862;[FCER1G, BTK]
GO:0016064;immunoglobulin mediated immune response;6.0;0.7586651285174919;0.7024528768488905;9.040737587590003;30.584352397600135;7.069023426578259;0.0010236307506175364;0.6846304993685643;[CD74, FCER1G, PRKCD, EXO1, INPP5D, BCL3, IRF7, TLR8, CD27, FCGR2B, IL13RA2, HLA-DQB1]
GO:0002902;regulation of B cell apoptotic process;9.0;0.7369933605727446;0.7647373054666613;9.117698628726131;22.875998380894767;6.8867018697843045;7.656390787466303E-4;0.7484268790654467;[LYN, IL10, CD74, MIF, AURKB, BCL6, BTK]
GO:0030593;neutrophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;5.382624473008031;0.004360933283440787;0.671508291047556;[CXCL6, CCL13, CXCL9, IL1RN, CSF3R, C5AR1, ITGB2, PIK3CD, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, LGALS3, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, PDE4B, CCL2, S100A12, CCL1, NCKAP1L, CCL19, CCL18, CCL23, TGFB2, CXADR, FCER1G, SYK, CCL21, CCL20, PPBP, VAV1, CXCL10, CXCL11, IL1B, XCL2, XCL1, S100A9, S100A8, PF4]
GO:0001818;negative regulation of cytokine production;5.0;0.5133656128089943;0.5469238182654175;7.031139619277432;44.35819177106142;4.304802954008995;0.0014846287587966433;0.5103888351227501;[CD83, TNF, PYCARD, HERC5, CDH3, DHX58, TRIM25, HOMER3, GHSR, CD96, LAG3, IL1R2, SLC11A1, IL23A, BTK, CD274, TWIST1, GATA3, INPP5D, NLRP3, HMOX1, NCKAP1L, ELANE, SLAMF1, TGFB2, TGFB1, PRG2, FN1, ISG15, INHBA, NFKB1, IL6, BCL6, BCL3, CD24, GPR18, ORM1, IFNA2, TNFAIP3, PTPN22, LRRC32, IFIH1, CD34, JAK3, HAVCR2, IL10, ANXA1, ARG1, DDX58, IRAK3, PDCD1LG2, CEACAM1, IFNG, BANK1, RARA, TLR8, XCL1, BPI, TLR6, TLR4, LTF, LEF1, NLRC3, DLL1, THBS1, GPNMB, TBX21, CSK, TIGIT, IL33, NR1H4, LILRB1, KLF4, PML, NLRP12, FCGR2B, LGR4]
GO:0007171;activation of transmembrane receptor protein tyrosine kinase activity;12.0;1.0;0.9481203125901445;9.628524252492122;1143.6879814690685;7.212124270218933;0.03827820748741112;0.8169486831672182;[GREM1, EGF, PDGFC, ADRB2]
GO:0030194;positive regulation of blood coagulation;8.0;0.7671156992804218;0.7585578496402109;9.34084218004034;205.4468638594546;6.518977089658987;0.006876121643202558;0.7083807915285978;[F2R, SERPINE1, THBS1, F3, SELP, THBD, PDPN, CD36, HPSE, TLR4, S100A9]
GO:0061098;positive regulation of protein tyrosine kinase activity;11.0;0.8436909121759173;0.8542744084176208;9.55953138100517;2154.6219316186807;5.8650506222523235;0.07211325701743153;0.7323679139043926;[CSF1R, NCF1, TGFA, GRM5, CCL5, STAP1, FYN, ACE, EGF, EREG, GREM1, CD24]
GO:0007173;epidermal growth factor receptor signaling pathway;9.0;0.7763722522362496;0.7844267512984139;9.040737587590003;32.38857880465376;5.788089581116195;0.0010840165847632744;0.6922437955322635;[TGFA, SLC30A10, EPS8, EFEMP1, REPS2, AKT1, PLCG1, TGFB1, EGF, GAB1, PTK2, EREG, BTC, VIL1, KIF16B, FES, HBEGF]
GO:0042572;retinol metabolic process;9.0;1.0;0.896240625180289;9.628524252492122;118.00963323224862;6.375876246018314;0.003949676222508656;0.722303232910233;[DGAT2, TTR, ALDH1A1, CYP1B1]
GO:0043420;anthranilate metabolic process;8.0;0.8933024483968273;0.8216512241984136;9.533214072687796;223.03738466346266;9.777073627680469;0.0074648605440717835;0.875;[KYNU]
GO:0042573;retinoic acid metabolic process;9.0;0.8259837884571596;0.8092325194088689;9.500690880982237;139.55611397069308;6.7325511899570465;0.0046708175422506696;0.740543606130341;[SCPEP1]
GO:0045600;positive regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.26328322821418;5.71663061713405;0.00382428925936973;0.6154690682008903;[CEBPA, CEBPB, PTGS2, FRZB, PRDM16, AKT1, TMEM64, MAPK14, BMP2, KLF5, SFRP2]
GO:0042574;retinal metabolic process;9.0;1.0;0.896240625180289;9.628524252492122;79.50217411028933;7.212124270218933;0.0026608662201599294;0.7650689957573628;[CYP1B1]
GO:0097053;L-kynurenine catabolic process;10.0;1.0;0.9152410118609203;9.628524252492122;764.3846786597122;9.083926447120524;0.025583267293192123;0.8797934328124444;[KYNU]
GO:0051289;protein homotetramerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;5.433268205826786;0.002859955186148837;0.6287769539759931;[CDA, DPYS, TK1, ACPP, FBP1, HM13, SAMHD1, CD79A, RXRA, VASP, SOD2, IMPDH2, CD247]
GO:0051045;negative regulation of membrane protein ectodomain proteolysis;9.0;1.0;0.896240625180289;9.628524252492122;966.2736676900156;7.697632086000634;0.032340310067742455;0.7898978880348613;[IL10, TIMP2, TIMP3, TIMP1]
GO:0001867;complement activation, lectin pathway;8.0;1.0;0.875;9.628524252492122;200.06168254027287;7.292166977892469;0.006695884470798082;0.747921758369865;[FCN1, C1S]
GO:0010575;positive regulation of vascular endothelial growth factor production;6.0;1.0;0.8231203125901445;9.628524252492122;64.54350789155374;6.481236761676141;0.002160213123744424;0.6545710619905948;[TGFB1, C5AR1, RORA, BRCA1, PTGS2, SULF1, SULF2, C3, IL1A, IL1B, C3AR1, CYP1B1, HPSE, NOX1]
GO:0033690;positive regulation of osteoblast proliferation;6.0;1.0;0.8231203125901445;9.628524252492122;63.05258358394898;7.379178354882098;0.0021103132289136558;0.7004918368257019;[BMP2, HPSE, GATA1, CYR61, LTF, CTHRC1]
GO:1904385;cellular response to angiotensin;8.0;1.0;0.875;9.628524252492122;462.69925393661634;7.379178354882098;0.015486127626965131;0.7523715242355574;[PRKCD, CDC6, SLC30A10, NFKB1]
GO:0006094;gluconeogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;174.6088252776196;5.926926025970411;0.005844000244301424;0.6540226378555745;[BPGM, FBP1, ATF3]
GO:0045859;regulation of protein kinase activity;9.0;0.5608425510848448;0.6766619007227115;8.333797084897721;159.5555227474585;3.0974744418360864;0.005340179755709658;0.5546456121830788;[, ADARB1, AKT1, PROK2, PRKACB, PRKCD, PRKAR1B, FPR1, PDGFA, THY1, IQGAP3, PRKCZ, FLRT2, PRKAR2B, PDGFD, PDGFC, S100A12, SFN, NCKAP1L, ELANE, LYN, ACE, FZD5, PLK1, FZD8, EIF2AK2, CDC6, AZU1, NR2F2, NOX4, PKIG, EZH2, CDKN1A, LRRC4, DUSP2, DUSP1, BGN, SIRT1, DUSP6, CKS2, LRRC19, NTF3, CCL19, CDKN2C, CCL21, GTF2H1, ELP4, CENPE, PKN1, CCNT2, NCF1, TNF, CLU, PYCARD, MEN1, MAP2K2, CISH, F2R, CDC25A, ADCYAP1, ADAM9, ADAM8, CSF1R, BLM, TNFRSF11A, PKMYT1, SOCS2, DRD4, MAP2K6, TNFRSF10B, CXCL10, PTPRC, CDK1, CSPG4, LAT, LRRK2, ITGB3, PTPN22, CYR61, HHEX, DUSP10, LCP2, CEBPA, NOD2, CCL5, FYN, CSK, PTPN6, IL1RN, CCNH, HERC5, TCL1A, PPP2R1A, TNFSF11, EPHB2, ACSL1, SLC11A1, PAQR3, MIF, EREG, SFRP2, IL23A, TRIB1, TGFA, EGR1, PTK2, CALM3, CD24, CD40, RAC2, CCR7, MAP4K1, EDN1, SYK, STRADB, IL18, GP1BA, CEACAM1, MDFIC, IL1B, KIT, TLR6, TLR4, CXCR4, PAK1, CD74, PODN, CD40LG, CAMK1, IL6R, PDGFRB, TSC2, CCNE2, HGS, CCNE1, CALCA, C5AR1, ADRB2, RASGRP1, CCNB2, CCNB1, STAP1, ECT2, TGFB2, TGFB1, CAV1, GH1, BMP2, GNAQ, TNFAIP3, GHR, GRM5, LRRTM4, NUP62, MYOCD, IRAK3, DCN, FGR, CCNA2, GREM1, PSRC1, IFNG, CHI3L1, PDE5A, LTF, THBS1, SNCA, EGF, MAPK14, CD4]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[MRGPRF, EDNRA, EDNRB, GPR171, C3AR1, AKT1, PROK2, HOMER3, PRKACB, PTGDR, TAS2R10, TAS2R13, TAAR2, TRHR, EREG, TIAM2, SFRP4, ADCY9, SFRP2, AGTR1, FPR1, FPR3, FPR2, C3, OR7D2, CCR10, CCR1, ABCA1, FZD1, GPR15, FZD5, OR2J2, FZD8, AZU1, NMBR, PPBP, GNG11, MARCO, PNOC, CALM3, OR7C2, GPR18, GPR19, GPR25, GABRB1, GRIK3, ADM, CD3E, AKAP12, CCR9, RAC2, FFAR2, CCR7, CCR6, CCR5, CCR2, EDN1, GPR37, ANXA1, GPR35, RHOG, GPBAR1, TACR3, AGTRAP, PTH2R, GP1BA, AVPR1A, SORCS3, VAV1, MC3R, PLCB1, CCL13, PTGER2, PTAFR, CXCR5, CXCR4, CXCR6, GNAI1, GNAI2, FGD3, FGD4, CXCR1, FRZB, NPY, CXCR3, CXCR2, FLNA, CCL19, GABRE, CCL18, GPR157, P2RY13, GABBR1, CCL23, CCL21, SORT1, GABRA5, CCL20, P2RY14, GPR6, RAMP1, LGR4, F2RL3, PF4, CHRM2, FCN1, CHRM1, CELSR1, CXCL13, CXCL16, RGS1, CCRL2, PDGFRB, CD97, GHSR, LHCGR, CISH, SPNS3, APLP2, F2R, NPY1R, DGKZ, PDGFRL, ADCYAP1, SPNS1, OR2C3, GNAZ, CALCA, SUCNR1, CALCRL, GPR87, C5AR1, GPR85, ITPR3, GPR84, ADRB2, GPR82, HRH4, PSAP, ECT2, DRD4, HTR1E, CAV1, GPR98, CXCL10, CXCL11, CXCL12, GNB2, GNAQ, OR7E24, TAS2R7, CXCL6, CXCL9, OR1G1, CXCL1, CXCL3, CXCL2, CXCL5, LTB4R, GRM5, CA2, PDE4B, PTGIR, ARHGEF12, GLP2R, OR2H1, XCL2, XCL1, CX3CR1, LRP1, OR1E1, P2RY6, GNA15, CCL8, PLN, CCL7, CNR1, P2RY2, OR2W1, CCL5, CCL4, CCL2, S1PR3, OR12D3, CCL1, S1PR5, SLC12A2, TSHR, OR11A1, PTPN6]
GO:0031032;actomyosin structure organization;6.0;0.7192862368539868;0.682763431017138;8.763526815005518;32.01253927882412;5.16195311083921;0.001071430880247358;0.5871028347338303;[ITGB5, LMOD1, F11R, EPB41L5, CNN1, EPB41L4B, RACGAP1, EPB41L3, MYH14, MYOZ2, MYH10, PDGFRB, MEF2A, TMOD1, PDGFRA, TPM1, SORBS1, KRT19, ZYX]
GO:0007187;G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;6.0;0.6997970393407541;0.6730188322605215;8.578702127993445;26.976932752798508;4.347727998726029;9.028936615729279E-4;0.5454633246350222;[CHRM2, CHRM1, GRIK3, ADM, LTB4R, AKAP12, GRM5, EDNRA, RGS1, PRKACB, PTGDR, LHCGR, PTGIR, EDN1, GPR37, ANXA1, GLP2R, NPY1R, MC3R, ADCYAP1, ADCY9, GNAZ, CALCA, CALCRL, PTGER2, FPR1, FPR2, GPR84, ADRB2, GNAI1, GNAI2, GNA15, PLN, CNR1, NPY, HRH4, PSAP, FLNA, CCL2, S1PR3, DRD4, CCR1, ABCA1, GABBR1, HTR1E, TSHR, MARCO, GNAQ, RAMP1, LGR4]
GO:0042100;B cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;50.60132884827668;6.166155715036245;0.00169358093831245;0.6384578026126634;[IFNA5, IL10, IFNA4, IFNA7, MEF2C, CR2, CD40, IFNA14, IFNA16, IFNA2, CD180, PRKCD, LEF1, IFNA8, HSPD1, CD79A, CD40LG, PTPRC, BCL2, IL7R, MS4A1, CARD11, IFNA21, IFNA10]
GO:0007188;adenylate cyclase-modulating G-protein coupled receptor signaling pathway;7.0;0.7090535922965819;0.7054461614054914;8.712233520617966;27.67007993335845;4.535326612620827;9.260926739143067E-4;0.5828561791408859;[CHRM2, CHRM1, GRIK3, ADM, LTB4R, AKAP12, GRM5, EDNRA, RGS1, PRKACB, PTGDR, LHCGR, PTGIR, EDN1, GPR37, GLP2R, NPY1R, MC3R, ADCYAP1, ADCY9, GNAZ, CALCA, CALCRL, PTGER2, FPR1, FPR2, GPR84, ADRB2, GNAI1, GNAI2, GNA15, PLN, CNR1, HRH4, PSAP, FLNA, S1PR3, DRD4, ABCA1, GABBR1, HTR1E, TSHR, MARCO, GNAQ, RAMP1, LGR4]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[CD86, TFRC, CD80, CD3E, TNFSF13B, PYCARD, IL6R, JAK3, ICOSLG, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, IL18, PDCD1LG2, ZAP70, IL23A, IL1B, XCL1, PRKCQ, CARD11, CD274, BLM, HHLA2, CD1D, CORO1A, AIF1, HLA-DMB, CCL5, NCKAP1L, CCL19, IL12RB1, VCAM1, LILRB2, CD4, IL6, CD40LG, PTPRC, CD6, DNAJA3, CD28, HLA-DPB1, CD24]
GO:0002721;regulation of B cell cytokine production;8.0;0.8933024483968273;0.8216512241984136;9.510741216835738;107.63791932510406;9.777073627680469;0.003602544291973033;0.875;[BTK]
GO:0033209;tumor necrosis factor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;30.19135422731818;5.395046993006588;0.00101047745553359;0.6268223193749;[CD40, TNFRSF13B, TNF, TNFSF13B, PYCARD, TNFSF11, CHUK, TNFRSF1B, LTA, LTB, BIRC3, TNFRSF11A, TNFRSF17, TNFSF14, TNFSF12, TNFSF13, TNFRSF10C, TNFRSF10B, NFKBIA, CD40LG, CD27, LTBR]
GO:0042590;antigen processing and presentation of exogenous peptide antigen via MHC class I;5.0;0.8933024483968273;0.736892236059334;9.377209824211215;32.556158890958;6.409777797693995;0.0010896253394395913;0.618037346520142;[ITGB5, IFI30, CD36, FCGR1A, FCGR1B, FCER1G, CHUK, TAP1]
GO:0032355;response to estradiol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;74.25476231829794;4.940791720728991;0.0024852400698459885;0.542913330229313;[IHH, BRCA2, ETS1, CTGF, RUVBL2, CD38, PDGFRB, IL10, GHSR, POSTN, ANXA1, DUSP1, TACR3, CCNA2, IL1B, RARA, PCNA, ABCB4, PTGS2, SOCS2, CST3, RBBP8, TGFB1, NR2F2, POU4F1, COL1A1, GH1, CD4, KIF18A, EZH2]
GO:0030178;negative regulation of Wnt signaling pathway;7.0;0.6835726970475526;0.6927057137809769;8.781226392104918;188.91844949246428;4.7018998124466425;0.006322930488946581;0.591374740326424;[RUVBL2, TLE4, RNF43, TSC2, AXIN2, AES, GREM1, SFRP4, SFRP2, PFDN5, LRP1, LEF1, APCDD1, FOXO1, FRZB, CTHRC1, FZD1, EGR1, CAV1, TMEM64, MAPK14, BMP2, DAB2, SNAI2]
GO:0030177;positive regulation of Wnt signaling pathway;7.0;0.7307253602413294;0.7162820453778652;9.040737587590003;188.4547261984632;4.948759890378168;0.006307410087620234;0.6039991761920099;[LRRK2, TNFAIP3, HHEX, RUVBL1, SOX4, WLS, AXIN2, SFRP4, DEPDC1B, SFRP2, DAAM2, NAIP, TLR2, YAP1, JUP, EGF, CAV1, SULF1, NFKB1, SULF2, COL1A1, BMP2, DAB2, LGR4]
GO:0046718;viral entry into host cell;7.0;0.7671156992804218;0.7344772148974115;8.935377071932177;28.374411874040543;5.346256828837156;9.496660301113433E-4;0.6243271881103005;[SCARB2, CD86, TFRC, ITGB5, CD80, ITGB3, F11R, ANPEP, CLEC5A, ITGB7, ITGB6, HAVCR1, CTSB, CR2, CR1, CXADR, EPHA2, GYPA, DPP4, NCAM1, SLAMF1, GPR15, CDK1]
GO:0044539;long-chain fatty acid import;11.0;1.0;0.9324289523296623;9.628524252492122;75.02792930111643;7.474488534686424;0.0025111172729558144;0.8146746435927894;[ACSL1, CD36, SLC27A2]
GO:0035860;glial cell-derived neurotrophic factor receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;31.002284443533863;7.697632086000634;0.0010376185600805164;0.7686572628545723;[SULF1, SULF2]
GO:0071918;urea transmembrane transport;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;48.128255323890414;8.390779266560578;0.001610809393072914;0.7800242071602487;[SLC14A1, AQP9]
GO:0043200;response to amino acid;5.0;0.6441938053840475;0.612337914552944;8.412128928167629;56.712201515420396;5.104244793218563;0.0018981063470534028;0.5512723279577749;[TNF, CTGF, ALAD, SESN3, PDGFRA, EDN1, CHUK, ARG1, MMP2, CYBB, COL4A1, COL6A1, RRAGD, NAIP, CEBPB, PCNA, ABCB4, PDGFD, PDGFC, FYN, LYN, COL1A1, COL3A1, COL1A2, COL5A2, BCL2L1]
GO:0006068;ethanol catabolic process;7.0;1.0;0.8509193652572005;9.628524252492122;292.83912655610527;7.292166977892469;0.009801062027729285;0.7238411236270654;[ALDH2]
GO:0006069;ethanol oxidation;7.0;1.0;0.8509193652572005;9.628524252492122;86.80492924435106;7.292166977892469;0.0029052828624440484;0.7238411236270654;[ALDH2, ALDH1A1]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[LGALS1, PSMD3, SKP2, ESCO2, MXRA8, SPARCL1, SDC2, C3, FN1, TF, SERPINA1, TIMP1, F5, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, FAM20C, FSTL1, CST3, SPP1, PSMC6, PSMC2, NUCB1, TNC, MEN1, IGFBP5, CISH, APLP2, IGFBP3, FBXW2, PSMD14, CUL5, SOCS2, IGFBP7, NAE1, WFS1, IL6, COPS5, CCDC22, UBE2M, FBN1, LAMC1, CYR61, VCAN, DTL, LAMB1]
GO:0097267;omega-hydroxylase P450 pathway;10.0;1.0;0.9152410118609203;9.628524252492122;253.27491700286936;7.57984905034425;0.008476883539459374;0.8028748447945538;[CYP4F2, CYP4A11, CYP1B1]
GO:0097028;dendritic cell differentiation;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;22.452520143917486;6.343086423195323;7.514656432606705E-4;0.6146267465268138;[LYN, TGFB1, SPI1, TREM2, LILRB1, GATA1, CAMK4, PRTN3, CCR7, LTBR, CCL19]
GO:0034765;regulation of ion transmembrane transport;6.0;0.45556283921517005;0.5509017321977295;6.676594601596523;33.03735142972539;3.697140432584879;0.0011057304206669666;0.512192246247148;[, KCNG2, FMR1, SLC8A1, AKT1, EPHB2, SCN1A, KCNH1, KCNH2, MEF2C, DAPK1, PRKCE, F2R, CACNA2D3, CYBB, ACTN4, ATP1B2, PDZK1, ATP1B1, GEM, KCNQ1, CFTR, KCNE3, KCNE4, HVCN1, TWIST1, ADRB2, THY1, CACNA1F, CORO1A, CD19, PLCG1, SCN3A, DRD4, LYN, TGFB1, CAV1, CXCL10, CXCL11, EHD3, FXYD2, FXYD6, CALM3, NOX1, KCNK5, CXCL9, CLIC3, CTSS, GRM5, JPH2, PDE4B, YWHAH, KCND2, GPR35, TRPC1, MMP9, DNM2, TMEM37, XCL1, SHANK3, NLGN1, CAMK2D, PTAFR, KCNA5, THBS1, PLN, FLNA, DMD, FYN, SNCA, SLC31A2, KCNJ15, KCNJ16, TSPAN13, NEDD4, FKBP1B, GOPC, PTPN6, F2RL3]
GO:0014912;negative regulation of smooth muscle cell migration;8.0;0.8933024483968273;0.8216512241984136;9.510741216835738;202.59948523211477;6.686031174322154;0.006780822443019889;0.7169239451870815;[MEF2C, MYOCD, LRP1, IGFBP5, IGFBP3, TPM1, SERPINE1, AIF1, TRIB1]
GO:0010572;positive regulation of platelet activation;9.0;0.8933024483968273;0.8428918493787028;9.592156608321247;334.5200598726648;8.16763571524637;0.011196085355429928;0.8139338954918922;[SELP, PDPN, TLR4]
GO:0045639;positive regulation of myeloid cell differentiation;7.0;0.7307253602413294;0.7162820453778652;9.186691500213083;278.20784311065285;5.311165509025885;0.0093113661381102;0.622532616383239;[CSF3, HMGB2, MPL, TNF, ETS1, CA2, TNFSF11, HOXA5, MED1, FOS, IFNG, IL23A, TRIB1, LEF1, GATA1, INPP5D, NCKAP1L, CCR1, CD74, JUN, JAG1, LIF, ISG15, INHBA, TMEM64, MAPK14, POU4F1, CD4, FES, ACIN1, PF4, IL17A]
GO:0007162;negative regulation of cell adhesion;5.0;0.5651597194614189;0.5728208715916296;7.400047131651798;38.26822196421712;4.255612709818223;0.001280802949978559;0.5078732437472537;[, CD86, IL1RN, PLXND1, CD80, SERPINE1, TNC, IHH, SPINT2, LGALS3, LGALS1, CDH1, ARHGDIA, ARHGDIB, TNR, CYP1B1, HOXA7, MEN1, LAG3, POSTN, SEMA6A, PRKCD, ACTN4, CLDN7, MAD1L1, CD274, TACSTD2, FBLN1, EPB41L5, PAG1, TGFB1, JAG1, PTK2, COL1A1, BMP2, CXCL12, PTPRC, BCL6, PLXNB2, SNAI2, TGFBI, IFNA2, PTPN22, LRRC32, ARHGAP6, CTLA4, JAK3, HAVCR2, IL10, ANXA1, ARG1, PAWR, PDCD1LG2, CEACAM1, XCL1, PDE5A, CEBPB, THBS1, GPNMB, EPCAM, HLX, TBX21, TIGIT, JAM2, CD74, CCL21, LILRB1, LILRB2, KLF4, DLC1, CD9, PTPN6, FCGR2B, SIPA1]
GO:1903078;positive regulation of protein localization to plasma membrane;8.0;0.8436909121759173;0.7968454560879586;9.434368238051164;218.50214452761784;5.845247994956144;0.00731307013817619;0.6739262542938873;[LRP1, TREM2, AKT1, EPHB2, PLS1, PRKCH, PRKCE, RHOG, SORBS1, VIL1, IFNG, EPHA3, EPHA2]
GO:0007169;transmembrane receptor protein tyrosine kinase signaling pathway;7.0;0.579397892394798;0.6406183114545996;7.564831067780425;28.111912685638995;3.5644675319289507;9.408804185094754E-4;0.533206400604739;[CYFIP1, SLA2, EPS8, STMN1, AKT1, EPHB2, EPHB1, EREG, BTC, BTK, EPHA3, EPHA2, SDC2, SH2D2A, TXK, TGFA, PDGFA, SLC30A10, PRKCZ, FLRT2, PDGFD, PDGFC, NCKAP1L, PLCG1, PAG1, LYN, PILRA, PTK2, COL1A1, NRP1, ITK, PTPRR, NRP2, CD3E, SYK, GAB1, GAB2, VAV1, HCK, KIT, PLCB1, HBEGF, PAK1, NTF3, SORT1, SORBS1, SULF1, SULF2, NCF1, NCF2, NCF4, CTGF, FGF5, EFEMP1, GRAP2, AP2M1, PDGFRB, PDGFRA, MATK, TSC2, CYBB, PDGFRL, DOK2, COL4A2, CD8B, KIF16B, COL4A1, CD8A, BLK, CSF1R, CUL5, RASGRP4, FOXO1, SOCS2, STAP1, TGFB1, CAV2, CRIM1, BMX, VIL1, GH1, NR4A3, FES, CSPG4, ITGB3, GHR, BLNK, MMP2, MMP9, FGR, ZAP70, LCK, ESRP1, LCP2, REPS2, POLR2E, FYN, CSK, POLR2I, POLR2J, POLR2K, POLR2L, TRAT1, EGF, MAPK14, CD4, CD7, TEK]
GO:0051085;chaperone cofactor-dependent protein refolding;5.0;1.0;0.7902410118609202;9.628524252492122;21.14140270213274;6.409777797693995;7.075837224132252E-4;0.618037346520142;[CD74, HSPA6, HSPE1]
GO:0009104;lipopolysaccharide catabolic process;7.0;1.0;0.8509193652572005;9.628524252492122;699.2048752589922;9.777073627680469;0.023401757931384683;0.8509193652572005;[AOAH]
GO:0045630;positive regulation of T-helper 2 cell differentiation;13.0;1.0;0.9625549647676366;9.628524252492122;2538.1941708228874;7.8311634786251565;0.08495107467099283;0.8630410292508717;[CD86, RARA, IL18, NLRP3, PRKCZ]
GO:0007166;cell surface receptor signaling pathway;5.0;0.43360584258713153;0.507043933154486;5.906854975555195;23.17027026302992;2.006850423521684;7.75488093814194E-4;0.39287143584790796;[, SLA2, F11R, TRBC1, C3AR1, AKT1, PRKACB, WLS, MEF2C, HHLA2, FPR1, PDGFA, FPR3, FPR2, GATA3, THY1, SLC30A10, KLRK1, PDGFD, PDGFC, LYN, ABCA1, JUN, JAG1, HLA-DRB4, FN1, VANGL1, COL1A1, COL1A2, HLA-DRB1, SIGLEC9, LRRC4, CTLA4, JAK3, HLA-DPA1, GPR35, BGN, PTH2R, FOS, SIRT1, F3, LRRC19, PTAFR, KCNA5, PTGS2, FSTL1, FRZB, NTF3, STAT4, FLNA, IL12RB1, IL12RB2, P2RY13, CASP8AP2, P2RY14, USP9Y, TMEM64, COL3A1, HLA-DPB1, LGR4, NCF1, NCF2, NCF4, F13A1, RORA, CXCL13, CTGF, EFEMP1, AP2M1, LAG3, IFNA14, CISH, IFNA16, IFNA10, BLK, CD274, GPR87, TACSTD2, LY96, TNFRSF11A, CORO1A, FOXO1, SOCS2, TNFRSF17, ZNF423, IFNA21, GRIA4, GPR98, TNFRSF10C, TNFRSF10B, BMX, NFKB1, CXCL10, CXCL11, CXCL12, PTPRC, LCN2, HLA-DRA, MYD88, CIITA, ITGAM, ITGB5, ITGB4, LRRK2, ITGB3, ITGB2, PIK3CD, FASLG, ITGAL, TNFSF13B, HHEX, FCGR3A, ITGAX, ITGB8, ITGB7, ITGB6, ITGA4, TNFRSF1B, ITGA7, BIRC5, LCP2, LCP1, BIRC3, IL2RG, TSPAN33, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, FCGR1A, FCGR1B, CTHRC1, TSPAN15, TSPAN13, FCGR2A, IL2RB, PTPN6, CD247, FCGR2B, ICAM2, ICAM3, IFI30, TNFSF11, TRIM25, EPHB2, EPHB1, RSAD2, HNF1B, MIF, EREG, BTC, SFRP4, SFRP2, IFI27, BTK, EPHA3, EPHA2, SDC2, TGFA, TSPAN8, CD19, TSPAN5, TSPAN2, CD14, PAG1, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, PPBP, PILRA, PTK2, ID1, CD28, SDC1, CD27, CD24, IGHM, NRP1, PTPRR, NRP2, CD40, TNFRSF13B, GRIK3, CD3G, PTPRK, CD3E, CD3D, CCR9, FCER1A, MUC13, CD38, CD37, CCR7, CCR6, MUC15, CD36, CCR5, CCR2, IL10, FCER1G, SYK, GAB1, IL18, GAB2, RGMA, LAT2, IL1A, IL1B, KIT, IGHD, GNAI2, PAK1, IGKC, PERP, IL32, CD74, IL33, SORT1, OSM, IL18R1, IL17A, CD86, CD80, TRAC, MPL, IHH, CELSR1, CCRL2, IL6R, PDGFRB, CD97, PDGFRA, THEMIS, CYBB, GEM, MUC3B, PDGFRL, OSCAR, DOK2, TYROBP, CD8B, CCNE1, CD8A, CARD11, TCF7, PSEN2, KIR2DL1, RASGRP4, VCAM1, CAV2, CRIM1, ISG15, INHBA, VIL1, GH1, IL6, BMP2, GNAQ, IL7R, IGKV3-20, SIRPB1, GHR, GRM5, NUP62, MMP1, MMP2, IRAK3, MMP9, IRF7, BCL2A1, SAMHD1, EGF, MX2, MAPK14, SOD2, CD2, CD4, CD6, CD7, CD9, TEK, CDA, CYFIP1, CLEC10A, EPS8, STMN1, GPR171, HOMER3, JUNB, DAPK1, PRKCE, PRKCD, HOXB9, DAAM2, PRKCQ, MAML3, PRKCZ, FLRT2, HMOX1, NCKAP1L, PLCG1, IGHA1, HLA-DQA2, HLA-DQA1, FZD1, FZD5, FZD8, GP6, SNAI2, CDK14, DENND1B, ITK, CDKN1A, TGFB1I1, ASGR2, TIMP1, ANXA1, SERPINB2, IFNGR1, NFAM1, IFNGR2, AES, FCER2, PLCB1, HBEGF, ENG, HLA-DQB1, CCL13, ALOX5, CCL19, CCL18, GPR157, CCL23, CCL21, CCL20, CARD9, NR1H4, G0S2, SULF1, SULF2, ZYX, PLP1, PF4, SEMA5B, CSF3, CSF3R, PLXND1, FMR1, ITGA2B, IL5RA, TNF, FGF5, PYCARD, CDH5, IGHG1, CDH3, FCGRT, GRAP2, IL13RA2, IL13RA1, TLE4, RNF43, SEMA6A, CLEC4A, CLEC4D, ADAM9, CLEC4E, CSF1R, CD151, CALCRL, CUL5, IGLV1-44, EIF2B3, DAB2, BCL6, BCL2, PLXNB2, CSPG4, LAT, BCL2L1, PTPN22, ADAMTS1, CR2, CR1, CHUK, LCK, ESRP1, IL3RA, XCL2, XCL1, CX3CR1, CEBPA, CEBPD, NOD2, P2RY6, PLN, P2RY2, POLR2E, IL21R, CSK, POLR2I, POLR2J, POLR2K, POLR2L, SEMA4B, KLF4, PML, P2RX5, KLF6, P2RX1, MNDA, CLEC2D, IL1RN, IFIT1, IFIT3, IFIT2, EDNRB, ICOSLG, SOX4, ACSL1, IL1R1, IL1R2, FLT3LG, RUNX2, IL23A, TLN1, PFN1, IGSF6, SH2D2A, TXK, TWIST1, APCDD1, CD79B, CD79A, INPP5D, CCR10, LIF, NMBR, MARCO, IFNA5, ROBO2, IFNA4, IFNA7, IFNA2, PRL, IFNA8, FFAR2, EDN1, GP1BB, GPBAR1, GP1BA, PDCD1LG2, LIME1, IL17RB, VAV1, HCK, CEACAM1, RHOU, TLR4, TLR2, GUCY2C, SP100, CXCR5, IFI6, CXCR4, CXCR6, LILRA1, LILRA2, CXCR1, CXCR3, CXCR2, LILRB1, LILRB2, SORBS1, LILRB3, PODN, KRT19, CD40LG, FCN1, IL18RAP, ARHGDIA, MATK, TSC2, COL4A2, KIF16B, COL4A1, KLRF1, PRTN3, KLRB1, C5AR1, CSF2RB, ADRB2, DTX3, CSF2RA, STAP1, KLRC1, BTNL8, TGFB2, STIL, TGFB1, NR4A2, NFKBIA, NR4A3, FES, KLRD1, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, OASL, TMEM100, LRRTM4, BLNK, PDE4B, DCC, GLP2R, PLAUR, AXIN2, DCN, TGFBR3, FGR, ZAP70, IFNG, OAS1, OAS3, LTA, LTB, CDH17, CAMK2D, CLEC12B, LEF1, DLL1, GMDS, REPS2, S1PR3, NCAM1, TRAT1, TSHR, LTBR]
GO:0044546;NLRP3 inflammasome complex assembly;6.0;1.0;0.8231203125901445;9.628524252492122;44.51706700895919;9.777073627680469;0.0014899461700306506;0.8231203125901445;[NLRP3]
GO:0045637;regulation of myeloid cell differentiation;6.0;0.620063164412167;0.633151894796228;8.465373442686442;67.16582126229967;4.39257856489138;0.002247979592334476;0.5477569846744829;[CSF3, CSF3R, SPI1, ITGA2B, MPL, TNF, ETS1, LGALS3, HOXA9, GPR171, TNFSF11, HOXA7, HOXA5, MED1, LHCGR, MEF2C, TYROBP, IL23A, PRKCQ, TRIB1, MYL9, GATA1, INPP5D, NCKAP1L, LYN, CCR1, NFE2, JUN, JAG1, LIF, ISG15, INHBA, NFKBIA, NR4A3, MAFB, FES, FBN1, HMGB2, CA2, KLF13, GP1BA, FOS, NME1, CEACAM1, IFNG, RARA, IRF7, TLR4, LTF, CEBPB, LEF1, DLL1, THBS1, CD74, LILRB1, TMEM64, LILRB3, MAPK14, MEIS2, POU4F1, CD4, MEIS1, CAMK4, ACIN1, PF4, IL17A, C1QC]
GO:0019371;cyclooxygenase pathway;10.0;1.0;0.9152410118609203;9.628524252492122;253.27491700286936;7.379178354882098;0.008476883539459374;0.7926125360964777;[TBXAS1, PTGS2, PTGS1]
GO:0019370;leukotriene biosynthetic process;8.0;0.8653626801206646;0.8076813400603323;9.488762310116963;324.40599840797483;6.781341354126479;0.010857576820271119;0.7217981122146513;[SYK, ALOX5]
GO:0019373;epoxygenase P450 pathway;10.0;1.0;0.9152410118609203;9.628524252492122;253.27491700286936;6.686031174322154;0.008476883539459374;0.7571649570480019;[CYP4F2, CYP4A11, CYP1B1, CYP4F12]
GO:0035606;peptidyl-cysteine S-trans-nitrosylation;10.0;1.0;0.9152410118609203;9.628524252492122;309.9752588804085;9.083926447120524;0.010374592955105871;0.8797934328124444;[S100A9]
GO:0019372;lipoxygenase pathway;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;153.6575605806622;7.138016298065211;0.005142780269808322;0.7400384854347593;[ALOX5, PTGS2]
GO:0042130;negative regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;581.9323154417883;5.734022359845919;0.01947675089275457;0.6894787953221185;[CD86, CD274, CEBPB, CD80, IHH, LRRC32, GPNMB, CTLA4, HAVCR2, IL10, TGFB1, ARG1, PAWR, LILRB1, PDCD1LG2, LILRB2, XCL1, PTPN6, PDE5A, MAD1L1]
GO:0034516;response to vitamin B6;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;87.04156493882871;9.777073627680469;0.002913202846179917;0.8509193652572005;[KYNU]
GO:0071902;positive regulation of protein serine/threonine kinase activity;11.0;0.6763753087927167;0.7706166067260205;9.206529842432747;1260.5827351979337;3.9422628906178643;0.04219056969626795;0.6340364598898325;[, IL1RN, CCNH, TCL1A, AKT1, PROK2, TNFSF11, ACSL1, MIF, FPR1, TGFA, PDGFA, IQGAP3, PDGFD, PDGFC, S100A12, ELANE, FZD5, FZD8, EIF2AK2, CDC6, NOX4, CALM3, CD24, EZH2, CD40, MAP4K1, EDN1, SYK, SIRT1, DUSP6, MDFIC, IL1B, KIT, CKS2, TLR6, TLR4, CXCR4, PAK1, NTF3, CCL19, CD74, CD40LG, PKN1, CAMK1, CCNT2, TNF, PDGFRB, MAP2K2, F2R, ADAM9, ADAM8, CSF1R, C5AR1, TNFRSF11A, ADRB2, RASGRP1, CCNB1, DRD4, MAP2K6, TGFB1, GH1, BMP2, CDK1, CSPG4, LRRK2, GHR, PSRC1, IFNG, PDE5A, LTF, NOD2, THBS1, CSK, SNCA, EGF, MAPK14]
GO:0014740;negative regulation of muscle hyperplasia;8.0;1.0;0.875;9.628524252492122;117.88012497015305;9.083926447120524;0.003945341697526185;0.839552420951524;[KLF4]
GO:0034351;negative regulation of glial cell apoptotic process;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;104.32654737607098;7.697632086000634;0.003491715652880169;0.7686572628545723;[PRKCH, PRKCD, CCL2, DLL1]
GO:0051928;positive regulation of calcium ion transport;8.0;0.7043150770688792;0.7271575385344395;8.848365694942547;69.31158403183679;5.085725745451326;0.002319796341169766;0.6350842511328143;[CXCL9, MYLK, LGALS3, JPH2, PDGFRB, TRPC3, TRPC1, F2R, ATP1B1, XCL1, KCNE3, THY1, CD19, CCL5, CCL4, CCL2, PLCG1, SNCA, CCR1, WFS1, CAV1, CXCL10, P2RX5, CD4, CXCL11, EHD3, CXCL12, CALM3, F2RL3]
GO:0090051;negative regulation of cell migration involved in sprouting angiogenesis;11.0;1.0;0.9324289523296623;9.628524252492122;662.774530299232;7.069023426578259;0.02218246707076338;0.7939391391080821;[KLF4, THBS1]
GO:0002762;negative regulation of myeloid leukocyte differentiation;8.0;0.7671156992804218;0.7585578496402109;9.352270875863963;700.1468303315412;5.948432231191374;0.02343328431995837;0.6792031009335148;[INPP5D, HOXA7, LYN, LILRB1, INHBA, LILRB3, NME1, CEACAM1, MAFB, RARA, TRIB1, TLR4, LTF, FBN1, C1QC]
GO:0002752;cell surface pattern recognition receptor signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;1037.7692336294238;9.083926447120524;0.03473320231790253;0.8969813732811862;[FCN1, FFAR2]
GO:0002755;MyD88-dependent toll-like receptor signaling pathway;12.0;0.8933024483968273;0.8947715367885583;9.5544162803384;412.6549923027037;6.280566066213989;0.013811191226989502;0.7693087532925187;[LY96, HSPD1, CD36, CD14, IRAK3, TLR1, BTK, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, MYD88, TLR2]
GO:0046580;negative regulation of Ras protein signal transduction;9.0;0.8259837884571596;0.8092325194088689;9.394909401310617;288.24654468039586;5.885253329569843;0.009647352445404638;0.6972127541467594;[STMN1, NUP62, TIMP2, EPHB2, TGFB2, ARAP3, BCL6, DLC1, FBP1]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[MPL, RORA, PHB2, ETS1, SLC8A1, LOXL2, AQP1, EDNRA, PLAU, MYB, AKT1, POSTN, PRKCE, ACTN4, ATP1B1, CLDN3, ADAM8, ABCB4, PSEN2, TWIST1, DPP4, CCNB1, HMOX1, EGR1, TGFB2, TGFB1, VCAM1, CAV1, NR4A2, BMP2, CXCL12, BCL2, NOX4, CD24, ALAS2, SUV39H1, ADM, ALAD, CD38, MYOCD, ADSL, EDN1, KCND2, MMP2, AGTRAP, SIRT1, CBFA2T3, TGFBR3, CCNA2, IL1B, LTA, TLR2, CXCR4, KCNA5, PTGS2, THBS1, ASCL2, CST3, PAK1, E2F1, PML, FABP1, TEK]
GO:0002758;innate immune response-activating signal transduction;9.0;0.6324783794010864;0.7124798148808322;8.79372655486915;406.8866713069129;4.647174912757396;0.013618130714412242;0.6338973663344365;[FCN1, CLEC10A, ICAM2, ICAM3, PRKACB, PRKCE, CD180, PRKCD, MUC3B, CLEC4A, CLEC4D, BTK, CLEC4E, S100A9, S100A8, CARD11, LY96, KLRK1, CLEC7A, S100A14, CD14, MAP2K6, LYN, NFKB1, NFKBIA, MARCO, MYD88, ITGAM, ITGB2, TNFAIP3, CTSS, IFIH1, MUC13, FFAR2, MUC15, CD36, HAVCR2, FCER1G, CHUK, SYK, DDX58, IRAK3, TLR1, HCK, IRF7, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, COLEC12, UNC93B1, NOD2, LILRA2, HSPD1, PAK1, FYN, CARD9, NR1H4]
GO:0014739;positive regulation of muscle hyperplasia;8.0;1.0;0.875;9.628524252492122;117.65934785475751;9.777073627680469;0.003937952486160401;0.875;[AIF1]
GO:2000753;positive regulation of glucosylceramide catabolic process;8.0;1.0;0.875;9.628524252492122;623.5788865307586;9.777073627680469;0.0208706241476218;0.875;[PRKCD]
GO:0051926;negative regulation of calcium ion transport;8.0;0.7140352122741334;0.7320176061370667;8.890925309361343;69.46225493434336;5.666199763507158;0.0023248391606816524;0.6647697194109919;[FMR1, PTGS2, PLN, DRD4, TGFB1, GPR35, LILRB1, LILRB2, GEM, FKBP1B, BCL2, CALM3]
GO:0031077;post-embryonic camera-type eye development;7.0;1.0;0.8509193652572005;9.628524252492122;36.784493016758105;8.390779266560578;0.0012311438773764656;0.7800242071602487;[BCL11B, FZD5, KLF4]
GO:2000755;positive regulation of sphingomyelin catabolic process;10.0;1.0;0.9152410118609203;9.628524252492122;1040.6474307865747;9.777073627680469;0.034829532986543094;0.9152410118609203;[PRKCD]
GO:0050832;defense response to fungus;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;69.94032091756767;6.193554689224359;0.002340839598908718;0.6398589874268261;[TGFB1, DEFA4, DEFA1, MPO, GNLY, S100A12, CTSG, S100A9, S100A8, LTF, IL17A]
GO:0070207;protein homotrimerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;6.444869117505266;0.002859955186148837;0.6805102716434839;[ARG1, MGST1, MIF, TCL1A, EMILIN1, CD247]
GO:0035434;copper ion transmembrane transport;9.0;0.8259837884571596;0.8092325194088689;9.434368238051164;100.43308211951074;7.9853141584524145;0.003361404874634337;0.8046099625986299;[ATP7B, SLC31A2]
GO:0050830;defense response to Gram-positive bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.334422371190153;0.0023911797157970473;0.6237219733958743;[SEH1L, HIST1H2BK, C5AR1, HMGB2, TNF, KLRK1, NLRP3, CD36, CAMP, HAVCR2, DEFA4, CARD9, RNASE6, RNASE3, DEFA1, LYZ, FGR, IL6, LTA, MYD88, TLR2]
GO:0070447;positive regulation of oligodendrocyte progenitor proliferation;9.0;1.0;0.896240625180289;9.628524252492122;486.0421787932986;8.67846133901236;0.016267394314649825;0.8400575416471059;[LYN, LRP2]
GO:1902600;proton transmembrane transport;8.0;0.7586651285174919;0.754332564258746;9.117698628726131;95.86613314633948;4.835431205071165;0.0032085532024895276;0.6222841766978864;[COX7B, COX6A1, COX7C, SLC36A1, COX8A, ATP5J2, COX6B1, COX7A2L, NDUFS7, HVCN1, ATP5J, ATP5I, ATP5H, ATP5O, COX5B, COX5A, ATP5L, CYC1, SLC15A3, NDUFA4, COX6C]
GO:0002764;immune response-regulating signaling pathway;5.0;0.5860072649471136;0.5832446443344771;7.893923197104016;48.795248251786205;3.532906727016733;0.0016331330461149228;0.4709140261775204;[, CYFIP1, CLEC10A, ICAM2, ICAM3, SLA2, TRBC1, C3AR1, PRKACB, ICOSLG, MEF2C, PRKCE, PRKCD, BTK, PRKCQ, HHLA2, TXK, FPR1, FPR3, FPR2, GATA3, THY1, CD79B, CD79A, KLRK1, CD19, INPP5D, NCKAP1L, S100A14, PLCG1, CD14, IGHA1, HLA-DQA2, HLA-DQA1, PAG1, LYN, JUN, HLA-DRB4, PTK2, MARCO, CD28, CD24, HLA-DRB1, IGHM, DENND1B, ITK, CD40, CD3G, CD3E, CD3D, CTSS, IFIH1, FCER1A, CTSH, CTLA4, MUC13, CD38, FFAR2, MUC15, CD36, HLA-DPA1, HAVCR2, FCER1G, SYK, FOS, GAB2, LIME1, VAV1, LAT2, TLR1, HCK, KIT, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, HLA-DQB1, TLR2, LILRA2, PAK1, IGKC, CARD9, NR1H4, LILRB1, LILRB2, HLA-DPB1, FCN1, TRAC, IGHG1, FCGRT, GRAP2, CD180, THEMIS, MUC3B, CLEC4A, CLEC4D, CLEC4E, S100A9, S100A8, CARD11, BLK, C5AR1, LY96, KIR2DL1, CLEC7A, IGLV1-44, MAP2K6, BTNL8, EIF2B3, BMX, NFKB1, NFKBIA, PTPRC, NR4A3, BCL2, HLA-DRA, IGKV3-20, LAT, MYD88, ITGAM, ITGB2, TNFAIP3, PIK3CD, PTPN22, FCGR3A, PDE4B, CR2, CR1, CHUK, DDX58, IRAK3, FGR, ZAP70, LCK, IRF7, LCP2, COLEC12, UNC93B1, CLEC12B, NOD2, HSPD1, FYN, CSK, FCGR1A, FCGR1B, TRAT1, CD4, FCGR2A, PTPN6, MNDA, CD247, FCGR2B]
GO:0002522;leukocyte migration involved in immune response;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;38.08781428465786;9.083926447120524;0.0012747648673000812;0.7876727335416686;[HCK]
GO:0002523;leukocyte migration involved in inflammatory response;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;29.137022145890857;7.379178354882098;9.751899096054872E-4;0.7004918368257019;[ITGB2, FFAR2, ADAM8, CCR6, SELE, S100A9, ELANE, S100A8, JAM3]
GO:0001678;cellular glucose homeostasis;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;49.180086311476984;5.514393750639154;0.0016460132296410052;0.6329257181104212;[FOXO1, HK3, LGALS1, SOX4, MEN1, SIRT1, PAX2, NME1, LIN28A, IL1B, NOX4, FOXA3]
GO:0046597;negative regulation of viral entry into host cell;8.0;0.9326813400603323;0.8413406700301662;9.548481544818586;84.95196338807416;6.832634648514029;0.002843265762795464;0.7244212536750128;[FCN1, GSN, IFNA2, TRIM25, PTX3, TRIM10]
GO:0070431;nucleotide-binding oligomerization domain containing 2 signaling pathway;13.0;1.0;0.9625549647676366;9.628524252492122;488.61025226297863;7.8311634786251565;0.01635334542256394;0.8630410292508717;[NFKBIA, NOD2]
GO:0015837;amine transport;5.0;0.7763722522362496;0.6784271379790451;9.022388448921806;29.451341070208834;7.8311634786251565;9.857098811337434E-4;0.6907270763441554;[AQP9]
GO:0050848;regulation of calcium-mediated signaling;7.0;0.6664901433067099;0.6841644369105555;8.734706376470026;45.070113835906206;5.266214121163619;0.001508456149618737;0.6202338003175094;[LRRK2, TREM2, SLA2, CD3E, TNF, TMEM100, JPH2, HOMER3, SYK, ZAP70, CAMK2D, PLN, CCL4, DMD, TRAT1, BST1, P2RX5, CD4, FKBP1B, CALM3]
GO:0035666;TRIF-dependent toll-like receptor signaling pathway;13.0;0.9326813400603323;0.9288956347978027;9.592156608321247;413.3481394832653;6.599019797332524;0.013834390239330937;0.8000291440890255;[CHUK, LY96, IRF7, TLR6, CD14, TLR4]
GO:0007193;adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway;8.0;0.7866048967936545;0.7683024483968273;9.117698628726131;28.36322711391944;5.334422371190153;9.492916862557204E-4;0.6478026081386739;[CHRM2, GNAZ, GABBR1, EDN1, CHRM1, GPR37, HTR1E, NPY1R, GRIK3, FPR2, GNAI1, GNAI2, AKAP12, MARCO, GRM5, EDNRA, ADCY9, RGS1, HRH4, PSAP, FLNA, S1PR3, DRD4]
GO:0007194;negative regulation of adenylate cyclase activity;12.0;0.8933024483968273;0.8947715367885583;9.589303539338841;6285.124034700197;6.481236761676141;0.21035744519701882;0.7795710619905949;[P2RY13, GABBR1, EDNRB, GPR87, HRH4, GNAI2, CCR2]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[SPARC, LST1, SPINT2, ADARB1, PHB2, IFIT3, CYP1B1, EPHB1, SOX7, SOX4, MED1, MEF2C, EREG, SFRP4, SFRP2, SPINT1, BTK, TRIB1, GATA3, GATA1, INPP5D, HMOX1, SFN, S100A11, LYN, JUN, BCL11B, FZD5, LIF, EIF2AK2, CDC6, NR2F2, NOX4, SNAI2, CDKN1A, BTG2, TNFRSF13B, TGFB1I1, ADM, PRL, PTPRK, BRCA2, LRRC32, HNF4A, TIMP2, CTLA4, CD33, HAVCR2, IL10, DUSP1, ARG1, PAWR, PDCD1LG2, CBFA2T3, NME1, IL1A, CEACAM1, IL1B, RARA, TLR2, PTGS2, ASCL2, AIF1, PAK1, GPNMB, FRZB, PDPN, CTNNA1, CCL23, CDKN2C, OSM, LILRB1, LILRB2, PODN, SULF1, FAP, FABP7, DLC1, PKN1, CD86, CD80, SIRPG, IHH, TNF, ETS1, CDH5, DACH1, MEN1, IGFBP5, IGFBP3, F2R, TPM1, TSC2, ADCYAP1, HGS, MAD1L1, CD274, CSF1R, CUL5, FBLN1, CNN1, NACC2, IGFBP7, TGFB2, TGFB1, RARRES3, CAV2, VDR, CAV1, HMGA1, DHCR24, INHBA, IL6, BMP2, BCL6, OGN, BCL2, TNFAIP3, CXCL1, DUSP10, ADAMTS1, NUP62, PTGIR, MYOCD, KLF13, AXIN2, TGFBR3, GREM1, TFDP1, IFNG, ASPH, LTA, XCL1, PDE5A, CEBPA, CEBPB, NLRC3, DLL1, THBS1, CCL8, E2F1, CCL2, ZNF503, CSK, E2F7, KLF4, SOD2, PML, MEIS1, DNAJA3, PMP22, CD9, PTPN6, MNDA, FCGR2B]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MED1, MEF2C, PRKCH, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, PDGFA, IQGAP3, GATA1, PRKCZ, PDGFD, PDGFC, HMOX1, NCKAP1L, PLCG1, ELANE, LYN, JUN, FN1, CDC6, NOX1, CDKN1A, ADM, HOXC10, TIMP1, JAK3, HLA-DPA1, HAVCR2, ANXA1, ARG1, FCRL3, SIRT1, F3, PAX2, MMP12, RARA, HBEGF, PTAFR, KCNA5, PTGS2, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, LRG1, HLA-DPB1, CSF3, CHRM1, TNC, TNF, CTGF, FGF5, PYCARD, CDH3, PPP1R16B, IGFBP5, F2R, MSH6, ADCYAP1, CD274, CSF1R, BLM, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, BCL6, CDK1, BCL2, HPSE, BCL2L1, ITGB3, FASLG, CYR61, TNFSF13B, LBH, ITGA4, XCL1, BIRC5, CX3CR1, SMARCD3, LRP2, NOD2, CCL5, E2F1, CTHRC1, PRRX1, PML, KLF5, PRC1, DNAJA3, PTPN6, AQP1, CDC20, TCL1A, EDNRB, SKP2, TNS3, ICOSLG, SOX4, FLT3LG, MIF, RUNX2, EREG, BTC, SFRP2, IL23A, TGFA, TWIST1, CD1D, PKHD1, SLAMF1, EGR1, EGR3, TNFSF12, TNFSF13, LIF, PTK2, BST1, ID1, CD28, CD24, CD320, NRP1, NRP2, ECM1, CD40, CTSZ, PRL, CD3E, BMI1, ESM1, RAC2, CTSH, CD38, CCR2, IL10, EDN1, SYK, RHOG, IL18, PDCD1LG2, AVPR1A, GAB2, NME1, HCK, CEACAM6, IL1B, KIT, YAP1, AIF1, GNAI2, CST3, PURA, PAK1, CXCR2, CD74, CDX2, OSM, LILRB2, KITLG, CD40LG, CD86, CD80, SIRPG, MPL, IHH, ETS1, IL6R, PDGFRB, GHSR, PDGFRA, MATK, CCNE2, CCNE1, PRTN3, CARD11, C5AR1, HTRA1, LTBP3, DPP4, CCNB2, CCNB1, TGFB2, TGFB1, VCAM1, CAV2, NR4A1, IL6, BMP2, LIN28A, NR4A3, IL7R, HMGB2, TNFAIP3, LAMC2, LAMC1, CXCL5, MYOCD, MMP2, GLP2R, MMP9, TGFBR3, CCNA2, GREM1, ZAP70, IFNG, NDUFS4, LTA, LTF, LEF1, DLL1, THBS1, HLX, S1PR3, EGF, LAMB1, MAPK14, MEIS2, TSHR, CD4, CD6, TEK]
GO:1901522;positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus;12.0;0.7140352122741334;0.8051379187272112;9.260799472366804;1467.8987330058965;6.641579411751319;0.04912924957061573;0.7877709925721352;[RUNX2, BMP2, RXRA]
GO:0001892;embryonic placenta development;5.0;1.0;0.7902410118609202;9.628524252492122;37.179255381886215;6.832634648514029;0.0012443562184742403;0.639662265535933;[MED1, CEBPA, CEBPB]
GO:0048538;thymus development;5.0;1.0;0.7902410118609202;9.628524252492122;35.890675140737365;6.039404009397101;0.0012012285974499148;0.5990964137624962;[SLC46A2, GATA3, CCNB2, HOXA3, BCL11B, MAFB, BCL2, MAD1L1]
GO:0001893;maternal placenta development;4.0;1.0;0.75;9.628524252492122;43.252245699280884;7.379178354882098;0.001447613739060994;0.6273715242355574;[RXRA, AKT1, NR2F2]
GO:0002740;negative regulation of cytokine secretion involved in immune response;10.0;1.0;0.9152410118609203;9.628524252492122;981.2960148552594;7.9853141584524145;0.03284309450812846;0.8236103492792612;[IL10, LILRB1, TNF]
GO:0050850;positive regulation of calcium-mediated signaling;8.0;0.7763722522362496;0.7631861261181248;9.283683766200392;239.92176968958296;6.039404009397101;0.008029965715936047;0.6838554019015759;[TREM2, CD3E, TNF, JPH2, CCL4, SYK, TRAT1, ZAP70, P2RX5, CD4, CALM3]
GO:0002732;positive regulation of dendritic cell cytokine production;8.0;0.8933024483968273;0.8216512241984136;9.54514264355307;385.4233449309147;9.777073627680469;0.012899772496347238;0.875;[NOD2]
GO:0043097;pyrimidine nucleoside salvage;9.0;0.811012628672052;0.801746939516315;9.507896264703508;2649.2611103990594;7.292166977892469;0.08866838518485125;0.769162383550154;[CDA, UPP1, TK1, DCK, TYMP]
GO:2000778;positive regulation of interleukin-6 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;618.0674169630446;6.599019797332524;0.02068616022119099;0.7527151911823093;[DDX58, F2R, TWIST1, PYCARD, IFIH1, IL1B, TLR8, IL17A]
GO:0032147;activation of protein kinase activity;11.0;0.6799073451904818;0.7723826249249031;9.164951513576677;1096.8683293671154;4.034070439870987;0.03671119586651001;0.6387315022281249;[, TNF, AKT1, PROK2, TNFSF11, PRKACB, MAP2K2, SLC11A1, F2R, PRKCD, PRKAR1B, ADAM9, CALCA, C5AR1, FPR1, TGFA, ADRB2, IQGAP3, PRKCZ, PRKAR2B, PDGFC, NCKAP1L, ECT2, DRD4, MAP2K6, TGFB2, TNFRSF10B, EIF2AK2, BMP2, CDK1, CSPG4, LRRK2, ITGB3, GHR, MAP4K1, SYK, STRADB, IL18, DUSP6, GREM1, MDFIC, IL1B, KIT, CHI3L1, TLR6, TLR4, CXCR4, NOD2, THBS1, PAK1, NTF3, CCL19, CD74, EGF, MAPK14, CD40LG, PKN1]
GO:0071315;cellular response to morphine;8.0;1.0;0.875;9.628524252492122;528.974071528598;8.390779266560578;0.017704286128305307;0.8041048419030481;[AIF1]
GO:0072643;interferon-gamma secretion;10.0;1.0;0.9152410118609203;9.628524252492122;137.06961104194002;7.8311634786251565;0.004587596526932657;0.8157270763441555;[LILRB1, GATA3]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[DENND1B, ITK, TRAC, PIK3CD, CD3G, PTPN22, CD3E, CD3D, GRAP2, TRBC1, PDE4B, ICOSLG, HLA-DPA1, CHUK, THEMIS, LIME1, ZAP70, LCK, BTK, PRKCQ, LCP2, CARD11, HLA-DQB1, HHLA2, TXK, GATA3, THY1, PAK1, INPP5D, FYN, CSK, PLCG1, HLA-DQA2, HLA-DQA1, PAG1, BTNL8, EIF2B3, HLA-DRB4, TRAT1, BMX, NFKB1, CD4, PTPRC, CD28, HLA-DPB1, HLA-DRA, CD247, LAT, HLA-DRB1]
GO:0035655;interleukin-18-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.8311634786251565;0.00101047745553359;0.7514054297404357;[IL18RAP, ALOX5, IL18, AKT1, IL18R1]
GO:0050853;B cell receptor signaling pathway;10.0;0.9326813400603323;0.8815816818910864;9.582004236857228;219.43154282413207;4.948759890378168;0.007344176262756358;0.6683208227957298;[, BLK, IGHM, ITK, TXK, PIK3CD, CD79B, CD79A, IGHG1, IGKC, CD19, TRBC1, CTLA4, CD38, NCKAP1L, IGHA1, LYN, MEF2C, SYK, BMX, LIME1, LAT2, PTPRC, LCK, BTK, IGHD, BCL2, PTPN6, MNDA]
GO:0031295;T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;354.8971974647038;5.845247994956144;0.011878089812402261;0.6951668794741764;[CD86, CD274, HHLA2, CD80, CD3E, TNFSF13B, DPP4, PAK1, KLRK1, LGALS1, GRAP2, BTLA, AKT1, CTLA4, FYN, CSK, CCL19, ICOS, ICOSLG, LYN, TNFSF14, CCL21, CAV1, PDCD1LG2, VAV1, CD40LG, LCK, CD5, CD28, PTPN6, CD24, CARD11]
GO:0009143;nucleoside triphosphate catabolic process;8.0;0.7140352122741334;0.7320176061370667;9.400265600511142;1170.1316013450335;7.212124270218933;0.03916325164694686;0.7438283705770736;[SAMHD1, SMPDL3A]
GO:0050861;positive regulation of B cell receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;365.0896954818653;7.8311634786251565;0.01221922354838398;0.7754860644832351;[LYN, PRKCH, NFAM1, STAP1]
GO:0071300;cellular response to retinoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;200.602279209425;5.54296712308321;0.006713977754809188;0.606587909038952;[LYN, ABCA1, YAP1, TNC, KLF4, PHB2, PAX2, AQP1, COL1A1, MYB, RARA, HOXA2, EPHA3]
GO:0046135;pyrimidine nucleoside catabolic process;8.0;0.7307253602413294;0.7403626801206646;9.333724712271477;1255.5710096994353;6.686031174322154;0.04202283175409332;0.7169239451870815;[CDA, DPYS, UPB1, TYMP, NT5E, DPYD, UPP1, APOBEC3A]
GO:0035646;endosome to melanosome transport;6.0;1.0;0.8231203125901445;9.628524252492122;33.20429938101479;7.474488534686424;0.0011113180183532213;0.7053660038532718;[RAB32]
GO:0030199;collagen fibril organization;5.0;1.0;0.7902410118609202;9.628524252492122;53.964823970696955;5.9928839937622085;0.0018061540931107725;0.5967173779995258;[TGFB2, COL14A1, LUM, COL11A1, COL12A1, LOXL2, COL1A1, GREM1, COL3A1, SFRP2, COL1A2, COL5A1, LOX, COL5A2, CYP1B1]
GO:2000304;positive regulation of ceramide biosynthetic process;9.0;0.9326813400603323;0.8625812952104552;9.59573442966913;909.7864372675522;7.57984905034425;0.03044973330070948;0.7838744581139225;[PRKCD, TNF, CYR61]
GO:0071548;response to dexamethasone;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;124.89021324540595;6.015873511986907;0.004179963043429046;0.6826520511697386;[PCNA, FECH, ABCB4, PTAFR, FOXO1, AQP1, GHSR, EDN1, TGFB1, ARG1, IL1B]
GO:0034394;protein localization to cell surface;5.0;1.0;0.7902410118609202;9.628524252492122;29.829169826127035;6.686031174322154;9.983554695705216E-4;0.6321649570480018;[FCN1, FLNA, PTPRK, VCL, CD177]
GO:0055012;ventricular cardiac muscle cell differentiation;7.0;1.0;0.8509193652572005;9.628524252492122;47.302935560632505;8.16763571524637;0.001583186683336236;0.7686126355688037;[MEF2C, MYOCD, RXRA, RARA]
GO:0046777;protein autophosphorylation;8.0;0.7763722522362496;0.7631861261181248;9.31486669363708;180.75330000196035;4.488806596985934;0.006049650283656873;0.604557778120715;[SLA2, GRAP2, AKT1, EPHB1, PDGFRB, PDGFRA, MAP2K2, DAPK1, MATK, VRK1, MELK, BTK, SIK1, BLK, CSF1R, TXK, THY1, LYN, EIF2AK2, BMX, EIF2S1, CLK4, PTK2, CLK1, FES, ITK, LRRK2, JAK3, MAP4K1, SYK, CAD, IRAK3, FGR, ZAP70, HCK, LCK, KIT, CAMK2D, AURKB, PAK1, FYN, CSK, CAMK4, TEK]
GO:0060603;mammary gland duct morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;32.20947323359611;8.16763571524637;0.0010780220824845236;0.7408135829017477;[CSF1R]
GO:0042177;negative regulation of protein catabolic process;7.0;0.7140352122741334;0.7079369713942671;9.105276108727574;231.8232476428224;5.040875179285974;0.007758915471227624;0.6087099563505541;[ALAD, LAMP3, TIMP2, TIMP3, TIMP1, IL10, IRAK3, TAF9, CST3, FLNA, FYN, SNCA, PML, MAD2L1]
GO:0045444;fat cell differentiation;4.0;0.8653626801206646;0.6826813400603323;9.292052015870908;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[STEAP4, FFAR2, MED1, SIRT1, PLCB1, CEBPA, CEBPB, RETN, ADRB2, PTGS2, FOXO1, PRDM16, EGR2, LAMB3, NOC3L, KLF4, NR4A2, NR4A1, ALDH6A1, LRG1, NR4A3]
GO:0002320;lymphoid progenitor cell differentiation;5.0;0.8653626801206646;0.7229223519212526;9.223059144383958;22.164838071467113;7.379178354882098;7.418371831928127E-4;0.6676125360964777;[SPI1, KIT, BCL2, GATA3, SOX4]
GO:0023014;signal transduction by protein phosphorylation;8.0;0.7248374789738407;0.7374187394869203;9.153100555777048;203.92357026499027;3.9689311377000256;0.006825138377471068;0.5779713229561524;[, IL5RA, TNF, FGF5, TNFSF11, KCNH1, MEN1, PDGFRB, MEF2A, KCNH2, PDGFRA, MED1, MEF2C, MAP2K2, PAQR3, EREG, BTC, TRIB1, PDGFA, CSF2RB, IQGAP3, CSF2RA, RASGRP1, RASGRP4, SPTA1, MAP2K6, LYN, TGFB1, PTK2, NFKB1, LAT, LRRK2, CTSH, CCR5, SPTAN1, JAK3, MAP4K1, CHUK, STRADB, IL18, GFRA3, DUSP6, IL1B, KIT, IL3RA, SHANK3, HBEGF, CAMK2D, NOD2, IL2RG, PAK1, CCL5, CCL2, NCAM1, FYN, EGF, MAPK14, MAPK13, KITLG, IL2RB, TEK]
GO:0048714;positive regulation of oligodendrocyte differentiation;10.0;1.0;0.9152410118609203;9.628524252492122;471.693664190925;6.943860283624253;0.01578716244373315;0.7703503496879909;[CXCR4, TLR2]
GO:0002554;serotonin secretion by platelet;10.0;1.0;0.9152410118609203;9.628524252492122;131.6544252072528;8.67846133901236;0.0044063551303965215;0.8590579283277371;[FCER1G, SYK, P2RX1]
GO:0023021;termination of signal transduction;7.0;0.8653626801206646;0.7836007053175329;9.434368238051164;144.8699869040881;8.67846133901236;0.004848668087156246;0.7947362817240173;[PRKCD]
GO:0006914;autophagy;4.0;0.6729672293956388;0.5864836146978194;8.39638057119949;37.75222312160081;4.39717627414001;0.001263532933085;0.4748717991491287;[LAMP2, HGS, S100A9, S100A8, FOXO1, PLEKHF1, ITGB4, LRRK2, PTPN22, DRAM1, VPS41]
GO:0043032;positive regulation of macrophage activation;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;126.59742726208806;6.641579411751319;0.004237101960174532;0.6905700452391912;[IL10, IL33, ITGAM, LRRK2, ITGB2, THBS1, HSPD1, STAP1, TLR6, TLR4, HAVCR2]
GO:0006919;activation of cysteine-type endopeptidase activity involved in apoptotic process;13.0;0.9326813400603323;0.9288956347978027;9.604426700913061;734.4853933519539;5.322726331426962;0.024582565121551242;0.7347594368888992;[FASLG, TNF, PYCARD, CTSH, F2R, F3, IFI27, LCK, S100A9, S100A8, NLRC4, HSPD1, NLRP3, SNCA, CASP8AP2, TNFRSF10B, HSPE1, PML, NLRP12, P2RX1, DLC1]
GO:0034146;toll-like receptor 5 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;9.777073627680469;0.013811191226989502;0.9481203125901445;[TLR5]
GO:2000553;positive regulation of T-helper 2 cell cytokine production;10.0;1.0;0.9152410118609203;9.628524252492122;874.8811381751227;7.9853141584524145;0.029281484352815565;0.8236103492792612;[IL6, RSAD2, NLRP3, XCL1, GATA3, PRKCZ]
GO:0071727;cellular response to triacyl bacterial lipopeptide;8.0;1.0;0.875;9.628524252492122;168.80270344913424;8.67846133901236;0.005649674571872418;0.8188169164668168;[TLR1, CD14, TLR2]
GO:0090025;regulation of monocyte chemotaxis;9.0;0.8933024483968273;0.8428918493787028;9.510741216835738;137.5287080193099;6.641579411751319;0.004602962089604771;0.7358913051622797;[LYN, CCR1, SERPINE1, FPR2, PLA2G7, AIF1, GREM1, CXCL10, CXCL12, CCL5, CCL1, S100A14, CCR2]
GO:0090026;positive regulation of monocyte chemotaxis;10.0;1.0;0.9152410118609203;9.628524252492122;859.35541097108;6.8867018697843045;0.028761852235543582;0.7674272657460779;[CCR1, CXCL10, CXCL12, CCL5, SERPINE1, CCL1, FPR2, S100A14, PLA2G7, AIF1, CCR2]
GO:0034144;negative regulation of toll-like receptor 4 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;354.70667396235325;7.697632086000634;0.011871713162238609;0.7898978880348613;[LYN, TNFAIP3, LILRA2]
GO:0090023;positive regulation of neutrophil chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;945.710466239641;6.343086423195323;0.03165207822087823;0.7568146869955557;[CXCL6, CD74, EDN1, CCL21, C5AR1, CXCL1, PPBP, CXCL3, CXCL2, CXCL5, IL23A, IL1B, CXCR2, C3AR1, RAC2, XCL1, CCR7, NCKAP1L, CCL19, PF4]
GO:0034142;toll-like receptor 4 signaling pathway;12.0;0.8436909121759173;0.8699657686781033;9.485423408851448;412.6549923027037;6.943860283624253;0.013811191226989502;0.8032296504172152;[ITGAM, PRKCE, ITGB2, NR1H4, LY96, NFKBIA, S100A14, CD14, TLR4]
GO:0043277;apoptotic cell clearance;7.0;1.0;0.8509193652572005;9.628524252492122;28.437470009997963;6.8867018697843045;9.517765291732001E-4;0.7031056191423581;[LRP1, ITGB3, MARCO, RARA, CD36]
GO:0090263;positive regulation of canonical Wnt signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;236.52854047757646;5.244474134527214;0.007916397387918217;0.6432026511327102;[YAP1, LRRK2, RUVBL1, SOX4, WLS, JUP, EGF, CAV1, AXIN2, NFKB1, SULF2, COL1A1, SFRP4, SFRP2, DAAM2, LGR4, NAIP]
GO:0090022;regulation of neutrophil chemotaxis;10.0;0.8933024483968273;0.861892236059334;9.517298617381897;138.915002380433;6.193554689224359;0.004649360114287637;0.731979686697602;[MPP1, CXCL6, CD74, EDN1, CCL21, C5AR1, CXCL1, PPBP, CXCL3, CXCL2, CXCL5, BST1, IL23A, IL1B, CXCR2, C3AR1, RAC2, XCL1, CCR7, NCKAP1L, CCL19, JAM3, PF4]
GO:0045454;cell redox homeostasis;5.0;1.0;0.7902410118609202;9.628524252492122;31.944097044200298;5.572381008289503;0.0010691401802485107;0.5752128357670632;[TXNDC15, SLC11A1]
GO:0045217;cell-cell junction maintenance;5.0;0.8653626801206646;0.7229223519212526;9.310070521373587;51.610367046990525;7.474488534686424;0.0017273525387479806;0.6724867031240476;[CSF1R, F2R, PRTN3, CD177]
GO:0044130;negative regulation of growth of symbiont in host;7.0;1.0;0.8509193652572005;9.628524252492122;102.69207226600344;7.212124270218933;0.0034370112418783067;0.7197477358342742;[IL10, LTA, CTSG, CD36, TNF, MPO, ELANE]
GO:2000321;positive regulation of T-helper 17 cell differentiation;13.0;0.9326813400603323;0.9288956347978027;9.611994950540911;2604.3016792955605;7.697632086000634;0.08716363348667819;0.8562122276222088;[IL23A, NLRP3, IL12RB1]
GO:0034136;negative regulation of toll-like receptor 2 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;354.70667396235325;8.390779266560578;0.011871713162238609;0.8253454670833372;[LYN, TNFAIP3, TLR6]
GO:0071726;cellular response to diacyl bacterial lipopeptide;8.0;1.0;0.875;9.628524252492122;168.80270344913424;8.390779266560578;0.005649674571872418;0.8041048419030481;[CD36, TLR6, CD14, TLR2]
GO:0090237;regulation of arachidonic acid secretion;9.0;0.8933024483968273;0.8428918493787028;9.485423408851448;83.13942816732954;7.9853141584524145;0.0027826018401329354;0.8046099625986299;[SYK, MIF]
GO:0034134;toll-like receptor 2 signaling pathway;12.0;0.9326813400603323;0.9144609826203107;9.590783924509275;412.6549923027037;8.16763571524637;0.013811191226989502;0.8658135829017477;[TLR2]
GO:0034374;low-density lipoprotein particle remodeling;7.0;1.0;0.8509193652572005;9.628524252492122;83.38206178822108;7.212124270218933;0.0027907225690680937;0.7197477358342742;[AGTR1, PLA2G7, MPO]
GO:0001695;histamine catabolic process;8.0;1.0;0.875;9.628524252492122;799.2000283083077;9.777073627680469;0.02674850571415016;0.875;[HNMT]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[SPI1, EHMT2, SLA2, MYB, HOXA2, HOXA7, JUNB, MEF2A, MED1, MEF2C, HOXB4, HOXB3, ATF3, GATA3, GATA1, PRDM16, HESX1, ELANE, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, BTG2, PAWR, PAX5, SIRT1, AES, MMP12, RARA, ASCL2, NR1H2, NR1H4, POU4F1, FOSB, TNF, DACH1, MEN1, TLE4, AEBP1, FOXO1, NACC2, WFS1, NFKB1, NFKB2, BCL6, CIITA, FHL2, FASLG, HHEX, RFC1, PEG3, CEBPA, CEBPB, RBBP8, E2F1, E2F7, PRRX1, KLF4, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, SOX7, SOX4, HNF1B, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H1, BMI1, XPO1, CD36, EDN1, PARP9, IL1B, SP100, SATB2, RXRA, CDX2, NEDD4, LOXL2, CHCHD3, EOMES, CCNE1, TCF7, TGFB1, CBX4, VDR, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, KLF12, IFNG, IRF7, FBP1, LEF1, AURKB, TBX21, SNCA, MEIS2]
GO:0002774;Fc receptor mediated inhibitory signaling pathway;8.0;1.0;0.875;9.628524252492122;130.16139686502353;8.67846133901236;0.004356384815420379;0.8188169164668168;[LYN, LILRB1, LILRB2]
GO:0045471;response to ethanol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;69.73224034292265;5.006389003214805;0.0023338753293357085;0.5462679783062231;[CSF3, SPI1, SPARC, TNC, EEF1B2, ALAD, PRKCE, CYBB, ADCYAP1, CLDN3, IL1B, CLDN7, RARA, S100A8, PSMD14, FECH, GATA3, CCL7, CNR1, FYN, CD14, GSN, VCAM1, CDK1, CD27]
GO:0070667;negative regulation of mast cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;83.65590509736859;9.777073627680469;0.0027998878581822827;0.8509193652572005;[LYN]
GO:0034128;negative regulation of MyD88-independent toll-like receptor signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;354.70667396235325;7.8311634786251565;0.011871713162238609;0.7967266896635242;[LY96, CD14, TLR4]
GO:0070668;positive regulation of mast cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;83.5280859103553;9.777073627680469;0.002795609865022748;0.8509193652572005;[LYN]
GO:2000334;positive regulation of blood microparticle formation;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;107.44151918580685;9.083926447120524;0.0035959709560594052;0.7876727335416686;[CD36, TNF]
GO:0050829;defense response to Gram-negative bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.407625775213448;0.0023911797157970473;0.627465598881932;[IGHM, HIST1H2BK, SERPINE1, HMGB2, PYCARD, CTSG, IL6R, CAMP, DEFA4, SLC11A1, RNASE6, RNASE3, AZU1, DEFA1, LYZ, SELP, CD4, IL6, IL23A, BPI, TLR4, LTF]
GO:0034123;positive regulation of toll-like receptor signaling pathway;8.0;0.7140352122741334;0.7320176061370667;9.09300601613576;411.4409909120541;6.781341354126479;0.013770559692974778;0.7217981122146513;[RSAD2, CAV1, PTPN22, TLR1, TLR5, LTF, TLR2]
GO:0034122;negative regulation of toll-like receptor signaling pathway;8.0;0.7140352122741334;0.7320176061370667;9.0094850440859;260.8137256220838;6.166155715036245;0.00872920067945721;0.6903374900225189;[LYN, LY96, TNFAIP3, IRAK3, LILRA2, TLR6, CD14, TLR4, LGR4]
GO:0035690;cellular response to drug;4.0;0.5629771490299041;0.531488574514952;7.020557509946895;41.90713853914268;4.145861845859104;0.0014025942129290189;0.462019567599527;[SPI1, TFRC, FMR1, TNF, ETS1, SLC8A1, AQP1, IL18RAP, CDH1, MYB, CYP1B1, KCNH2, MEF2C, PRKCE, PRKCD, CYBB, KCNQ1, CFTR, BLM, FECH, ABCB4, FOXO1, PDGFD, HMOX1, ECT2, EGR1, TGFB1, JUP, NFKB1, IL6, ID1, CDK1, EZH2, LRRK2, TNFAIP3, PTPN22, BRCA1, PDE4B, MAP4K1, EDN1, ANXA1, PPP1R12A, ARG1, CAD, SIRT1, PAX2, DNM2, NME1, CCNA2, IL1B, FBP1, PCNA, PTAFR, NOD2, PTGS2, AIF1, GNAI1, CST3, CCL7, CTNNA1, FYN, KLF4, MAPK13, FABP1, RAD51, CD69]
GO:0034121;regulation of toll-like receptor signaling pathway;7.0;0.609056648853049;0.655447689683725;8.322272599045768;87.36499042264505;5.666199763507158;0.002924027606059212;0.6406890846681925;[LY96, TNFAIP3, PTPN22, LILRA2, CD36, CD14, LYN, RSAD2, FCRL3, CAV1, IRAK3, TLR1, IRF7, TLR6, TLR5, TLR4, LGR4, LTF, TLR2, BIRC3]
GO:0090241;negative regulation of histone H4 acetylation;12.0;0.9326813400603323;0.9144609826203107;9.60254876608886;1490.3225296813393;8.16763571524637;0.049879753865236;0.8658135829017477;[SPI1, SIRT1]
GO:0043299;leukocyte degranulation;8.0;0.811012628672052;0.780506314336026;9.223059144383958;48.80626136022181;3.5624655292582776;0.0016335016449431083;0.5571846528378576;[CDA, CYFIP1, ABCA13, PSMD3, C3AR1, PRSS3, PRKCD, RNASE3, RNASE2, BIN2, PADI2, CFD, FPR1, FPR2, CFP, GNS, C3, S100A12, NCKAP1L, ELANE, S100A11, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, GRN, PTAFR, ALOX5, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, RAB31, ADAM8, SLC27A2, S100A9, S100A8, BRI3, HVCN1, GPR84, CORO1A, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, HPSE, LAT, ITGAM, ITGB2, PIK3CD, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, FGL2, TTR, CPPED1, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, CD14, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CCT2, FCER1G, MME, RHOG, LAT2, HCK, CEACAM1, CEACAM6, KIT, CEACAM8, TLR2, LILRA3, CST3, CXCR1, CXCR2, CD58, CCT8, GCA, LILRB2, LILRB3, QPCT, CD68, FCN1, MPO, PLAU, SIRPA, CD97, CHRNB4, CD93, CYBB, OSCAR, DOK3, TYROBP, PRTN3, VCL, PSMD14, C5AR1, RASGRP1, MGAM, HSPA6, NR4A3, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, PLAUR, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0046323;glucose import;10.0;0.8933024483968273;0.861892236059334;9.461470167828956;38.205824888540654;7.212124270218933;0.00127871457600939;0.7840693824379941;[SORT1]
GO:0002793;positive regulation of peptide secretion;7.0;0.6162540371078848;0.6590463838111429;8.05612761173837;82.41339311992232;4.224114042758852;0.002758302100485337;0.56694075384528;[FCN1, TNF, PYCARD, CLEC5A, TNFSF11, SOX4, WLS, POSTN, PRKCE, F2R, GOLPH3L, MIF, ADCYAP1, ADAM9, ADAM8, CLEC4E, S100A9, S100A8, CFTR, BLK, CD274, CSF1R, TWIST1, GATA3, PRKCZ, RASGRP1, TMEM27, NLRP3, CD14, MYH10, TGFB2, TGFB1, FZD5, CRTAM, IL6, ACHE, ORM1, LRRK2, PTPN22, IFIH1, CD38, FFAR2, CD34, HAVCR2, IL10, CHUK, SYK, DDX58, IL17RB, MMP12, TLR1, FGR, IL1A, IL1B, IGHD, TLR8, TLR4, TLR2, NOD2, CD58, CCL19, IL33, NR1H2, NR1H4, MAPK14, CD2, NLRP12, CD244, IL17A]
GO:0002553;histamine secretion by mast cell;10.0;1.0;0.9152410118609203;9.628524252492122;188.83492405524427;8.67846133901236;0.006320134967730841;0.8590579283277371;[LYN, BTK]
GO:0002548;monocyte chemotaxis;7.0;1.0;0.8509193652572005;9.628524252492122;125.46101547564297;6.039404009397101;0.004199067280386423;0.6597747671587765;[CCL13, CCL23, CALCA, ANXA1, CCL21, CCL20, TNFRSF11A, LGALS3, IL6, CCL8, CCL7, CCL5, CCL4, XCL2, TNFSF11, CCL2, XCL1, S100A12, CCL1, CCL19, CCL18, IL6R, CCR2]
GO:0046330;positive regulation of JNK cascade;12.0;0.8436909121759173;0.8699657686781033;9.567899630675686;1762.0380321839782;4.909539177224887;0.058973827205923174;0.6991943744303455;[IL1RN, NCF1, TNF, CTGF, PYCARD, TNFSF11, CCR7, MAP4K1, EDN1, SYK, MDFIC, IL1B, TLR6, PLCB1, TNFRSF11A, NOD2, RASGRP1, PAK1, CCL19, SLAMF1, FZD5, CCL21, CARD9, FZD8, CD40LG, CD27, PKN1, LTBR, FCGR2B, NOX1]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SERPINE1, PHB2, AKT1, PROK2, IER3, MED1, MEF2C, PRKCH, DAPK1, PRKCD, CLDN7, PRKCQ, GATA3, SLC30A10, GATA1, PRKCZ, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, EIF2AK2, AZU1, SNAI2, CDKN1A, BTG2, CHL1, TIMP1, JAK3, ANXA1, SERPINB2, DUSP1, ANXA5, SERPINB9, SIRT1, PAX2, RARA, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, NR1H4, POU4F1, FABP1, PF4, TNF, CLU, LAMP3, CLEC5A, F2R, ADCYAP1, MSH2, ADAM8, CSF1R, BLM, CORO1A, FOXO1, SOCS2, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, DAB2, CXCL12, COPS5, BCL6, BCL3, CDK1, BCL2, MYD88, BCL2L1, LRRK2, FHL2, FASLG, CYR61, TNFRSF1B, ADAMTS20, BIRC5, BIRC3, CX3CR1, CEBPB, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, IL2RB, IL1RN, SLC46A2, IFIT3, AQP1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB2, EPHB1, FLT3LG, HNF1B, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, PTK2, VNN1, ID1, CD28, CD27, NRP1, BRCA1, CTSH, CD38, CCR7, CCR5, IL10, EDN1, FCER1G, STRADB, HCK, RNF144B, IL1A, CEACAM6, IL1B, CEACAM5, KIT, YAP1, IFI6, AIF1, GNAI2, CXCR2, PDPN, CTNNA1, CD74, LILRB1, CD40LG, GRINA, MAD2L1, IHH, MPO, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, STIL, CBX4, CAV1, NR4A2, NFKBIA, VIL1, IL6, NR4A3, NAT8, IL7R, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, MYOCD, PLAUR, MMP9, GREM1, NDUFS3, IRF7, ZMYND11, LTF, BCL2A1, TAF9, LEF1, DLL1, THBS1, AURKB, HSPD1, SNCA, SOD2, TEK, NAA15]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[MYB, AKT1, CYP1B1, HOXA5, MEF2C, DAPK1, PRKCD, ATF3, HMOX1, SFN, PLCG1, BARD1, LYN, JUN, NOX4, NOX1, ADM, CTLA4, TIMP3, ANXA1, DUSP1, PAWR, SIRT1, F3, DUSP6, AES, PTGS2, FGD3, FGD4, FRZB, CASP8AP2, GSN, BIK, G0S2, POU4F1, TNF, CTGF, PYCARD, IGFBP3, F2R, MELK, MAL, ADAM8, S100A9, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, BCL2, BCL2L1, PLEKHF1, PIK3CD, FASLG, CYR61, ITGA4, TFDP1, LCK, NLRC4, CCL5, E2F1, CCL2, GZMA, GZMB, PML, P2RX1, MNDA, IFIT2, PPP2R1A, SOX7, SOX4, TIAM2, SFRP4, SFRP2, CDC34, IFI27, SIK1, INPP5D, TP53BP2, TNFSF12, ITM2C, TOP2A, CD40, CTSZ, CTSH, IL10, VAV1, IL1B, CXCR2, CTNNA1, SORT1, LILRB1, PPP1CA, NLRP12, CD40LG, FAP, DLC1, PDGFRB, NLRP3, ECT2, TGFB2, TGFB1, VDR, CAV1, INHBA, EIF2S1, IL6, BMP2, NR4A3, JMY, UBE2M, TNFAIP8, YWHAH, ARHGEF12, PLAUR, MMP9, DNM2, IFNG, LTA, CAMK2D, BCL2A1, THBS1, HSPD1, CNR1, SNCA, HSPE1, SOD2, LTBR]
GO:0006909;phagocytosis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;28.437470009997963;5.618190544320798;9.517765291732001E-4;0.610434838299289;[NCF2, ITGB3, NCF4, ICAM3, ITGAL, CD36, ANXA1, CD93, ANXA3, SLC11A1, DNM2, PECAM1, RARA, PRTN3, CD302, LRP1, CEBPE, PLD4, CORO1A, CD14, ELANE, SLAMF1, MARCO]
GO:0002309;T cell proliferation involved in immune response;7.0;0.8653626801206646;0.7836007053175329;9.517298617381897;137.0826054799011;8.390779266560578;0.004588031439076979;0.7800242071602487;[SLC11A1, LILRB1]
GO:2000587;negative regulation of platelet-derived growth factor receptor-beta signaling pathway;8.0;1.0;0.875;9.628524252492122;232.7313460095171;8.390779266560578;0.007789308706325424;0.8041048419030481;[MYOCD, LRP1]
GO:0034599;cellular response to oxidative stress;4.0;0.7248374789738407;0.6124187394869203;8.935377071932177;68.67201153720991;4.519578255652688;0.0022983904253524798;0.48113144217596127;[NCF1, ETS1, AQP1, IL18RAP, MYB, AKT1, CYP1B1, PDGFRA, DAPK1, TPM1, PRKCD, CYBB, FANCD2, BTK, MGST1, FOXO1, PDGFD, ECT2, JUN, EIF2S1, NR4A2, IL6, CDK1, NOX4, EZH2, LRRK2, TNFAIP3, PTPRK, CD36, GPX2, ANXA1, CHUK, ARG1, FOS, MMP9, SIRT1, PAX2, DNM2, CCNA2, PCNA, AIF1, CST3, SNCA, KLF4, SOD2, MAPK13, FABP1]
GO:0033026;negative regulation of mast cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;301.33162323320204;9.777073627680469;0.010085298248760914;0.896240625180289;[FCER1G]
GO:0034115;negative regulation of heterotypic cell-cell adhesion;8.0;1.0;0.875;9.628524252492122;130.132988179366;7.57984905034425;0.004355434002277579;0.7626338329336335;[IL10, IL1RN, KLF4]
GO:2000342;negative regulation of chemokine (C-X-C motif) ligand 2 production;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;89.04410360278419;9.083926447120524;0.002980226013094716;0.8154717862087246;[KLF4]
GO:0015855;pyrimidine nucleobase transport;6.0;0.811012628672052;0.7286266269261705;9.271849308553389;30.144488250768884;8.390779266560578;0.001008908893475126;0.7522251544931926;[AQP9, SLC28A1]
GO:2000345;regulation of hepatocyte proliferation;6.0;0.8933024483968273;0.7697715367885581;9.461470167828956;64.60584473889057;7.212124270218933;0.002162299481925267;0.6919486831672181;[MED1, CEACAM1, TNFAIP3, SULF2]
